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ABSTRACT
Chronic fatigue syndrome (CFS) describes a condition
characterised by severe fatigue of at least six months'
duration. In this thesis, it is argued that the complexity
of CFS with respect to other symptoms, the patients'
response to their illness and the determinants of emotional
distress, has yet to be fully recognised. This may have
narrowed the focus of research and limited the range of
treatments available.
The first of the three studies investigated CFS from the
patients' perspective. The findings challenge some of the
generalisations concerning CFS, particularly those relating
to the patients' attributions and their choice of coping
strategies. They also suggest that the effects of the
condition may have been underestimated and that certain
influences on emotional distress may have been overlooked.
The second study assessed a number of variables thought to
be associated with emotional distress and psychological
adjustment. The results show that uncertainty and lack of
social support were significantly correlated with anxiety
and depression while functional impairment was more closely
linked to cognitive difficulties and other illness-related
measures.
The third study evaluated a management programme which
acknowledges the complexity of CFS. After six months,
significant differences between the treated patients and
waiting-list controls were found for a number of variables,
including fatigue, somatic symptoms, anxiety and perceived
self-efficacy. However, many patients continued to record
high levels of emotional distress, showing that the
programme was not sufficient to deal with all the problems
experienced.
The findings suggest that variables such as uncertainty,
lack of social support, self-efficacy and illness severity
may all play an important role in the psychological ad-
justment to CFS. Increased awareness of these possible
influences may further enhance understanding of this illness
and thus improve patient care.
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CHAPTER_ 1 
A. brief review of the literature
1.1 Introduction
Chronic fatigue syndrome (CFS) is the term used to describe
a number of disorders characterised by disabling, ongoing
fatigue. Although the nomenclature for these conditions is
comparatively new, the disorders themselves are not. Indeed,
references to illnesses closely resembling CFS have been
documented in the British literature since 1750 (Bakheit
1993). Some cases of CFS are closely associated with and may
represent psychiatric disorders (David 1991, Hickie et al
1995, Wessely 1994). Others have been linked with infections
such as glandular fever and Lyme disease (Bruce-Jones et al
1994, Coyle et al 1994) and exposure to toxins (Behan and
Haniffah 1994, Chester and Levine 1994). However, much of
the attention in recent years has focused on a mysterious
illness known as myalgic encephalomyelitis (ME) or post-
viral fatigue syndrome (PVFS).
The following review will describe the history and clinical
features of ME and discuss some of the research and contro-
versies relating to CFS in general and ME in particular.
1.1.1 Historical background
The first detailed description of the illness ME can be
found in a report on the epidemic at the Los Angeles County
General Hospital in 1934 (Gilliam 1938). The outbreak,
which coincided with an epidemic of poliomyelitis, lasted
seven months and affected 198 members of staff. The
presenting symptoms included headache, nausea, sensory
disturbances e.g. numbness, and a stiff neck or back.
Localized muscular weakness developed in 80t of the cases
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and paraesthesiae in 426. Some patients also suffered from
sore throat, fever, "easy fatigue" and "emotional instabi-
lity".
The illness generally lasted between four and eight weeks
but a significant proportion of the patients experienced
relapses. Some of these were attributed to overexertion,
others to cold and damp weather. A few, however, were
deemed to be "hysterical" in nature.
Aside from the relapses, the illness had a number of other
unusual features. For instance, there was a marked varia-
bility in the severity of symptoms and, with regard to
muscle weakness, a variability in location. There were also
variations in physical signs so that a group of muscles
sometimes performed normally on one test but abnormally a
week later.
Another unusual characteristic of the disorder was the
protracted recovery. In fact, Gilliam observed that 55% of
the patients continued to experience symptoms and were still
unwell and absent from duty 28 weeks later.
Although the initial symptoms were suggestive of polio-
myelitis, this diagnosis was rejected for a number of
reasons. For instance, there was no evidence of severe
muscle wasting which is a characteristic feature of polio
(Ramsay 1988). Moreover, the muscle pain and tenderness in
these patients persisted much longer than expected, the
cerebrospinal fluid was invariably normal and the mortality
rate was far lower than that associated with polio. Never-
theless, Gilliam believed that there was a connection be-
tween the illness and the polio virus.
Since then, similar epidemics have been documented through-
out the world (Acheson 1959, Jenkins 1991a, Ramsay 1988).
Virtually all of these featured symptoms and signs sug-
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gesting the involvement of the brain, spinal cord and
peripheral nerves. Moreover, most occurred between the
months of May and November; they had a bi-phasic onset with
a worsening of symptoms after the first week, and they were
characterised by marked fluctuations in symptoms and signs.
Also noted were high rates of psychological disturbances,
and a close link between exacerbations of symptoms and
exertion (Acheson 1959, Ramsay 1988).
However, the epidemics were not identical. For example,
neurological signs such as cranial nerve lesions were much
more common in the outbreaks affecting Los Angeles, Durban,
the Royal Free and Middlesex hospitals while the Royal Free
Hospital epidemic was unusual in terms of the high incidence
of lymphadenopathy (Ramsay 1988).
1.1.2 Sporadic cases
The first person to focus on the sporadic cases was Dr.
Melvin Ramsay, who had been the consultant physician at the
Royal Free Hospital in London at the time of the outbreak
there. In an article published in 1957, he described 34
patients aged from 9 to 45, many of whom were seen after the
end of the epidemic and most of whom had had no contact with
the hospital cases. However, they were clinically very
similar (The Medical staff of the Royal Free Hospital 1957).
Ramsay also noted in this report that all the patients
experienced sequelae consisting of emotional lability and a
proneness to fatigue.
Interestingly, descriptions of sporadic cases seen between
1964 and 1967 (Ramsay 1978, Scott 1970) indicated a slight
change in the nature of the illness. Typical symptoms still
included headache, myalgia, giddiness, emotional lability,
fatiguability and visual disturbances such as diplopia, but
there was far less evidence of the cranial nerve palsies
which had been observed in the past. In fact, reports of
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any type of paralysis became increasingly rare after 1960
(e.g. Calder and Warnock, 1984, Dillon 1970, Innes 1970).
Hyde et al (1992, P. 114) has recently suggested that this
change may be linked with the introduction of the polio
vaccine in the late 1950s. However, this remains a matter
for debate.
Ramsay himself explained the differences between the epi-
demic and sporadic cases, particularly those seen after
1955, in terms of the time when the patient presented to the
doctor. While the former were generally seen immediately
after the onset of the symptoms, sporadic cases often con-
sulted their general practitioner "after the initial illness
was long passed". At this stage, he observed, patients were
more likely to present with symptoms such as muscle fati-
guability, impairment of memory and an inability to con-
centrate (Ramsay 1978).
Aside from identifying the different characteristics of the
acute and chronic phases of the illness, Ramsay was also the
first specialist to emphasize that recovery was often incom-
plete, and that some showed no recovery at all.
1.1.3 Chronicity
The chronicity of the illness had been observed in a number
of the early reports including that by Gilliam (1938). How-
ever, most observers were not aware that the condition could
last for years. For instance, when Acheson (1954) described
the epidemic at the Middlesex Hospital, he noted that "ex-
cessive fatigue and intermittent backache were present in
several cases for 3 or 4 months after return to nursing
duties. As there were no objective signs, the significance
of these symptoms was difficult to assess". Meanwhile
Pellew, who reviewed the epidemic in Adelaide (1951), wrote
that while recurrences did occur, and psychological sequelae
were prolonged in some people, the prognosis was "univer-
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sally good".
However, a more systematic follow-up revealed a different
picture. For instance, Sigurdsson and Gudmundsson (1956)
examined 39 of those involved in the epidemic in northern
Iceland in 1948 and found that six years later, nearly a
half still had muscle tenderness and neurological signs.
Indeed, only 13% regarded themselves as completely well.
The chronicity of ME was also observed by Marinacci
(Marinacci and Von Hagan 1965). In 1937, he had worked as
an intern in the Los Angeles General Hospital and had come
into contact with many of the patients from the epidemic in
1934.  Some were still hospitalized; others had been re-
admitted because of a recurrence of symptoms. Marinacci
reported that many carried the label of 'malingerer' and
'compensationitis'. "This attitude often produced a conflict
between the patient and the attending staff, and the pa-
tients were transferred from clinic to clinic, and from
department to department". Between 1948 and 1952, he exa-
mined 21 of the patients again. Even though it was more than
14 years after the epidemic, they were still experiencing
fatigue, memory problems, muscle spasms and pain.
Given the interest in the epidemics and the limited number
of follow-up studies, the extent and the severity of the
chronic symptoms were not fully appreciated until Ramsay's
report in 1978. This revealed that some patients remained
ill for at least ten years (Ramsay 1978, 1988) and began to
redirect many researchers' attention towards the chronic
phase of the condition.
Ramsay's observations were supported by those of Hyde and
Bergmann (1988). They interviewed 10 patients from the
Iceland epidemics of 1948 and 1955, and reported that 40
years on, only two (20%) were in good health. The others
still experienced fatigue, muscle pain, tenderness and
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weakness, all of which had also been documented in the
previous report (Sigurdsson and Gudmundsson 1956).
1.1.4 The Mass Hysteria debate
The failure to isolate an infectious agent in most of the
epidemics, the low mortality associated with the illness,
the high attack rate among women and the presence of symp-
toms such as emotional lability, led some to suggest that
the disorder has an hysterical origin (for a review see'
Acheson 1959, Jenkins 1991a).
For example, two psychiatrists who reassessed the litera-
ture in 1970 argued that, although some of the epidemics
could be attributed to "altered medical perception" among
medical staff, others were almost certainly the result of
anxiety and mass hysteria (McEvedy and Beard 1970a and b).
Taking the Royal Free outbreak as an example of the latter,
they noted that most of those affected had been young and
socially segregated young females, that the illness had not
spread beyond the institutional population and that it had
not affected many male members of staff. This, they felt,
supported the view that the illness was a result of hys-
teria. However, they did not speculate as to what may have
triggered the anxiety, or what may have led to the lympha-
denopathy or the morphological abnormalities seen in cir-
culating lymphocytes (Crowley et al 1957, Medical Staff of
the Royal Free Hospital 1957).
The majority of ME specialists rejected the mass hysteria
theory, pointing out, for example, the objective evidence of
central nervous system involvement, the difference between
the emotional disturbances in ME and those associated with
hysteria, the chronicity of the former and the fact that in
one study, the putative agent had been transferred to mon-
keys (Editorial 1978, Jenkins 1991a, Leitch 1994, Ramsay
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1988). It has also been noted that the nurses were not
socially segregated and that a very high proportion of the
staff and students at the hospital were female, so that
there were relatively few men at risk (Gosling 1970). This
analysis was supported by Crowley et al (1957) who examined
the attack rates among the staff in residence. They found
that the proportion of cases among the men and women was
almost the same: 20 versus 19 per 100 respectively. Thus the
preponderance of female patients may simply have reflected
the large number of women in the population at large. More
recently, Goudsmit (1993) argued that if the epidemic had
indeed resulted from anxiety in a segregated group of women,
then one would have expected a high proportion of cases in
the Elizabeth Garrett Anderson Hospital and Maternity Home,
both of which were part of the Royal Free Hospital and both
of which were run for and by women. However, these two
hospitals remained relatively unaffected (Crowley et al
1957).
A further argument against McEvedy and Beard's explanation
is that the epidemic showed certain features which are far
from typical in mass hysteria. According to Sirois (1983)
who reviewed 70 outbreaks of the latter, most last between
10 and 20 days and affect primarily women in the first years
of adolescence. Yet, the epidemic at the Royal Free Hospi-
tal lasted for four months (from July 13th 1955 until No-
vember 24th) and only a minority of those affected were
under 20 years old (Crowley et al 1957).
Finally, the existence of sporadic cases which clearly re-
sembled those seen in the epidemics (e.g. Ramsay 1957, Scott
1970), plus the evidence of viral involvement both in the
Royal Free patients (Parish 1994, personal communication)
and in others (Innes 1970), does not support the view that
all cases can be explained in terms of mass hysteria or
anxiety.
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Three years after writing the review of the Royal Free
cases, McEvedy and Beard published a follow-up study of 71
affected patients (1973). This indicated that the latter
had higher Neuroticism scores than a comparison group of
unaffected nurses; that they had more admissions to hospital
and that they had borne fewer children. On the basis of
these findings, McEvedy and Beard suggested that the majori-
ty of the affected nurses were probably normal women who had
behaved hysterically under stress, but they maintained that
some must have been "pathological hysterics". An alter-
native explanation, that their results reflected the segue-
lae of the illness, was not considered. Likewise, while the
higher rate of sick-leave prior to the epidemic may have
been an indication of neurosis, it could equally have been
a sign of poorer general health and therefore of greater
susceptibility to infection.
Although the doctors who attended the patients totally re-
jected the hysteria explanation, they admitted that a number
of the cases at the Hospital were unusual and that some of
these might have suffered from anxiety. In fact, this is
the reason why these patients were omitted from the main
report on the epidemic published in 1957 (Ramsay personal
communication).
The articles on the mass hysteria theory proNed. biqa/
influential. Indeed, it may be argued that McEvedy and
Beard's conclusions did much to direct the scientific
community's attention away from virological aspects of the
illness for well over ten years. More importantly, their
'either mind or body' approach provided the basis for the
organic versus psychological debate which continues to this
day (Leitch 1994).
1.2 Current terminology and definitions 
The condition that became known as ME in 1956 has had a
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variety of other names (Acheson 1959, Hyde et al 1992).
Some of the older terms reflected the assumed links between
the acute illness and poliomyelitis, e.g. abortive polio
(Gsell 1949). A few referred to the places where epidemics
had taken place, for instance 'Akureyri disease' (Sigurdsson
and Gudmundsson 1956) and 'Tapanui Flu' (Snow 1992). Ameri-
can researchers proposed the name 'epidemic neuromyasthenia'
(e.g. Henderson and Shekolov 1959) but this implies that the
illness is confined to outbreaks and suggests a connection
with myasthenia gravis. Since this could be misleading, the
name was dropped (Editorial, BMJ 1978).
Other terms, like ME and PVFS, have linked the illness to
disease processes and specific aetiological factors. How-
ever, since many patients seen today do not show evidence of
inflammation of the spinal cord and peripheral nerves (i.e.
encephalomyelitis), and given that virtually identical con-
ditions can be triggered by infections other than viral
ones, these terms are no longer regarded as accurate.
Consequently, many researchers prefer the name chronic
fatigue syndrome; a neutral term which focuses on the most
common symptom without reference to presumed causes (Holmes
et al 1988).
The original working case definition for CFS, proposed in
1988, required the presence of persistent or relapsing,
debilitating fatigue or easy fatiguability in someone who
had no previous history of similar symptoms. It was further
specified that the fatigue should be severe enough to reduce
or impair daily activity to less than 5n of the patient's
premorbid level; that it should have been present for a
period of at least 6 months, and that it should not resolve
with bedrest.
An additional requirement was the presence of at least six
of the eleven listed symptoms and two or more physical
findings. If the latter were not present, patients were
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required to have eight of the symptoms listed. Clinicians
were also asked to exclude a number of other disorders,
including chronic psychiatric conditions such as endogenous
depression and anxiety neurosis, and medical disorders such
as malignancies.
Four years later, the Centers for Disease Control (CDC)
recommended a revision of the criteria for CFS in order to
include people with fibromyalgia (if they also fulfilled the
original criteria), and people with recurrences of adequate-
ly treated Lyme borreliosis, toxoplasmosis and brucellosis
(Schluederberg et al 1992). It was also decided that pa-
tients suffering from non-psychotic depression (concurrent,
one month post onset or six months or more before onset)
should be included, as should anyone with somatoform
disorders and anxiety disorders. However, it was agreed that
these cases should be identified clearly to allow separate
analysis of the data.
During the evaluation of the criteria in 1994, it was felt
that the inclusion of six or more symptoms was too restric-
tive. The case definition was amended accordingly (Fukuda et
al 1994) and now requires the presence of just four symptoms
from a list of eight. For further details, see Appendix I.
In the United Kingdom, criticisms of the original CDC
criteria led a British clinicians to formulate their own
guidelines for research (Sharpe et al 1991). These 'Oxford
criteria', which are still in use today, differentiate CFS
from a subtype named post-infectious fatigue syndrome
(PIFS).
According to the guidelines, CFS can be diagnosed where the
fatigue has a definite onset and is not 'life-long'.
Furthermore, the principal symptom, chronic fatigue, has to
be severe, disabling and affect physical and mental func-
tioning. A separate category of post-infectious fatigue
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syndrome (PIFS) allows researchers to identify those
patients whose illness was triggered by a specific
infectious agent. To qualify, there has to be definite,
laboratory evidence of infection either at onset or
presentation. As in the case of the CDC criteria,
established medical diseases and psychiatric conditions such
as schizophrenia and eating disorders are excluded. However,
the number of exclusions are limited, and the 'Oxford
criteria' for CFS are probably the broadest of all those
currently in use.
Australian researchers have also devised their own research
criteria. For instance, those formulated by Lloyd et al
(1990a) require the presence of chronic and disabling
fatigue which is exacerbated by minor exercise and the
presence of neuropsychiatric dysfunction such as new onset
short-term memory dysfunction. If alternative diagnoses can
explain the symptoms, the case must be excluded.
1.2.1 Disadvantages of the criteria for CFS 
Both the CDC and Oxford criteria are widely used but it has
recently become clear that they are identifying a number of
disorders, not just one (Bock and Whelan 1993, Hickie et al
1992, Hickie et al 1995a, Hyde et al 1992, Klimas and
Fletcher 1995, Straus et al 1994).
For example, Hickie (1993a) studied 565 patients with CFS
and found that 30% suffered from somatisation disorder,
based on the presence of a diverse range of somatic and psy-
chological symptoms, abnormal illness behaviour and concur-
rent psychological morbidity. This is not surprising, since
as Buchwald (1994) has pointed out, eleven of the minor
symptoms listed in the original CDC case definitions also
contribute to four DSM-III-R diagnoses. Thus patients en-
dorsing symptoms characteristic of CFS are often simul-
taneously endorsing symptoms of psychiatric illnesses like
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major depression and somatisation disorder (see also Hickie
1993b, Katon and Russo 1992, Katon et al 1991).
As far as the Oxford criteria are concerned, these auto-
matically exclude some patients simply because their illness
did not have a definite onset (e.g. Shepherd 1992). More-
over, research has indicated that they too may cover a
number of disorders. For instance, Wassif et al (1994)
studied 10 patients who fulfilled the Oxford criteria for
CFS. However, dynamic tests of muscle function and muscle
histology revealed that one person suffered from myopathy
while a second had polymyositis. Similarly, Lynch et al
(1991) completed a follow-up of 42 patients who met the
Oxford guidelines and found that after 18 months, 29 (69%)
still fulfilled those criteria. In the intervening period,
9 had received a medical diagnosis and 3 had developed a
psychiatric illness. Although these disorders could have
represented co-morbidity, Lynch and his colleagues decided
that the initial complaint of fatigue was probably part of
the prodromal phase of the other disorders and that the
predictive validity of the criteria was thus quite poor.
Aside from the lack of specificity, there are a number of
other problems which limit the value of both the CDC and
Oxford criteria. For example, as Straus et al (1994) noted,
the earlier American case definitions (Holmes et al 1988,
Schluederberg et al 1992) listed the presence of fever
twice, once as a minor criterium and once as a physical
sign. The presence of sore throats was also listed twice.
Secondly, the requirement for a greater than 50% reduction
in the level of activity is not only difficult to measure,
but the actual amount of activity could be related to socio-
economic considerations, not just to the severity of fa-
tigue.
There has also been criticism in relation to the Australian
criteria (e.g. Wilson et al 1994a). Indeed, neither they,
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nor the CDC and Oxford guidelines are currently recommended
for clinical use and none are considered as particularly ac-
curate or valid (Fukuda et al 1994, Wessely 1995).
1.2.2 The diagnosis of ME
There are a number of definitions and guidelines which have
been formulated for the diagnosis of ME. For clinical
purposes, some specialists use the definition suggested by
Ramsay (1988) and Dowsett (Dowsett et al 1990 and Dowsett
and Welsby 1992). This recognises both acute onset cases
which follow an infection and the cases which develop more
gradually.
The cardinal features of ME as described in Dowsett and
Welsby (1992) and Macintyre (1992) are considered to be:
1. Generalised or localised muscle fatigue following
minimal exertion with prolonged recovery time.
2. Neurological disturbances.
3. Variable involvement of cardiac and other bodily
systems.
4. An extended relapsing course with a tendency to
chronicity.
5. Marked variability of symptoms in the course of a day.
For research purposes, ME specialists have devised what have
become known as the 'London criteria' (National Task Force
Report 1994). These require the presence of fatiguability
following minor exertion, evidence of central nervous in-
volvement and the marked fluctuation of symptoms. Further-
more, the symptoms should have lasted at least six months
and must be ongoing.
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The emphasis on both fatiguability and central nervous
system involvement means that the criteria for ME are
consistent with the guidelines for PVFS formulated by Ho-Yen
(1993) and the case definitions of CFS developed by Austra-
lian researchers (Lloyd et al 1990a) and Walsh and Cunha
(1993). They are also similar to the definitions of.PVFS
adopted by Behan and his colleagues (Behan and Bakheit 1991)
and Weir (1991).
The criteria for ME differ from the American and Oxford
definitions for CFS in three ways. Firstly, the latter do
not require evidence of central nervous system dysfunction.
Secondly, they do not include any references to the fluctu-
ation of symptoms or the close links between symptoms and
exertion. Thirdly, the older CDC criteria place a much
greater emphasis on infection-related symptoms such as mild
fever, sore throat and tender glands compared to the
definitions of ME (Hyde et al 1992).
The view that ME may not be identical to all cases covered
by the term CFS led the National Task Force on CFS, PVFS and
ME, an independent body of experts which was set up to ad-
vise the British Department of Health, to describe the
various disorders as the "chronic fatigue syndromes". They
also chose to distinguish between specific subgroups, for
instance, giving the name CFS(ME) to cases of CFS who also
met the criteria for ME. In line with their approach and si-
milar suggestions by Wilson et al (1994a) and Schluederberg
et al (1992), this classification will also be adopted here
to denote cases diagnosed as either ME or PVFS.
1.2.3 CFS(ME) versus other fatigue states 
Since the introduction of the term CFS, many researchers
have expressed concern about the growing emphasis on the
symptom of fatigue (e.g. Hyde et al 1992). For instance, it
has been pointed out that tiredness is a common complaint
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among the general population (Cathebras et al 1992, Popay
1992), and associated with a variety of disparate causes
(Cope et al 1994, Pawlikowska et al 1994). Indeed, as recent
studies have shown, most patients who seek help for chronic
fatigue do not fulfil the criteria for CFS(ME) or strictly-
defined CFS 1 (Wessely et al 1995, Wilson et al 1994a). For
example, in one study of 611 people attending their general
practitioners, 70 (11.5t) reported experiencing fatigue for
three months or more (David et al 1990). Of these, only one
person (1.410 was thought to have CFS(ME).
These results are consistent with those of Elnicki et al
(1992) who identified only one case (2t) of CFS among 52
patients with chronic fatigue. Similarly, a study of 135
patients complaining of fatigue for one month revealed that
only six (4.0) met the CDC criteria for CFS (Manu et al
1988a). It is possible therefore, that factors which are of
aetiological and therapeutic significance for most patients
presenting with unexplained fatigue may not be relevant to
people with either CFS or subgroups such as CFS(ME). Until
more is known about the differences between chronic fatigue
and CFS, generalising findings from one sample to another
may lead to an inaccurate interpretation of the data and
possibly to inappropriate advice and an exacerbation of
symptoms (cf. Wessely et al 1995).
Unfortunately, researchers do not always distinguish between
subgroups of patients with chronic fatigue (e.g. Pawlikowska
et al 1994). Moreover, where subgroups are identified, it
is not always clear whether the diagnosis was made by clini-
cians using accepted definitions. For instance, MacDonald
et al (1993a) noted that 4 (23.5%) of their CFS patients
thought that they had CFS(ME). However, these researchers
did not state how this diagnosis had been made.
1 Strictly-defined CFS refers to cases which fulfil the
Australian criteria, or early versions of the CDC criteria
(1988, 1992).
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A number of features can be used to distinguish CFS(ME) from
other fatigue-related disorders. One is the nature of the
fatigue. For example, Durndell (1989) reported that a group
of students with CFS(ME) were able to differentiate between
their fatigue and the normal tiredness which might follow an
activity such as a sporting event. According to Durndell:
"the latter was described as pulsating, exhilarating and
pleasant, whilst the former was described as overwhelmingly
negative, draining, like flu and being ill".
A second difference between CFS(ME) and other disorders
relates to the marked fluctuations in symptoms and signs
(e.g. Durndell 1989, Patarca et al 1993, Ramsay 1988). The
presence of the latter can be used to differentiate CFS(ME)
from the condition colloquially referred to as 'tired-all-
the-time' or TATT (Dowsett and Welsby 1991). A third feature
which may distinguish CFS(ME) from other conditions is the
characteristic link between exertional and fatigue. Research
has shown that this is far less pronounced in psychiatric
disorders such as depression (White et al 1995). A diag-
nosis of depression is further supported by the presence of
anhedonia, apathy, reduced feelings of self-worth, suicidal
ideation, delusions and psychomotor retardation, all of
which are less common in CFS(ME) (Calabrese et al 1992).
Another disorder which may be confused with CFS is hyper-
ventilation or effort syndrome (Nixon 1993). However, while
overbreathing has been documented in some patients with CFS,
research to date has not found this to be a common problem
in the patient group as a whole (Riley et al 1990, Saisch et
al 1994).
Since a number of conditions now referred to as CFS are
clearly different from the disorder described in 1988 (cf
Price et al 1992), some American specialists have referred
to the more severe condition as CFS with encephalopathy or
chronic fatigue immune dysfunction syndrome (Bell 1991,
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Peterson et al 1992, Pross 1992, Suhadolnik et al 1992).
1.2.4 CFS(ME) and fibromyalgia 
CFS(ME) patients may report areas of muscle tenderness
similar to those documented in fibromyalgia. However, the
latter more often has a gradual onset, morning stiffness is
a more prominent symptom, fatigue tends to be worse early in
the day, and there are generally fewer signs of ongoing
infection (Calabrese et al 1992, Yunus 1994). Fibromyalgia
is also more common than CFS, affecting an estimated 2-4% of
the population at large (Wolfe 1993). While further clari-
fication is clearly required, the consensus of opinion seems
to be .that the two conditions share certain similarities,
but that they are not one and the same (Ho-Yen 1994,
Norregaard et al 1993, Wysenbeek et al 1991).
1.3 The clinical picture of CFS(ME) 
The illness seen nowadays tends to start as an unremarkable
viral infection, with myalgia, lymphadenopathy and in some
cases, a gastro-intestinal or respiratory upset (Shepherd
1992). However, instead of recovering, patients begin to
experience profound fatigue following activities which were
previously completed without difficulty. Also typical is a
prolonged delay in the restoration of muscle power (Ramsay
1988).
The fatigue, which some have likened to that reported by
people with multiple sclerosis (Behan and Bakheit 1991), is
invariably accompanied by other complaints. For instance,
many patient report a flu-like malaise, general weakness and
neurological symptoms such as disequilibrium and vertigo
(Dowsett et al 1990, Murdoch 1987, Shepherd 1992).
The involvement of the autonomic nervous system may lead to
frequency of micturition, night sweats, palpitations and
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disturbances in thermoregulatory control e.g. feeling weak
after a hot bath (Macintyre 1992, Ramsay 1988, Shepherd
1992). Patients may also experience sensory disturbances
such as paraesthesia, tinnitus and hyperacusis as well as
visual abnormalities such as photophobia (Potaznick and
Kozol 1992), sluggish accommodation (Hyde and Jain 1992)
and/or increased sensitivity to certain patterns (Smith
1991). At the same time, problems with co-ordination may
lead to falls, while clumsiness can make it harder to com-
plete fine motor tasks.
Neuropsychological symptoms associated with CFS(ME) include
headaches and cognitive problems such as loss of short-term
memory, an inability to concentrate and difficulty in fin-
ding the right word (Fleming 1994). In addition, many pa-
tients become emotionally labile, and some also begin to
experience panic attacks, depression (Macintyre 1992,
Shepherd 1992) and sleep disorders (Krupp et al 1993,
Whelton et al 1992).
Aside from the fatiguability, the muscle weakness and ap-
parent central nervous system dysfunction, there may also be
symptoms associated with impaired circulation. This mani-
fests itself in cold extremities, low temperatures and a
sudden facial pallor (Ramsay 1983). Other symptoms commonly
reported by patients with CFS(ME) include gastro-intestinal
disturbances such as recurring nausea and abdominal pain,
and the development of adverse reactions to alcohol, foods
and chemicals (Hobbs et al 1989, Innes 1970, Smith 1989).
All these symptoms show a marked diurnal and cyclical
variability in their intensity, and although it is not
always possible to identify a specific cause for the
exacerbations, reports suggest that the condition may worsen
as a result of over-exertion, concurrent infections, changes
in the weather, and in some cases, by 'stress' (Dowsett et
al 1990, Komaroff 1994).
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Unfortunately, since the adoption of the term CFS, less
attention has been paid to some of the features and symptoms
of CFS(ME), e.g. the fluctuations and the presence of neu-
rological complaints. For instance, David and Wessely
(1993) summarised the illness as "characterised by a main
complaint of fatigue, both mental and physical, with other
somatic symptoms and mental phenomena like worry and depres-
sion present". This is consistent with other descriptions
of CFS and although it is recognised that space often pro-
hibits a fuller discussion, the emphasis on fatigue may have
limited many clinicians' understanding of CFS(ME). It may
also undermine the diagnostic process, since there is still
no laboratory test for CFS(ME), and physicians have little
to guide them except their knowledge of symptomatology
(Holmes et al 1988, Weir, 1991).
In the interest of clarity, the following sections will
include CFS(ME) and CFS(PIFS) under the general heading of
CFS. However, where the findings relating to a specific
sample has not been documented in any study using the
criteria for CFS, and generalisation to the latter might
therefore not be valid, the reference to the specified
subgroup will be retained.
1.4 Epidemiology
Cases of CFS have been documented around the world, from
America to Japan and from Norway to South Africa (Hyde et al
1992, Kawai and Kawai, 1992). Moreover, it has been diag-
nosed in all age groups, from children of 5 to senior
citizens of 76 (e.g. Hilgers and Frank 1992, Hinds and
McCluskey 1993).
Estimates of its prevalence tend to vary depending on the
definitions used and the presence of local epidemics. How-
ever, it does not appear to be a common disorder. For in-
stance, Lloyd et al (1990a) studied a rural population in
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Australia on the basis of which they suggested a prevalence
of 37 cases per 100,000. In contrast, a British study in-
volving a number of Scottish general practitioners identi-
fied an average of 1.3 cases per 1000 patients (Ho-Yen and
McNamara 1991).
Both studies revealed that the illness affected all clas-
ses. In the Australian sample, only 14% were professionals
while in the Scottish sample, the figure was 5%. Thus there
appears to be little support for the media's portrayal of
the illness as 'Yuppie flu'.
Although some studies have found that CFS affects a greater
proportion of females than males (e.g. Bates et al 1994,
Hyde et al 1994, Murdoch 1987), this may, in part, reflect
gender-based differences in help-seeking behaviour and the
patients' access to treatment (Richman et al 1994). Such a
view is supported by findings from community surveys which
have generally shown the ratio of women to men to be less
than 2:1. For example, among the patients assessed by Ho-Yen
and McNamara (1991), the ratio was 1.8:1, while Lloyd et al
(1990a) reported a ratio of 1.3:1.
Another variable which could have produced an overrepresen-
tation of females in some studies is age. For instance, a
retrospective assessment of 393 CFS patients from Northern
Ireland indicated that there were proportionately more women
among older age-groups than among younger patients (Hinds
and McCluskey, 1993). Indeed, among patients under 20
years, the ratio of females to males was 1:1, while for
those between 20-39 it was 2.6:1. The ratio fell there-
after to 1.7:1.
Studies using broader definitions are more difficult to
interpret. One study of a CFS-like illness lasting at least
three months was estimated to affect at least 127 per
100,000 (Murdoch 1987). Another study which used compara-
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tively broad criteria estimated the prevalence of CFS to be
560 per 100,000 (Lawrie and Pelosi 1995).
As for prognosis, most of the existing research supports
Ramsay's observation that recovery is often very slow. For
example, a retrospective survey of 1826 CFS patients who had
been ill between 1935 and 1992 revealed that the condition
lasted on average for 6.7 years and although 61% noted a
partial recovery, only 2% had recovered completely (Hyde et
al 1994).
These findings are similar to those of a smaller study by
Wilson et al (1994b). This showed that 63% had improved and
6% had made a complete recovery in the three years since
their participation in clinical trials. However, Hinds and
McCluskey (1993) found that only 18.6% of their patients had
recovered fully within 6.5 years. More recently, Clark et
al (1995) reported that of the 19 patients they assessed,
37% recovered in the next 2.5 years. The rate was slightly
reduced if patients suffered from a concurrent psychiatric
condition. The predictors of recovery included a lifetime
Table 1. Course of the illness: the results from two
surveys.
Dowsett et al	 Hinds/McCluskey
	
1990	 1993
	
(N.420)
	
(N.234)
Fluctuating course (W)
	 20	 41.7
Steady (%)	 25	 14.4
Improving (W)
	 31	 34.7
Worse (%)
	
24	 5.1
Duration range	 <12 mths-60 yrs
	 6 mths-26 yrs
21
history of dysthymia, the presence of more than eight unex-
plained symptoms other than those listed as criteria for
CFS, increased length of fatigue, less education and being
older than 38.
Table 1 summarises data relating to the progress of the
illness. The finding that relatively few patients follow a
deteriorating course has also been documented by others
(Hyde et al 1994).
1.5 Research into CFS 
1.5.1 Research focusing on the role of viral infections 
The occurrence of epidemics and the frequent reports that
the illness began after an infection have led a number of
researchers to suggest that CFS may be a post-viral syn-
drome. Among the micro-organisms which have been implicated
in the pathogenesis of CFS are enteroviruses (Behan and
Behan 1993, Dowsett 1988) and the Epstein-Barr virus (Jones
1993).
In Britain, interest has focused primarily on enteroviruses
such as Coxsackie B (CBV). Studies in Scotland using the
ELISA CBV IgM test found that about 40 per cent of people
with CFS had abnormally high levels of IgM antibodies in
their blood. In comparison, only 9% of controls were CBV
IgM positive (Bell et al 1988). Meanwhile an American study
recently identified elevated antibody titres to Coxsackie B1
in 75% of the patients and Coxsackie B4 in 45% of the pa-
tients with CFS (Manian 1994). These rates were signifi-
cantly higher than those found in age and gender matched
controls.
Other researchers have identified the viral protein VP1,
which is common to all enteroviruses, in both the blood and
Stools of about half of their patients with CFS (Yousef et
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al 1988). However, the presence of VP1 and the elevated
levels of antibodies against CBV are also found in other
patient groups (Halpin and Wessely 1989) and given this lack
of specificity (Miller et al 1991), their value for diag-
nostic purposes is extremely limited.
Another way of identifying the presence of enteroviruses is
by using the polymerase chain reaction (PCR) assay. In a
recent study, this test detected enteroviral sequences in
41% of the patients with CFS, compared with 27% of acutely
ill people with suspected enteroviral disease, and 2% of
healthy controls (Clements et al 1995).
Perhaps more significant is the evidence of enteroviral in-
fection in the central nervous system and muscles (Archard
1988, Gow et al 1991, Innes 1970). For example, enteroviral
sequences were detected post mortem in the hypothalamus,
brainstem, heart and skeletal muscle of a patient with
CFS(ME) (McGarry et al 1994). The virus, which had a 83%
similarity to Coxsackie virus B3, was not found in four age
and sex-matched patients who died from cardiovascular dis-
eases or in people who committed suicide during severe
depression.
Others studies have detected enteroviral sequences in muscle
tissue (e.g. Bowles et al 1993). However, while this is
considered to be highly pathological, it is not specific for
CFS. For instance, Gow et al also detected enteroviral RNA
in patients with malignancies of the colon and breast.
There is also other evidence implicating enteroviruses in
CFS. For instance, some have noted the clinical similarity
between the CFS(ME) and polio (e.g. Gilliam 1938), while
others have pointed out that none of the patients from the
1948 outbreak of CFS(ME) in Iceland succumbed to the polio
epidemic there in 1955 (e.g. Ramsay 1988). Since this took
place before mass vaccination, their apparent immunity to
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polio might have resulted from previous exposure to another
enterovirus (see also Hyde et al 1992, p. 122). This theory
is also consistent with the discovery of a mutant entero-
virus by Cunningham et al (1990) and the identification of
an apparently novel enterovirus by Galbraith et al (1995).
Critics of the viral persistence theory have noted that
enteroviral RNA has been detected in only a proportion of
the patients with CFS(ME). While this is true, the findings
reported to date can not be taken as proof that the virus
was not present in others. For instance, it has been
suggested that the infection may be focal and that the
lesion site could have been missed on biopsy (Gow and Behan
1991). Moreover, the PR assays may not have been sensitive
enough (Fekety 1994).
A second virus which has been linked with CFS is the
Epstein-Barr virus (EBV), (Jones 1993, Straus et al 1985).
EBV is a DNA virus which can lie dormant in the cells for
years. However, during periods of physical or mental
stress, the virus may be reactivated producing symptoms
which are virtually identical to those of CFS. About 20% of
CFS patients show evidence of reactivated EBV in their blood
(Smith 1989) and the virus has also been identified in
muscle (Archard et al 1988). However, both Natelson et al
(1994) and Woodward and Cox (1992) found antibody levels to
EBV unhelpful when trying to distinguish between different
patient groups. As a result, they proposed that the presence
of antibodies were a general marker of illness rather than
an indicator of a specific disease.
This may also be true for enteroviruses. There are studies
where several members of a family became ill at the same
time but where one had a positive VP1 test and the others
had high titres to reactivated EBV. Such findings support
the hypothesis that increased levels of antibodies against
both viruses may just be a manifestation of a general immune
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disturbance, caused by another agent yet to be identified
(Smith 1989 and see section 1.5.3 below).
Other viruses which have been implicated in CFS include
human herpes virus-6 (Buchwald et al 1992, Levine and
Komaroff 1993) and the human T-lymphotropic virus type I and
II (DeFreitas et al 1991). The presence of the former is
generally regarded as a marker of illness rather than
primary infection, while attempts to confirm an aetiological
role for the retrovirus have so far been unrewarding (Flugel
et al 1992, Gow et al 1992, Khan et al 1993). It is cur-
rently considered to be a passenger virus (Prof. R.A. Weiss,
personal communication).
More recently, a new infectious agent resembling cytomega-
lovirus (CMV) was isolated and cultured from the cere-
brospinal fluid and blood of a patient with CFS (Martin et
al 1994). Repeated culturing of the virus over a three-year
period indicated that it had established a clinically per-
sistent infection. Since there were no overt clinical signs
of an inflammatory reaction, the researchers have named it
a 'stealth' virus.
While it is now generally accepted that CFS is not caused by
one particular micro-organism, the presence of viral protein
in muscle and brain tissue several years after the acute
phase supports the view that many cases represent some kind
of chronic infection (Behan et al 1993, Dowsett 1988, Fekety
1994). In these patients, the virus is believed to
interfere with the normal specialized functions of the host
cell without causing tissue damage (Oldstone 1989).
1.5.2 Evidence of disease in brain and muscle
Aside from the isolation of viral RNA from brain and muscle
tissue (McGarry et al 1994), the persistent viral theory is
also supported by evidence of pathology and functional
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disturbances in the CNS. For instance, MRI scans from
patients with CFS have revealed a number of abnormalities
including lesions of the frontal lobe and cerebellum
(Buchwald et al 1992, Daugherty et al 1991, Fisher Portwood
1988, Hyde et al 1992 p.425, Schwartz et al 1994a).
Pathological changes have also been observed in muscle
tissue. For example, an analysis of muscle biopsies
identified a number of abnormalities including atrophy of
type II fibres and structural changes in the mitochondria
(Behan et al 1991). However, the clinical significance of
these findings remains unclear (Behan and Behan 1993).
Aside from the reports of ongoing pathology, there is also
growing evidence of functional abnormalities in the central
nervous system and muscles. For instance, SPET scans have
identified marked reductions in the blood flow (hypoper-
fusion) in a number of areas in the brain (Costa et al 1994,
Douli et al 1992, Ichise et al 1992, Simon et al 1991,
Troughton et al 1992). One study compared CFS patients with
people suffering from major depression and AIDS (Schwartz et
al 1994b). Significant hypoperfusion was found in 80% of the
patients with CFS, and the pattern of the defects and simi-
larities with the AIDS patients were "consistent with the
hypothesis that the chronic fatigue syndrome may be due to
a chronic viral encephalitis".
This was echoed by Costa et al (1995) who conducted two
studies comparing people with CFS(ME), healthy volunteers
and patients with major depression. All the scans of the
CFS(ME) patients revealed hypoperfusion in the brainstem.
Moreover, the perfusion ratios in this area were signi-
ficantly lower than those of the depressed patients and the
healthy volunteers. Discussing these findings, Costa and
colleagues suggested that there could be a relationship
between their findings and "direct neuronal damage by a
viral agent."
26
There is also evidence supporting early suggestions of
hypothalamic dysfunction (Hill et al 1959, Ramsay 1978).
For instance, patients with CFS were found to have signi-
ficantly higher levels of prolactin when challenged with
buspirone than either healthy controls or people suffering
from clinical depression (Bakheit et al 1992). This parti-
cular finding led them to suggest that some of the symptoms
of CFS may be linked to an increased sensitivity of the
hypothalamic 5-hydroxytryptamine receptors.
There have also been other signs of central nervous system
disturbance in CFS. For instance, researchers have reported
a reduction in the levels of growth hormone and abnormali-
ties in the production of the latter when challenged with
steroids like dexamethasone (Majeed et al 1995a). Similarly,
Bakheit et al (1993) found abnormalities in the secretion of
arginine and vasopressin.
Another hormone which has been implicated in CFS is corti-
sol. For instance, Demitrack et al (1991) found a number of
abnormalities relating to cortisol secretion, including a
reduction in total plasma cortisol, an elevated basal eve-
ning ACTH concentration and an attenuated ACTH response to
ovine corticotropin hormone. It was suggested that these
results reflected dysfunction of the hypothalamic-pituitary-
adrenal axis, but later studies using different samples
found no abnormality in cortisol levels (Hilgers and Frank
1992, Richardson 1995). Consequently, the role of cortisol
and its relationship with the symptoms of CFS remains un-
clear.
Other studies assessing CNS function have also produced in-
consistent results. For example, Prasher et al (1990)
studied patients with CFS(ME) and found abnormalities in the
cognitive evoked potentials, particularly the N2 and P3
components, but this was not replicated in patients with CFS
(Scheffers et al 1992).
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There has been also been research evaluating muscle func-
tion in patients with CFS but again, the findings have not
been consistent. For instance, electrical recordings made
by Jamal and Hansen (1985) using single fiber electromyelo-
graphy revealed significantly increased jitter in 751; of
their CFS patients. However, a more recent study on people
with CFS found abnormalities in only 17% of those tested
(Roberts and Byrne 1994). Similarly, Wong et al (1992)
reported changes in skeletal muscle metabolism and reduced
intracellular concentrations of ATP after exercise, but this
was subsequently challenged by Kent-Braun et al (1993) and
Barnes et al (1993).
Some findings appear to be more robust. For instance, Lane
et al '(1994) found raised levels of lactate levels at com-
paratively low work rates while Teahon et al (1988) and
Preedy et al (1993) reported a reduction in the muscle RNA
content. The latter indicates a fault in the ability to
synthesise muscle protein. Furthermore, Japanese re-
searchers have reported finding a deficiency in serum
acylcarnitine in 38 patients with CFS (Kuratsune et al
1994). They believe that this may be associated with
mitochondrial abnormalities and accordingly, with muscle
weakness and fatigue (see also Majeed et al 1995b). Mean-
while, abnormalities in cardiac function have been noted by
a number of researchers including Lerner et al (1993) and
Montague et al (1989).
In contrast, general measures of muscle strength have been
normal (Lloyd et al 1988, Lloyd et al 1991a, Gibson et al
1993, Rutherford and White 1991). Indeed, where abnormali-
ties have been found, they have been restricted to specific
muscle groups (Maffulli et al 1993).
Unfortunately, methodological flaws mean that the research
on muscle function must be interpreted with care. For in-
stance, some of the tests may have been too demanding for
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the more severely affected sufferers and the samples used
may therefore not be representative. Similarly, where
studies did not include sedentary controls, it is possible
that the documented abnormalities reflect a lack of physical
fitness, rather than the presence of disease.
1.5.3 Research assessing the immune system.
The fact that a number of different microbial pathogens can
produce very similar symptoms has led to the suggestion that
the primary cause of these illnesses may lie in the body's
response to infection, not the nature of the infectious
trigger. This is supported by several studies which have
found changes in the immune system consistent with ongoing
antigenic stimulation.
Evidence of immune activation include:
1. the increased expression of surface antigens and adhesion
molecules, both of which are usually associated with the
presence of disease (e.g. Gupta and Vayuvegula 1989, Landay
et al 1991),
2. the presence of circulating immune complexes (Bates et al
1995, Behan et al 1985, Buchwald and Komaroff 1991, Komaroff
1994),
3. the shift in the ratio of the CD45RA/CD45R0 T cells and
increases in the number of 'mature' D45R0 T cells which
express surface adhesion markers (Straus et al 1993),
4. raised levels of cytokines (e.g. Chao et al 1990, Cheney
et al 1989, Cheney 1992, Landay et al 1991, Lever et al
1988, Linde et al 1992, Lloyd et al 1991b, Patarca et al
1995).
Studies have also found an increased number of CD56 cells,
which may have natural killer cell-like functions (Klimas et
al 1990, Morrison et al 1991, Tirelli et al 1993), and
raised - levels of immunoglobulins, including IgE and IgG
(Bates et al 1995, Hobbs et al 1989). The increase in IgE
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is associated with allergic reactions which are also mani-
festations of immune hyperactivity (Hobbs et al 1989).
These findings have led some researchers to propose a theory
which posits that CFS is the result of a disordered immune
response to viral antigens and other factors such as stress
(see Figure 1).
Agent X	 immune system activation
Production of cytokines
Interferon	 Interleukin-2	 Other cytokines
Symptoms of CFS
Figure 1. The immune dysfunction theory of CFS
(Adapted from Bell 1991).
It has been suggested that a compromised immune system
allows the reactivation of latent viruses, and that these
contribute to the morbidity of CFS both directly, by
damaging certain tissues (e.g. pharyngeal mucosa) and
indirectly, by eliciting an ongoing immunological response.
The activated immune system produces cytokines like
interleukin-2 and interferon, and it is these which are
believed to cause many of the symptoms of CFS (Bell 1991,
Komaroff 1992, Lloyd et al 1994a). However, it is not clear
whether the immune system remains activated because of the
continued presence of an infectious agent or because of a
failure in the process which should inhibit and suppress the
response.
While some of the evidence supports the theory, there are a
30
substantial number of findings which do not. For instance,
the general failure to find either elevated levels of CD-8
T cells or markers such as CD57 which indicate cell activa-
tion, suggests that if there is ongoing infection, it is
very mild (Strober 1994). Furthermore, studies have also
demonstrated reduced immune responses, both in vivo (e.g.
Lloyd et al 1992) and in vitro (Aoki et al 1993, Caliguiri
et al 1987, Gupta and Vayuvegula 1991, Klimas et al 1990).
These are difficult to explain in terms of immune activa-
tion. The theory is also inconsistent with findings of
normal levels of cytokines (e.g. Ho-Yen et al 1988, Straus
et al 1989) and reduced levels of immunoglobulin subsets,
particularly IgG3 (Lloyd et al 1989, Peterson et al 1990).
Some of the conflicting findings may be due to differences
in the samples studied and the infectious triggers thought
to be involved. It has also been suggested that immuno-
logical markers may change according to the severity and
stage of the illness (Ho-Yen et al 1991). This idea is
supported by Landay (1991), Cheney (1992) and Ojo-Amaize et
al (1994), all of whom found a relationship between immuno-
logical status and severity of the disease.
Another factor that may have contributed to the confusion is
the variation in techniques and tests employed. For
example, a number of researchers have documented normal
numbers of certain surface molecules but they did not test
for specific subsets. It is therefore possible that
evidence of immune activation might have been overlooked
(cf. Landay et al 1991).
It has also been pointed out that the failure to detect a
clear-cut and reproducible abnormality of lymphokine/cyto-
kine secretion may reflect the insensitivity of the tests
used and the rapid clearance of these substances from the
circulation (Strober 1994).
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Perhaps the most consistent finding to date is that of a
significant impairment of natural killer (NK) function (e.g.
Caliguiri et al 1987, Klimas et al 1990, Morrison et al
1991, Pross 1992). Indeed, according to Strober (1994),
these findings provide the strongest evidence that immune
disturbances are primary rather than secondary to chronic
infection.
Immunological changes and depression,
It has recently been suggested that the changes in immune
function are not due to infection but a result of mood
disturbance (Straus et al 1993). To support this view, it
has been pointed out that immune activation has also been
found in patients suffering from major depression (Maes et
al 1992, Masuda et al 1994). Moreover, lymphocytes taken
from CFS patients show reduced responses to mitogens, a
finding which has also been noted in depressed populations
(Stein et al 1991). However, findings from controlled trials
have shown that most of the abnormalities identified in
relation to CFS are different from those seen in depressed
patients tested at the same time (Lloyd et al 1992, Landay
et al 1991). This suggests that the two conditions are
immunologically distinct.
Immune dysfunction versus viral persistence
At the moment, there appears to be slightly more support for
the view that immune changes are secondary to, rather than
the primary cause of CFS. For instance, two recent studies
have investigated the theory of general immune disturbance
by measuring the levels of antibody titres to a number of
different viruses. In the first, testing was restricted to
two herpes viruses, Epstein-Barr virus and human herpes
virus-6, both of which have been linked with CFS (Natelson
et al 1994). The researchers argued that if the illness was
the result of a primary, nonspecific immunological problem
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allowing viral reactivation, then the levels of antibodies
to both viruses should be elevated. On the other hand, if
the illness was due to a specific infection and the immune
changes a result of this, then rises in the levels of anti-
bodies to one virus would not necessarily be matched by
rises in the antibody titres to the other. The results
supported the latter view.
The second study measured antibody titres to 18 common
viruses including EBV and CBV (Manian 1994). It was found
that 95% of patients with CFS had high titres to either EBV
VCA IgG, Coxsackie B1 or Coxsackie B4. However, simulta-
neously elevated levels of antibodies to the EBV and
Coxsackie antibodies were detected in only 20 of cases.
Thus in 80% of the patients, the elevation of viral antibody
titres was not due to a nonspecific immune response.
Further support for the view that the immune abnormalities
are not the primary cause of CFS comes from Griffin (1991).
In her review, she mentions that the combined presence of
immune activation and immunosuppression has also been docu-
mented during a number of acute and chronic viral infec-
tions, including those caused by the measles virus and HIV.
Thus the inconsistencies noted above are consistent with a
viral cause.
On the other hand, it is also possible that viral infection
is only one of the factors underlying this disorder. There
may be co-factors which, when present, allow the virus to
evade destruction by the immune system. In addition, genetic
influences could explain why some people recover faster from
the same infection than others. In this respect, it is
interesting to note that the HLA-DR/DQ haplotype, plus HLA-
DQ3 and HLA-DR4 antigens were found to be more prevalent in
patients with CFS than in a group of matched, healthy
controls (Keller et al 1994).
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Some commentators, however, believe that the evidence for a
persistent viral infection is very limited, pointing out for
instance, the generally subtle abnormalities in the immune
system, the variable findings with regard to pathology, the
failure to find notable reductions in muscle strength, the
comparatively high prevalence among white, middle-aged
women, and the similarities between the symptoms of CFS and
depression (e.g. Beamn and Wessely 1994, Deale and David
1994, Hotopf and Wessely 1994, Manu et al 1992). This has
led a number of researchers to suggest that while infection
may trigger many cases of CFS, other factors may play an
important role in perpetuating it (see also section 1.5.5).
1.5.4 Miscellaneous theories. 
In the past few years, CFS has been attributed to a number
of localised lesions. For instance, Chester (1993)
hypothesized that some cases of CFS might be related to
disorders of the nose. In his view, this explains the high
incidence of allergies, the links with weather changes and
the symptoms relating to the upper respiratory tract. CFS
has also been associated with damage to the spine. For
example, Perrin (1993) suggested that abnormalities in the
thoracic and upper lumbar region could undermine the func-
tioning of the sympathetic nervous system, resulting in
symptoms such as headaches, dizziness, palpitations, and
disturbed sleep.
So far, these explanations have received little attention.
This may be partly because CFS is regarded as a complex,
multi-system disease (e.g. Dowsett et al 1990), and partly
because localised lesions can not explain the epidemics, nor
abnormalities such as the presence of viral genetic material
in the muscle and brain (e.g. Behan and Behan 1993). Never-
theless, disorders in specific parts of the body could be
responsible for some cases of unexplained chronic fatigue.
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CFS has also been linked to nutritional deficiencies (e.g.
Cox et al 1991, Jacobsen et al 1993). For instance, Van
Riel et al (1988) found that despite an adequate intake,
many CFS patients had less vitamin B„ B, and C than a
control group. More recently, McLaren Howard et al
(submitted for publication) compared 30 CFS(ME) patients
with 11 healthy controls and reported that the former had
significantly lower levels of magnesium, potassium, zinc,
chromium, selenium, glutathione peroxidase, vitamins B i , B2,
B„ and B, and ten out of 39 amino acids in plasma. The
CFS(ME) group also had higher levels of serum glutathione-S-
transferase indicating increased 'toxic stress'. The
reductions in both omega-6 and omega-3 series of essential
fatty acids were suggestive of a block at the delta-6-
desatuiase level, a finding consistent with infection
(Horrobin and Manku 1990).
Reduced levels of essential fatty acids have also been im-
plicated as a cause of the abnormalities in red cell shape
(Simpson et al 1993). Compared with healthy individuals,
patients with CFS(ME) were found to have a reduction in the
number of cells with cup forms but an increase in the pro-
portion with altered margins. According to Simpson and his
colleagues (1993 and personal communication), the changes in
the red cell shape reduce the filterability of the blood,
thus impairing blood flow and limiting the supply of oxygen
and substrates to the tissues. The inadequate delivery of
nutrients to the muscles could lead to weakness, fatigue and
reduced aerobic work capacity (cf. Riley et al 1990). Simi-
larly, the impaired blood flow to the hypothalamus might
result in sleep disturbance, irregular temperature regu-
lation and emotional lability (Simpson 1990). Essential
fatty acids act'by improving the flexibility of the cells,
thereby increasing perfusion of oxygen in the micro-
circulation and the filterability of the cell membrane
(Dutta-Roy 1990, Simpson et al 1993).
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Given that similar changes in red cell shape have also been
documented in other conditions characterised by fatigue,
e.g. pernicious anaemia and MS, the abnormalities cannot be
used to confirm the diagnosis. However, Simpson's theory is
consistent with the view of CFS(ME) as a multi-system dis-
order and compatible with recent findings of hypoperfusion
in certain areas of the brain (e.g. Costa et al 1995,
Goldstein et al 1995, Ichise et al 1992, Schwartz et al
1994b, Simon et al 1993).
Finally, some researchers have implicated the overuse of
antibiotics and exposure to neurotoxins as contributory
factors in the aetiology of CFS. So far there is little
evidence linking antibiotics with the onset of CFS (Hyde et
al 1994, Smith 1989). However, a study of patients who
developed a CFS-like condition following exposure to orga-
nophosphate pesticides showed that toxic chemicals can
produce abnormalities of hypothalamic function resembling
those seen in people with CFS (Behan and Haniffah 1994).
Moreover, the similarity between CFS and Gulf War Syndrome
supports the argument that neurotoxins may have effects on
the brain and immune system similar to those documented in
CFS (NIH Workshop Statement 1995).
Although much remains unclear, the abnormalities which have
been found in the blood, muscles and brains of patients all
support the view that there is ongoing disease in some cases
of CFS (Behan and Behan 1988, Lieberman and Bell 1993,
Preedy et al 1993, Ramsay 1988, Simpson et al 1993). Useful
information relating the role of infection and immunology
may be obtained from further controlled research into CFS,
as well as investigations into post-polio syndrome (Bruno et
al 1994ab, 1995), fatigue connected to organophosphate
poisoning and the CFS-like condition in horses and mice
(Behan and Haniffah 1994, Chao et al 1992, Ricketts et al
1992, Shepherd 1993).
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1.5.5	 Research into the psychological and psychiatric
aspects of CFS. 
The failure to find consistent evidence of disease in the
patient group as a whole has focused attention on the role
of mood disorders, maladaptive beliefs and 'stress'. For
example, some have suggested that CFS represents an atypical
form of depression (e.g. Higgins 1992). This view is suppor-
ted by a number of studies which have found high rates of
major depression in people with CFS (e.g. Lane et al 1991,
Manu et al 1988, Taerk et al 1987, Wessely and Powell 1989,
see also chapter 4). Moreover, it has been pointed out that
depression can also cause profound fatigue, sleep disorders
and cognitive disturbances (Buchwald 1994, Komaroff 1994,
Pepper et al 1993, Ray 1991).
However, other findings are inconsistent with this view.
For example, Hickie et al (1990) found that the pattern of
symptoms in CFS patients was significantly different from
that seen in patients with non-endogenous depression (cf
Jenkins 1991b). Similarly, Pepper et al (1993) reported
that CFS patients had a distinct psychiatric profile com-
pared with patients with major depression.
CFS and major depression have also been found to differ in
terms of the type of neuropsychological deficits (Sandman et
al 1993); the diurnal variation in energy levels (Wood et al
1992); severity of overall disability (Natelson et al 1995);
response to exercise (Lane et al 1995); the type of neuro-
endocrine responses (Bakheit et al 1992, Beamn et al 1995,
Beamn and Wessely 1994, Cleare et al 1995, Demitrack et al
1991, Majeed et al 1995); and the pattern of cerebral hypo-
perfusion (Costa et al 1994, Goldstein et al 1995, Schwartz
et al 1994b).
Finally, the concept of CFS as a form of affective disorder
conflicts with the general consensus of opinion that this
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illness is a heterogeneous entity with a multifactorial
aetiology (Beamn and Wessely 1994, Wilson et al 1994a).
A more frequently expressed view is that the presence of
mood disorders plus the patient's adherence to maladaptive
beliefs and coping strategies play a major role in main-
taining the symptoms of CFS (Wessely et al 1989, Sharpe
1993).
According to the cognitive-behavioural model of CFS, the
patients' tendency to attribute their symptoms to a physical
cause begins a vicious circle of avoidance, frustration,
depression and further fatigue. Thus it has been argued that
when patients become ill, normal postviral debility is in-
terpreted as a result of continued disease which leads them
to extend their period of rest and convalesce (e.g. Butler
et al 1991, Wessely et al 1991). This reduces their physi-
cal fitness so that symptoms are elicited at increasingly
lower levels of activity. The patients' belief that the
cause of their predicament is entirely viral leads them to
reject alternative explanations and coping behaviours so
that their continued inactivity reduces their fitness even
more. At the same time, their lack of perceived control
compounds the feelings of frustration, helplessness and
depression. This in turn adds to the fatigue, leading to
even more inactivity, depression and so on.
Some regard the influence of unhelpful cognitions as para-
mount, since these can influence a number of behaviours, not
just inactivity (Sharpe 1994, Surawy et al 1995). For
example, Surawy et al (1995) have suggested that a desire to
achieve high standards of performance and an extreme need to
meet the expectations of others may lead people to 'press
on' in the initial stages, when they should rest. At the
same time, the patients' need to achieve combined with their
perfectionism and an unwillingness to show weakness may
trigger episodic attempts to perform at premorbid levels.
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When these inevitably fail, patients may feel frustrated and
become increasingly preoccupied with the symptoms and
invalidism. This will result in increasing disability,
demoralization and depression.
The model also posits that patients with CFS tend to attri-
bute their illness to an external cause primarily to avoid
a loss of self-esteem (Manu et al 1992a and b). This
explanation is supported by Powell et al (1990) who found
that people with CFS had higher levels of self-esteem than
patients suffering from depression. It is also consistent
with the research by Cope et al (1994a) which found that a
tendency to somatise was the most important predictor of
fatigue, six months after a viral illness. Although the
raised somatisation scores could have reflected the presence
of physical disease (Robbins and Kirmayer 1991), it is
equally possible that the patients' somatising may have led
to more important emotional problems being neglected, thus
prolonging the fatigue (cf. Sharpe 1994).
Indeed, it has been difficult to evaluate the influence of
specific beliefs in the aetiology of CFS. For instance,
although it is well documented that most patients tend to
attribute their illness primarily to a physical cause (e.g.
Powell et al 1990, Ray et al 1992b, Sharpe et al 1992, Ware
and Kleinman 1992, Wilson et al 1994), the limited knowledge
of the aetiology of CFS makes it impossible to judge the
'correctness' of this attributional style (Powell et al
1990). Thus while a particular belief or view may be
closely related to poor outcome (e.g. Wilson et al 1994b),
it does not necessarily follow that those attributions are
wrong and that a change in attitude would lead to a
reduction in fatigue and distress. Moreover, the findings of
Wilson et al were not supported by Bonner et al (1994) who
found that belief in a physical cause did not predict
outcome.
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Other aspects of the cognitive-behavioural model of CFS have
also been difficult to assess. For instance, since all the
pre-1995 definitions for CFS required patients to have
reduced their activity levels by at least 5n, some of the
sufferers who remained active and whose symptoms can there-
fore not be attributed to physical deconditioning may have
been excluded. This could have produced unrepresentative
samples and made it difficult to determine the real in-
fluence of inactivity on the symptoms of CFS. Interes-
tingly, where avoidance of activity was assessed, re-
searchers found that it did not predict either fatigue or
psychological well-being (Vercoulen et al 1994).
Indeed, there is still comparatively little objective
evidence that fatigue is largely the result of physical
deconditioning (Gibson et al 1993, Lane et al 1994, Montague
et al 1989). Similarly, the findings have also failed to
show that CFS is due to a lack of motivation (Lloyd et al
1991a, Rutherford and White 1991) or disuse atrophy
(Connolly et al 1993).
While there is as yet little supportive evidence for the
cognitive-behavioural model, particularly for the CFS
population as a whole, it is possible that the combination
of maladaptive beliefs and behaviours could be a major
determinant of chronic fatigue in subgroup (Macdonald et al
1993a). It is also likely that concurrent depression may
delay recovery from infection (cf. Cluff 1991) and there is
evidence that both depression and maladaptive beliefs can
increase the patients's perceived disability and actual
emotional distress (see Chapter 4).
The role of stress. 
A number of researchers have hypothesized that somatisation
may be one way of dealing with high levels of 'stress'. For
example, Ware and Kleinman (1992) interviewed a number of
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patients with CFS and found evidence of distressing expe-
riences and exhausting work schedules prior to the onset of
fatigue. As a result, they proposed that some patients may
have used illness as a means to escape from their busy
lives.
This 'flight-into-illness' theory was subsequently chal-
lenged by Mechanic who noted that it conflicts with the
presence of ongoing distress and the observation that many
patients actively continue to seek treatment (Mechanic 1993,
p.79). It has also been pointed out that since the findings
were based on retrospective reports, they may have been
influenced by memory distortion and 'effort after meaning'
(Cope et al 1994a, Hotopf and Wessely 1994).
On the other hand, there is some support for the argument
that stress may be implicated in CFS. For example, research
has found that stress can lead to a reduction in immune
competence (Adler and Matthews 1994). In one study, mobi-
lization stress caused a transient depression of virus-
induced interferon production in mice, aggravating the
course of the influenza and allowing the virus to penetrate
the brain (Chetverikova et al 1987). Experimental stress
has also been shown to increase the susceptibility of mice
to other viruses, including herpes simplex, poliomyelitis
and Coxsackie B (Rasmussen 1969).
In humans, stress has been associated with the development
of minor respiratory infections such as colds (Cohen et al
1991, Evans and Edgerton 1991) and with the reactivation of
herpes viruses such as EBV (Kiecolt-Glaser and Glaser 1987).
In terms of CFS, the immunosuppressive effect'of distress
could help to explain why the immune system fails to clear
the initial infection and why the illness becomes chronic
(cf. Cluff 1991, Adler and Matthews 1994, Stein et al 1991).
However, while there are some retrospective and anecdotal
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reports linking stress and the onset of CFS, the results of
more formal research have been inconsistent. For example,
Stricklin et al (1990) found that patients with CFS had more
severe stress in the 12 months prior to illness than a group
of healthy controls. In contrast, Durndell (1989) reported
no difference in the number of life stress events, or in the
perception of those events between CFS patients and con-
trols. Others have also failed to demonstrate a significant
link between life events and the onset of fatigue lasting at
least 6 months (Bruce-Jones et al 1994, Lewis et al 1994).
Approaching the subject from an epidemiological perspec-
tive, Hyde et al (1994) estimated that people in high stress
jobs who were not in contact with infectious disease or with
a recently immunized public had a relatively low risk of
developing CFS. However, they added that pre-existing
exhaustion due to demands at work etc could compromise the
immune system, thereby increasing certain individual's
vulnerability to CFS.
It is worth noting, however, that while stress may lead to
immune suppression and hence to an increased susceptibility
to disease (Adler and Matthews 1994, Hotopf and Wessely
1994), most of the immunological changes which have been
associated with stress are different from those reported in
patients with CFS. Indeed, evidence of immune activation
such as that documented in the literature on CFS is
comparatively rare in relation to stress (e.g. Landay et al
1991, Lloyd et al 1994a, Patarca et al 1995). Moreover,
stress has been tentatively linked with reduced levels of
IgA (Jemmott et al 1983), which tend to be normal in
patients with CFS (Behan et al 1985, Gupta and Vayuvegula
1991, Hobbs et al 1989, Lloyd et al 1989).
Thus while it is possible that stress may make people more
vulnerable to the infection which may trigger CFS, there is
as yet little support for the view that the failure to re-
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cover can be attributed to a stress-induced attenuation of
the immune response.
A psychodynamic view
Taking a slightly different approach, Taerk et al (1994)
hypothesized that CFS may be the end result of early dis-
turbances in the mother-child relationship. They proposed
that these lead individuals to turn to others on whom they
then become overly dependent. The strained relationship
with the mother also undermines their ability to ideal with
stress, which leads to physiological instability and makes
these individuals susceptible to a variety of diseases later
in life. When the person loses or is separated from those
on whom he/she has become dependent, this triggers changes
in the hypothalamic-pituitary-adrenal axis and the immune
system, which then provides the basis for CFS. In their
view, a psychotherapeutic relationship which allows the
patient to internalize new selfregulatory tension-reducing
structures can help to stabilize the illness and reduce
fatigue.
Research on personality
Others researchers have chosen to focus on the personality
of patients with chronic fatigue. For instance, Stricklin
et al (1991) used the Minnesota Multiphasic Personality
Inventory and found a profile suggesting a neurotic or
psychophysiological illness rather than an hysterical one.
A second study also identified the 'neurotic triad' but
noted a significant amount of heterogeneity (Blakely et al
1991). Indeed, one subgroup appeared to have no psychiatric
disorders at all. Meanwhile, a comparison of 40 patients
with CFS(ME) and multiple sclerosis revealed almost iden-
tical scores for both neuroticism and extraversion
(Goudsmit, unpublished).
43
As yet, studies have not identified a specific personality
related to CFS. Although it has been suggested that
patients may be motivated by a strong need to achieve (e.g.
Sharpe 1994, Surawy et al 1995, Ware and Kleinman 1992),
Stricklin et al (1990) found no difference between CFS(ME)
patients and healthy controls on a measure assessing this
trait.
Researchers have also assessed Type A behaviour which has
been linked with an increased incidence of infectious
mononucleosis, a condition which can also lead to chronic
fatigue (Barton and Hicks 1985). Although Durndell (1989)
and Lewis et al (1994) found that CFS patients had similar
global Type A personality scores to comparison groups, both
reported that some individuals may have pushed themselves
prior to the onset of illness. Thus it is possible that a
tendency to ignore symptoms and remain active could have
predisposed some people to develop CFS. On the other hand,
it can not be ruled out that the high activity levels before
the onset of fatigue may simply have reflected the patient's
personal circumstances, e.g. an inability to take time off
and rest (Hyde et al 1994, Shepherd 1992, see also Chapter
3) .
To summarise, studies have indicated that personality and
stress may increase a person's vulnerability to infection
but there is as yet little evidence that these same factors
play a major role in perpetuating CFS.
Neuropsychological research. 
Findings from studies assessing neuropsychological func-
tioning have been generally supported patients' reports of
difficulties related to memory and concentration. For
example, sufferers tested by Smith (1992) and Smith et al
(1993) had deficits in selective and sustained attention, as
well as impaired recognition and recall. These abnorma-
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lities persisted over time and were observed in both a well-
defined hospital sample and a group taken from the commu-
nity.
Meanwhile, DeLuca et al (1993) showed that the impairments
noted in a group of patients with CFS were similar to those
of people with multiple sclerosis. Like Smith et al, they
examined the possibility that the cognitive deficits might
have resulted from co-existing depression but found the
correlation between depressed mood and performance to be
weak. Although a later study failed to reproduce some of
their earlier findings, they identified abnormalities in
information processing speed and once again found that
neither depression nor anxiety were related to performance
(DeLuca et al 1995).
The influence of mood on cognitive functioning was also
assessed by Sandman et al (1993) who tested 39 patients with
CFS, 23 patients suffering from major depression and 129
age-matched healthy controls. Their results indicated that
the patients with CFS were vulnerable to interference and
slow or uncertain in decision making. "Apparently, CFIDS
patients made weak memory traces that were easily per-
turbed". The results also revealed that the cognitive and
memory profiles of people with CFS were distinctly different
from those of patients with depression. Their findings are
in agreement with those of Johnson et al (1994), who sug-
gested that the documented problems may reflect deficiencies
in information processing and the encoding of the memory
trace.
It should be noted here that many of the abnormalities which
have been found are comparatively subtle, and that a number
of studies have failed to find differences between CFS
patients and controls (e.g. Altay et al 1990, Grafman et al
1993, Macdonald et al 1993b, Ray et al 1993a). According to
Ray et al (1993a), the inconsistencies may be related to the
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differences in the composition of the samples and the mea-
sures used. They also suggested that the performance on
cognitive tasks could be influenced by differences in the
severity of fatigue, physical malaise and emotional
distress. However, since the impairments are often quite
specific, it might be argued that these variables do not
affect the patient's response on every task (e.g. Grafman et
al 1993, Krupp et al 1994, Ray et al 1993a).
In general, the documented neuropsychological impairments
associated with CFS appear to be consistent with multifocal
cerebral dysfunction (Bastein and Thomas 1988, Smith 1991,
Riccio et al 1992, Thompson 1989). Nevertheless, the incon-
sistencies between the studies mean that the significance of
the abnormalities remains difficult to determine.
1.6 Treatment 
A large number of treatments have been evaluated for CFS
including interferon-a (Brook et al 1993), acyclovir (Straus
et al 1988), transfer factor (Lloyd et al 1993), psycho-
therapy (Taerk and Gnam 1994), diet (Durndell 1989), amino-
acids (Bralley and Lord 1994), vitamin B12 (Simpson 1991),
kutapressin (Ablashi et al 1994), other nutritional
supplements (Aoki et al 1993), osteopathy (Perrin 1993),
Chinese medicine (Lee 1992, Jiang and Franks 1994), herbs
and homeopathy (Leyton and Pross 1992) and combinations of
various therapies (e.g. Anderson 1988, Dowson 1993, Hilgers
and Frank 1993). However, relatively few of the treatments
have been subjected to double-blind, placebo-controlled
clinical trials. Of those that have, only four were found
to be superior to a placebo. These are an antiviral and
immunoregulatory agent known as Poly(I).Poly(C„U)
'Ampligen', high dose intravenous immunoglobulin, evening
primrose oil and IV magnesium sulphate (Behan et al 1990,
Cox et al 1991, Lloyd et al 1990b, Strayer et al 1994).
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There are still no published reports of a controlled trial
of anti-depressants. However, the results of open trials
indicate that although certain drugs appear to be helpful in
improving general functioning and reducing pain (Goodnick
and Sandoval 1993), the effects on the illness as a whole
tend to be variable (Behan et al 1994, Hickie and Wilson
1994, Klimas et al 1993, Jenkins 1991, Weir 1991). More-
over, there is anecdotal evidence that CFS patients are
sensitive to drugs and as a result may not tolerate the
therapeutic dosages required (Abbey 1994, Bell and Concemi
1994, Wilson et al 1994b).
As for cognitive-behavioural therapy, controlled studies
have been generally disappointing (Friedberg and Krupp 1994,
Lloyd et al 1993). Although an early open trial led to
improvements in about 80 5i of patients with CFS (Bonner et al
1994, Butler et al 1991), these findings have not been rep-
licated by others (e.g. Cox and Findley 1994). Neverthe-
less, there is some evidence that a cognitive-behavioural
approach is helpful for more general fatigue (Sharpe 1994
personal communication), and for individual patients with
maladaptive beliefs (Faas 1992). A more detailed discus-
sion of CBT can be found in Chapter 5.
Given the limited number of effective treatments available,
some physicians have focused primarily on lifestyle manage-
ment and symptomatic care (e.g. Bell and Concemi 1994, Ho-
Yen 1993, Wilson et al 1994a). Views on exercise continue
to vary although most specialists currently advise CFS
patients to accept the limitations imposed by the illness,
to balance rest and activity and to avoid overexertion and
'stress'. A few also recommend vitamin and mineral supple-
ments, sometimes in combination with a low-sugar, low-yeast
diet plus anti-fungal medication (Dawes 1991). So far,
anecdotal reports suggest that this regime is beneficial in
a proportion of cases, but there has been only one study to
test this approach (Hilgers and Frank 1992), and the theory
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on which it is based still lacks scientific support.
1.7 Discussion
As noted above, the literature on CFS reveals many incon-
sistencies and ambiguities. Thus in some cases, the illness
follows an infection while in others, the onset is gradual.
In some patients, there is evidence of ongoing infection but
this has not been found in others. Even in those with post-
infectious CFS, a number of micro-organisms have been impli-
cated, suggesting that different infections can result in
the same clinical syndrome.
In terms of the psychological aspects of CFS, research seems
to indicate that many patients fulfil criteria for psychi-
atric illness. However, here too, no single disorder has
been consistently linked with all patients and the dif-
ferences between CFS and depression suggest that the fatigue
can not be explained in terms of mood disorder alone.
While the controversies about the aetiology of CFS have been
generally acknowledged, a number of issues have yet to be
fully addressed. For instance, the current emphasis on
fatigue may have reduced some clinicians' awareness of the
severity and disability associated with other symptoms,
particularly those related to cognitive function.
Another issue which must be considered is the diagnosis of
CFS. As discussed above, the use of less restrictive
definitions means that CFS has become an umbrella term which
covers a number of disorders (e.g. Bock and Whelan 1993,
Klimas and Fletcher 1995). For instance, recent studies on
CFS have described patients with giardiasis, major
depression, somatisation disorder, fibromyalgia as well as
post-viral syndromes and Lyme disease (Coyle et al 1994,
Levine et al 1992, Straus et al 1994). According to Straus
et al (1994), the fact that the CDC case definition allows
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a number of different conditions to be included under the
rubric of CFS has broadened "the scope of the clinical
entity to the point at which it is no longer definable".
The heterogeneity of CFS may be one possible explanation for
the inconsistent findings which have been documented, for
instance, in relation to cognitive impairments (e.g. Smith
et al 1993 versus Macdonald et al 1993b), attributions (e.g.
Wessely and Powell 1989 versus Ray et al 1992b), the rate of
depressive disorders (e.g. Yeomans and Conway 1991 versus
Wessely and Powell 1989) and the type of depressive symptoms
(e.g. Powell et al 1990 versus Hickie et al 1990). On the
other hand, the inconsistencies could also be due to the
fluctuation of the disorder (Patarca et al 1993) or the use
of different laboratories and measures.
To reduce the 'noise' introduced by the inclusion of dif-
ferent disorders, both the CDC and Australian researchers
have recommended that specific subgroups be distinguished
and that their results be analysed separately. This will
enable scientists to compare different fatigue syndromes,
and to identify similarities and differences.
A third issue concerns the research into the psychological
and social aspects of CFS. To date, most studies have
focused on the prevalence of psychiatric morbidity and the
patients' adherence to a set number of maladaptive beliefs
and behaviours. As a result, there is a lack of information
concerning the impact of CFS and the patients' response to
their illness. Indeed, the current knowledge about the
nature of the attributions or the types of coping strategies
used, may actually be incomplete. Moreover, in contrast to
the research on other chronic disorders, little is known
about some of the additional factors which may underlie
emotional distress (Mayou and Hawton 1986, Rodin et al 1991,
Wells et al 1989). For example, there have been few studies
assessing the possible influence of social support, and how
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this may affect the patient's psychological health.
This lack of knowledge about the nature of the illness, the
types of coping strategies used and the possible deter-
minants of emotional distress suggests that the full
complexity of CFS may not yet have been recognised.
Further research into the psychological and social effects
of CFS is therefore required, not only to obtain a fuller
understanding of the illness-as-lived, but also to identify
more effective ways of alleviating the patients' distress.
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CHAPTER 2 
Reactions to chronic illness and disability
"All chronic illnesses represent assaults on
multiple areas of functioning, not just the body.
Patients ... may face separation from family,
friends, and other sources of gratification; loss
of key roles; disruption of plans for the future;
assault on self-images and self-esteem; uncertain
and unpredictable futures; distressing emotions
such as anxiety, depression, resentment, and help-
lessness; as well as such illness-related factors
as permanent changes in physical appearance or in
bodily functioning."
(Turk 1979)
Although it is generally accepted that CFS has a profound
effect on those who suffer from it, there has been com-
paratively little research into the psycho-social conse-
quences of the illness. To help determine which factors may
be involved, and how these might affect adjustment to CFS,
it was decided to examine the research on other chronic
disorders. Section 1 focuses on the process of adaptation
and the assessment and prevalence of emotional distress.
This is followed by a review of the various factors which
have been associated with adjustment and distress in the
chronically-ill and a discussion about the variables which
may play a similar role in patients with CFS.
2.1 The process of adjustment 
Chronic conditions are rarely stable and for most patients,
changes in the illness or disability cause disruption at
various times throughout their lives. Adaptation is there-
fore an ongoing process, not an end state (Dimond 1983, Turk
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and Rudy 1986).
In most cases, the patients' reactions to the changes vary
according to the demands placed on them and their resources
at the time. However, there appears to be general agreement
about what patients should aim for. According to Dimond
(1983), successful adaptation is achieved when one's way of
life "sustains hope, diminishes fear, and preserves a
quality of life that takes account of, perhaps transcends,
but is not controlled by, the limitations of the illness".
In contrast, Wright (1960) suggested that patients needed to
change certain attitudes. For example, she believed that
they should subordinate concerns about physique to factors
such as personality and effort and that they had to contain
the effects of their disability so that the latter would not
affect how they perceived every aspect of their life. She
also felt that patients should learn to value their own
assets and strengths instead of basing judgements on a
comparison with others.
A completely different approach to the study of adjustment
has been to assess the reactions to specific events. For
instance, Moos and Tsu (1977) identified 7 major 'adaptive
tasks' which most patients encounter while they are ill.
These include:
1. Dealing with symptoms and incapacitation, learning to
control symptoms and prevent exacerbations.
2. Dealing with the hospital environment, treatments and
procedures
3. Developing adequate relationships with professional
staff and dealing with problems that may occur.
4. Preserving a reasonable emotional balance, for instance,
by managing upsetting feelings, by dealing with anxiety and
apprehension if the outcome of the illness is uncertain, and
most importantly, maintaining some hope, even when its scope
is sharply limited by circumstances.
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5. Preserving a satisfactory self-image, and maintaining a
sense of competence and mastery (which often necessitate a
change of personal values as discussed by Wright, above).
6. Preserving relationships with family and friends,
dealing with feelings of isolation and alienation.
7. Preparing for an uncertain future, the loss of functions
such as sight, speech etc., and in some cases, death.
According to Moos and Tsu, people's reactions to these tasks
are generally aimed at re-establishing their sense of social
and psychological equilibrium. Responses which achieve a
"new balance" and which promote maturation and personal
growth are regarded as adaptive. Conversely, those which
lead to psychological deterioration and decline are
maladaptive.
The adaptation to chronic disorders can also be studied
using the cognitive-motivational-relational theory developed
by Lazarus (1991, 1993, Cohen and Lazarus 1979). This
focuses on the ways in which individuals appraise changes in
their relationship with the environment and how they react
to those appraisals. For instance, it posits that if a
person judges new demands to be manageable, these will be
interpreted in a positive way, as a challenge and an
opportunity for growth. Similarly, where outcomes relating
to change are judged to be either irrelevant to the person's
well-being or goals and unlikely to lead to harm or loss,
they may be ignored. Thus, changes in these situations are
unlikely to produce significant distress. Indeed, it is
only when a particular demand threatens the individual's
well-being, values or goals, and the person does not feel
able to master or control that demand, that he or she may
experience psychological distress. Moreover, if the
individual fails to solve the problem or to regulate their
emotional distress, it may adversely effect their health,
their daily functioning and their morale.
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Whether a situation is judged to be threatening depends on
individual characteristics, e.g. a person's knowledge,
beliefs, goals, values and personality; and environmental
variables, e.g. the imminence of harm and the resources
which are available to deal with the harm. Similarly, how
a patient responds to the threat will be determined by a
variety of factors such as the individual's options for
coping, the expected outcome, and whether the person will be
blamed or not if things go wrong.
Another influence on both appraisal and response is the
state of a person's health (Nerenz and Leventhal 1983). For
instance, it has been pointed out that fatigue and dysphoria
may both make demands seem more overwhelming and distressing
than they are, and undermine people's confidence about their
ability to cope (Lazarus 1991, Fontana and Palfai 1994).
Likewise, cognitive deficits might interfere with the pro-
cessing of information, and the performance of any coping
strategies which require a high level of concentration
(Earll 1989). Similarly, pain or feeling ill may disrupt
focused thinking (Trieschmann 1989), leading to maladaptive
responses and possibly, to emotional distress (Donoghue and
Siegel 1993, Harkapaa 1991).
In summary, psychological disturbances can be perceived both
as stressors which threaten well-being and undermine coping,
and as the effect of the persons's inability to cope with
other 'stressors' (Lazarus et al 1985).
The following section will outline the various types of
psychological disturbances associated with chronic illness
and disability and discuss the prevalence of the more
serious psychiatric disorders such as depression.
2.1.1 The psychological response to illness and disability
Psychological disturbances associated with illness or disa-
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bility may involve one emotion or a combination. They can
also vary in intensity, from mild to severe. If psycho-
logical symptoms occur within three months of the onset of
physical illness or trauma and they cause significant im-
pairment, they are classed as 'adjustment disorders' (Razavi
and Stiefel 1994). The latter differ both from acute stress
reactions, which are transient and last for a shorter period
of time, and from post-traumatic stress disorder, which is
dominated by the reliving of the trauma in memories and
dreams, and the avoidance of activities and situations which
remind the person of the stressful event.
Another disorder related to illness is organic mood syndrome
(Lloyd 1991). This is diagnosed when psychological distur-
bances appear to be aetiologically related to specific or-
ganic factors such as infection, a degenerative process in
the brain, or the effects of certain drugs. Also recognised
are generalized psychological distress and the more specific
and severe psychiatric diagnoses.
According to Mayou and Hawton (1986), the most common form
of affective disorder among the medically-ill is an
undifferentiated neurotic syndrome and only a small, but im-
portant minority suffer from more specific psychiatric
conditions. The latter are best diagnosed using specific,
standardized measures or structured interviews (Rodin et al
1991). However, the former may be assessed using general
measures of emotional distress such as the General Health
Questionnaire (GHQ).
Information about the patient's psychological state may also
be obtained indirectly, through data about self-care and the
I Although the presence of psychiatric disorder is a
clear indication of psychological suffering, it is generally
accepted that it does not capture the experience in its
entirety (Breslau and Davis 1986, Rodin et al 1991).
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prevalence of suicides, drug-abuse and divorce (Craig et al
1990, Krause and Crewe 1987, Long 1989, Wilkinson 1989).
Other researchers have combined measures of the patient's
psychological well-being with information about physical and
social functioning to give an indication of the person's
quality of life and/or satisfaction with life (Anson et al
1993, Fallowfield 1990, Fuhrer et al 1992, Schulz and Decker
1985). However, some of these measures have been criticised
for relying on the value judgements of professionals or the
general public as to what actually constitutes a good or
poor quality of life (Wilkinson 1989).
Additional assessments of the patient's response to their
condition have focused on self-concept (Matson and Brooks
1977); acceptance of disability (Woodrich and Patterson
1983); behaviour (Walford et al 1993); participation in
various activities (MacDonald et al 1987, Terry 1992,
Stenager et al 1991); and functional impairment (Rosenstiel
and Keefe 1983). Indeed, since chronic conditions can
affect so many aspects of daily life, many studies now use
multiple indicators, notably measures of emotional well-
being, physical impairment and functional capacity, to give
a more complete view of adjustment and distress (cf.
Goodenow et al 1990).
The prevalence of psychological distress and psychiatric
morbidity
Studies have shown that psychiatric disorders as well as
subclinical distress tend to be more common among the
medically ill and disabled than in the population at large
(Rodin et al 1991, Robins et al 1984, Weissman and Myers
1978). For instance, Cavanaugh (1984) studied 335 hospi-
talized patients and found that 61% had a GHQ-30 score above
5, indicating the presence of emotional distress. The rates
of depression (Beck Depression Inventory score >13) varied
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according to the illness, from 55.6% in people with gastro-
intestinal conditions to 14.3% in people with endocrine
diseases.
Similarly, Derogatis et al (1983) assessed 215 cancer
patients and assigned a psychiatric diagnosis in 47% of
them. Six per cent were judged to have depression or
dysthymia, while just 2% fulfilled the criteria for clinical
anxiety. Likewise, a study of patients with long-standing
diabetes mellitus (type 1) revealed that 51% were suffering
from one or more psychiatric disorder (Popkin et al 1988).
Major depression was diagnosed in 10.7% and phobic disorder
in 20%.
The estimated prevalence of affective disorders doesn't just
vary from group to group but also within groups. Taking
depression as an example, the estimates in patients with
diabetes have ranged from 8.5% to 60% (Lustman et al 1992).
This does not include a study of patients suffering from
additional complications, which revealed 74% to be depressed
(Leedom et al 1991). With regard to multiple sclerosis, es-
timates of affective disorders have varied from 14% (Joffe
et al. 1987) to 90% (Dabs et al 1983). The latter was
identified in patients with a progressive course; in those
with a more stable condition, the rate of emotional distur-
bance was much lower (39%). Similarly, Cummings (1992) in
his review of the research on depression in Parkinson's
disease listed rates from 9 to 81%, with a mean of 40%.
Some of the recent estimates of depression in other
medically-ill populations are shown in Table 1.
There are a number of reasons why the research relating to
the prevalence of psychiatric disorders should be inter-
preted with caution (Rodin et al 1991, Rodin and Voshart
1986). For example, estimates may vary depending on:
a. the type of measure used (e.g. self-report measures
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Table 1.	 Depression in patients suffering from medical
conditions.
Depression % Measure Group Authors
7 Interview AIDS Atkinson et al. 88
11 Interview S.L.E. Hay et al. 92
12.5 Interview Muscle Dis. Wood et al. 91
17 Interview R.A. Frank	 et al. 88
19 Interview M.I. Forrester et al .92
20 Interview SCI Judd et al. 89
25 HAD Rectal cancer MacDonald 1988
38 BDI Chronic pain Blakely et al. 91
60 Interview Tinnitus Sullivan et al. 88
Key
BDI	 Beck Depression Inventory
HAD	 Hospital Anxiety and Depression Scale
R.A.	 Rheumatoid arthritis
S.L.E.	 Systemic lupus erythematosus
M.I.	 Myocardial Infarction
Muscle Dis. Muscle diseases
M.S.	 Multiple sclerosis
focus on depressive symptoms whereas standardised interviews
can identify depressive illness),
b. the suitability of the measure for a particular sample,
c. the use of different cut-off points,
d. the heterogeneity of the sample (e.g. general medical
population or sub-divided into groups according to diag-
nosis, stability, severity).
e. the unwillingness of some patients to admit to symptoms
of depression.
The effect of different types of criteria and measures was
clearly demonstrated by Bukberg et al (1984). They studied
90 patients with various types of cancer and found that 42*
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met the standard DSM-III criteria for major depression.
However, using the BDI, 33% were classified as suffering
from depression while on the Hamilton Rating Scale, only 17%
had scores above the accepted cut-off point.
Some of the discrepancies documented above can be attributed
to the inclusion of somatic complaints. According to
Cavanaugh (1991), the core symptoms of depression in the
medically-ill are the same as those reported by psychiatric
patients e.g. anhedonia, frequent crying, severe indecisi-
veness and a loss of interest in people. Similarly, a sense
of failure and sense of punishment are signs of depression
which are generally not confounded by the presence of
physical illness (Clark et al 1983). However, there are a
number of symptoms which are common to both medical and
psychiatric illness and whose inclusion can produce an
artificially high estimate of psychiatric morbidity. These
include fatigue, insomnia, loss of appetite, psychomotor
retardation and difficulties with concentration (Bukberg
1984, Cavanaugh 1991, Clark et al 1983, Frank et al 1988,
Krupp et al 1988, Minden 1986, Starkstein et al 1990).
Interest in co-existing psychiatric disorders and emotional
distress has been fuelled by an increased awareness of their
effects. For instance, it has been found that medically-ill
patients with anxiety and depression do much worse in terms
of physical, role and social functioning than patients who
are psychologically well (e.g. Devellis 1993, Wells et al
1989). More specifically, depression has been shown to
increase the risk of angina and emotional instability in
people recovering from myocardial infarction (Ladwig et al
1994) and it was associated with marked psycho-social and
behavioural dysfunction in patients with rheumatoid
arthritis (Beckham et al 1992). In multiple sclerosis,
depression has been linked to immune disregulation (Foley et
al 1992) while a study on cancer patients found that
improvements in affect was related to positive changes in
59
immune status (Fawzy et al 1990a).
Psychiatric morbidity and distress have also been linked to
less effective coping (Zautra and Wrabetz 1991) and may
interfere with clinical management and rehabilitation (Malec
and Neimeyer 1983, Mayou and Hawton 1986, Rodin and Voshart
1986, Rodin et al 1991).
2.2 Factors affecting psychological adjustment 
2.2.1 The effects of social and economic problems 
When considering the possible sources of emotional distur-
bance, it is important to take into account the social as
well as the financial consequences of chronic illness and
disability. For instance, a variety of surveys over the
years have revealed that people with disabilities have a
higher rate of unemployment and lower income compared to the
non-disabled (Lonsdale 1990). Furthermore, fewer disabled
people of working age own their own home, and financial help
to enable disabled people to live independently is not
always adequate to meet the costs involved (Disability
Rights Bulletin, Summer 1993).
Some of these limitations reflect political and judicial
systems. For example, the social security benefits for
people who became disabled as a result of war or industrial
injury are much higher than those for people whose disabili-
ty resulted from illness, even though the degree of impair-
ment may be same (Disability Rights Handbook 1994).
Other constraints on people with chronic conditions often
reflect attitudes among the general population. Thus people
with chronic disorders may be subjected to discrimination,
both when applying for work and in terms of their salary
(Nelson 1992). Lastly, the inaccessibility of certain
buildings means that some disabled people are effectively
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barred from particular training courses, schools, jobs and
recreational activities.
2.2.2 The problem of stigma
Some conditions carry a social stigma (e.g. psoriasis,
cancer, AIDS) and this may lead patients to conceal their
illness or disability if possible (Goffman 1963, Lonsdale
1990). For instance, they may 'cover up' and 'keep up , in
order to appear normal and avoid the negative reactions from
others (Locker 1983, Robinson 1988, Wiener 1984). If that is
not possible, for example, if the effects of the condition
are difficult to hide, then the person may be made to feel
inferior and deviant.
Stigma may lead others to infer additional negative attri-
butes, for example, it may be assumed that an individual
with a physical disability is also emotionally or intel-
lectually impaired. This further reinforces the inferior-
status position of the disabled, and accordingly, their
ability to influence decisions which concern them (Thoresen
and Kerr 1978).
The media sometimes reinforce the stereotypes of stigmatized
groups by providing selective information and presenting
composite portraits of the people involved (Schur 1980).
However, since stigmatization often lowers people's self-
confidence and self-esteem, the 'victims' are generally not
inclined to challenge erroneous information about them-
selves.
Stigma can also affect a patient's medical and emotional
health. For example, feelings of stigma attached to rectal
cancer was found to be related to an increased risk of poor
sleep, fatigue and complications after surgery; with greater
use of tranquillisers and analgesics, and with increased
rate of clinical depression and anxiety (Macdonald 1988).
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Finally, like other social constraints on people with
chronic disorders, stigma can undermine psychological health
simply by reducing the number of resources which patients
can draw on to deal with the consequences of their disease
(Dimond 1983, Locker 1983).
2.2.3	 The effects of demographic and illness-related
variables 
2.2.3.1 Demographic variables 
a. Age
Since previous experience of illness and coping might help
in the process of adaptation, it has been suggested that
older patients may react to certain conditions with more
confidence and maturity than younger ones. On the other
hand, age-related disorders which cause brain damage and/or
cognitive disorganization might impair coping capacity and
undermine adjustment (LipowSki 19O.
The different possibilities are reflected in the research.
Thus studies have linked increased emotional distress both
with youth (e.g. Tate et al 1994, Mishel et al 1984, Noyes
et al 1990, Viney and Westbrook 1981), and with maturity
(e.g. Carroll et al 1993, Cassileth et al 1984, Gilchrist
and Creed 1994, McIvor et al 1984).
b. Gender
To date, the research has failed to find a consistent dif-
ference in the way men and women react to chronic illness
and disability. For instance, while Tate et al (1994) found
that men with spinal injuries reported more distress than
women, Coyle and Roberge (1992) reported that female pa-
tients with a variety of disorders had higher scores on a
depression scale than males. Similarly, Forrester et al
(1992) found that major depression was more common among
women than men following myocardial infarction but Woodrich
and Patterson (1983) showed that women were more likely to
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accept their disability than men.
c. Baucation
Higher levels of education have been associated both with
lower levels of psychological distress (Christman et al
1988, Moser et al 1993, Viney and Westbrook 1981) and with
acceptance of disability (Woodrich and Patterson 1983).
This is consistent with the view of Ben Sira (1983), that
education is an important resource which enables patients to
find and use effective coping strategies.
d. Socio-economic status 
Low income has been correlated with high depression scores
(e.g. Coyle and Roberge 1992, Tate et al 1994, McIvor et al
1984), as has low social class (Nielsen and Williams 1980).
2.2.3.2 Illness-related variables 
a. Onset and course 
It has been noted that conditions with a gradual onset may
provide more time for patients to adjust to diminishing body
function than those with a sudden onset. Likewise, it may be
easier to cope with relatively stable, predictable disorders
than with diseases which lead to sudden and unexpected prob-
lems such as seizures, loss of bowel control, loss of recent
memory or severe pain (Dimond 1983).
It has also been suggested that chronic and unstable condi-
tions such as multiple sclerosis can encourage the develop-
ment of patterns of somatisation. According to Pavlou and
Stefoski (1983), the long-term uncertainty and changing
nature of the symptoms, plus their severity, raises the
likelihood that people will become increasingly vigilant and
involved in their bodies. Furthermore, since each new symp-
tom may signal a deterioration, patients may demonstrate
heightened responses to minor physical changes (cf Trigwell
et al 1995).
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b. Severity of symptoms and disability 
A number of studies have shown that depression in the
medically-ill is at least partly related to the severity of
the symptoms and degree of impairment. For example, Stewart
et al (1965) examined patients using a standardized inter-
view and found that 20% of the severely affected were
clinically depressed. In contrast, only 3% of those with
milder illnesses were suffering from depression.
More recently, Cassileth et al (1984) studied a group of 758
out-patients and reported that patients with cancer who were
capable of normal activity had significantly lower scores
for psychological distress than people who were experiencing
more symptoms or who were bedridden. Their findings are
consistent with those of Bukberg et al (1984), Craig et al
(1994), Folkman et al (1993), Forrester et al (1992),
Littlefield et al (1990), McIvor et al (1984), Moffic and
Paykel (1975), Noyes et al (1990), Skevington (1986), Tate
et al (1994), Viney and Westbrook (1981) and Wineman (1990).
However, some studies have failed to find any significant
link between level of disability and emotional distress
(e.g. Christman et al 1988, Coyle and Roberge 1992, Dabs et
al 1983, Gilchrist and Creed 1994, Hay et al 1992, Maybury
and Brewin 1984, Ron and Logsdail 1989, Moller et al 1994).
c. Site and extent of disease 
Levels of psychological distress have also been associated
with the site and/or extent of the lesion. For example,
Fleminger (1991) examined 30 patients with Parkinson's
disease and found that individuals whose symptoms were worse
on the left side were more likely to become depressed and
anxious than patients whose symptoms were worse on the right
side. This supports the hypothesis that depression in these
patients may, at least in part, be due to striatal dopamine
depletion in the right cerebral hemisphere.
Likewise, a number of studies on people with spinal cord
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injuries have found higher rates of depression among quadri-
plegics, who have lesions in the neck region, compared to
paraplegics, who have lesions lower down (e.g. Judd and
Brown 1992, MacDonald et al 1987). Furthermore, Carroll et
al (1993) reported higher depression scores in cancer
patients with active disease and metastases.
Sometimes a particular condition can alter the emotional
repertoire of the patient. For instance, people may become
more emotionally labile following a stroke (Gregg et al
1989).
d. Illness intrusiveness 
Illness intrusiveness refers to the effects of physical im-
pairment on valued activities and interests. According to
Devins et al (1992), this results in patients having less
access to positive and rewarding experiences and it comprom-
ises their personal control over important outcomes.
Research on this subject is in its infancy but studies have
already shown that multiple sclerosis is more intrusive than
either rheumatoid arthritis or end-stage renal disease
(Devins et al 1993a). Furthermore, illness intrusiveness was
found to be correlated with depression in all three patient
groups, even after controlling for relevant variables such
as the severity of symptoms (Devins et al 1992, 1993b). The
measure used to assess illness intrusiveness is currently
being validated for British samples.
e. Duration
Increased psychological distress has been documented both in
recently diagnosed patients (e.g. Cassileth et al 1984,
Richards 1986, Shadish et al 1981) and in those who have
been ill or disabled longer (e.g. McIvor et al 1984). Time
has also been linked with increased acceptance of disability
(Woodrich and Patterson 1983).
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f. Visibility of the condition
A number of researchers have associated the visibility of
the condition with the risk of emotional distress. For
instance, Andreasen and Norris (1977) identified psycho-
logical problems in 30% of patients who had been severely
burned up to five years previously. They observed that the
burns had led to an altered self-image and in some cases, to
an identity crisis. In their opinion, those who had ad-
justed well had redefined their self-image in terms of non-
physical and intangible attributes such as courage, perse-
verence and living for others (cf. Wright 1960). Disfigure-
ment as a result of diseases like cancer has also been
linked with increased distress, particularly among women
(Noyes et al 1990).
However, having a visible disability can have certain advan-
tages. For example, Viemero (1991) studied patients with
muscular dystrophy and found that the visibly disabled
reported less depression than those whose disease was not
yet visible. The latter had more difficulties in forming new
friendships and they felt more ashamed when they had to ask
for help. These difficulties were not related to the disa-
bility per se, but to the fear of negative reactions to
disability.
g. Past history of illness 
Previous experience of illness can be both a help and a
hindrance. For instance, a past history of angina and mood
disorder has been linked with depression following myocar-
dial infarction (Forrester et al 1992). On the other hand,
previous stressful experiences in relation to illness and
hospitalization were found to help children with cancer
withstand the subsequent stressors of a bone marrow
transplant (Pot-Mees 1989).
A history of depressive episodes does not appear to have
such a protective effect. Indeed, they have been linked
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with subsequent emotional distress in both general medical
patients (Moffic and Paykel 1975), and the chronically-ill
(Minden et al 1987, Lustman et al 1988).
h. Information 
Information from health care professionals affects not only
how patients perceive their illness but also how they cope
(Marteau 1989, Nerenz and Leventhal 1983). It can reduce the
ambiguity, anxiety and fear associated with certain condi-
tions, and increase perceived control (Counte et al 1983,
Dimond 1983). It is especially important in chronic disor-
ders such as rheumatoid arthritis, where the patient not
only has to manage a variety of distressing symptoms but
also has to learn to adapt to new and more limited life-
styles (Locker 1983).
Where patients do not receive adequate information from
medical staff, they or their families may 'shop around' and
seek knowledge from others with experience of the disease
(Comaroff and Maguire 1981, Davis 1963). However, if those
people lack the necessary expertise, their advice could be
harmful and cause further distress (Shepherd 1992).
2.2.4 Psychological factors 
2.2.4.1 Personality
A number of personality dimensions have been associated with
psychological adjustment. These include resilience
(Visotsky et al 1961), sense of coherence (Antonovsky 1987),
learned resourcefulness (Rosenbaum 1988) and a number of
characteristics discussed below. Conversely, the lack of
these traits have been linked with emotional distress and
psychiatric morbidity.
a. Fardiness 
Hardiness is a composite of three dimensions: commitment,
control and challenge. It has been suggested that hardy
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people feel able to control or influence the events in their
lives, and that they are deeply involved and committed to
certain activities. They also tend to perceive change as an
exciting challenge to further development (Kobasa 1979).
Research to date has indicated that hardiness may also
moderate the negative effects of stress on health (e.g.
Hills and Norvell 1991, Kobasa et al 1982). Moreover, a
study on patients with systemic sclerosis revealed that
hardiness was positively correlated with psychological
adjustment (Moser et al 1993).
However, the construct of hardiness has been criticised
because it overlaps to some extent with neuroticism. This
should be taken into account when interpreting the research
(Williams et al 1992).
b. Optimism versus pessimism
Optimism has been defined as "an inclination to ... antici-
pate the best possible outcome" (Scheier and Carver 1987).
It's a disposition or orientation, and as such, tends to be
fairly stable over time.
In terms of outcomes, optimism has been linked with fewer
reports of symptoms, with less depression and with a faster
rate of recovery from heart surgery (Scheier and Carver
1987). It has also been associated with less uncertainty and
psychological distress in gynaecological cancer patients
(Mishel et al 1984); with emotional well-being in people
with asthma (Maes and Schlosser 1988) and with good coping
in newly diagnosed cancer patients (Weisman and Worden
1976).
In contrast, pessimists appear to be more inclined to dwell
on negative experiences, and will use more denial and dis-
tancing than optimists (Carver et al 1989, Scheier and
Carver 1987). Research has suggested that pessimists also
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have poorer immune function (Kamen and Seligman 1989) and
that they suffer from more ill-health in the long-term
(Peterson et al 1988). However, as in the case of
hardiness, there is evidence that neuroticism may have
confounded some of the findings relating to pessimism (Smith
1989).
c. Self-esteem
Self-esteem has been defined as "pride in oneself in which
one becomes aware of and accepting of one's imperfections
while cherishing one's inherent strengths and positive qua-
lities" (Lazarus 1991, p. 441). It may be undermined by
illness, especially if an individual's sense of self is
rather fragile, or it is closely tied to the person's
physical integrity or bodily appearance (Rodin et al 1991).
Low self-esteem has been linked with increased psychological
distress three months after a heart attack (Terry et al
1992) and with reduced psychological well-being in patients
with rheumatoid arthritis (Krol et al 1994). It has also
been associated with feelings of vulnerability in patients
with cancer (Weisman and Worden 1976) and with negative
beliefs about pain (Williams and Thorn 1989). However, it
was not related to the risk of developing a cold (Cohen et
al 1991).
2.2.4.2 Attribution
Although the patients' views of what caused their illness
may not be accurate, having a causal explanation for symp-
toms is associated with more positive outcomes than not
having an attribution at all (Turnquist et al 1988). How-
ever, it has been difficult to identify which types of
belief are associated with successful adjustment. For in-
stance, certain attributions may be linked with a positive
outcome at one stage of illness, but with poor outcome in
another (Van den Bout 1988). Nevertheless, there is some
evidence that explanations which attribute symptoms to ex-
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ternal sources tend to be related to poor adjustment
(Turnquist et al 1988). More specifically, it has been
suggested that blaming another agent may reduce some
patients' sense of control which in turn might promote
feelings of helplessness and hence increase emotional
distress (Butler et al 1991, Cope et al 1994b, Lawrie and
Pelosi 1994).
Recent research into the relationship between certain
beliefs and adjustment has focused in particular, on the
influence of perceived control.
a. Locus of control 
People's attributions about the onset of their illness may
be independent of the perceived controllability of future
outcomes. Thus people might blame their fatigue on an
external agent such as a virus, yet still see the outcome as
something they can control through diet, relaxation, and
adjuvant medical interventions.
Much of the research into the effects of perceived control
has been stimulated by the concept of )Locus of control 
(Rotter 1975). This divides people, dispositionally, into
those with an internal locus and those with an external
locus. People with an internal locus of control perceive
that outcomes are determined by their own actions or their
own "relatively permanent characteristics". In contrast,
people with an external locus perceive outcomes to be the
result of luck, chance, fate or the result of powerful
others.
A number of studies have linked an internal locus of control
with successful adaptation and adjustment to illness and
disability. For instance, both Schulz and Decker (1985) and
Devins et al (1993c) found that greater perceived control
was correlated with increased psychological well-being.
Similarly, Partridge and Johnston (1989) showed that an
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internal locus was associated with faster recovery from
strokes and fractured wrists, while Frank et al (1987)
reported that people with spinal injuries who were high on
internal locus of control appeared to be better adjusted.
Conversely, Craig et al (1994) found that feeling out of
control was a predictor of long term depression in people
with spinal cord injuries. Moreover, Shadish et al (1981)
noted that external locus of control was related to
increased psychological distress in their disabled patients
(Shadish et al 1981).
It has recently been suggested that the actual experience of
illness or disability may shift perceptions of control,
increasing attributions to chance and powerful others (Nagy
and Wolfe 1983). This is supported by a study on patients
with back pain which found that those with the severest
symptoms reported lower levels of internal locus of control
but stronger beliefs in others (Harkapaa 1991).
While one might deduce from the literature that attempts to
stimulate the patients' internal locus may be adaptive, it
is important to note that people may perceive control over
one aspect of their well-being but not over another. For
instance, Affleck et al (1987a) reported that patients with
rheumatoid arthritis tended to perceive more control over
their symptoms than over the course of their disease, which
they saw as being controlled by others. In this study,
greater perceived control over symptoms and treatment was
related to positive mood and to psychosocial adjustment,
while greater personal control over the course of the
disease was associated with increased mood disturbance and
poorer adjustment. According to Affleck and colleagues,
perceived personal control over symptoms aids adaptation,
but a belief in personal control where there is little, may
be counterproductive. Thus any attempt to increase a pa-
tient's confidence about controlling outcomes where this is
actually unrealistic, is likely to lead to frustration as
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well as demoralization.
Other studies have also cast doubts on the view that an
internal locus of control is invariably related to positive
adjustment. For instance, perceived control was not asso-
ciated with depression in patients with HIV (Folkman et al
1993), nor with psychological distress three months after a
heart attack (Terry 1992). Moreover, it was not related to
effective coping with health problems (Zautra and Wrabetz
1991), and did not predict health status 10 months after
myocardial infarction (Affleck et al 1987b).
It has been argued that perceived control may sometimes have
an indirect effect on well-being, for instance, through its
influence on coping (Folkman et al 1993). According to
Folkman (1984), people who feel in control of their lives
may be more likely to appraise demands in terms of chal-
lenge; they therefore experience fewer negative emotions and
will therefore be in a position to engage in more efficient
problem-focused coping. Conversely, people who feel less
control may appraise the same demand as a threat, thus
experiencing more negative emotion which in turn impedes
problem-focused coping.
This view is supported by studies showing that people with
an internal and external locus do tend to use different
types of strategies (Harkapaa 1991), and that those used by
externals may be less effective (Frank et al 1987). However,
whether changing patients' attributions will automatically
lead to the use of more adaptive coping strategies remains
unclear. Indeed, it may not even be helpful in the manage-
ment of chronic illnesses where shared control with others
in the family, and with health professionals, might be more
appropriate (Earll 1989).
Thus further research is required to establish if changing
people's locus of control is of actual clinical value or
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whether it may be more useful to concentrate on specific
beliefs about the symptoms and their ability to cope. Until
then, attempts to amend patient's beliefs about the control
over their condition as a whole may be premature and coun-
terproductive.
b. ,Self-efficacy
In contrast to the locus of control which focuses on the
person's perceived influence on outcomes or reinforcement,
self-efficacy describes the patients's belief or feeling
that they can exercise some control over specific behaviours
and tasks (Bandura et al 1988, Bandura 1989) 2 . It is
therefore a narrower concept than locus of control.
It has been argued that if people are confident that they
can do what is required to achieve a certain outcome, this
will increase their motivation and their perseverance in the
face of adversity (Holman and Long 1992). It has also been
proposed that self-efficacy influences the self-enhancing or
self-hindering nature of people's thoughts and therefore
their vulnerability to depression and stress .
Although levels of self-efficacy are dependent, in part, on
the person's previous experiences, it is not a generalised
trait and can be modified through learning and practising
certain activities and techniques. For instance, a course
which taught self-management techniques to patients with
chronic arthritis raised self-efficacy scores and signi-
ficantly reduced those for depression and pain (Long et al
1989). Moreover, there was a positive correlation between
self-efficacy and improvements in health.
Other studies support the view that self-efficacy is associ-
2 In theory, people can believe that they have control
over certain behaviours (self-efficacy) but regard an
outcome or reinforcement as being outside their control
(outcome expectancy), and vice versa.
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ated with positive outcomes. Thus Terry (1992) found that
high levels were correlated with low scores for trait anxi-
ety, as well as low psychological distress, three months
after myocardial infarction.
c. Illusion
Some patients have a tendency to evaluate themselves and
their degree of control or mastery in an overly positive way
and they may be unrealistically optimistic in the face of
adversity (Rodin et al 1991). However, this is not always
maladaptive. In a few situations, adhering to illusions may
help reduce feelings of helplessness and distress (Langer
1976). For instance, believing that one has influence over
the cause of illness or relapses, can help patients to cope
with the fear and uncertainty of conditions like cancer
(Taylor 1983).
2.2.4.3 Uncertainty
Uncertainty is a perceptual state which occurs when internal
or external stimuli are vague or unclear. In terms of ill-
ness, lack of clarity can make it difficult to interpret the
meaning or significance of changes. There may also be ambi-
guity concerning diagnosis, prognosis, symptoms, treatment,
and/or relationships with others (Moser et al 1990).
One condition surrounded by a great deal of uncertainty is
AIDS. Although much is known about the disease, it is still
difficult to predict the course that the illness will take,
the type and severity of the symptoms which patients will
experience and the effects of any treatments tried. Suf-
ferers also face the prospect of an undignified death (Weitz
1989).
In other illnesses, uncertainty may arise as a result of
marked fluctuations in the severity of symptoms, as in
multiple sclerosis (Robinson 1988) and rheumatoid arthritis
(Wiener 1975). In these cases, the changeability in symptoms
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means that the patient's appraisal about being able to ma-
nage is constantly challenged (Robinson 1988).
The Uncertainty in illness theory
The Uncertainty in illness theory (Mishel 1988) explains how
patients cognitively process illness-related stimuli and
construct meaning in these events.
According to Mishel, how much uncertainty is perceived
depends on the salience and pattern of the symptoms,
familiarity with illness-related events and situations, the
degree of congruence between the expected and the unexp-
ected, the patients' information-processing abilities
(cokgnitive capacity), their confidence in a credible
authority such as doctors, their own education and the
availability of social support (see Fig.1).
Mishel (1988) proposed that those with an external locus of
control may perceive uncertainty as threatening, people with
a disposition towards internal control may appraise it as an
opportunity and see it as a sign that there is still hope.
However, although there is some evidence that lack of
certainty can be perceived in a positive way (e.g. Taylor
1983), it is more often regarded as a source of distress
(Davis 1960-1). Indeed, studies on a number of different
conditions have linked increased uncertainty with pessimism
(Mishel et al 1984), emotional distress (Christman et al
1988, Wineman 1990) and poor adjustment (Mishel and Braden
1987, Moser et al 1993, Wineman 1990). It has also been
associated with a reduction in self-help (Braden 1990), a
reduced sense of mastery (Mishel et al 1991, Mishel 1990),
a lack of motivation, poor expectations about the future
(Mishel et al 1984) and a reduction in active behaviours
(Mishel et al 1984, Christman et al 1988). These findings
indicate that uncertainty may undermine the psychological
well-being of the medically-ill and as such, should be taken
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into account when considering the variables associated with
emotional distress.
2.2.4.4 The role of life events and stress 
Distressing life events can have a direct as well as in-
direct effect on psychological well-being (Andrews et al
1978, Folkman et al 1993). For instance, they may influ-
ence immune function (Adler and Matthews 1994, Brown and
Harris 1989) and increase the susceptibility to relatively
minor disorders such as colds (Cohen et al 1991).
The relationship between stress or 'daily hassles' on the
one hand, and adjustment on the other (Kanner et al 1981)
may be mediated by variables such as perception of control
and the choice of coping strategy. The literature on the
links between coping and emotional distress will be discus-
sed in more detail below.
2.2.5 The relationship between coping and psychological 
Adjustment 
Lazarus (1991) defined coping as 'cognitive and behavioural
efforts which are used to manage specific or internal
demands that are appraised as taxing or exceeding the re-
sources of the person'. The strategies which people chose
are often divided into two categories, namely problem-
focused ones, which are directed at managing the difficulty
and changing the actual situation for the better, and
emotion-focused ones, which are primarily aimed at regu-
lating emotions, including distress.
Commonly used problem-focused coping strategies include:
1. information-seeking. This involves searching for know-
ledge which will enable a person to learn more about the
problem and what can be done to deal with it. It provides
a basis for action and rationalisation.
2. direct actions. These include concrete acts like taking
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medicines, arguing with opponents and running away (escape-
avoidance).
3. inhibition of action. This includes the holding back of
impulses that may increase the probability of negative
outcomes.
Commonly used emotion-focused strategies include:
1. intrapsychic strategies. These involve ways of
reappraising the situation and redirecting attention, and
include defence-mechanisms such as denial and intellectua-
lization, wishful thinking, minimizing the threat, and
ignoring or withdrawal of attention (distancing).
2. turning to others for help and/or support. (However,
where support is needed for direct actions, this may also be
regarded as a problem-focused strategy).
Which approach is chosen depends on a number of factors. For
example, the choice of strategy may vary according to the
severity or stage of illness (Bracken and Shepard 1980,
Buddeberg et al 1991, Cohen and Lazarus 1979, Davis 1963,
Heim et al 1993, Matson and Brooks 1977, Shapiro et al 1994,
Viney and Westbrook 1982, Visotsky et al 1961). Other
influences include the number of medical problems (Ehmann et
al 1990), the physical environment i.e. whether one is in
hospital or at home (Christman et al 1988, Heim et al 1993)
and the site of the lesion (Krantz and Deckel 1983).
Situational variables may also play a role. For instance,
research has shown that distancing and escape-avoidance are
used more often in situations which are regarded by the
person as outside their control (Folkman et al 1993).
Conversely, problem-focused strategies are more common in
encounters appraised as controllable (Folkman et al 1986,
Carver et al 1989).
It is important to underline that coping strategies may
change over time because what is attended to, and the
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threats themselves, also change. Moreover, the complexity
of most stressful encounters means that people will tend to
use a variety of strategies, changing from one to another on
the basis of feedback (Lazarus 1991).
In addition to illness and situation-related variables,
coping may also be influenced by a personality factors such
as optimism (Carver et al 1989) and by the level of
education (Lacroix 1991).
Recent research on coping has also looked at the way in
which patients use information. For instance, Miller et al
(1988) proposed that some people, referred to as 'monitors',
might be more inclined to attend to symptoms and to seek out
information about illness and treatments than others. In
contrast, 'blunters' may prefer to avoid and distract
themselves from threat-relevant information.
This view is supported by a study of hospital attenders
which showed that high monitors (information-seekers) deman-
ded more tests, more details about their health problems and
more counselling from their doctors than the low monitors,
who typically ignored information. Interestingly, the
former preferred to play a less active role in their own
care than their low-monitoring counterparts. Thus it ap-
pears that the high monitors sought information, not so much
to control their illness but to reduce uncertainty and
concomitant arousal.
In terms of outcome, blunting has been associated with
reporting of psychological symptoms and with complaints
related to infections such as colds and flu (Davey et al
1993).
The actual act of seeking information has also been
associated with positive psychological adjustment (Felton
and Revenson 1984). However, it has been suggested that
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this may be partly due to its value as an attention-
diverting strategy, helping patients to focus away from
pessimistic thoughts towards seemingly more useful matters.
Another variable which may affect the choice of coping
strategy is mood. For example, depression has been asso-
ciated with a greater use of emotion-focused coping such as
wishful thinking, with increases in self-blame (Beckham and
Adams 1984) and with the seeking out of social support
(Coyne et al 1981, Vitaliano et al 1989, 1990). These
strategies appear to be influenced by the actual level of
depression, rather than constitutional differences or a
general vulnerability (Parker and Brown 1982).
Anxiety too may affect coping. Fisher (1986) hypothesized
that anxiety would produce "ragged, disorganised, unplanned"
behaviours, leading to a reduction in efficiency and compe-
tence. Nevertheless, moderate levels of certain emotions
may be adaptive (Dirks et al 1978).
In contrast to the illness-related variables and the effects
of mood noted above, there is little evidence that either
income or gender influence coping in the chronically-ill
(Ehmann et al 1990, Viney and Westbrook 1982).
Coping and adjustment 
In terms of outcome, the effectiveness of most strategies
must be judged in context (Lazarus 1991). Thus an approach
which is helpful in one situation may be far less useful in
another. For example, although denial prior to diagnosis of
breast cancer temporarily reduces emotional distress, it
also delays diagnosis and treatment and therefore increases
the risk of metastases and poor outcome. At this stage, the
efforts at coping do not meet the requirements of the envi-
ronmental conditions being faced, and they are therefore
regarded as maladaptive. On the other hand, the same stra-
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tegy used after diagnosis might help the person to deal with
the threat of death and may even lengthen survival time
(Greer 1991, Taylor 1983).
While it is therefore important to consider the context,
there is evidence to suggest that efforts to enhance coping
skills may lead to a overall reduction of psychological
distress (Fawzy et al 1990b, Cunningham et al 1993). In
terms of the efficacy of specific strategies, active
behavioural approaches appear to be useful in reducing
depression for some patient groups, while more emotion-
focused strategies, e.g. distancing and passive-armidance
seem to have the opposite effect (Ehmann et al 1990, Fawzy
et al 1990; Felton and Revenson 1984, Folkman et al 1993).
This does not mean that problem-focused strategies are
always adaptive. For instance, Terry (1992) studied patients
recovering from myocardial infarction and found that
problem-focused strategies were not related to any measures
of favourable adaptation.
Finally, it is worth noting that the influence of coping
efforts may be more limited than is sometimes claimed. For
instance, Macrae and Costa (1986) suggested that coping
strategies might be used particularly as a means of main-
taining good spirits despite adversity, and they observed
that in some situations, coping behaviours had only modest
effects on wellbeing. This view is supported by Felton and
Revenson (1984) whose research showed that the effects of
coping on adjustment were approximately equal in strength to
the effects of adjustment on coping. On the basis of these
findings, they concluded that coping appears to have a re-
latively modest role.
Coping with uncertainty
To deal with uncertainty, patients have used a number of
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strategies, for instance, information seeking (Comaroff and
Maguire 1981, Weitz 1989) and pacing of activities (Wiener
1975). They have also engaged in affect management through
denial, avoidance, optimism and by comparing themselves with
other patients (Mishel 1988, Comaroff and Maguire 1981).
Furthermore, some have coped by choosing to believe that
they have control over their illness, even though in
reality, this is very limited (Taylor 1983).
2.2.6 The role of culture 
Cultural norms determine how a society reacts towards the
disabled, whether they are accepted or isolated, pitied or
censured (Cassel 1982). Another way in which culture may
influence health care was described by Lopez (1989). He
argued that doctors who do not have a great deal of contact
with a certain group of patients may have a more homogeneous
view of these individuals and as a result, may only consider
a relatively limited range of diagnoses. In his view,
stereotypic beliefs concerning certain races, women or older
people can interfere with the process of gathering evidence
to test diagnostic impressions and hypotheses. In this way,
hypotheses may be prematurely accepted as valid, leading to
diagnostic errors, inappropriate management and increased
distress for the patient concerned.
Culture may also influence the actual labelling of symptoms.
For example, neurasthenia is a relatively common diagnosis
in some countries and rare in others (Ware and Kleinman
1992) while low blood pressure is regarded as a disorder in
Germany but not in the UK (Wessely et al 1990). This is
important because the actual diagnosis not only determines
the treatment offered by physicians but also the attitude of
the general population and the coping strategies adopted by
the patient. This will be discussed in more detail in the
section on support from physicians.
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2.2.7 The role of social support 
Another factor which is thought to play a major role in the
psychological adjustment to chronic illness and disability
is social support. This has been defined in various ways
(Wortman and Dunkel-Schetter 1987), but generally refers to
the presence of others or the resources provided by them,
prior to, during or following a stressful event (Ganster and
Victor 1988).
Social support may include any or all of the following
components:
1. help to clarify or further one's understanding of prob-
lems and possible solutions (cf informational support),
2. help with fears, making people feel valued and loved,
caring, sympathy, understanding and reassurance,
3. provision of tangible assistance (practical help) with
chores and tasks,
4. provision of feedback on how one is doing,
5. provision of physical comfort,
6. access to material resources (this is sometimes referred
to as instrumental support),
7. provision of companionship, reducing people's sense of
isolation and strengthening their sense of identity in times
of uncertainty (Bloom 1982, Cohen and Wills 1985, Ganster
and Victor 1988, Fiori et al 1986).
It has been suggested that the most important aspect of
support is the recipient's perception of affection, ac-
ceptance and the affirmation of personal worth (Justice
1994, Sarason et al 1988). However, this generalisation does
not take into account the changing needs of patients with
chronic conditions.
Direct and indirect effects 
Social support has both direct and indirect effects. Direct
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effects encompass the general positive influences of social
support, irrespective of whether a person is under stress.
For instance, relationships may reduce or prevent illness by
providing people with regular positive experiences, and a
sense of predictability and stability during periods of
rapid change (Cohen and Wills 1985, Stout et al 1964).
Social support may also enhance well-being by facilitating
health-promoting activities such as proper sleep, exercise
and the appropriate use of alcohol and drugs (House 1988).
Research on the direct effects of social support has linked
it with successful coping with various crises (Andrews et al
1978), while a lack of support has been associated with des-
tructive behaviours (Brennan and Moos 1990) and an increased
risk of illness and mortality (Bloom 1982, Joseph and Syme
1982, Rosengren et al 1993).
As well as exerting a direct effect on well-being, social
support may also help to reduce illness indirectly by acting
as a buffer between the individual and the negative psycho-
logical consequences of stress. According to Cohen and
Wills (1985), contact with others may prevent a stressful
event from being appraised as harmful and bolster one's
perceived ability to cope. Social support can also in-
fluence later appraisals and reactions, for instance, by
facilitating an adaptive counter response or by moderating
physiological processes (e.g. Henry 1986).
It has been suggested that the buffering effects of social
support may help to reduce people's general vulnerability to
distress and disease (e.g. Brown and Harris 1989) and
increase their resistance and resilience (e.g. Cassel 1976).
Structural and functional characteristics
In addition to the direct and indirect effects, it is also
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useful to distinguish between the structural and functional
characteristics of support. Structural characteristics
include the size of the social network, the frequency of
contacts, the stability of the support over time and the
source of support, e.g. whether it comes from family and
friends, or from more informal sources e.g. club members,
church fellowship or a support group. Functional charac-
teristics include the perceived quality of the available
support, i.e. whether people feel that there is someone they
can turn to if need be, and the satisfaction with the sup-
port received.
The distinction is important since there is evidence that
structural measures tend to be associated with main (direct)
effects whereas functional measures are more frequently
associated with interactive or buffering effects (Cohen and
Wills 1985). Furthermore, it has been found that the qua-
lity of support is generally a stronger predictor of health
outcome and psychosocial dysfunction than the quantity of
the support (Broadhead et al 1983, Fiori et al 1986,
Fitzpatrick et al 1991).
The effects of social support are also influenced by a
number of other variables. In terms of dealing with chronic
illness and disability, research has shown that social
support may lead to different outcomes depending on:
a. the type and stage of illness i.e. whether it is serious
or trivial, treatable or manageable (Ell et al 1992, Elliott
et al 1992, Neuling and Winefield 1988, Revenson 1993),
b. the environment, e.g. whether one is at home or in
hospital (Broadhead et al 1991),
c. the specific needs of the patient, e.g. whether they
desire information, reassurance, tangible assistance,
economic help etc (Dakof and Taylor 1990, Neuling and
Winefield 1988),
d. the nature of the support provided, and whether it
matches the needs of the patient (Broadhead and Kaplan 1991,
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Revenson 1993),
e. the psychological state of the patient, e.g. depression
may limit the amount of support offered or perceived
(Billings et al 1983, Fitzpatrick et al 1991),
f. the source of the support e.g. partner, friend,
relative, health-care professional (Elliott et al 1992,
Neuling and Winefield 1988),
g. the extent of the support, e.g. sufficient, inadequate
(e.g. Stewart and Sullivan 1982, Faucett and Levine 1990),
h. the health and skills of the support provider, e.g.
whether they have the patience required, the knowledge to
give the right advice etc, the strength to assist with needs
relating to self-care (e.g. Strauss et al 1984).
One study which examined the effects of different types of
social support given to cancer patients found that emotional
support (presence, concern, affection) from family and
friends was regarded as most helpful (Dakof and Taylor
1990). Most unhelpful was a lack of emotional support,
avoidance of contact and misguided support. In terms of help
from other patients and physicians, informational support
was most helpful and misguided or absent informational
support was considered as unhelpful. About 40% complained
about not receiving enough emotional support from these
quarters and many were upset when other patients acted in a
self-destructive or foolish way. These findings, plus those
of Neuling and Winefield (1988) and Elliott et al (1992),
underline the importance of distinguishing the sources and
types of the support since they may have different effects
on outcome.
Finally, the presence of social support may affect the
actual choice of coping strategies. For instance, Moos and
Moos (1990) found that those adults who received support
from their spouse and friends relied more on approach coping
(e.g. seeking guidance and support) when dealing with stres-
sors and were less likely to use avoidance strategies, espe-
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cially cognitive avoidance and emotional discharge compared
to those who received less support.
Positive and negative effects of social support in the
chronically-ill 
Social support has been shown to have beneficial effects on
the well-being of patients with various chronic conditions
(e.g. Bowden et al 1980, Fitzpatrick et al 1991, Goodenow et
al 1990, Lloyd and Cawley 1983, Ray 1992, Schulz and Decker
1985, Terry 1992, Wineman 1990). More specifically, it has
been found that support can help people to accept their ill-
ness (Martin 1982) and enhance their ability to cope and
comply with difficult treatment regimes (Ganster and Victor
1988, Gregg et al 1989). It has also been linked with
reductions in psychological distress (Goodenow et al 1990,
Littlefield et al 1990, Revenson et al 1991) and with higher
levels of functioning (Goodenow et al 1990, Ward and Leigh
1993). Moreover, it was a significant predictor of higher
natural killer cell activity in women with breast cancer
(Levy et al 1990).
Conversely, lack of support has been correlated with in-
creased depression (e.g. Revenson et al 1991, Wineman 1990)
and anxiety (Whalley Hammell 1994), while limited attach-
ments and "loneliness" have been associated with reductions
in immune function (Kiecolt-Glaser et al 1984, Theorell et
al 1995).
However, support can hinder as well as help patients to
cope. This was summarised by Suls (1982) as follows:
Positive effects 	 Negative effects 
Prevention reduce uncertainty/worry 	 increase uncertainty
and worry
set good example 	 set bad example
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Positive effects 	 Negative effects 
share problems	 create new problems
distract	 distract
contact with germs
Coping	 label beneficial
provide sympathy
give helpful information
Recovery
	 maintain regimen
contrast with health
(incentive)
create desire to stop
being a nuisance
label negative
subject to irri-
tation and resent-
ment
give misleading in-
formation
discourage regimen
contrast with health
(depressant)
create power/depen-
dence need
For example, while being part of a social network allows
people to share their problems, this can both reduce fear
and create more uncertainty and anxiety. Furthermore, the
presence of others can make people feel embarrassed thus
increasing their distress.
Research has also shown that people may actually withhold
support. For instance, when confronted by the suffering of
others, some individuals may try to protect themselves from
the fear of illness and feelings of vulnerability by con-
vincing themselves that the patient was to blame (Lerner and
Simons 1966). Negative views may co-exist with positive
ones, or they may dominate. For example, if an illness can
be linked to the patient's behaviour, e.g. lung cancer to
cigarette smoking, significant others may signal their irri-
tation and resentment to the person concerned. It has also
been observed that where conditions have no clearly identi-
fiable organic cause, some people find it hard to accept the
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patients' suffering and this could result in conflict and
increased distress (Donoghue and Siegel 1993, Faucett and
Levine 1990).
In the case of diseases like cancer, others may feel help-
less or find it difficult to hide their pessimism. These
factors, and the strain of certain conditions, can cause
people to turn away from those who are ill and therefore
reduce their social support (Buunk and Hoorens 1992,
Mitchell and Moos 1984, Wortman and Dunkel-Schetter 1979).
Social support and uncertainty
Support from others may help to reduce uncertainty and as a
result, limit the level of emotional distress (Mishel 1988).
For instance, on the basis of their study on women with gy-
naecological cancer, Mishel and Braden (1987) claimed that
the awareness that help was available reduced the uncer-
tainty about the future. This allowed the women to invest in
their present relationships and activities, thus improving
psychosocial adjustment.
The support from the physician.
It has been suggested that the ability of practitioners to
communicate with and support their patients is of enormous
influence (Davis 1963, Lloyd 1991, Macdonald 1988). This is
true both in the prediagnostic phase and following diagnosis
(Stewart and Sullivan 1982).
One factor which may undermine the communication between
physicians and patients and thus limit support is that both
groups approach illness from different perspectives. As
Toombs (1992) has pointed out, physicians approach illness
from a scientific perspective; their training leads them to
focus on signs and symptoms and on identifying a particular
disease state. In a sense, they reclassify the patient's
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experience of illness in terms of the findings of the basic
sciences, with the body as scientific object.
Patients have a totally different view of illness. To them,
it is a disruption to everyday life; a subjective and unique
experience which limits their ability to engage the world in
habitual ways. Illness represents a loss of total body in-
tegrity, certainty, control and freedom to act. It reduces
choices, and the suffering is related to all these factors,
not just the biological malfunctioning of one or more or-
gans.
It has been proposed that the physicians' emphasis on the
biological body leaves them with an incomplete knowledge of
the illness and the suffering that it causes (Baron 1985).
The resulting lack of understanding may lead to inappro-
priate treatments and consequently, to the suboptimal
management of the illness.
A more specific problem associated with the biomedical
approach relates to the patients who do not meet the cri-
teria for disease. If clinicians cannot find evidence of
abnormalities on 'objective' tests or if the patient's com-
plaints do not correlate with demonstrable pathoanatomical
and pathophysiological findings, they may well conclude that
the patient does not have a bona fide disease. Consequent-
ly, patients may be told that "there is nothing wrong", or
that the illness "is all in your head"; two assessments
which not only contradict actual experience but imply that
the distress is not legitimate. In such cases, the physi-
cian's failure to construe their illness as a 'disease
state' is an additional source of suffering which the
patient must cope with.
According to Rippere (1992a), the inaccurate labelling of
disorders as psychogenic may have a negative effect on
social interactions with significant others. This view is
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consistent with that of Stewart and Sullivan (1982) who
studied a number of patients with multiple sclerosis and
found that the prediagnostic uncertainties, plus the doc-
tors' refusal to legitimize the adoption of the sick role
during this period, led to negative reactions from family
and friends and to emotional conflicts and tension. All
these factors combined to cause what they refer to as "a
type of iatrogenic disease". In fact, they found that
"feelings of frustration, worry and intermittent periods of
depression were nearly universal. Over half of the patients
also reported experiencing more severe psychological
problems". In their opinion, the latter was directly
attributable to the stress of the doctom-petiel%t
relationship..
Support from groups 
During his survey of people with arthritis, Locker (1983)
discovered that a major source of support for his patients
were fellow sufferers. Apparently, those not affected could
not understand the pain associated with the disease, and
consequently tended to minimize the distress. The shortage
of support led many patients to join self-help groups.
Support groups have also been found to play an increasingly
important role for patients with other chronic disorders,
such as motor neurone disease and multiple sclerosis.
Robinson (1988) summed up the benefits of the British
organisations for people with MS as follows: "they provide
a means of focusing hope, anger, desperation, needs for
companionship in a common situation, a wish to help others,
a search for practical advice, and many other concerns which
cannot easily be met in the intimacy of family life, or in
the colder world of professional medicine".
In conclusion, it appears that the many benefits of social
support will be optimised when it fits and satisfies the
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needs of the individual (Broadhead et al 1983). Greater
awareness of the patient's wishes and the importance of
support may help improve psychological well-being and reduce
the rate of psychiatric morbidity in the chronically-ill.
2.3 Discussion
The research shows that different illnesses and conditions
exert different demands on the person. Therefore, it is
important when assessing psychological adjustment to take
into account the severity and stability of the symptoms, not
just the nature of the pathology and the duration of impair-
ment (cf Walford et al 1993). This is particularly relevant
for conditions like CFS, which are characterised by a number
of different and fluctuating symptoms. Indeed, the change-
ability of CFS means that variables which are linked to
adjustment in cross-correlational studies should also be
examined using longitudinal designs (cf. Kobasa 1985,
Patarca et al 1993).
Given the differences between the various conditions, any
comparison of psychological morbidity among the chronically-
ill must take into account such variables as the severity of
symptoms and the level of overall disability in each of the
patient group. Moreover, if assessing the influence of a
medical disorder on emotional distress, note should be made
of specific influences such as the attitude of the general
population towards that condition, and the availability of
treatment. For instance, it is possible that disorders like
CFS, which are surrounded by controversy and for which there
is limited treatment, may provide more challenges for people
than conditions which are acknowledged as genuine sources of
disability and for which there are several treatments to
reduce or control the most distressing symptoms.
Further consideration is also required when assessing the
influence of personality on adaptation. For instance, there
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is evidence that measures of personality dimensions such as
hardiness and pessimism may be confounded by neuroticism
(e.g. Smith 1989). Indeed, it has been suggested that the
instruments used to measure constructs such as hardiness,
optimism, self-esteem and locus on control actually form a
single major dimension which Marshall et al (1994) call 'op-
timistic control'. Thus the relationships between those
constructs and adjustment may be partly due to fact that the
measures may be tapping the same underlying domain. If
these issues are not addressed, it will be difficult to
evaluate their role in the psychological adjustment to
chronic illness and disability.
In terms of examining the influence of attributions and
perceived control, research seems to indicate that confi-
dence about being able to manage certain aspects of the
illness may be associated with successful adjustment.
However, when considering conditions like CFS, two problems
need to be addressed. Firstly, given the lack of clarity
regarding the aetiology of the syndrome, one cannot judge
whether a viral attribution is correct or incorrect.
Moreover, a somatic attribution cannot be regarded as
maladaptive, simply on the basis that it is statistically
associated with ongoing ill-health (Powell et al 1990).
Since there is also a positive relationship between somatic
attributions and poor outcome in patients with known
'organic' diseases, the significance of an external versus
internal attributions has yet to be established (Salkovskis,
personal communication, Trigwell et al 1995).
The same argument applies to the research into perceived
control. The complexity of many conditions means that
patients may feel they can control specific symptoms but not
the course or outcome of disease. Furthermore, some of their
beliefs may be realistic, others may be regarded as illu-
sions. Again, lack of knowledge about the mechanisms
underlying CFS makes it difficult to assess which aspects of
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the disorder are controllable and to what extent. Given
these uncertainties and the literature on other conditions,
it may be more useful to focus on self-efficacy, i.e.
perceived control over certain behaviours, and how this
relates to coping and adjustment (cf. Holman and Long
1992).
Another variable which has received limited attention in
relation to CFS is uncertainty. Given the fluctuating nature
of CFS and the difficulties relating to its diagnosis, this
variable should be taken into account when considering the
psychological effects of this condition (e.g. Wineman 1990).
Research on the effects of CFS might also focus on the
nature of coping. Studies on other chronic disorders suggest
that patients may use a variety of strategies, depending on
the nature and severity of the symptoms, the stage of the
illness, concurrent mood and the success of the strategies
(Davis 1963, Fisher 1986, Lazarus 1991, Matson and Brooks
1977). However, the range of strategies used by patients
with CFS has yet to be determined. Moreover, since a
specific strategy may have different effects at different
times and on different aspects of functioning, research on
the relationship between coping and adjustment should
include a number of different outcome measures, and if
possible, study their effects over time (Lazarus 1993).
There is also limited knowledge about the extent of social
support given to patients with CFS and its relationship with
emotional distress. The literature on other disorders sug-
gests that social support can be of enormous benefit, but it
remains unclear how support exerts its effects. For in-
stance, information provided by others may lead to an in-
creased perception of control, so that threats are more
likely to be seen as challenges and they arouse less dis-
tress. Equally, it could make people aware of adaptive
responses and therefore affect coping more than primary
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responses and therefore affect coping more than primary
appraisal. At the same time, information could enhance mood
(e.g. optimism) and thereby influence the neuroendocrine
pathways. Unfortunately, these questions require compre-
hensive studies which, given the health of many people with
CFS, may not be practical. Other issues which might be
addressed include the influence of the uncertain aetiology
on support and the effects of support provided by different
sources. Moreover, studies should distinguish between the
quality and quantity of the support (e.g. Cohen and Wills
1985, Faucett and Levine 1990).
Finally, given the importance of the doctor-patient
relationship,. it may be useful to assess the satisfaction
with medical support and advice in studies relating to
adjustment and treatment of CFS.
The table below summarises some of the variables which are
thought to influence psychological adjustment in the
chronically-ill and disabled.
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CHAPTER 3 
Study into the experiences of patients with chronic
fatigue syndrome 
"It was unfair to have an illness without a name,
without recognition, without outer signs, without
looking ill, without knowing what to do to get
better" (2.34).
3.1 Introduction
Accounts of the psychological aspects of CFS suggest that
most patients- respond to their symptoms in similar ways
(e.g. Sharpe 1994, Taerk and Gnam 1994). A recurring theme
is that sufferers adhere to fairly straightforward aetio-
logical models, that they are reluctant to consider the
possible role of emotional problems (Lawrie and Pelosi 1994,
Surawy et al 1995) and that they use ineffective coping
strategies (Lewis et al 1994).
One view which many patients appear to share is that CFS is
a result of ongoing infection (Shepherd 1992). According to
Wessely et al (1989, 1991), this belief "conveys certain
advantages, irrespective of its validity. It is simple,
frequent and easily accepted". He also notes that it
removes self-blame and guilt and avoids the stigma of mental
illness. However, the disadvantages are that it also takes
away some control over the symptoms and that it may lead
patients to reject potentially effective treatments.
The patients' tendency to blame a physical cause has been
documented by several studies. For example, both Wessely
and Powell (1989) and Manu et al (1993) found that the vast
majority of their patients attributed their condition to
non-psychological factors. However, other studies have
shown that the adherence to external attributions may not be
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as widespread as some have suggested (Ray et al 1992b,
Yeomans and Conway 1991, Ware and Kleinman 1992).
In terms of behaviour, it is often assumed that patients
with CFS tend to adopt a fairly passive approach to their
illness. As Wessely et al (1991) put it, the reaction of
many is to "rest and to wait either for remission or a
medical cure".
This view supported by Blakely et al (1991) who found that
patients with CFS tended to use more escape/avoidance and
distancing than people with chronic pain. However, other
researchers have shown that people with CFS also use
problem-focused strategies (Lewis et al 1994). These will be
discussed in more detail in Chapter 5.
The portrayal of patients with CFS as passive 'victims' who
do little other than rest also conflicts with studies
carried out by self-help groups. For instance, a survey
conducted by the British patient association Action for ME
revealed that rest, hydrotherapy, relaxation techniques,
dietary changes, massage, anti-candida treatment, healing
and aromatherapy were all assessed as useful by at least 50%
of respondents (Interaction 1991, 8). Least helpful were
antibiotics, steroids, fasting, tranquillisers and graded
exercise. In all, 71% of those who improved attributed this
to some or all of the therapies they had tried.
In the past, modern medicine has tended to ignore and dis-
count subjective experience in favour of the hard, objec-
tive, quantitative data of laboratory tests, x-rays and so
forth. As a result, few scientists have been aware of the
patient's lived experience and what that experience means to
the person concerned (Baron 1985). However, as Cassell
(1982) pointed out, the physician can not begin to address
the patients' suffering unless attention is paid to such
meaning. Indeed, he believes that "failure to understand
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the nature of suffering can result in medical intervention
that (though technically adequate) not only fails to relieve
suffering but becomes a source of suffering itself".
Toombs (1992) has therefore advocated that doctors should
take more account of the patients' own story, the 'clinical
narrative', to find out what is significant to them, what
their values are, and how they would like their illness to
be treated. This approach may be particularly relevant to
CFS, where the emphasis on fatigue may have limited the
recognition of the strain associated with this condition.
Moreover, the simplified accounts of the illness and the
patient's experiences may have resulted in an underesti-
mation of the real psychological sequelae of CFS (Dutton
1992).
To summarise, there has been relatively little research on
the psychological and social aspects of CFS as viewed by the
patients. Moreover, the interest in fatigue and the paucity
of information about other sources of disability and dis-
tress may have led many researchers to regard psychological
disturbances as a cause rather than a response to the ill-
ness.
3.2 Research aims 
Given the lack of research, it was decided to conduct an
exploratory study into the illness from the patients'
perspective, focusing in particular on the difficulties
which they face and the type of coping strategies they use.
3.3 Method
Information was obtained from interviews and questionnaires,
providing both qualitative and quantitative data.
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3.3.1 The interviews (Group 1) 
Six local practices, giving access to at least 15 general
practitioners, were approached for permission to interview
patients with CFS (then known as ME or PVFS). Of those
contacted, one doctor replied that he had no ME patients and
one practice did not reply. However the others were happy
to co-operate with the study and to send on letters asking
for volunteers. A few also provided names directly.
When approached, one patient felt too ill to take part at
that time and one had recovered to the extent that he
thought that he was unsuitable. Since it is not known how
many letters were sent out by the general practitioners, it
is not possible to calculate the exact response rate.
Seven of the interviews took place in the patients' homes
and the responses were taped for later transcription. How-
ever, due to circumstances beyond the researcher's control,
the other interviews were conducted via the telephone and
the researcher attempted to take down the responses as fully
as she could.
The patients attended a total of 11 different doctors, with
the majority coming from practices in Twickenham and
Teddington.
Although it was hoped that the general community sample
would be representative of the patient population as a
whole, it was found that all the 17 people in this group
were or had been members of either the ME Association or
Action for ME. This may have coloured the people's views of
the illness and their approach to treatment. Nevertheless,
the interviews provided an opportunity to explore the
personal experiences of patients in much more detail than
the questionnaires.
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The choice of questions reflected the aims of the study,
i.e. to learn more about the illness from the patients'
perspective. These are described in more detail in section
3.3.3.
No one was paid for their participation.
3.3.2 The questionnaires ( roup 2) 
One hundred people, chosen at random from the membership
list of the ME Association, were sent a letter asking for
volunteers. In total, 66 replied that they were willing to
participate. Of the ten who did not return their question-
naires, one withdrew, one had recovered and did not feel she
could be useful, and five had moved or did not wish to be
contacted further. Three copies were apparently lost in the
post. The remaining three completed the questionnaires but
these could not be used because the respondents had not been
formally diagnosed. This left a total of 53 questionnaires,
giving a response rate of 53% for the sample as a whole and
80% among those who initially agreed to participate.
3.3.3 D._eAliall
The first part of the questionnaire requested demographic
information (age, gender, marital status, work status, edu-
cation, housing and income). This was followed by questions
about the illness, for instance, whether the onset was acute
and triggered by a specific infection or gradual; the du-
ration and course of the illness; the main symptoms; how the
diagnosis was made and who had made the diagnosis (people
who had not been diagnosed by a physician were not included
in the statistical analysis).
In the second part, patients were requested to list the fac-
tors which they saw as causes of their own illness. They
were also asked which factors they regarded as general
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causes of CFS and which factors they saw as irrelevant or
unlikely causes. This would help to establish if, as has
been suggested, patients have a tendency to blame external
factors such as viruses.
The rest of the questionnaire focused on the effects of the
illness and the strategies which patients had used to cope
with them. Again, it was felt that open-ended questions
would be most appropriate. To guide patients, there were
three separate questions relating to the consequences of the
illness. The first asked about the effect of the condition
on activities, career and so on; the second focused speci-
fically on relationships and the third enquired about the
consequences of their illness on their personality, feelings
and attitudes.
The section on coping strategies asked what patients had
done to deal both with day-to-day symptoms and with the
illness in general. A question enquiring about advice they
would give to newly diagnosed sufferers was added to give an
indication which strategies they regarded as the most help-
ful. Finally, two more questions asked the patients to sum
up the experience of CFS and to assess their future. A copy
of the questionnaire can be found in Appendix 1.
The interviews were structured in a similar way to the
questionnaires, but using additional questions to explore
specific issues of interest, such as the nature of fatigue,
the history of psychiatric disorders and the choice of cer-
tain coping strategies.
3.4 Results 
3.4.1 Pinalysis 
Replies from both groups were divided into categories in
order to provide quantitative information about the symp-
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toms, attributions, extent of the illness and the types of
coping strategies used. The categories were selected using
information from the literature on CFS and other chronic
illnesses. Following a preliminary analysis of the data,
further categories were added to the list in order to cover
responses which had not been anticipated.
Since the questions asked during the interviews were vir-
tually identical to those in the questionnaire, it was
decided to analyse the data from both samples in the same
way, although results will be reported separately for the
two groups. Where patients have been quoted, their group
and identification number are noted in brackets.
3.4.2 Demographic information
The demographic information is presented in Table 1. The
mean age of both groups was 41 years and just over three-
quarters of the subjects were female. Of those who had
completed their education, over a half had been to college
or university and approximately a quarter had received some
kind of professional training. Three people in both groups
were either still at school or at college.
At the time of the interview, 6 of the subjects in Group 1
(35W) were working full-time and 7 (41%) had either retired
or left their job. However, during the whole course of the
illness, 15 people (88% of the group) had either left their
job and retired, or changed their job or working hours be-
cause of illness. In Group 2, nearly 38W of the respon-
dents were working full or part-time, and 45% had either
retired or were unemployed. Nineteen reported that they had
actually lost their jobs because of their illness. Sixty
per cent had stopped or changed their job or working hours.
In terms of socio-economic status, the majority in both
groups were classed as professional or manual skilled. Two
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Table 1.	 Demographic information for Groups 1 and 2.
Group 1 Group 2
Age (years) No.	 (SD) No.	 (SD)
Mean 41	 (11.5) 41 (15.09)
Range 14-62 11-74
Gender No.
	 (%) No.
	 (%)
Male 4	 (23.5) 11	 (21)
Female 13	 (76.5) 42	 (79)
Education No.	 (%) No.
	 (t)
Finished school 3	 (20)* 9	 (19.6)*
College/university 8	 (53.3)* 26 (56.5)*
Professional training 4	 (26.7)* 11 (23.9)*
Total who completed
secondary education 15 46
Still at school 1 3
Still at college 2**
Did not finish school or
missing data 4
Mean age on completion of Years Years
education	 22.9	 20.9
* Percentage of those who
completed secondary edu-
cation, including those
presently retraining.
**Includes one person now
retraining
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Table 1 cont. 
Group 1 Group 2
Current occupation No. ( 90 No. (t)
Student 3 (17.6) 4 (7.5)
Housewife 0 5 (9.4)
Unemployed 1 (5.9) 12 (22.6)
Employed part-time 0 7 (13.2)
Employed full-time 6 (35.3) 13 (24.5)
Retired 7 (41.2)t 12 (22.6)
Change of occupation*
Left job, retired or
No. (t) No. (t)
Reduced hours at work 11 (64.7) 25 (59.5)
Reduced/stopped study 2 (11.8) 6 (14.3)
Changed job only 4 (23.5) 1 (2.4)
None 10 (23.8)
No information/occupation 11
Classification of occupation**
Professional 6 (37.5) 15 (30.6)
Managerial 1 (6.2) 9 (18.4)
Manual skilled 5 (31.3) 16 (32.7)
Manual unskilled 3 (18.8) 3 (6.1)
Student 1 (6.2) 6 (2.2)
Not classified/at school or
missing information 1 4
t all for medical reasons.
One also ticked 'housewife'.
* Group 2 n=42.
** Group 1 n=16, Group 2 n=49
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Table 1 cont. 
Group 1	 Group 2
Marital status	 No. (%)
	
No. (%)
Single	 6 (35.3)	 17 (32.1)
Married	 6 (35.3)	 26 (49)
Cohabiting	 1 (5.9)	 6 (11.3)
Separated	 0	 1 (1.9)
Divorced	 3 (17.6)	 3 (5.7)
Change in marital status due
to illness	 0	 1
Children	 No. (%)	 No. (%)
Yes	 7 (41)	 28 (53)
No	 10 (59)	 25 (47)
Income per week*	 No. (%)	 No. (%)
<£70	 4 (26.7)	 15 (30)
£70-200	 7 (46)	 24 (48)
>£200	 4 (26.7)	 11 (22)
Information missing/no
income	 2	 3
Housing
	
No. (W)	 No. (%)
Owner/occupier	 13 (71.7)	 38 (71.7)
Private tenant	 2 (11.8)	 4 (7.5)
Council tenant	 1 (5.9)	 5 (9.4)
None of the above	 1 (5.9)	 6 (11.3)
Live alone**	 No. (W)	 No. (%)
Yes	 6 (37.5)	 9 (17)
No	 10 (62.5)	 44 (83)
Missing information	 1
* Group 1 n=15, Group 2 n=50.
** Group 1 n=16, Group 2 n=53.
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of the three students in Group 1 had worked before their
illness and were classified according to that work.
About one-third of the patients were single and around a
half were either married or cohabiting. Only one person had
changed marital status during the illness.
The income of the majority was comparatively low and often
consisted of state benefits. However, most (71%) owned
their own home.
3.4.3 Data on the nature of the illness 
As shown in Table 2, nearly one-half of the patients in both
groups developed CFS suddenly and many were able to link the
onset with a specific viral illness, e.g. influenza or
glandular fever. In Group 1, blood tests were used in 70%
of patients both to exclude other conditions and to support
the diagnosis of CFS(ME) (e.g. the VP1). In contrast, inves-
tigative tests were used less frequently in Group 2. The
greater use of tests in the former may be partly due to the
some of the local doctors' special interest in the illness.
Patients had been ill for a mean of 8.3 years (Group 1) and
5.2 years (Group 2). More specifically, 53% of the inter-
viewees and 32% of the questionnaire sample had been ill for
more than 5 years. In the majority, the illness followed a
fluctuating course. Indeed, only 2 people reported that
their illness had been stable.
3.4.4. Main symptoms 
As shown in Table 3, the most frequently reported symptom
was fatigue. In fact, all the subjects in Group 1 and 94%
of subjects in Group 2 mentioned either fatigue or
exhaustion as their main symptom. The three respondents who
didn't, noted the effects of tiredness in later sections, so
107
Table 2.	 Details of illness-related variables.
Group 1 Group 2
Onset No. (%) No. (90
Sudden 3 (17.6) 13 (24.5)
Sudden following specific
viral infection 6 (35.3) 13 (24.5)
Gradual 8 (47.1) 27 (51)
Diagnostic tests No. (1) No. (%)
Elisa IgM (CBV) 1 (5.9) 2 (3.8)
VP1 6 (35.3) 6 (11.5)
Blood tests to exclude
other conditions 12 (70.6) 10 (19.2)
Brain scan 1 (5.9) 1 (2)
At least two of above 7 (47.1) 12 (23.1)
None 2 (11.8) 21 (40.4)
Duration of illness
Mean years (SD) 8.26
	 (8.9) 5.2	 (6.8)
Range 19 mths-40 yrs 7 mths-41 yrs
Progress of illness No.	 (%) No.	 (%)
Same 1	 (5.9) 1	 (2)
Fluctuating 10	 (58.8) 21	 (39.6)
Generally deteriorating 1	 (5.9) 11	 (20.7)
Generally improving 2	 (11.8) 3	 (5.7)
Fluctuating, now improving 3	 (17.6) 17	 (32.1)
they may simply have forgotten to include this symptom in
their list.
Other symptoms, in order of prevalence, were muscle aches
and memory impairment (53 and 51% respectively) and concen-
tration problems (over 80% in both groups). A significant
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Table 3. Main symptoms reported by Groups 1 and 2.
Symptom	 Group 1	 Group 2
No (%) No (%)
Fatigue/exhaustion 17 (100) 50 (94)
Muscle pain, tenderness 9 (53) 27 (51)
Memory problems 9 (53) 16 (30)
Concentration problems 6 (35) 27 (51)
Weakness 6 (35) 18 (34)
Headaches 5 (29) 24 (45)
Malaise 5 (29) 9 (17)
Nausea 5 (29) 7 (13)
Pain 5 (29) 20 (38)
Visual disturbances 5 (29) 21 (40)
Walking difficulties 4 (24) 12 (23)
Dizziness, fainting 3 (18) 13 (25)
Moodiness 3 (18) 14 (26)
Sensitivity to temperature 3 (18) 11 (21)
Allergies 2 (12) 5 (9)
Depression 2 (12) 11 (21)
Sleep disorders 2 (12) 12 (23)
Panic attacks 2 (12) 4 (8)
Digestive disturbances 1 (6) 11 (21)
Neurological problems 1 (6) 11 (21)
Confusion 1 (6) 7 (13)
Sore throats 1 (6) 7 (13)
Swollen, tender glands 1 (6) 3 (6)
Slowing down 1 (6) 1 (2)
Palpitations 0 10 (19)
Speech disturbances 0 2 (4)
Thrush 0 1 (2)
Hysteria 0 1 (2)
Loss of libido 0 1 (2)
number of patients also listed pain, headaches, visual
disturbances, dizziness, walking difficulties, nausea and a
flu-like malaise. Up to a quarter of patients reported
suffering from moodiness and/or depression.
The least common symptoms in both groups were swollen
glands, speech disturbances, hysteria, thrush and slowness.
Five people in Group 2 reported muscle twitches as a main
symptom and two admitted to "apathy". One also noted swal-
lowing difficulties while one interviewee, an accomplished
pianist, related how her illness prevented her from playing
the piano. Although she had no problem sight-reading, she
said that her brain wouldn't translate the information on
the sheet to her fingers. She described this as a type of
"musical dyslexia".
Several of the interviewees mentioned difficulties with sex,
including loss of libido and being too tired. However,
these were not regarded as main symptoms. Other problems
which were reported included intolerance to alcohol and ear
symptoms.
3.4.5 Attributions regarding the illness 
a. Attributions about their own illness 
As the first columns in Tables 4a and b show, the main
factors which were considered responsible for the patient's
own illness included viruses, a pressured and busy
lifestyle, stress, and a reduced resistance to infection.
A recurring theme was that of working through a viral
infection and taking insufficient time off to convalesce.
For instance, one respondent attributed her illness to the
following factors:
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"Catching what I thought was a cold and not giving
in to it. Carrying on going to work. Trying to
cope with a full-time job, housework and children
and everything else. Perhaps putting a strain on
me making me low and susceptible to any virus that
comes along. Trying to do too much in effect"
(2.6).
From the interviews, it became clear that the term 'stress'
was often used to refer to "overdoing it", pressure at work
and at home, as well as the presence of emotional problems.
A number of patients saw a link between the 'stress' in
their lives and their illness. For instance, one respondent
noted that she'd had to deal with her own illness (glan-
dular fever), getting married, moving house and "builders
wrecking the house", all within one year. In addition, she
worked 15 hours a day, 7 days a week until as she put it "I
came to a grinding halt". In the year before the current
illness, she suffered from colds every month. In her view:
"The body could no longer cope. But you don't
realise how ill you are until it's too late"
(2.3).
Others led less busy lives, but the reaction was generally
the same. Thus instead of resting at the start of what
appeared to be a normal respiratory infection, they con-
tinued to focus on their emotional problems, using strate-
gies such as exercise to deal with them.
When patients attributed their ill-health to other factors,
these too were generally not judged as requiring them to
convalesce. For instance, one person thought her symptoms
were due to the change of life and that's why she did not
take time off to rest.
It is important to note, however, that not everyone per-
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Table 4a. Attributions regarding aetiology: Group 1
Causes	 Own	 General	 Unlikely
No. (t)
	 No. (t)	 No. (t)
Infection	 15 (88)	 13 (77)
	
0
Immunological factors	 1 (6)	 4 (24)	 0
Lowered resistance	 7 (41)	 6 (35)	 0
Pressure	 7 (41)	 2 (12)	 0
Stress	 8 (47)	 2 (12)	 3 (18)
Fatigue	 4 (24)	 2 (12)	 0
Genetics	 4 (18)	 1 (6)	 1 (6)
Illness/surgery	 4 (24)	 0	 0
Life Events .	 4 (24)	 0	 0
Drugs	 1 (6)	 1 (6)	 2 (12)
Allergies	 0	 0	 1 (6)
Candida	 0	 0	 7 (42)
Pollution	 1 (6)	 3 (18)	 2 (12)
Chemicals	 1 (6)	 0	 0
Vaccination	 1 (6)	 0	 0
Diet	 0	 0	 0
Change of house	 0	 0	 0
Change of job	 1 (6)	 0	 0
Relationship problems	 1 (6)	 0	 0
Change marital status	 0	 0	 0
Personality factors	 1 (6)	 4 (24)	 1 (6)
Psychological factors*	 0	 1 (6)	 13 (77)
Accidents	 0	 0	 0
Not sure	 0	 1 (6)	 0
Combination	 1 (6)	 0	 0
Others	 4 (24)	 2 (12)	 3 (18)
*Includes depression/fear of activity and hypochondria
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Table 4b. Attributions regarding aetiology: Group 2
Causes	 Own	 General	 Unlikely
No. (%)	 No. (t)	 No. (%)
Infection	 37 (70)	 37 (70)	 0
Immunological factors	 7 (13)	 15 (28)
	
0
Lowered resistance 	 18 (34)
	
17 (32)	 0
Pressure	 30 (57)	 12 (23)
	
0
Stress	 21 (40)	 16 (30)	 8 (15)
Fatigue	 12 (23)	 9 (17)	 0
Genetics	 1 (2)	 4 (8)	 2 (4)
Illness/surgery	 10 (19)
	
1 (2)	 0
Life Events .	 11 (21)	 4 (8)	 0
Drugs	 5 (9)	 7 (13)
	
2 (4)
Allergies	 4 (8)	 4 (8)	 5 (9)
Candida	 1 (2)	 2 (4)	 5 (9)
Pollution	 1 (2)	 7 (13)
	 2 (4)
Chemicals	 1 (2)	 4 (8)	 0
Vaccination	 2 (4)	 1 (2)	 0
Diet	 3 (6)	 6 (11)	 4 (8)
Change of house	 5 (9)	 0	 0
Change of job	 2 (4)	 0	 0
Relationship problems	 6 (11)	 1 (2)	 0
Change marital status	 1 (2)	 0	 0
Personality factors	 1 (2)	 5 (9)	 1 (2)
Psychological factors*	 3 (6)	 1 (2)	 23 (43)
Accidents	 1 (2)	 0	 0
Not sure	 0	 2 (4)	 7 (13)
Combination	 1 (2)	 5 (9)	 0
Others	 11 (21)	 6 (11)	 6 (11)
*Includes depression/fear of activity and hypochondria.
113
ceived their busy lives in a negative way. For instance,
one lady related that she had:
"always worked hard and played hard ... my life
was full, fast and wonderful, the happiest time I
have ever had, and I was very strong, both mental-
ly and physically" (2.34).
Nevertheless, like others, she attributed her illnesses to
going beyond her limits as a result of which her body lost
its ability to fight off infections.
Some of the factors which were reported less often as causes
included diet, the use of antibiotics, thrush, personality
factors, operations, lighting and pollution.
b. J3e1iefs regarding the illness in general 
The types of attributions about the illness in general are
shown in the second column of Tables 4a and b. As before,
the majority of patients mentioned viral infections as a
major cause.
While most of the subjects reiterated the view that infec-
tion and lowered resistance played an important role, far
fewer mentioned stress or pressure this time and many more
identified personality factors. Several of the interviewees
observed that the illness appeared to be more common in very
busy people who take on too much and go beyond their limits.
One of them, who had counselled many patients observed that:
"ME people are generally very active and very busy
people - on the go, motivated people ... conscien-
tious, perfectionist" (1.7).
A less common view was that CFS tended to affect mainly
"sensitive people" (1.11).
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Pollution was also regarded as more important this time.
For instance, a number linked immune function with pestici-
des in food, the overuse of antibiotics, the Pill etc. One
also associated environmental factors with a perceived
increase in infectious agents:
... There seem to be more viruses around ... As
a child, I didn't get all these strange viruses.
You got flu and you got a cold, but not these
strange things" (1.1).
Other factors which were mentioned by the interviewees as
possible causes included additives and mercury fillings.
c. Factors regarded as unlikely causes 
When asked about the unlikely causes of CFS, a large number
in both groups rejected the view that the illness was purely
psychological or 'all in the mind' (see third column, Tables
4a and b). Also mentioned in this regard were drugs, hypo-
chondria, laziness and boredom, malingering, lack of motiva-
tion, phobias, "being a yuppie", amalgam dental fillings and
wanting attention. One respondent wrote:
"If I 'needed' an illness I'd certainly pick
something else" (2.44).
It was possible during the interviews to ask about unlikely
causes in more detail. For instance, while less than half
of Group 2 believed that psychological factors like hyper-
ventilation and clinical depression did not play a major
role in CFS, 77% of the interviewees rejected these as main
causes.
In response to the question about specific theories, most
dismissed the idea that CFS was due to inactivity and/or
depression. One interviewee said:
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"Initially perhaps I did overrest and I got rather
unfit. Then it was striking the balance and get-
ting yourself fit enough to carry on and walk and
do things like that and not ... relapsing. Doing
a little bit but not too much ... I try to do
something everyday to keep my system going ..."
(1.3).
There was no evidence that patients in this study had become
afraid of exercise to the extent that they avoided all ac-
tivity. Although some exercised until they relapsed, they
tried again, often changing the nature of the exercise e.g.
from swimming to yoga. Moreover, they were not put off by
symptoms. For instance, one person who tried yoga found that
she felt rotten two days later. However, she persevered and
now feels that it really helped her.
Those who had experienced clinical depression in the past
noted how different this was from CFS. In their view, the
former was associated with more general tiredness, more
apathy, anhedonia and the loss of hope. One interviewee who
had suffered from depression from the age of 16 said:
"...you do get depressed with this illness, but it
lifts the minute the physical symptoms lift ... I
know it's an entirely different feeling, the
feeling of longterm depression. When you're de-
pressed, when the world's at an end, you haven't
any energy, you don't want to do this and you
can't see any future. Throughout the 8 years of
ME I've always been able to see a future. There's
always been hope".
Q: Were you apathetic, like not wanting to get
out of a chair, whereas in ME you want to, but you
can't?"
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A: "Absolutely" (1.3).
The differences between CFS and clinical depression were
also outlined by another interviewee. She had experienced
a period of depression earlier in her life and said that she
remembered:
"enormous apathy, you burst into tears without
knowing why you're crying. It's like a sort of
grey cloud that descends on you. You feel impos-
sibly tired, you drag yourself about ..."
She also noted that the energy levels did not change so
quickly when .she was depressed, and that her mood did not
fluctuate quite so much as it does now she has ME.
... The depression in ME is different. Although
it's very real and very acute at times, it lifts,
it passes and you have days when at least mentally
you feel quite normal. That doesn't happen in
depression. It really is a relentless thing.
This is why it's so horrible to go through. There
isn't any hope in the way that you have hope in
between your spasms of depression in ME" (1.8).
Nevertheless, psycho-social factors were regarded as in-
fluential later on. For instance, a number identified
factors such as 'stress' as something which exacerbated
their condition, while support and care from others had the
opposite effect.
3.4.6 The effects of CFS 
Many patients reported that the illness had had a profound
effect on their lives (see Table 5). All except three sub-
jects mentioned that they'd had to reduce activities, par-
ticularly walking, travelling and driving and hobbies. Many
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Table 5.	 Main effects of the illness
Effect	 Group 1 Group 2
No.
	 (%) No.
	 (%)
Activities	 15	 (88) 52	 (98)
Job	 14	 (82) 25	 (47)
Social life	 13	 (76) 25	 (47)
Housework	 9 (53) 17	 (32)
Can't make plans	 7	 (41) 13	 (25)
Change plans for future 	 2 (12) 2	 (4)
Slowed down	 2 (12) 11	 (21)
School/higher education 	 2 (12) 16	 (30)
Finances
.	1	 (6) 8	 (15)
Change in environment	 1 (6) 0
Diet	 0 8	 (15)
patients had had to give up or change their jobs, and the
women had been forced to limit the amount of shopping and
housework. Some patients also had problems reading, talking
and writing, and a minority had changed their diet to reduce
nausea or 'allergies'. One respondent summed her life up as
follows:
"My whole life has been curtailed. I have to plan
everything around the illness. I can't walk or
run, or decorate, or play energetically with my
children. All my strength seems to have gone (and
I was quite strong physically.) Mentally I am
much less 'intelligent', my long and short term
memory have been affected as my ability to con-
centrate, study, learn and write. My judgement
and reasoning are not as good (and I was very
bright). My brain is permanently "out to lunch"
(2.44).
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The limitations, both physical and mental led one inter-
viewee to sum up her situation as "a sheltered life" (1.12)
while a respondent wrote that she felt that she was "merely
existing, as opposed to living in a creative way" (2.50).
Another, now recovering, described how the ME had led to a
reduction of choice and control in the sense that she could
not always shop, go out, drive or even have a bath when she
wanted to or needed to.
The responses indicate that although patients were able to
do less overall, the extent of their impairment varied quite
considerably and they could identify good periods as well as
bad ones. The unpredictability of the illness also meant
that many had difficulties making plans. This was noted by
a number of people in Group 2 but specific questioning of
Group 1 revealed that it was a much more common experience
than their responses had indicated.
One described the situation as follows:
Physical activity has to be considered almost
daily - and it is difficult to make plans ahead.
At times I can do an almost normal amount - and it
is then ... necessary to beware of 'overdoing it'.
Some days it is only possible to do the barest
essentials - and to abandon plans for e.g. gar-
dening, decorating, walking, even shopping. At
worst, there is no alternative to bed rest, for at
least part of the day. This, of course, is very
puzzling for one's family and friends, and often
precludes long term projects" (2.62).
A number of patients noted that the fluctuating nature of
the illness also restricted their activities outside the
home because of the fear that others would be unsympathetic
if they began to feel unwell and that they might not be able
to find the help they need. One interviewee summed it up by
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saying:
"you are afraid of getting into a situation you
can't cope with" (1.15).
One rather surprising effect described by a number of the
patients was that they were no longer getting different
viral infections. Instead, their reactions tended to be an
exacerbation of ME symptoms:
"If I'm with people who've got germs, I tend to in
the days subsequent, feel very ill. I have all
the symptoms of ME, I feel very tired, my glands
tend to.swell up but I don't actually get it. I
dose myself up with vitamin C and it's the
fighting off that makes one feel ill" (1.3).
3.4.6.1 The effect on relationships 
As shown in Table 6, many patients reported that CFS put a
great strain on their relationships. Indeed, over 80%; from
both groups noted problems in this regard.
Table 6. The effect of the illness on relationships.
Effect Group 1
No.	 (%)
Group 2
No.
	 (%.-)
Relationships strained 14 (82) 43 (81)
Lost contact with friends 7 (41) 17 (32)
Relationships improved 4 (24) 12 (23)
Marriage closer 1 (6) 6 (11)
Marriage strained 0 7 (13)
None 1 (6) 1 (2)
Many revealed that they had lost contact with friends and
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about 12% admitted to feelings of isolation and loneliness.
Relationships were also affected by difficulties in fol-
lowing and therefore having conversations. However, about
a quarter considered that CFS had had a positive effect on
their relationships. The following describe some of the
most frequently reported experiences.
a. The lack of understanding 
Many mentioned a lack of understanding and sympathy and most
attributed this to their friends and family's limited know-
ledge of the illness.
Most reactions fell into three categories:
1. scepticism regarding the status of the illness, i.e. the
suggestion that it did not exist in a any form, and that the
person was therefore not sick,
2. belief that the illness had a psychological basis, e.g.
that it was a type of nervous breakdown or just hypochon-
dria, and consequently, that help was available if they
wanted it or that they could pull themselves out if it,
3. acceptance that the patient was ill and that they
required help.
Many patients commented on the difficulty they had expe-
rienced trying to persuade their family and friends that
they were genuinely unwell and not malingering or exag-
gerating; for instance, that they really had something which
can not be cured with a brisk walk or a holiday. For in-
stance, one person wrote that:
"some members of my family were sceptical about
the illness and my degree of suffering. With
friends I found myself having to justify what I
was doing and explain the nature and type of
illness which I was suffering from" (2.13).
Another noted:
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"I think that some friends regard me as a bit of
a hypochondriac as I am always feeling ill ... It
makes me angry inside at times to think that I
have suffered and conquered so many stages of ill-
health in my life and no-one believes me" (2.29).
Not surprisingly, a number of patients lost friends as a
result of their illness, either because the contact was
broken or because of conflicts. One person felt that people
interpreted the fatigue personally, that is, they thought
that the patient was tired of them. Others believed that
friends avoided contact because they felt embarrassed, that
they didn't know what to say.
An interviewee summed up the problem as follows:
"The illness is so contrary to anything that
anybody else has experienced before - they just
don't understand" (1.7).
This was echoed by a respondent who identified a problem
common to many whose disability is invisible:
"It would have helped if there had been some
viable symptom of the illness (apart from ap-
pearing very tired and lazy!) which other people
could understand and relate to more easily"
(2.13).
There was also disbelief among doctors. One nurse wrote
that:
"Even on the neurological ward the doctors, con-
sultants did not believe in its existence and I
was continually having to defend the disease"
(2.17).
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The fluctuations in the illness was identified as a com-
plicating factor by a number of patients. As one respondent
commented, when others see you looking better, they:
"do not realize that each day is different, and
you go back to being ill again" (2.9).
A number of respondents stated that they coped with the
distress associated with relationships by avoiding certain
people or pretending they were fine. For instance, one
person wrote that she had stopped seeing a close friend
because the latter couldn't accept her illness and was
insensitive.
"She kept on saying things that upset me and I
felt ... that I'd been putting all the energy into
maintaining the friendship ... I felt very hurt
and ... the only option was to 'get out'" (2.39).
To stop others worrying, or to avoid difficult questions,
some lied about their condition when they were feeling
unwell. Others sometimes avoided the topic of CFS alto-
gether:
"A lot of people are either patronising or totally
non-understanding. Because there is such doubt
surrounding ME I feel disinclined to keep on ex-
plaining why I can not commit myself or be sure
that I'll be O.K. on a certain day" (2.47).
b. The effect on children and family life 
The strain of the illness also appears to have had a major
effect on people's relationship with their partners and
children.
"It's been devastating for my husband and son.
Over the years it's slowly destroyed our lives
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until the point came where I was so ill we thought
I would die. My husband became mentally and
physically worn out washing me, feeding me and
looking after my son and eventually had 3 months
off work, which still left him with everything
else as we had no family to help and our two
requests for home help were refused. It broke my
heart to see my son's unhappiness. He used to cry
a lot and became very introvert. Although it
wasn't my fault, I still felt very guilty. I
couldn't be a wife or a mother or hold a proper
conversation, as I couldn't remember the day, time
or people's names" (2.21).
Again the problem of having an invisible illness came to the
fore:
"The children ... cannot relate to mum being ill
when I don't look particularly ill. If I had a
broken arm or something 'visible' I think try
could have coped better. Now they are older they
understand more ... I feel that I have failed my
children in not being able to do things with them,
and for them" (2.63).
On a more positive note, one mother observed that her
illness meant that she had more time to sit and talk with
her children and another felt that it was good for her
children to have more responsibility. Many also referred to
having become closer to their families, and a number des-
cribed how their relatives and friends had been prepared to
learn about the illness and support the patient.
Finally, the illness prevented a few patients from actually
building up relationships. As one admitted:
"I never had a steady boyfriend, never had steady
124
relationships with people of the opposite sex. I
was too ill and too tired to give people the time
they need" (1.6).
3.4.6.2 The effect of CFS on the person
The illness seemed to affect people in different ways (see
Table 7). The majority noted feelings and emotions such as
frustration, anger and unhappiness. Many also thought that
it had changed their personality, their attitudes and their
sense of being in control.
Table 7. Effect of the illness on the person.
Effect	 Group 1
	
Group 2
No. (%) No. (%)
Emotional distress 12 (71) 39 (74)
Changes in personality
(esp. self-confidence) 9 (53) 26 (49)
Changes in attitude 9 (53) 20 (38)
Learned from it 4 (24) 8 (15)
Accept situation 2 (12) 7 (13)
Limited life 2 (12) 2 (4)
More positive outlook 2 (12) 9 (17)
Isolation/loneliness 2 (12) 10 (19)
Lost control over life 2 (12) 3 (6)
Change in appearance 1 (6) 3 (6)
Gained respect for body 1 (6) 1 (2)
Guilt 0 5 (9)
Why me? 0 1 (2)
a.	 Emotional distress
Over 70% of the patients mentioned experiencing some form of
emotional distress as a result of their illness. Many were
frustrated by the limitations in their lives, including the
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inability to do trivial things like washing their hair,
lifting the washing out of the washing machine etc. Others
were upset by the lack of understanding about CFS (see
above).
Some linked their emotional state to the changes in their
symptoms. For instance, one person who described herself as
generally "cheerful and carefree" became "irritable and
depressed" when her symptoms worsened. Others also related
how exacerbations upset and depressed them, although some
managed to cope better than others. As one respondent put
it:
"I am grateful for a good day and look forward to
the next day if it is a bad day. If I have had a
few good days and feel I am going into remission
I do get upset if I am ill again, but I have
learnt to live with it" (2.40).
However, another summarised the experience as follows:
I never realised that one could feel so dreadful
and still stay alive" (1.5).
b. Effects on personality
About half the patients noted that their personality had
changed. Some felt that the illness had made them more
patient, understanding, tolerant, serious and mature. Others
had become more introspective, shy and reserved. One opti-
mist had changed into a pessimist, finding that events which
used to be challenges were now more likely to be evaluated
as problems. Other negative effects which were mentioned
included becoming more short-tempered and self-centred,
being less out-going and spontaneous, and loss of confi-
dence, particularly about being able to complete tasks. The
limitations imposed by the illness also affected people's
perception about themselves in another way. As one
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interviewee said:
"It's bad for your self-esteem because you
suddenly find yourself unable to cope with
situations you didn't even know were situations
that required coping with" (1.5).
C) changes in attitudes and other aspects of self 
A number of interviewees mentioned how the experience of
illness had led them to change their attitudes to life, to
other people, to their diet, the environment and to them-
selves. People described how they had become more tolerant
and patient, less materialistic, less critical of others,
and that they obtained more pleasure from simple things.
Some noted having become more aware of spiritual matters and
the importance of good health. One person also mentioned
that she'd become more assertive in her relationships, and
a few had changed their political affiliation. One inter-
viewee said:
"It's altered my values and I appreciate different
qualities in people and put more importance on
qualities in myself, like having time for people,
having the strength to carry on. I have a high
opinion of anyone who's had to cope with a setback
in his life" (1.13).
The fact that more people in this group reported changes in
their attitudes may have been due to being asked to ela-
borate on this point.
Some people noted the lack of control, particularly the in-
ability to fight the illness, ignore it or work through it.
As one person put it:
"I used to feel I had more control over myself,
body and the world. I now feel things are more
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complicated, beyond my control to a greater extent
- that I have to meander a path through what I
want to do and what I can do - the gap is far
greater than it used to be" (2.55).
A few felt that the illness had also led to a change in
their appearance.
"I also look much older - the eyes have been a
sure sign of my state of health" (2.26).
Finally, several patients said that they had learned from
the experience, for instance, that life is more than work,
education and achieving. One summed it up as follow:
"I have learned not to become flustered, to take
life as it comes, and enjoy whatever small
pleasures I may find. Learned to 'stop and smell
the roses' in fact" (2.16).
3.4.7 Coping
People were asked two questions about coping. The first
focused on the ways they dealt with symptoms on a day-to-day
basis; the second asked about the ways they coped with the
illness as a whole.
a. Coping with symptoms 
As shown in Tables 8a and b, rest was the main coping stra-
tegy used to deal with the symptoms. Indeed, it was men-
tioned by 88W of the patients in Group 1 and 74% of those in
Group 2. This was often combined with the pacing of
activities and relaxation (for instance, with yoga and
meditation).	 A significant number also tried drugs,
particularly antidepressants.	 The following section
describes the strategies in more detail.
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Table 8a. Main coping strategies employed by Group 1.
Ways of coping	 With symptoms
No.	 (%)
With illness
No.
	 (%)
Activities* 4 (24) 2 (12)
Accept illness 0 1 (6)
Allergy treatment 2 (12) 0
Alternative medicine 15 (88) 0
Avoid stress 2 (12) 0
Keep problems to oneself 0 0
Diet 12 (71) 0
Distancing from illness 0 0
Diversion of .attention 3 (18) 1 (6)
Drugs 7 (41) 0
Find good doctor 1 (6) 0
Hobbies 3 (18) 0
Holidays, outings 1 (6) 0
Humour 1 (6) 1 (6)
Seek information 0 1 (6)
Pacing, live within limits 10 (59) 5 (29)
Plan activities, 2 (12) 1 (6)
Positive outlook 2 (12) 8 (47)
Religion, faith 1 (6) 1 (6)
Relaxation (e.g. yoga) 6 (35) 3 (18)
Rest 15 (88) 4 (24)
Sleep more 2 (12) 1 (6)
Seek social/emotional
support 6 (35) 4 (24)
Vitamin, mineral supplements 7 (41) 0
e.g. includes gentle exercise (such as walking),
gardening, voluntary work, listening to music.
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Table 8b.	 Main coping strategies employed by Group 2.
Ways of coping	 With symptoms
No.	 (%)
With illness
No.
	 (t)
Activities* 18 (34) 18+ (34)
1- (2)
Accept illness 0 7 (13)
Allergy treatment 4 (8) 1 (2)
Alternative medicine 16 (30) 3 (6)
Avoid stress 8 (15) 3 (6)
Diet 24 (45) 4 (8)
Distancing from illness 1 (2) 0
Diversion of attention 5 (9) 3 (6)
Drugs 12 (23) 5 (9)
Find good doctor 2 (4) 4 (8)
Hobbies 3 (6) 4 (8)
Holidays, outings 1 (2) 6 (15)
Humour 4 (8) 6 (11)
Keep problems to oneself 1 (2) 1 (2)
Pacing, live within limits 26 (49) 11 (21)
Plan activities 7 (13) 3 (6)
Positive outlook 9 (17) 15 (28)
Religion, faith 3 (6) 9 (17)
Relaxation 16 (30) 10 (19)
Rest 39 (74) 10 (19)
Focus on self 1 (2) 1 (2)
Seek information 6 (11) 3 (6)
Sleep more 6 (11) 4 (8)
Social life 2 (4) 4 (8)
Seek social/emotional
support 7 (13) 28 (53)
Vitamin, mineral supplements 17 (32) 0
+ added activities - reduced activities
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Rest and conserving energy
Resting for certain periods was clearly the most common way
patients tried to deal with their symptoms. However, no one
mentioned staying in bed all day or for long periods of
time. Nor did many people report an increase in time spent
asleep.
Resting was often combined with a process referred to as
pacing. Eleven (65&) of the interviewees and 32 (60%-) of
the respondents noted that they used pacing either to con-
trol symptoms and or the illness. It involves working out
how much one can do without triggering a relapse. Most
patients had adopted this approach through trial and error
and from experience. However, it often amounted to making an
educated guess. Others referred to listening to their body
in order to estimate what they could do.
Pacing was not easy. For instance, one interviewee said:
"When I do start picking up, I have to resist the
temptation to start running around and doing
things. If I do have energy, I start using it
really quickly ... too much. I always end up
feeling much worse a few days later" (1.2).
However, those who used this strategy generally found that
they were able to do more as a result. Indeed, one or two
reported that it allowed them to live a reasonably normal
life.
Aside from limiting activities, a few mentioned that they
could reduce exacerbations by controlling other known trig-
ger factors, e.g. certain foods. Someone who suffered from
food sensitivities commented on the effects as follows:
"Quite importantly, every outing has to be planned
with military precision if we want to eat out.
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Due to food allergy there can be no spontaneity or
surprise meals out" (2.56).
Complementary medicine 
A very large percentage of Group 1 reported that they had
tried alternative medicine and vitamin and mineral supple-
ments. Many had also experimented with their diet. The use
of supplements was also reported by patients in Group 2 but
other forms of self-help, such as dietary changes and
alternative therapies, were less common. The interest in
alternative medicine did not stop patients trying more
orthodox treatments as well. In fact, far more people in
Group 1 used drugs such as anti-depressants.
Practical help 
Some of the coping strategies were practical. One person
moved to a house which would be easier to keep clean and
another asked her employer for a transfer so she did not
have to travel so far to get to work. People also used aids
such as crutches to enable them to walk, and made lists to
compensate for their poor memory. Others planned their ac-
tivities. As one patient explained:
"I bring downstairs everything I'll need during
the day, so that I don't have to go upstairs again
until bedtime (I'm fortunate to have a downstairs
toilet). Throwing the washing downstairs ahead of
me - this is a bit untidy I know, but I found it
easier to collect it at the bottom than to carry
it down. Keeping the things I am going to use
most of the day on a level with my arms, to avoid
bending or stretching up too often. This tends to
take up room on the worktops, but again, is worth
the saving on effort" (2.16).
Emotion-focused strategies 
Seeking emotional support, either from professional counsel-
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lors or from other patients was mentioned by a third of
patients in Group 1 and 13 of those in Group 2. Others
related how they coped by diverting attention away from
thoughts about their illness and by keeping themselves
occupied. One person kept a diary, and had embarked on an
Open University course primarily to distract her attention.
Trying to keep positive and humour were mentioned by only a
few.
Exercise 
Some patients made a determined effort to keep active, for
instance, by taking short walks, playing the piano, doing
woodwork, painting and gardening. One interviewee dis-
covered weight-training when recovering; others limited
themselves to gentle physiotherapy and massage. One patient
wrote:
"I do try to keep fairly active, (that doesn't
mean running around the block!) and tend to set
myself small targets to reach. It is important to
feel that one is achieving something albeit small"
(2.30).
Less common coping strategies included avoiding alcohol,
taking warm baths and Christian healing, all of which were
regarded as useful. One interviewee tried a graded exercise
regime but found it unhelpful.
b. Coping with the illnes in general 
In response to the question what people did to stop being
overwhelmed by the illness in general, there was a slight
change of emphasis. In contrast to the largely practical
approach towards symptoms, e.g. resting, dietary changes and
drugs, people used more emotion-focused strategies to deal
with the illness as a whole. These included adopting a
positive outlook, for instance, telling oneself that they
would recover and concentrating on what they could do,
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rather than what they couldn't. In addition, many sought
and appreciated support from family and friends. As one
person revealed:
"Above all, I think positive thinking and belief
in myself has helped me most. Also talking
through my fears and problems either with a friend
or other ME sufferers and letting go of emotions
and negative feelings and having a good cry now
and then or expressing anger if I feel like it
..."	 (2.5).
Others valued the help from professionals such as general
practitioners and counsellors. A few also mentioned the
support from fellow patients.
In addition to the above, some also mentioned living within
one's limits and accepting the fluctuating nature of the
disorder as a way of dealing with the illness in general.
Again, there was a tendency to use a number of different
strategies. One person summed up her approach as follows:
"Gentle acceptance, relaxation and keeping within
my limitations, which of course become wider as
time goes on, these are the things which help me
deal with the illness at this time. Coupled with
a sense of humour! When you drop glasses on the
kitchen floor, when you were sure they were going
on to the draining board, or realise that you
can't see the ball the men are kicking around the
pitch while you are watching the World Cup Series,
if you can see the funny side, it eases the
strain" (2.16).
However, some admitted that they were occasionally over-
whelmed. One noted that at such times:
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"Support from my husband and friends was invalu-
able. When the doctors tell you there's nothing
they can do to help, you feel very lonely" (2.3).
Finally, a number of patients were clearly helped by having
a religious faith while others compared their situation with
those who were worse off than themselves in order to keep a
sense of proportion and feel better about their lives. As
one person told herself: "if other people can survive this
(and worse) then so can I" (2.63).
3.4.8 Advice to others 
As Table 9 shows, the advice which most patients would give
to new sufferers is to get sufficient rest. However, no one
recommended total bedrest except for a short period in the
early stages. During the chronic phase, the general advice
was to 'listen to your body' in order to assess how much
rest was needed, and to remain as active as possible within
one's own limits. Some also referred the value of balancing
rest with energy output, while a few recommended gentle
exercise as part of the approach.
A significant number mentioned the need to remain positive
and about one-third recommended patient groups, both for
information on the illness and as a source of support. As
one respondent explained:
"They will understand how you are feeling and
sympathise, offer advice, and make you realise
that you are not alone and that there is a future
for you. If ever there was a time when a 'trouble
shared is a trouble halved' becomes true, it is
for the ME sufferer" (2.18).
One of the interviewees felt that coming to terms with the
illness was perhaps the most difficult part of recovery. He
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Table 9. Advice which would be offered to a new patient.
Advice	 Group 1
	 Group 2
No. (%)	 No. (%)
Rest	 14 (82)	 32 (60)
Be positive	 7 (41)	 24 (45)
Join group	 7 (41)	 16 (30)
Pace yourself	 5 (29)	 16 (30)
Accept the illness/yourself 	 5 (29)	 12 (23)
Alternative medicine	 5 (29)	 9 (17)
Seek emotional support	 4 (24)	 14 (26)
Seek information	 4 (24)	 12 (23)
Listen to body	 3 (18)	 9 (17)
Change diet	 2 (12)	 9 (17)
Find a good G.P.	 2 (12)	 8 (15)
Keep sense of humour 	 1 (6)	 3 (6)
Take exercise	 1 (6)	 3 (6)
Enjoy activities	 0	 8 (15)
Keep diary	 0	 7 (13)
Accept help, benefits 	 0	 6 (11)
Change lifestyle	 0	 6 (11)
Sleep	 0	 3 (6)
Have a hobby	 0	 2 (4)
Take vitamin supplements 	 0	 2 (4)
Drugs	 0	 1 (2)
also said that newly diagnosed sufferers should be reminded
that life has a lot to offer even if you have ME. Others
concurred with this.
Although many had tried alternative medicine, particularly
in Group 1, surprisingly few would recommend it to new suf-
ferers. When it was, the approach was generally guarded:
"There is no miracle cure but don't be dissuaded
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by anyone from trying alternative therapies. They
could ease your suffering but be sure you can cope
financially and chose a qualified practitioner"
(2.21).
There was also advice on dealing with sceptics. Some thought
that patients should ignore, and not worry about people who
don't understand. One wrote:
"Don't let people (including doctors) make you
feel guilty for being ill. You are sick, not mad"
(2.44).
Other advice included: finding a knowledgeable GP, avoiding
stress, being. patient, remaining aware of the spiritual side
of life, getting fresh air, avoiding alcohol and anaesthe-
tics, keeping a lively mind and a sense of humour. Several
people also advocated certain changes in lifestyle, such as
eating sensibly and learning to relax. In contrast, almost
no one recommended extra sleep or taking particular drugs.
3.4.9 What having CFS meant to the patients 
This question asked respondents to sum up the experience of
CFS in their lives. Not surprisingly, the answers some-
times overlapped with those given in the section dealing
with the effects in more general terms.
The replies suggest that the illness had caused a great deal
of emotional distress (see Table 10). For example, many
mentioned feeling despair, pain, sadness and utter frus-
tration. It had been a "trauma" (1.14), a "disaster" (1.7),
"hell on earth" (2.3) and something that "totally destroyed
my life" (1.15). Most notably, it was seen as a lonely
fight, a battle and struggle against a lack of under-
standing. One summed up how she felt as follows:
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"It has meant that two years of my life have been
taken away from me ... feeling a victim ...
feeling 'persecuted' and imprisoned in a bedroom
for a crime I didn't commit! It means misunder-
standing - a continual battle - struggling against
doctors, psychologists, specialists, dentists,
friends etc. to be taken seriously. It means
loneliness and isolation. It means depression and
sadness. It means boredom" (2.39).
Table 10. The meaning of illness
Experience	 Group 1	 Group 2
No. (9) No. (%)
Emotional distress
(eg frustration, anger) 12 (71) 30 (60)
Change in lifestyle 5 (29) 14 (26)
Change of view of person,
priorities 4 (24) 10 (19)
Learning experience 3 (18) 8 (15)
Change in relationships 2 (12) 12 (23)
Change of job/career 2 (12) 7 (13)
Change of personality 2 (12) 6 (11)
Slowing down 2 (12) 5 (9)
Loss of control over life 1 (6) 1 (2)
Change in attitudes 1 (6) 9 (17)
Change of housing 1 (6) 1 (2)
Loneliness 0 7 (13)
To another, CFS meant:
"A devastated life ... I know this ailment is not
fatal and therefore we should thank our lucky
stars but the disruption it brings to a normal
life is unbelievable" (2.38).
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The enforced change in lifestyle, and in particular, the
amount of time spent resting was generally seen in negative
terms. One said:
"I begrudge the time that's been wasted over the
last 7 years because I'm not going to get them
back again" (1.8).
People also noted a sense of loss in relation to themselves
as people. One described this as "almost like a bereave-
ment" (2.44).
As mentioned above, the illness also affected relationships
and work. Even though some returned to their jobs after a
time, the illness often meant that they had moved down on
the career and promotion ladder. Ambitions had to be given
up. One, who had to "jettison" her ambitions, described the
illness as follows:
"It's been a kind of crossroads in a way ... it
pushes you in a direction - you don't make the
decision - it makes it for you" (2.8).
Someone who had started to improve wrote about the continued
care which had to be taken:
"I dislike the feeling of being a bit unwell or
tired now and again ... and of having to be
conscious of this instead of just doing what I
want to do. It's a nuisance, a bore or irritation"
(2.35).
However, some saw positive aspects, the illness having
changed their priorities and outlook on life. Another looked
forward saying:
... I do feel very fortunate to have had the
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experience. The rest of my life is going to be
more fulfilling, rewarding and worthwhile than if
this hadn't happened" (2.3).
Several referred to suffering caused by the lack of
understanding. One summed up her experience as follows:
"I am labelled neurotic and I could write a book
about the soul destroying things that doctors have
said to me... Deep inside, I have feelings of
anger and resentment bottled up about this. Oc-
casionally it bubbles up to the surface if anyone
dares to suggest 'it's all in the mind.'" (2.29).
Another person summed up the confrontation with disbelief as
follows:
"It has hurt to be called a malingerer" (2.41).
Finally, one respondent noted that ME had led to "a great
cynicism towards the medical profession in general, and a
questioning of our drug-orientated medical treatments".
However, it had also resulted in "a reawakening of my
Christian faith, and a desire to grow spiritually" (2.1).
3.4.10 Views of the future 
While the assessment of the experience was overwhelmingly
negative, 15 (88.2%) of interviewees saw their future in
generally positive terms. However, there was less optimism
in Group 2 where just 31 (58.5%) felt that their future
would be better. Nevertheless, the majority were cautiously
optimistic, hopeful that things would get better and realis-
tically, predicting a slow recovery and having more control.
For instance, one person wrote that she intended to live
life to the full, but qualified this by adding that:
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"I shall adapt it to my abilities, but I intend to
enjoy everything I am able to ... I am determined
that although I must live with ME it will be kept
in its place!!!"	 (2.44).
Another felt more ambivalent:
"Well, it can't be any worse (or can it)" (2.7).
Others replied that they took one day at a time and
preferred not to think too far ahead.
"If I think of the future, I become depressed, so
the most sensible thing to me is to take things
day by day" (2.22).
There was little sign of a general hopelessness; only a tiny
minority in both groups responded in clearly negative terms
and expressed fear of what might happen to them. As one
admitted:
"I ... feel despair that things may never change.
The possibility of being really ill (confined to
bed, unable to do anything) haunts me" (2.63).
Finally, one expressed the hope that in the future:
"doctors - especially GPs - would learn to respect
ME as a "proper" illness, so that ME sufferers of
the future, do not have to fight to convince
her/him, that they are ill - I find this is quite
inhuman" (2.34).
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3.5 Discussion
The main findings from this exploratory study suggest that
CFS caused a great deal of emotional distress and that many
patients lacked support from their friends, families and
physicians. The results also indicate that the illness
caused a wide range of symptoms in addition to fatigue and
that patients used a combination of coping strategies to
deal with the physical and the emotional aspects of their
illness.
Before discussing the data in more detail, it should be
pointed out that neither Group 1 or Group 2 may have been
representative of the patient population as a whole. Group
2 consisted of members from a national self-help association
and although an attempt was made to obtain a more represen-
tative sample through general practitioners, all the inter-
viewees turned out to be members of that organisation's
local branch. Since that particular group was very active,
it is possible that their views may have coloured those of
the participants in this research.
Compared with other patients, both Group 1 and 2 contained
a larger proportion of women, more professionals and more
chronic cases than the community sample described by Lloyd
et al (1990). In fact, the subjects in the present study
were probably more like the clinic attenders studied by
Dowsett et al (1990) and Ray et al (1992b).
3.5.1 Symptoms 
As expected, fatigue and exhaustion were reported by almost
everyone. Also common were muscle pain and tenderness,
memory and concentration problems, visual disturbances (e.g.
photophobia) and weakness. The pattern of symptoms provided
by patients was consistent with the London criteria for
CFS(ME) as well as the descriptions of CFS(ME) by specia-
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lists such as Ramsay (1988) and Dowsett et al (1990). They
were also compatible with their doctors' diagnosis of 'ME,
or 'post-viral fatigue syndrome'.
Interestingly, neither Group 1 nor Group 2 reported the high
levels of depression, allergies and sore throat/pharyngitis
which have been documented in some of the other studies on
CFS (e.g. Hilgers and Frank 1992, Tirelli et al 1993,
Straus et al 1985). More specifically, while most of the
patients admitted to periods of unhappiness and frustration
(see section on the experience of CFS), the interviewees did
not feel they were clinically depressed. Indeed, a number
of the patients revealed that they had suffered from serious
depression in the past, and were therefore able to compare
and contrast this with their present condition.
The low prevalence of allergies and sore throats was unex-
pected, given descriptions in the literature and the in-
clusion of pharyngitis in the CDC case definition of CFS
(Bell 1991, Holmes et al 1988, Straus et al 1985). It is
possible that these symptoms were present but not regarded
as troublesome or that the symptoms had been treated and
were no longer a problem. Certainly, many of the inter-
viewees had made changes to their diet specifically to
reduce allergy-linked reactions. As far as sore throats
are concerned, it has been suggested that these are less
common and severe among chronic cases (Jessop 1990). This
could explain the low incidence among the subjects in this
study; 88 54- of Group 1 and 81% of patients in Group 2 had
been ill for at least two years and further inspection of
the data revealed that sore throats were less common in
those who had been ill longer.
The presence of symptoms like photophobia, which can not be
explained solely in terms of fatigue, demonstrate that the
illness is more complex than is sometimes implied in the
medical press (e.g. Thomas 1993).
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3.5.2 )3e1iefs about causation
In this study, only three subjects in Group 2 (6%) and two
interviewees (12%) believed that infection was the sole
source of their ill-health. The majority attributed their
illness to a combination of external and internal factors,
for instance, by referring to an increased susceptibility to .
infection due to lifestyle or 'stress'.
The tendency to attribute the illness to external and in-
ternal sources has also been reported by other researchers.
For instance, Ray et al (1992b) noted that 43% of their
patients believed that their condition was due to physical
and psychological factors. Likewise, Yeomans and Conway
(1991) found that 33% of their subjects felt the main cause
to be an infection, although 67% accepted that psycho-
logical factors might have played a contributory role.
The results of this study are also consistent with those of
Ware and Kleinman (1992). They reported that while 8% of
patients attributed their illness to "stress only", a large
proportion cited stress either as the single probable cause
or as a contributory factor. As in the present study,
stress was often invoked as the instigating factor in a
chain reaction leading to hypothesized immune dysfunction
and subsequent viral infection - a kind of "biopsychosocial"
aetiological model. Furthermore, their subjects also re-
ferred to psychosocial factors such as overwork, to having
led "lives of intense activity and involvement before their
illness began" and to having been "always on the go".
The identification of psychosocial influences as contribu-
tory factors was also reported by Cathebras et al (1992) who
noted that "most fatigue patients willingly acknowledged
psycho-social causes for their symptoms". Moreover, Wood
et al (1991) stated that 62% of their patients believed
psychological factors played a part in their illness. This
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contrasts with Wessely and Powell (1989), who found that
only 3 out of 47 subjects (6%) attributed their condition to
psychological factors.
The fact that many of the people in this study accepted that
their own actions (e.g. overdoing it) may have predisposed
them to ill-health does not support the view that most
patients with CFS adhere solely to external attributions in
order to avoid blame and responsibility (Abbey 1993).
When asked to speculate about the likely causes of CFS in
general, the vast majority of patients continued to impli-
cate infection. In contrast, fewer regarded pressure and a
busy lifestyle as an important cause, and in Group 2, only
two respondents mentioned stress. On the other hand, pollu-
tion and immunological factors (e.g. immune dysfunction)
were considered to be more influential as general causes and
amongst the interviewees, so were personality factors such
as perfectionism.
It is unclear why patients felt that psychological factors
were less important as a cause of illness in general, but
the results do indicate a willingness to accept a multi-
factorial aetiology. One possible explanation for the dis-
crepancy is that when considering general causes, the pa-
tients may have been influenced by the scientific litera-
ture. For example, the reviews of the research in the ME
Association's newsletter have tended to emphasise studies
implicating viral and immunological factors and have gene-
rally been highly critical of theories focusing on a psycho-
logical causes. This could be one reason why the subjects
rejected explanations implicating a lack of activity,
helplessness and hyperventilation. This does not mean that
the scientific literature was accepted at face value; some
of the interviewees also mentioned that the persisting
infection theory seemed to fit their experience of the
illness better than the psychiatric theories.
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The patient organisation's critical stance towards alterna-
tive medicine combined with their own experiences may also
explain the dismissal of candida as a likely cause. At the
time of the study, many health magazines had discussed the
problem of candida and a significant number of subjects had
tried an anti-candida diet. However, while not rejecting
the possibility that a yeast infection might play a role in
perpetuating or exacerbating symptoms, most felt that it was
unlikely cause of the illness itself.
3.5.3	 The effects of CFS 
The patients' accounts revealed that the illness had affec-
ted almost every aspect of their lives and that it had been
a major source of disruption and distress. For instance,
many had had to reduce the number of hours they worked, or
take sick leave. This often meant a change in income and
indeed, just under a third had become dependent entirely or
almost entirely on benefits. Women noted problems doing
housework and looking after their children and a significant
proportion had had to give up their social life.
The illness had also led to marked changes in their persona-
lity and attitudes. For instance, many felt that being ill
had made them more introspective and reserved, but also more
patient and less critical of others. Some also mentioned
that it had reduced their confidence about what they were
able to do and achieve. Moreover, a significant proportion
noted a change in values and priorities. For example, some
reported having become more spiritual, less materialistic
and obtaining more pleasure from simple things. Although not
all the effects on self-concept and values were positive,
most of the changes were consistent with those described by
Wright (1960) as requirements for successful adjustment.
In terms of relationships, over 80% mentioned that the
illness had led to strained communications and conflicts.
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Some of these appear to have emanated from people's doubts
about the aetiology of the illness and the severity of the
symptoms. As a result, a significant number of patients
stated that they had lost friends and that they felt mis-
understood and unsupported.
One factor which may have influenced both sufferers and
significant others is the fluctuating nature of the disease.
Some patients referred to experiencing 'good' days and 'bad'
days; others mentioned not being able to plan their lives
and having periods when they did not know how they would
feel from one day to the next. This led to a reduced sense
of control and immense frustration.
The changeability of the symptoms may also have contributed
to some of the conflicts between the patients and their
families and friends. For example, the fact that a person
is physically and mentally capable of going shopping one
day, but not at the same time the following week is hard to
comprehend, especially when there are no visible signs of
impairment (cf. Viemero 1991). As a result, many outsiders
may have questioned whether the patient was genuinely ill.
A further problem which might have contributed to the lack
of understanding and sympathy towards patients is the actual
nature of the symptoms. Like those of early multiple scle-
rosis, they may be perceived as nothing more than "exag-
gerated versions of conditions experienced by many people in
the rough and tumble of everyday life" (Robinson 1988).
Since most people regard complaints like fatigue, dizziness
and headaches not only as transient but also as trivial and
eminently manageable, it is not surprising that the general
population's perception of the disability associated with
CFS may differ from that of the patients.
People's doubts about the severity of CFS may have been
reinforced by the media's description of the disorder as
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'Yuppie flu', as well as some commentators' portrayal of
patients as overworked people who wish to escape their busy
lives (cf. Ware and Kleinman 1992).
The findings of this study suggest that where the lay con-
cept of the illness was inaccurate, friends and relatives
often questioned the effects of the disorder and accused
some patients of exaggerating. Others simply did not wish
to accept a change in their relationships, for example,
fearing a loss of help and support from the person who was
ill as a result of which they refused to legitimise the
patient's complaints (cf. Wiener 1975).
While it is . possible that criticism might encourage some
patients to be more active, most of subjects in this study
reported that it simply led to tension, conflict and rejec-
tion (cf. Faucett and Levine 1990, Ware 1992). Neverthe-
less, about a quarter of the subjects indicated that certain
relationships had actually improved. In these cases, the
other people involved had clearly accepted the patients'
assessments of their condition as being valid and they were
helpful and supportive.
The illness has also led to distressing experiences with
doctors. Some problems stemmed from uncertainties about the
aetiology of the illness while others were related to the
doctor's emphasis on the influence of psychiatric disorders
and their refusal to acknowledge the extent of the disa-
bility. Similar difficulties in the doctor-patient rela-
tionship were also documented by Denz-Penhey and Murdoch
(1993) who concluded that both parties "were operating on
different levels of knowledge". In their view, many
doctors' had an "inadequate and impoverished view" of the
illness. This 'abnormal illness perception' had led to
adherence to models which denied the ill person's experience
and was unhelpful in assisting either the doctor-patient
relationship or the healing process. Similar difficulties
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in connection with medical advisors have also reported in
other studies on CFS (Woodward et al 1995) and in accounts
on people suffering from MS (Stewart and Sullivan 1982).
One effect of the illness which is more difficult to explain
is the change in the experience of other infections, parti-
cularly the inability to sustain a raised temperature. This
phenomenon was mentioned by several interviewees and has
also been noted by others (e.g. Shepherd 1989), but why it
occurs remains unclear.
The responses to the question asking patients to sum up the
experience of CFS underlined both the disabling nature of
the condition and the emotional distress associated with it.
Some referred to the impact of the symptoms, the inability
to lead a normal life and the problem of obtaining practical
help and treatment. Others focused on the lack of under-
standing and the immense difficulties to obtain recognition
of their disability (see also Denz-Penhey and Murdoch 1993).
The combination of factors, physical, psychological and
social, meant that many regarded the illness not only in
terms of loss and limitations, but also as a traumatic and
devastating experience, an assault (cf. Turk 1979), a
battle, or struggle. Some felt it was a waste of time, that
they were merely existing rather than living. Nevertheless,
some also identified a positive side, for instance, that
they had learned valuable lessons from it.
In contrast to the largely negative views of the experience,
the majority saw their future as being better. The apparent
optimism was not mere wishful thinking; nearly 40% in both
groups had already noted signs of improvement. They may
also have been heartened by the steadily growing increase in
research and awareness of the disease among doctors, and by
the more sympathetic images of the disabled in the media.
Nevertheless, a few did admit to fears about the future, and
some preferred to take each day at a time.
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In general, the finding that many were fairly optimistic and
had a positive attitude towards their disability conflicts
with the portrayal of patients as hopeless, helpless and
depressed (Butler et al 1991, Sharpe 1994).
3.5.4 Coping with symptoms 
The principal coping strategy used by people with CFS in
this study appeared to be that of rest. However, none of the
patients advocated resting all day or 'total bed rest'. In-
stead, people increased the amount of rest and this was of-
ten related to the level of activity.
A number of patients used a strategy referred to as pacing.
This is also used by other patient groups, e.g. those
suffering from rheumatoid arthritis (Wiener 1975) and post-
polio syndrome (Bruno 1994b). It involves the identification
of activities one is able to do, how often, and under what
circumstances. Thus it is essentially a matter of balancing
disability on the one hand and available resources on the
other. Pinder (1988) observed that when "making such
calculations, various options are negotiated - or 'traded
off' - in search of the most viable outcome at any point in
time".
The use of this strategy contrasts with reports of patients
with CFS who consistently avoid all activity or who occa-
sionally attempt activities at premorbid levels because of
a personal desire to maintain high standards (Butler et al
1991, Surawy et al 1995, Wessely et al 1991).
Social and emotional support from relatives and friends was
another source of help. So was the additional advice and
understanding provided by fellow sufferers, counsellors and
therapists (cf Locker 1983, Robinson 1988). In terms of
medical help, many interviewees found their GP to be under-
standing and supportive, but they were offered little other
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than symptomatic treatment and lifestyle advice. Never-
theless, those who were prescribed drugs like antidepres-
sants did try them. Two were also accepted on a rehabili-
tation programme. One interviewee tried graded exercise,
which she found unhelpful; another was taught to do gentle
exercise within the limits of his capabilities and found
this beneficial.
Given the shortage of orthodox medical treatment, many ended
up exploring complementary therapies; in this study, 88 96 of
the interviewees had tried at least one type, and more than
one-third in both groups took vitamin and/or mineral supple-
ments.
Another common strategy was to experiment with diet. Some
tried the anti-candida diet, avoiding sugar, yeasts and
molds. Others eliminated certain foodstuffs from their
diet, and/or introduced more organic food. The greater use
of complimentary medicine in Group 1 may have reflected the
fact that the local group leader is the daughter of a homeo-
path and has a specific interest in alternative approaches
to health.
In trying to deal with the illness as a whole, people relied
more on positive thinking and other emotion-focused strate-
gies. Many referred to remaining optimistic, concentrating
on what they had and hoping for new treatments, for more
understanding, and for a cure. It is of interest, here,
that optimism has been linked with effective coping in other
conditions (e.g. Scheier and Carver 1987, Weisman and Worden
1976).
Few patients used strategies such as normalisation (Wiener
1975). It is possible that most of the patients in this
study did not cover up the fact that they were unwell be-
cause they were too ill to do so. Indeed, only two people
mentioned that they preferred to keep symptoms to themselves
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and in both cases, it was because they did not want to bur-
den friends and/or cope with possible conflicts.
Similarly, only a few people mentioned that they tended to
compare themselves with others who were worse off than them-
selves. In their opinion, this helped them to put their own
problems in perspective and deal with self-pity. This ap-
proach is also used by other patients groups e.g. Smith
(1979) and Taylor (1983).
The variety of coping strategies which were reported is
inconsistent with the notion that people with CFS are
generally passive, and that they do little other than rest
and wait for a cure. Moreover, the findings do not support
the view that these patients are rigid in their response to
fatigue and indeed, the references to changing values and
priorities indicates that many did adapt to changing
circumstances (cf. Surawy et al 1995).
Restraints on coping
As noted above, CFS is characterised by marked fluctuations
in the severity of symptoms. Although over-exertion was
identified as one of the commonest reasons for exacer-
bations, the coping strategies used gave only a certain
amount of control. Consequently, many patients had only a
limited idea of which symptoms they would have to deal with
at a given time, how severe they would be and how long any
flare-ups would last.
Research on other disorders has suggested that the change-
ability of symptoms requires frequent reassessments and
modifications to coping strategies and that it makes it more
difficult for people to evaluate the effectiveness of the
latter (Mishel and Braden 1988, Strauss et al 1984). This
should be taken into account, not just when considering the
sources of emotional distress but also when assessing the
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outcomes associated with specific strategies and treatments
(Sibley 1988).
A second constraint on coping were the symptoms themselves.
Muscle weakness and fatigue limited activities, including
ones which might be therapeutic such as exercise. Similar-
ly, nausea sometimes caused difficulties with eating and
taking medicines. In terms of Lazarus's theory, this means
that CFS was not only an ongoing source of change in the
person-environment relationship but also a factor which
reduced the choice of available coping strategies (Lazarus
1991).
The effectiveness of coping
The effectiveness of the strategies mentioned by the pa-
tients with CFS was difficult to assess from the available
data. Some patients admitted to being overwhelmed and
feeling despair at times. However, many people had tried a
number of different approaches, and some of these, such as
rest and pacing, were felt to be helpful. Indeed, the
patients believed that with careful planning or pacing, they
were able to conserve sufficient energy to complete certain
tasks every day. In the long-term, they felt that pacing
allowed them to limit their dependence on others and in many
cases, that it reduced the number of relapses. However,
while it appeared to help them to retain a degree of control
over their lives, it may also have restricted their activi-
ties and in some cases, increased their isolation (cf. Ray
et al 1995).
As far as social support is concerned, a significant number
mentioned this both to deal with the symptoms and with the
illness as a whole. However, as noted above, many reported
having been confronted with a lack of support which caused
them great distress. According to Bloom (1982), support
from others aids adaptation to illness because it can
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decrease a patient's sense of vulnerability, reduce feelings
of isolation, maintain the person's sense of identity,
increase access to useful information and provide a source
of affection and acceptance. On this basis, it might be
useful to study the effects of support on both emotional
distress and the level of symptoms and disability in more
detail.
The limited use of coping strategies such as avoidance and
wishful thinking is noteworthy since these have been linked
to poor adjustment in people with other conditions (e.g.
Frank et al 1987, Felton and Revenson 1984, Vitaliano et al
1989). Instead, many CFS patients appeared to have ap-
proached their illness in ways which has been associated
with good coping (e.g. Weisman and Sobel 1979). These
include staying optimistic, being practical about the kind
of solutions that are feasible, flexibility in not insisting
upon a rigid approach to any problem and resourcefulness in
finding support or additional information that helps imple-
ment behaviour.
It is also interesting to note the similarities between the
strategies used by the CFS patients and those employed by
people with multiple sclerosis and rheumatoid arthritis (see
for instance, Locker 1983, Robinson 1988).
Finally, some indication of the perceived value of various
coping strategies can be obtained from the advice which
patients would give to new sufferers. The most frequently
cited coping strategy was rest. Moreover, about 40 per cent
advocated that people should adopt a positive attitude and
slightly fewer advised that they pace their activities and
join a patient group (for support and information).
The recommendations were generally consistent with the
strategies which patients used themselves. However, one
anomaly was the cautious approach to alternative medicine,
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particularly by Group 1. Although many felt it was useful,
the expense and the limited effectiveness of some of the
therapies may have reduced the extent of their enthusiasm.
3.6 Ouestions arising from the research,
The findings above suggest that both the severity of
symptoms and a lack of social support may be important
sources of psychological distress. Further research is
required to clarify the influence of these variables in more
detail, for instance, by distinguishing between types of
symptoms and sources of support. Secondly, given the
uncertainty and unpredictability associated with this
illness and the difficulties this apparently caused in terms
of planning activities, it may be useful to assess in a more
formal way if these variables are correlated to functional
impairment and psychological well-being. Lastly, research is
needed to determine if the patient's strategies of rest and
pacing are associated with a positive outcome, or whether,
as suggested by the cognitive-behavioural model, these will
perpetuate the fatigue and undermine recovery.
3.7 Summary
This study showed that the illness caused considerable
disruption and distress. Some of this could be due to the
controversy relating to the status of the illness since the
outside world did not always recognise CFS as a genuine
disease (Pepper et al 1993).
The results also revealed that most patients engaged in
fairly complex reasoning far beyond that described by the
cognitive-behavioural models (e.g. Butler et al 1991, Sharpe
1992, 1994, Surawy et al 1995). Indeed, many patients
attributed their illness to a combination of internal and
external factors, and did not reject a role for psycho-
logical variables as has been suggested.
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The finding that patients used a variety of coping strate-
gies and that they did not reject psychological help when
offered contrasts with the view that many adopt a passive
approach to the illness and that their response to their
symptoms is largely limited to rest.
Finally, this study suggests that the extent and impact of
the social and psychological consequences of CFS may have
been underestimated.
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CHAPTER 4 
Study into the psycho-social sequelae of chronic fatigue 
syndrome (myalgic encephalomyelitis) 
4.1 .Introduction
The presence of emotional distress in the chronically-ill is
now acknowledged as a serious problem which can limit the
individual's quality of life and exacerbate symptoms, under-
mine adaptation and even prevent recovery (Billings et al
1983, Butler et al 1991, Sharpe 1994, Wells et al 1989).
However, little is known about the variables which may cause
or exacerbate emotional distress in patients with CFS.
Although a number of studies have investigated the psycho-
logical aspects of this illness, most of the attention has
focused on the nature and prevalence of psychopathology
(e.g. Blakely et al 1991, Kruesi et al 1989, Krupp et al
1994, Millon et al 1989, Taerk et al 1987, Wessely and
Powell 1989, Wood et al 1991). Using a variety of criteria
and measures, it has been estimated that between 13% and 79%
of patients suffer from current major depression (Yeomans
and Conway 1991, Millon et al 1989). However, one study
failed to find any patient who fulfilled the criteria for
psychiatric illness (Peterson et al 1991).
The lack of agreement concerning the actual prevalence of
clinical depression can be attributed, at least in part, to
the differences in instruments and cut-off points (see Table
la). Another potential source of error is the inclusion of
symptoms like fatigue, insomnia and cognitive deficits,
which are part of the clinical picture of CFS as well as
depression (Dutton 1992, Millon et al 1989, Ray 1991, Thase
1991). As a result, a number of studies have omitted one or
more of these complaints from their assessment of psychi-
atric morbidity (e.g. Katon et al 1991, Kruesi et al 1989,
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Macdonald et al 1993a, Wessely and Powell 1989, Wood et al
1991). However, others have not (Buchwald et al 1994, Hickie
et al 1990, Krupp et al 1994, Lane et al 1991, Manu et al
1988, Pepper et al 1993, Walford et al 1993).
In some cases, correcting the data for overlapping symptoms
made no significant difference to the results (e.g. Wood et
al 1991). On the other hand, Katon et al (1991) found that
omitting fatigue from the criteria reduced the rates of
current major depression from 15.3% to 10.2%.
Certain disability-related items included in questionnaires
may also inflate prevalence rates. For example, Yeomans and
Conway (1991) noted that 33% of their patients had a score
of 11 or more on the depression subscale of the Hospital
Anxiety and Depression Scale (HAD). However, when the item
'I feel as if I am slowed down' was omitted, this reduced
the scores to such a degree that no one reached the cut-off
point for caseness.
In spite of the difficulties in estimating the prevalence of
mood disorders, it is generally accepted that depression is
more common in patients with CFS than in the population at
large (Fukuda et al 1994, Hickie et al 1990). To assess
whether the higher rates could be attributed to the degree
of disability, some researchers have compared CFS with other
medically-ill groups. For instance, Krupp et al (1994) and
Pepper et al (1993) found that patients with CFS had higher
levels of self-reported depressive symptoms and a greater
frequency of major depression than people with MS.
Similar studies have compared CFS patients with people
suffering from rheumatoid arthritis (Katon et al 1991),
cystic fibrosis (Walford et al 1993) and neuromuscular and
muscle disorders such as myasthenia gravis, myopathies and
muscular dystrophy (Wessely and Powell 1989, Wood et al
1991). However, in the majority of studies, the comparison
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groups were not matched for the degree of impairment or se-
verity of symptoms. For example, where fatigue was measured,
the levels recorded by these medically-ill samples were sig-
nificantly lower than those of the patients with CFS. Where
fatigue was not assessed, other illness-related variables
showed that the comparison group had fewer symptoms than the
patients with CFS (Katon et al 1991). Thus although CFS has
been associated with a greater frequency of psychiatric dis-
orders than other disabled groups, the failure to take into
account their higher levels of symptomatology and their
greater functional impairment means that the relationship
between illness-related factors and psychopathology is still
far from clear.
Another variable which may influence psychological distress
and psychiatric morbidity is the intrusiveness of the dis-
ease (Devins et al 1993ab, Schubert and Foliart 1993). For
instance, one can not assume that the impact of fatigue or
nausea on a person's life will be identical to that caused
by weakness in one's legs. Other illness-related variables
which should be considered when assessing emotional distress
include:
1. the nature of the disease, i.e. whether it affects pri-
marily physical functioning or also 'mental' activities;
whether the symptoms are localised or systemic,
2. the course of the disease, i.e. whether it is stable,
fluctuating, or progressive and likely to lead to premature
death,
3. whether symptoms can largely be controlled,
4. whether there are additional complications or concurrent
disorders (Dabs et al 1983, Leedom et al 1981, Paradis et
al 1993, Rodin et al 1991).
Thus in terms of identifying the degree of emotional distur-
bance attributable to illness and disability, it is impor-
tant not to limit the assessment to one symptom or to one
measure of disability or impairment. This is particularly
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important in the case of multi-system disorders like CFS,
where some symptoms may be overlooked or simply misun-
derstood (cf. English 1991, Fleming 1994, and Study 1). For
instance, Ray et al (1992a) found that cognitive diffi-
culties and somatic symptoms were significantly related to
a number of measures of emotional distress, yet the possibi-
lity that these complaints may undermine psychological well-
being is rarely considered.
Instead, the tendency has been to regard the presence of
mood disorders among patients with CFS as reflecting primary
psychiatric illness and little else (e.g. David 1991, Hotopf
and Wessely 1994). Although it is acknowledged that psycho-
logical disturbances may occur as a reaction to disability,
most researchers have conceptualized the latter in fairly
narrow terms (David 1991). As a result, the role played by
variables such as social support in the adjustment to CFS
remains unclear.
4.1.1 The role of psycho-social factors in CFS 
In one of the few longitudinal studies which included emo-
tional distress as an outcome variable, the only predictor
was found to be the score on the affective inhibition sub-
scale of the Illness Behaviour Questionnaire (Wilson et al
1994b). Variables which were not related to psychological
adjustment included duration of illness, premorbid psychi-
atric diagnoses, neuroticism, belief in a somatic cause or
denial. However, the use of measures assessing illness
behaviour has recently been challenged. According to
Trigwell et al (1995) the similarity of the results from
patients with CFS and MS suggests that the findings may
reflect the nature of a condition rather than the presence
of psychopathology.
There is also a lack of clarity about the relationship
between somatic attributions and emotional distress (Bonner
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et al 1994, Vercoulen et al 1994 and see Chapter 3. Never-
theless, there is evidence that negative thinking about the
illness, e.g. denial and self-blame, may lead to maladaptive
coping, an increase the perceived disability and disruption
of social relationships (Antoni et al 1994). Similarly,
maladaptive thoughts might result in greater functional
impairment and more severe fatigue (Petrie et al 1995). A
link between dysfunctional cognitions and disability has
also been documented in other patient groups (e.g. Rodin et
al 1991), and has stimulated interest in treatments such as
cognitive-behaviour therapy (see Chapter 5). As for the
disruption in relationships, one study found that negative
social support was significantly correlated with both
depression .and anxiety (Ray 1992). Conversely, positive
support was associated with reduced anxiety scores.
The levels of support for people with CFS may have been
undermined by the generally unsympathetic publicity in the
media. During the past few years, the press have trivi-
alised this illness, dismissing it as 'yuppie flu' (e.g.
Hodgkinson 1991), while medical articles have accentuated
the role of psychiatric factors (Thomas 1993, Lawrie and
Pelosi 1994) and portrayed sufferers in an exceedingly
negative light (cf. Read 1993). It is possible that this
may have reduced the available support not only from friends
and family but also from health care professionals. Indeed,
Fleming (1994) noted that in her dealings with doctors, she
"encountered undermining attitudes and hurtful words" and
that she only obtained the help and advice she needed by
going outside the NHS.
It has also been suggested that doubts about the origins of
an illness may lead some to withdraw or reduce their support
(Woodward et al 1995). For instance, Faucett and Levine
(1990) surveyed patients suffering from chronic pain and
found that where the cause was an organic lesion, people
were much more sympathetic than where the cause was unknown.
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They also reported that the patients who were denied social
support were more likely to suffer from depression. If
Faucett and Levine are correct, people with CFS would
receive less support and lose more friends than people whose
condition has a known, organic cause e.g. spinal cord
injury.
As well as increasing distress directly, lack of support may
undermine the patient's well-being indirectly. For instance,
Lewis et al (1994) proposed that low levels of perceived
support might lead to immunological changes which could
predispose individuals to depression as well as CFS.
Another possible source of emotional distress which has
received comparatively little attention so far is perceived
uncertainty. According to Mishel (1988), feelings of
uncertainty can result from ambiguities concerning the
illness itself, a lack of information about the diagnosis or
seriousness of the illness, and the unpredictability of the
course and outcome.
With regard to CFS, the lack of a specific diagnostic test
means that there may be continuing doubts about what is
wrong. The illness also has a highly variable course and in
many cases, an unknown outcome. Likewise, the presence of
cognitive dysfunction may undermine the patient's ability to
process information, thus further increasing uncertainty
(Mishel 1988). However, although this aspect of the illness
has been implicated as one factor undermining successful
coping (e.g. Ray 1991), there has been little research to
assess its role in more detail.
Research into other disorders has identified a wide range of
variables associated with emotional distress and psychiatric
morbidity (see Chapter 2). For instance, studies on pa-
tients with spinal injuries have identified a number of
possible influences, including demographic variables such as
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age (Tate et al 1993) and gender (Tate et al 1994), disabi-
lity-related variables such as level and completeness of
lesion (Fullerton et al 1981, Judd and Brown 1992, MacDonald
et al 1987), level of handicap (Tate et al 1993, 1994),
duration (Richards 1986) and the severity of pain (Craig et
al 1994). Additional predictors (see Tables lb and lc)
include economic difficulties (Tate et al 1994) and social
factors such as isolation (Tate et al 1994).
Research on other disorders has also underlined the com-
plexity of the relationship between social support and
emotional distress. To summarise, it has been found that
the effects of support may vary according to the provider
(e.g. partner or friend), the time one has been ill or
disabled (Dakof and Taylor 1990, Elliott et al 1992, Neuling
and Winefield 1988) and the severity of disease (Ell et al
1992). Studies have also shown that it is important to
distinguish between the quality or adequacy of support and
the availability of support (e.g. Fitzpatrick et al 1991,
Goodenow et al 1990), with the former often having a greater
influence on emotional well-being than the latter. Clearly,
these factors should also be taken into account when asses-
sing patients with CFS.
Other aspects of adjustment 
To date, few studies on CFS have examined the variables
associated with functional impairment. However, as in the
case of research on emotional distress, a number of dif-
ferent factors may be involved. For instance, Vercoulen et
al (1994) found that problems with work, housekeeping and
general level of activity were related to difficulties with
mobility, impaired concentration, strained relationships as
well as psychological variables such as anxiety and depres-
sion.
According to the cognitive behavioural model, there should
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be a strong and direct relationship between depression and
impairment and more specifically, between depression and
fatigue. However, while studies support an association
between the latter and depression (McDonald et al 1993, Ray
et al 1992a), the correlations have generally been modest.
Moreover, not all the findings have been consistent. Given
the paucity of research, further studies are required to
clarify the association between the symptoms of CFS,
including cognitive difficulties, and functional impairment.
Research aims 
Given the present lack of knowledge about the possible
sources of emotional distress and disability in patients
with CFS, it was decided to study the key variables which
have been implicated in research on other disorders, and to
compare the results with those of people with spinal cord
injuries (SCI). The latter were chosen because in contrast
to CFS, it has a known cause, the course and outcome are
more predictable and the condition is accepted as a genuine
source of disability. As a result, it was felt that they
would provide useful information regarding the psychological
consequences of having a chronic and disabling disorder,
without many of the uncertainties which surround CFS.
The main aims of the study were:
1. to determine the degree of adjustment, social support and
uncertainty in patients with CFS and to compare the results
with those of people with a spinal cord injury. In this
study, adjustment was assessed using three variables:
anxiety, depression and functional impairment.
2. to determine the relationship between adjustment on the
one hand and illness or disability-related variables, social
support and uncertainty on the other.
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4.3.1 Sample characteristics and procedure
The CFS group consisted of consecutive patients attending
the Neurocare Support Centre at Romford Hospital and the
Microbiology clinic at St. Andrew's Hospital, Billericay.
All had been diagnosed by an experienced specialist as suf-
fering from ME using the criteria described by Dowsett et al
(1990) and Ramsay (1992) 1 . People whose diagnosis was in
doubt, or who suffered from another disorder characterised
by fatigue, were not included in this research. The sample
was therefore relatively homogenous and could be designated
as CFS(ME). Most of the patients were enrolled during cli-
nic visits. However, a few were sent a letter by the consul-
tant asking for volunteers.
Since a small number of questionnaires for the CFS(ME) group
were lost when the consultant moved to another hospital, it
was not possible to establish exactly how many were given
out. However, it has been estimated that the number lies
between 70 and 90, and given that 67 were completed and re-
turned, the response rate is at least 74% and may be as high
as 96%.
Thirty-six per cent of the patients reported having another
condition in addition to CFS(ME). The illnesses mentioned
included asthma, epilepsy, eczema, hypothyroidism, hyper-
tension, migraines and psoriasis. Some were transient, some
were controlled with medication and others were not causing
problems at the time of testing. However, seven respondents
reported having a second chronic disorder which was also as-
sociated with significant levels of fatigue and/or emotional
distress. They included pernicious anaemia, seasonal affec-
tive disorder, major depression and arthritis. One person
1 See Appendix 1.
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who suffered from a number of conditions also noted that a
recent bereavement was causing additional "exhaustion".
Because of the confounding influence of these particular
disorders in evaluating the adjustment to CFS(ME), particu-
larly in relation to the levels of fatigue and emotional
distress, and in line with advice from the American Centers
for Disease Control (Schleuderberg et al 1992) and Austra-
lian researchers (Wilson et al 1994a), the consultant agreed
that these seven patients should be excluded from the main
sample. Further details relating to this 'CFS-plus' group
can be found in Appendix II.
Two other cases were later excluded from the main sample,
one because the respondent denied having symptoms which had
been observed by both the consultant and her assistant, and
the other because the patient was undergoing tests for sus-
pected post-polio syndrome.
The comparison group consisted of people with spinal cord
injuries (SCI). These were approached by the psychologist
attached to the Regional Spinal Injuries Centre at Southport
General Infirmary. One hundred individuals who attended the
Centre and who had lesions from C6 to L5 were sent a letter
which described the study and asked for volunteers. Since
the vast majority had lesions above T10, it could be assumed
that they would have marked difficulties with physical func-
tions, particularly walking (Grundy et al 1986). Unfortuna-
tely, it was not possible to match for gender since the
number of women with SCI tends to be relatively small.
Thirty people responded to the letter and were sent ques-
tionnaires. Three did not return them, and one refused to
participate because of the nature of the study. Another
respondent had recovered from his injury and therefore felt
unable to participate. The response rate among the volun-
teers was therefore 83W.
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Four (16%) of the respondents in the SCI group reported
having a concomitant disorder unrelated to their injury.
However, in none of the cases were these associated with
significant chronic fatigue or emotional distress and they
were therefore not likely to confound the evaluation of the
latter.
Every participant was provided with a stamped addressed en-
velope to return the completed questionnaires. None were
paid.
4.3.2 Measures
All the participants were asked to fill in the following
questionnaires:
The Profile of Fatigue-Related Symptoms (PFRS) 
This 54-item measure developed by Ray et al (1992) assesses
the pattern and severity of a number of symptoms commonly
reported by patients with CFS. Respondents rate the extent
to which they experienced symptoms during the past week on
a 7-point scale from 0 ('not at all') to 6 ('extremely').
The score is the mean of the items for each subscale.
A, principal components analysis of the original data yielded
4 scales: emotional distress, cognitive difficulty, fatigue
and somatic symptoms. The internal consistency of each of
the scales was high, ranging from .88 to .96, while the
correlations between the scales were lower (range .44-.64).
The test-retest reliability was high (range .86-.97) and the
subscales correlated well with the relevant mood and symptom
measures.
The Medical Outcomes Study (MOS): physical functioning
subs cale 
Originally adapted from the Rand Health Insurance Experi-
ment, the MOS Short-Form consists of 20 items focusing on
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physical and role functioning, mental health, health per-
ception and pain (Stewart et al 1988). The subscale eva-
luating physical functioning contains 6 items which assess
the extent to which health interferes with a variety of
activities, e.g. walking, sport, climbing stairs etc. Since
this is the only MOS subscale used in this study, the
answers were scored from 1-3, following Katon et al (1991),
rather than 1-100 as originally specified. The values were
summed to produce a single variable with higher scores
indicating better functioning.
This measure is both short and reliable (a .86), and has
been used to assess a number of patient groups, including
people with hypertension, coronary heart disease, diabetes,
myocardial infarction and depression. It was also one of
the measures used by Katon et al (1991) in their research
into CFS (see Table la).
A further question to determine the subject's degree of
impairment was devised by the researcher. It was named
'help required' and addressed the patient's need for
assistance when engaging in 8 basic activities of daily
living (e.g. getting in and out of bed, cooking, eating
etc). Positive responses were summed and analysed
separately from the data above.
Mishel Uncertainty in Illness Scale - Community Form (MUIS-
C)
This 23 item Likert-format scale is the only currently
available, validated measure assessing the uncertainty
related to illness (Mishel and Epstein 1990). It was
developed from the original four-factor MUIS scale for use
by patients who are not hospitalized.
The items in the community form focus on 4 different aspects
of uncertainty: the ambiguity of cues related to illness and
treatment, the complexity of these cues, the inconsistency
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of information and the unpredictability of symptoms and
outcome. The responses are scored from 1 to 5 with the
highest score representing greater uncertainty. If an item
is not applicable, it is scored zero. The total for the
MUIS-C can range from 0 to 115, and represents one factor.
To make some of the questions applicable to the samples
being studied, all items referring to 'pain' were changed to
'symptoms' and all references to illness were changed to
'condition'. Likewise, since many of the patients with CFS
were not having treatment as such, items focusing on the
latter were amended to include advice, and people were
instructed to take the last consultation with a doctor as
their reference.
Since the unpredictability of the illness might be an impor-
tant influence with regard to CFS, and given that the MUIS-C
includes only one item which addresses this aspect of the
condition, it was decided obtain a more detailed assessment
of this variable by adding a further four items. These were
all taken from the original MUIS (Mishel and Epstein 1990),
and the total scores for this complete subscale range from
0-25.
Normative data are available for patients with epilepsy,
myocardial infarction, lupus, multiple sclerosis and cancer.
Moreover, De Groot recently used the MUIS-C in a study in-
volving CFS patients (personal communication).
The alpha co-efficients for the MUIS-C have been found to be
in the moderate to high range (u..75 -.90).
Life Stressors and Social Resources Inventory (LISRES): 
subscales for interpersonal resources and stressors 
This measure, devised by Moos and Moos (1988), focuses on
stressors and resources in a number of areas including phy-
sical health, finances, interpersonal relations, as well as
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positive and negative life events. The subscales addressing
interpersonal resources and stressors were chosen to provide
both quantitative and qualitative information about social
support, or lack of it, in an outpatient sample.
Three of the subscales assessed the quality of support pro-
vided by the spouse/partner, friends and relatives. These
measures consist of 11 items each, five relating to stres-
sors and six relating to resources. All the answers are
rated on a 5-point scale from 1 ('never') to 5 ('often').
The score for the subscale is the sum of the scores divided
by the number of items.
Two additional subscales enquired about the subject's
contact with friends and relatives. The items were taken
from the LISRES friends resources subscale but scored
separately from those above to give a measure of the number
of close contacts as opposed to the quality of support. Each
subscale consisted of two questions which were scored from
1 signifying no contact to 5 referring to contact with four
or more friends or relatives, or to contact several times a
week. The score for each subscale, called 'contact with
friends' and 'contact with relatives', consisted of the
total for the two questions.
A further question asking if respondents had lost friends as
a result of the illness/disability was added to those from
the LISRES. This item was named 'loss of friends' and the
scores ranged from 1 ('none') to 5 ('most').
To reduce the load on the subjects, it was decided to omit
the additional subscales for male and female parents and
children. For the same reason, and because of the overlap
with questions for functional impairment, it was also de-
cided to omit the items asking about membership of clubs and
attendance at religious services. The exclusion of these
questions means that it was not be possible to compare all
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the subscales with the normative data available.
The complete subscales from the LISRES were found to have
high reliability and good construct and concurrent validity.
Internal consistencies (Cronbach's alpha) for resources from
spouse, partner, children, family and friends ranged from
.82 to .91; those for stressors from .77 to .86.
Research using the LISRES has been limited to patients with
rheumatoid arthritis and people suffering depression and
alcoholism.
Background Information
This questionnaire asked for demographic information inclu-
ding the subject's gender, age, years of education beyond
16, occupation, marital status and house ownership. It also
included an item to determine whether income consists en-
tirely of social security benefits ('Low Income').
General Information CFS(MB) 
This questionnaire was completed by the CFS(ME) patients
only, and asked for information about the main symptoms
experienced, the onset of the illness (i.e. acute/gradual),
the duration and course of the illness, the use of drugs,
treatments tried and the presence of other medical condi-
tions which might colour the responses. A further question,
asking whether the subject had been told that the condition
would improve, was added to provide a separate indication of
uncertainty regarding the future.
The effect of the illness was assessed by two questions
taken from Ray et al (1992b). The first, 'level of acti-
vity', measured what the patient was able to do compared to
the past. Answers consisted of five ranked alternatives
ranging from 'I can do hardly anything compared with before'
(scored 1) to 'I can do most of what I could do before'
(scored 5). The second question focused on the frequency of
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symptoms and asked if patients experienced symptoms 'all of
the time' (scored 1), 'most of the time', 'some of the time'
or 'rarely' (scored 4). For these variables, higher scores
therefore indicated higher levels of activity and less
frequent symptoms.
General Information SCI 
In this questionnaire, people with SCI were asked about the
cause of the injury, the site of the lesion, the main symp-
toms associated with the injury and the presence of other
medical conditions. Items also enquired about the course of
the disability, the level of activity, frequency of symptoms
and the use of drugs. Since it can be assumed that in most
cases, the lesion is permanent and that significant improve-
ments were unlikely, the question to assess uncertainty
about prognosis was rephrased to determine if doctors had
given any indication about possible improvement.
Measures assessing adjustment 
Hospital Anxiety and Depression Scale (HAD) 
This is a 14-item self-rating scale specifically designed to
assess anxiety and depression in people with medical con-
ditions (Zigmond and Snaith 1983). It has two subscales:
anxiety and depression, each with 7 items rated from 0 to 3.
To reduce false positive ratings due to presence of symptoms
common to medical conditions and affective disorders, items
referring to somatic symptoms have been excluded. Neverthe-
less, one item: "I feel as if I am slowed down" may still be
unduly influenced by the presence of disease and disability.
Since this particular item may not be an independent indica-
tor of emotional disturbance (Yeomans and Conway 1991), a
corrected Depression score was calculated omitting this
question.
The HAD is a reliable measure with a Cronbach's alpha of .93
for the anxiety scale and .90 for the depression scale
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(Moorey et al 1991). It is widely used and has been compared
with both clinical rating scales and standardised interviews
(Lewis and Wessely 1990, Snaith and Zigmond 1994). It has
also been used in a number of studies on CFS, including
those by Yeomans and Conway (1991), Wessely and Powell
(1989) and Wood et al (1992).
The total subscale scores range from 0 to 21. Scores from
0-7 indicate normal levels of anxiety and depression, scores
of 8 or 9 are regarded as indicating possible (borderline)
cases of clinical disorder while scores of 11 or above are
considered to reflect probable cases of morbidity (Snaith
and Zigmond 1994).
Functional Impairment Scale 
This measure consists of four visual analogue scales cov-
ering the ability to work and manage the home, as well as
the ability to take part in social and private leisure
activities (Marks 1986). Participants are asked how much
their condition has affected each of the designated areas,
with ratings ranging from 0 ('not at all') to 8 ('very
severe'). The scores are summed and treated as a single
variable.
This scale was used by Butler et al (1991) in their research
on patients with CFS.
Copies of all the questionnaires can be found in Appendix 1.
4.4 Results 
4.4.1 Initial analysis 
The alpha co-efficients were computed for the three complete
measures used, i.e. the PFRS, the MUIS and the Functional
Impairment Scale.
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Table 2. Summary of Alpha coefficients for reliability
Variable	 CFS(ME) group	 SCI group
PFRS
Fatigue .93 .95
Emotional distress .95 .94
Cognitive difficulty .95 .93
Somatic symptoms .91 .81
MVIS-C
Uncertainty .86 .94
Functional impairment
All subscdles .79 .81
The reliability of all the above scales was satisfactory for
both groups, with co-efficients ranging from .79 to .95.
4.4.2 The CFS(ME) group
Demographic information
The mean age of the CFS(ME) patients was 37.3 years (SD
13.4). Forty-two (72%) of the subjects were female and 16
(28%) were male. Just over half the group were either mar-
ried or cohabiting while 41% were single. All except three
patients had completed secondary school and 31% had also
completed college or university.
At the time of the study, 26% were engaged in full or part-
time work while a further 26% were unemployed or on sick-
leave. In total, 72% reported that they had changed their
jobs or reduced their hours because of their illness and
nearly one-third currently had an income consisting solely
of social security benefits. For more detailed information,
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see Appendix II.
Illness-related variables 
The median duration of the illness was 3.5 years (the
distribution of the latter being positively skewed). Ten
patients had been ill for 10 years or more and 4 people had
been unwell for at least twenty years.
Fifty-two per cent of the CFS(ME) group described their ill-
ness as having begun suddenly and 60 96 felt able to identify
an infectious condition which occurred at the start. Thus in
some cases, the illness followed an apparent infection but
developed only slowly after that. Forty-seven per cent of
the patients thought that the diagnosis was made solely on
the basis of their clinical history. Indeed, where tests
were done, this was usually to exclude other conditions, not
to support the diagnosis of CFS(ME).
At the time of the assessment, 17% of the patients con-
sidered their illness to be fluctuating, 41% were stable,
29% were improving and only 12% felt that they were getting
worse. In terms of their disability, 91% reported having
symptoms most or all of the time and about 60% were able to
do less*than 50% compared to what they did before. Just 16%
were able to do three-quarters or more of the activities
they used to do.
As regards medication, 66% of the CFS(ME) group were taking
some type of drug and in at least 18 cases (31%), these in-
cluded antidepressants. For more detailed information, see
Appendix II.
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4.4.3 The SCI group
Demographic information
The mean age of the SCI group was 36.5 (SD 7.26) and 20
(80%) of the respondents were male. Just over half the group
were married or cohabiting while 40% were single. At the
time of the study, 28% were unemployed or on sick leave.
Sixty-eight per cent, however, had retired or reduced their
hours because of their disability and 52% had an income
consisting solely of social security benefits. For more
detailed information, see Appendix II.
Disability-.related variables 
The injuries had occurred a median of 11.00 years (SD 8.80)
previously and 20% had been disabled for twenty years or
more. In approximately half the group, the injury had
resulted from a road traffic accident but in three cases, it
had been caused by illness.
Sixty-four per cent of the group had lesions from C5 to T10,
and a further 4 respondents (16%) had a lesion at the level
of T12. The injuries of the remaining subjects were between
Li and L5. In 13 cases (52%), the lesions were complete.
Seventy-two per cent of the group made use of a wheelchair,
and only one person (with a lesion at L5) was able to walk
without any mobility aids. The condition was classed as
stable by 64%, while 16% reported that it was fluctuating.
Only three people (12%) felt their health was getting worse.
Injury-related symptoms such as pain, muscle spasms, numb-
ness and infections were common, with 88% reporting at least
one of these. Less than 30% experienced symptoms most or
all of the time, while 48% were able to do a half (or less)
compared with their previous level of activity.
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The commonest drugs used by this group were pain killers and
muscle relaxants. Some subjects were also on antibiotics.
For further details of disability-related factors, please
consult Appendix II.
4.4.4 Comparison between groups 
The following sections compare the samples in terms of
demographic and illness-related variables, as well as the
measures of adjustment, uncertainty and social support.
Where variables were scored using an ordinal and interval
scale, differences between the groups were assessed using
the two-tailed Mann-Whitney U test (Siegel 1956). The latter
was considered to be more appropriate than the parametric T-
test because of the difference in sample size, the skewness
of some of the data (e.g. functional impairment, duration,
support from friends) and the lack of homogeneity of va-
riance (Hays 1994). Categorical data were analysed using the
Chi-square test. To reduce the possibility of Type I errors,
alpha was set at 0.01.
Demographic variables 
The results indicated that the CFS(ME) and SCI groups were
similar in terms of age, marital status and years spent in
education from the age of 16. However, the CFS(ME) group
contained a greater percentage of women (x =19.5, p<.001),
and more people who had completed college, university or
some kind of professional training.
In terms of their housing, fewer CFS(ME) patients lived
alone compared to the people with SCI. On the other hand,
there were more people among the SCI group who owned their
own home.
Financially, a greater percentage of people with SCI were
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dependent on social security benefits (51 96 versus 2990.
Illness and disability-related variables 
The SCI group had been disabled longer (p=.002) and they
were more impaired in terms of physical functions like
walking than the people with CFS(ME) (p=.0009). They also
required help with a greater number of activities (p=.003).
However, the CFS(ME) patients reported experiencing symptoms
more frequently (p<.0001). There was no difference between
the groups in terms of their reported overall level of acti-
vity compared to the past.
Specific symptoms were measured by the PFRS. As Table 3
shows, the CFS(ME) patients reported significantly more
fatigue and cognitive difficulties than the SCI group
(p=.0003, p<.0001 respectively). There was also a trend
towards more severe somatic symptoms in the CFS(ME) group
(p<0.02).
Table 3. Mean scores (SD) for the PFRS subscales
CFS(ME) group	 SCI group
Mean	 SD	 Mean	 SD
Fatigue 3.77 1.23 2.22 1.75**
Cognitive difficulty 3.34 1.45 1.29 1.37**
Somatic symptoms 2.40 1.29 1.63 .94
** p<0.001
Uncertainty
The CFS(ME) group (N=57) reported significantly more un-
certainty than the people with SCI (mean 66.26 versus 56.71,
p<0.01). They also had higher scores on the subscale meas-
uring unpredictability (mean 17.18 versus 14.45, p<0.01).
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It should be noted, however, that there were a number of
subjects who felt that many of the items on the MUIS did not
apply to them. Since inclusion of large numbers of missing
answers would have made it difficult to interpret low
scores, it was decided to use only those questionnaires
where more than 80% of the items had been completed. This
affected the SCI group in particular, reducing the sample
size to 21 for uncertainty and 22 for unpredictability.
In answer to the question whether a doctor had told them
that their condition would improve, 43 (74%) of the CFS(ME)
group answered yes, compared to 5 (20W) of the people with
SCI. This difference was highly significant (x= 18.8,
p<.0001).
Social support 
The results of the various measures assessing social support
are shown in Table 4. No significant differences between
the groups were found.
Adjustment 
In this study, adjustment was assessed using the scores on
the HAD and the Functional Impairment Scale (see Table 5).
Due to missing data, the number of cases varied per sub-
scale. Given the strong relationship between the emotional
distress subscale of the PFRS and the scores on the HAD, it
was decided not to include the former in the analysis.
There was no significant difference between the CFS(ME) and
SCI groups with respect to the severity of anxiety. How-
ever, the uncorrected depression scores of the CFS(ME) group
were significantly higher than those of the SCI group
(p=.002) and there was a trend towards significance when one
fatigue-related item was omitted (p=.03).
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Further analysis revealed that there were more people in the
CFS(ME) group who scored above the cut-off points indicating
clinical anxiety and depression (see Table 6). However, the
difference between the groups did not reach significance.
It should also be noted that correcting the depression
subscale reduced the number of cases of mild and more severe
depression in both groups.
In terms of functional impairment, the CFS(ME) group was
found to be significantly more disabled than the people with
SCI (p=0.01).
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Table 5. Means (and SD) for anxiety, depression and
functional impairment
CFS(ME) group	 SCI group
Mean	 SD	 Mean	 SD
Anxiety
	
9.65	 4.03	 8.32	 5.51
Depression	 8.24	 3.03	 5.61	 3•55*
Depression
corrected	 5.72	 2.98	 4.13	 2.86
Functional
impairment	 22.57	 5.07	 17.64	 8.91*
* ps_.01
Table 6.	 Prevalence of possible and probable cases of
anxiety and depression
Anxiety
	 Depression	 Depression
corrected
Scores	 CFS(ME) SCI	 CFS(ME) SCI	 CFS(ME) SCI
>8	 No.	 39/57	 12/25	 38/58	 8/23	 16/58	 3/24
68	 48	 55	 35	 27.5	 13
>11	 No.	 27/57	 8/25	 13/58	 2/23	 4/58	 0/24
47	 32	 22	 7	 7	 0
4.4.5 Relationships between variables 
The following report focuses primarily on the relationship
between key variables and adjustment in each group. The
results concerning the other variables are summarised in the
text but more detailed information can be found in Appendix
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Some of variables were found to be skewed, with Z exceeding
the critical value for p<.01. They included functional
impairment and duration (CFS(ME) group only), and support
from friends (SCI group only). To allow comparisons to be
made, both within and between the groups, it was decided to
analyse all the data using Spearman's rho (two-tailed).
However, if the data met the assumptions for parametric
tests, the adjustment variables were also analysed using
Pearson's r (for details, see Appendix II). Significant
relationships using Pearson's r will be noted in the Tables
where appropriate.
The CFS(ME) 'group
None of the demographic variables in this study were signi-
ficantly correlated with other measures except for age and
relative stressors (r,. -.37, p<.01).
The analysis of the illness-related variables revealed a
number of inter-correlations. For example, duration was re-
lated to the number of years a person had been diagnosed
p.001), while the level of activity correlated both
with fatigue (r,.-.44, p<.001) and cognitive difficulty rs
-.35, p<.01). For more detailed information, see Appendix
The relationship of demographic and illness-related
variables with adjustment 
None of the demographic variables, and none of the general
illness-related measures were associated with anxiety or
depression (see Table 7). However, there were significant
correlations between fatigue and somatic symptoms on the one
hand and anxiety on the other. Moreover, when the symptom
scores were analysed using Pearson's product moment corre-
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lation, the coefficient between cognitive difficulty and
depression just reached significance (r..34, p<.01).
There were also significant correlations between illness-
related variables and functional impairment. For instance,
the latter correlated with physical functioning as measured
by the MOS subscale, showing that difficulties related to
work, looking after the home etc were strongly linked with
the ability to walk, carry etc. Functional impairment also
correlated significantly with cognitive difficulties, but
not with fatigue or somatic symptoms.
The correlation co-efficients between the outcome measures
themselves were very weak, ranging from -.04 (anxiety and
functional impairment) to .25 (functional impairment and
depression).
Table 7. Correlations (Spearman's Rho) between illness
variables and adjustment: the CFS(ME) group
Anxiety Depression Depression
corrected
Functional
impairment
Duration .10 .13 .13 .23
Years
diagnosed -.04 .07 .08 .40*
Physical
functioning .11 .10 .15 -.38*
Fatigue •34*a .23 .17 .33
Cognitive
difficulty .32 .32b .26 •37*
Somatic
symptoms .52** .14 .17 -.01
* p .01 ** p .001
r	 .32 p..016 b r	 •34*
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The relationship between uncertainty and other variables 
Neither uncertainty nor unpredictability were related to
demographic variables or any of the illness-related meas-
ures. However, as shown in Table 8, uncertainty showed a
strong association with levels of emotional distress, parti-
cularly anxiety (r..56, p<.001). In contrast, there was only
a weak relationship with functional impairment. There were
no significant relationships between unpredictability and
any of the key variables.
Table 8. Correlations (Spearman's Rho) between uncertainty,
social support and adjustment: the CFS(ME) group
Anxiety Depression Depression Functional
corrected	 impairment
Uncertainty	 .56** .42* .48** .12
Unpredictability	 .12 .14 .17 -.02
Interpersonal resources
Friends
	
-.20 -.34 _.39*a -.08
Spouse/partners	 -.09 -.25 -.25 -.07
Relatives
	
-.14 -.33 _.35*/) -.08
Interpersonal stressors
Friends
	
.17 .16 .17 -.12
Spouse/partners	 .40 .37 •43* -.19
Relatives	 .31 .29 .28 .01
Contact
Friends
	
-.33* -.34* -.37* -.11
Relatives
	
-.01 .04 .07 -.19
Loss of friends	 .24 .26 .24 •39*
* p.01	 ** p<.001
a r . -.33 p.	 .012	 b r . -.31 p. .018
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TABLE 9b. Correlations between interpersonal stressors,
uncertainty and illness-related variables:
the CFS(ME) group
Friends
stress
Relative
stress
Spouse
stress
Loss of
friends
Duration .33 .14 .06 .32
Years diagnosed .23 .18 .21 •34*
Physical
functioning .28 .09 .31 -.10
Fatigue -.12 .04 -.18 .17
Cognitive	 .
difficulty .10 .06 -.19 .15
Somatic
symptoms .07 .09 .13 .05
Uncertainty .13 .26 .12 .36*
Unpredictability -.08 -.10 .24 -.18
* p .01 ** p<.001
The correlations between uncertainty and social support are
shown in Table 9a. Uncertainty was found to be correlated
with two social support measures: the loss of friends ( r. =
.36, P<.01) and a lack of support from relatives (r. -.37,
p<.01).
Interpersonal relationships 
Like the illness-related variables, some of the measures of
interpersonal resources and stressors also correlated with
one another (see Appendix II). For instance, contact with
friends was significantly related to resources from friends
(r...61, p<.001).
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There were few significant associations between interper-
sonal relationships and illness. For example, the loss of
friends correlated significantly with years since diagnosis,
and resources from the family was negatively associated with
physical functioning. However, there were no significant
relationships between either interpersonal resources or
stressors and the number of symptoms, their frequency, the
duration of illness and the requirement for help. More
detailed information on the relationship between support and
illness-related variables can be found in Table 8 and
Appendix II.
As far as the association with emotional distress is
concerned, contact with friends was negatively correlated
with both anxiety and depression. An inverse relationship
was also found between resources from friends and the cor-
rected depression score but this was not significant when
the analysis was repeated using Pearson's r. Likewise, the
correlation between resources from relatives and depression
reached significance using Spearman's rho, but not with
Pearson's r. Lastly, there was a significant relationship
between stress with partners and depression when the score
was corrected. However, the correlation with anxiety just
failed to reach significance.
None of the social support measures were related to
functional impairment, except for the loss of friends
p<.01).
Multiple regression analysis 
The data from the CFS(ME) group were analysed further using
hierarchical multiple regression. This method was preferred
over alternatives because it gives researchers more control
over variables of theoretical interest and because stepwise
regression requires a larger cases-to-IV ratio (Tabachnick
and Fidell 1983). The variables of particular interest were
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those relating to the symptoms, measures of disability, so-
cial support and uncertainty.
The three dependent variables were depression 2 , anxiety and
functional impairment.
In the two equations relating to emotional distress, fatigue
was the first independent variable to be entered. This
symptom is generally regarded as the main complaint asso-
ciated with CFS(ME) and early entry would give an indication
of the influence of the remaining variables independent of
fatigue.
The second variable of interest was social support. The
correlation coefficients were examined to determine which of
the support variables were likely contributors to emotional
distress and this was entered next. Initial analysis had
identified contact with friends, resources from friends,
lack of support from the spouse and uncertainty as possible
predictors. Contact with friends was selected since this was
most consistently related to both anxiety and depression.
Also, since not every subject was married, inclusion of
spouse-related stressors would have significantly reduced
the number of cases used and the results may not have re-
flected the experience of the sample as a whole. Resources
from friends was rejected because of the discrepancy between
parametric and non-parametric correlation co-efficients.
Uncertainty was the final variable to be entered to give an
indication of its influence on depression and anxiety after
the aforementioned variables had been accounted for.
Examination of the correlation coefficients relating to
2 Since the two depression scores appeared to be
strongly correlated (r 0.98), it was decided to use only
the corrected scores in the regression analysis.
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functional impairment revealed that it was not closely
associated with either uncertainty, social support or with
fatigue. Instead, it appeared more strongly associated with
three illness-related variables, namely the number of years
patients had been diagnosed, cognitive difficulty and
physical functioning. To assess their relative influence on
functional impairment, years diagnosed was entered first
while the MOS subscale measuring physical functioning was
entered last.
Because the scores for functional impairment and years
diagnosed were not distributed normally, the values were
transformed by calculating the square root (in the former's
case after reflexing them first).
All analyses were performed using SPSS/PC Regression.
Results of the multiple regression analysis 
Table 10 gives the results of the analysis using anxiety as
the dependent variable.
The results indicated that fatigue, contact with friends and
uncertainty accounted for 41% of the variance in anxiety.
Both contact with friends and uncertainty significantly
added to the prediction but uncertainty had a stronger
effect.
Table 11 displays the results of the analysis where the
corrected depression score was the dependent variable.
It was found that lack of contact with friends contributed
to the prediction of depression, as did uncertainty. How-
ever, the three variables explained just 27% of the vari-
ance. As before, uncertainty was the strongest predictor,
adding significantly to the variance in depression even
after the influence of two other variables had been accoun-
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ted for.
Table 12 gives the results of the analysis with functional
impairment (transformed) as the dependent variable.
The findings revealed that physical functioning was the
strongest predictor in this equation. The three variables
explained 38%- of the variance in functional impairment, and
each variable made a unique contribution to the equation.
Given the modest number of subjects, it is difficult to draw
firm conclusions. However, in terms of both depression and
anxiety, the data suggest that uncertainty was a significant
predictor of emotional distress. Noteworthy is also the
limited effect of fatigue, particular in relation to depres-
sion. Finally, the patient's physical limitations as meas-
ured by the MOS subscale, were found to be the strongest
predictor of functional impairment.
Table 10. Results of a hierarchical multiple regression
analysis with the anxiety score as the dependent
variable
Variable R2 R2
change
Mult.
r
F
change
Zeta T
Fatigue .09 .09 .31 5.61 .26 2.47
Contact
with
friends .21 .11 .46 7.67* -.23 -2.08
Uncertainty .41 .20 .64 17.76** .46 4.21**
*	 ** p .001
207
Table 11. Results of a hierarchical multiple regression
analysis with the corrected depression score ab
the dependent variable
Variable R2 R2
change
Mult.
r
F
change
Zeta T
Fatigue .03 .03 .18 1.84 .15 1.28
Contact
with
friends .17 .14 .41 8.92* -.29 -2.43
Uncertainty . .27 .10 .52 7.23* .33 2.69*
* p .01
Table 12. Results of a hierarchical multiple regression
analysis with functional impairment as the
dependent variable
Variable R2 R2
change
Mult.
r
F
change
Zeta T
Years
diagnosed .12 .12 .34 7.01* -.25 -.22
Cognitive
difficulties .27 .15 .52 10.34* -.27 -2.2
Physical
Functioning .38 .11 .62 9.17* .36 3.0*
* p<.01
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As in the CFS(ME) group, there were no significant relation-
ships between demographic variables and the other measures,
except for age which was correlated with duration (r. .63,
p<.001).
There were also a number of inter-correlations between the
various disability-related variables. For instance, better
physical functioning was significantly related to greater
activity (r. ..64, p <.001), lower lesions (r.	 .58, p<.001)
and a lesser requirement for help (r. 	 -.76, p<.001). For
more detailed information, see Appendix IIB.
Of the PFRS subscales, fatigue was significantly correlated
with the number of injury-related symptoms (r. .62 p<.001).
Similarly, somatic symptoms correlated with impaired physi-
cal functioning (r. -.58 p<.01) and with a greater fre-
quency of symptoms (rs . -.65, p<.001).
The relationship between disability-related variables and
adjustment 
The relationship between various measures of disability,
symptoms and adjustment are depicted in Table 7b.
It was found that fatigue correlated significantly with
depression while cognitive difficulty correlated signi-
ficantly with anxiety. Neither of these symptom subscales,
however, were significantly related to functional impair-
ment. Indeed, only somatic symptoms showed a significant
correlation with this adjustment measure.
There were a number of other variables which were also
strongly associated with functional impairment. For
example, it was linked both to higher lesions and lower
physical functioning.
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Table 7b. Correlations (Spearman's Rho) between disability-
related variables and adjustment: the SCI
group
Anxiety	 Depression Depression Functional
corrected impairment
Duration	 -.03	 -.36	 -.45	 .18
Lesion	 .05	 -.13	 -.07	 -.59*
Physical
functioning	 .08	 -.29	 -.14	 -.77**
Fatigue
	
.35
	
•57*	 .42	 .37
Cognitive .
difficulty
	 .60*	 .50a	 •44b	 •34
Somatic
symptoms	 .39	 .41	 .25	 .61*
* p .01 ** p<.001	 a r	 .51	 b r	 •53*
The relationship between uncertainty and other variables 
Uncertainty and unpredictability were not related to any of
the demographic variables. Moreover, there was no associa-
tion between unpredictability and any of the other measures.
However, there were significant correlations between uncer-
tainty and disability-related measures e.g. the frequency of
symptoms (r. -.58, p<.01). For further details, see Appen-
dix IIB. The degree of uncertainty was also strongly cor-
related with the severity of fatigue and more modestly, with
somatic symptoms.
In terms of interpersonal relationships, there was a
significant positive correlation between uncertainty and
support from relatives although this was not replicated when
the scores were analysed using Pearson's r.
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Table 8b. Correlations (Spearman's Rho) between un-
certainty, social support and adjustment: the
SCI group
Anxiety Depression Depression
corrected
Functional
impairment
Uncertainty
	
.21 .43 .42 .22
Unpredictability	 .15 .17 .19 .09
Interpersonal resources
Friends	 -.27 -.26 -.36 -.26
Spouse/partners	 -.56 -.23 -.28 .06
Relatives	 -.27 -.11 -.12 .04
Interpersonal stressors
Friends
	 -.03 -.26 -.26 -.35
Spouse/partners	 .13 -.09
-.19 -.16
Relatives	 .01 -.47 -.38 -.20
Contact
Friends
	 -.23 -.22 -.17 -.22
Relatives	 -.28 .03 -.09 .04
Loss of friends	 -.01 -.19 -.17 .52*
** p .01 ** p<.001
Neither uncertainty nor unpredictability were related to any
of the adjustment measures.
Social support
The results of the LISRES subscales revealed a number of
inter-correlations between variables, showing for instance,
that if patients were supported by their relatives, they
were also likely to receive support from friends (see
Appendix IIB for details).
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As Tables 8b, 9c and 9d show, few other relationships
reached significance. There were no strong correlations
between the social support variables and adjustment, except
for loss of friends and functional impairment. Loss of
friends was also positively correlated with higher lesions
and reduced physical functioning. However, in the latter
case, only the nonparametric correlation reached signi-
ficance.
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Table 9d. Relationships between interpersonal stressors,
uncertainty and disability-related variables:
the SCI group
Friends
stress
Relative
stress
Spouse
stress
Loss of
friends
Duration .34 .50 .23 .37
Lesion .18 .12 -.13 -.58*
Physical
functioning .15 .30 .27 _•53*a
Fatigue .25 -.03 -.17 -.03
Cognitive	 .
difficulty -.03 -.09 -.27 .08
Somatic
symptoms .10 .05 -.18 .33
Uncertainty .27 .22 -.18 .02
Unpredictability -.07 .14 .10 .06
a r	 .50 p..014
4.5 Discussion
The findings of this study revealed that the CFS(ME) pa-
tients were significantly more depressed and functionally
impaired than the people with spinal cord injuries. They
also reported higher levels of faEigue, more problems with
memory and concentration and greater uncertainty. However,
there were no significant differences between the groups in
terms of anxiety and perceived social support.
Further analysis showed that lack of contact with friends,
uncertainty and the severity of symptoms were significantly
related to emotional distress in the patients with CFS(ME).
This was not the case in the comparison group, where emo-
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tional distress was more strongly associated with the
severity of symptoms and level of disability.
Variables which were associated with functional impairment
in the CFS(ME) group included physical functioning, cog-
nitive difficulties and the number of years a person had
been diagnosed. In the SCI group, functional impairment was
also linked with disability-related variables, particularly
physical functioning and somatic symptoms.
4.5.1 Adjustment to CFS(ME) and SCI 
The finding of higher depression scores in the CFS(ME)
patients compared to the people with spinal injuries is
difficult to explain. While the two groups were matched in
terms of their level of current activity, the greater
severity of the fatigue and cognitive difficulties in the
CFS(ME) group may have added to their depressive mood. On
the other hand, the higher scores could be an indication of
more extensive psychiatric morbidity among the patients with
CFS(ME).
The latter is supported by the finding that there were more
cases of possible clinical depression among the CFS(ME)
patients than in the comparison group (55% versus 35%). A
similar trend was also found for probable depression (22%
versus 7%), and this was replicated, even when the fatigue-
related item 'I feel as if I'm slowed down' had been removed
(7% versus 0%).
Cases of possible and probable anxiety were also more common
among the patients with CFS(ME). Indeed, using a cut-off
point of 8, the number of cases of possible clinical dis-
order among this group was 68%, which not only exceeded the
estimate for the people with SCI (48%) but also all pre-
viously reported estimates for CFS (e.g. Buchwald et al
1994, Lloyd et al 1990, Lynch et al 1992, Katon et al 1991,
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Millon et al 1989, Pepper et al 1993, Wood et al 1994). The
number of cases of probable clinical anxiety was slightly
lower: 47% of the patients with CFS(ME) had a score of 11 or
more on the HAD, compared with 32% of the people with SCI.
It should be noted here that the HAD is a screening tool and
that a formal psychiatric interview is required to confirm
the diagnosis (Thase 1991). However, comparing the results
with those of studies which also used the HAD shows that the
findings reported above were generally similar to the rates
documented in certain medically-ill groups. For example, a
study of two groups of cancer patients revealed that 40% and
30% respectively suffered from possible clinical depres-
sion. In addition, 59 and 68% respectively scored on or
above the cut-off point of 8 suggesting possible clinical
anxiety (Greer et al 1992). Other researchers have repor-
ted slightly lower rates among their patients (e.g. Carroll
et al 1993) but this may reflect differences in disease
activity and impairment, and it is therefore difficult to
draw firm conclusions (Rodin et al 1991).
With regard to the patients with SCI, the levels of depres-
sion among the SCI group were similar to those of other
community samples (e.g. Frank et al 1985, Malec and Neimeyer
1983, MacDonald et al 1987). However, the number of cases
of possible clinical anxiety was rather higher than expected
(cf. Table lb). The raised scores may reflect more severe
psychopathology or it may be due to other factors, such as
the use of a rating scale (e.g. Judd et al 1989, Rodin et al
1991).
As far as functional impairment is concerned, the CFS(ME)
group had significantly higher scores than the people with
SCI. This suggests that CFS(ME) had a more global effect on
patient's lives than SCI. It is also consistent with the
reports from patients documented in Study 1.
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4.5.2 Variables associated with adjustment 
Emotional distress 
The results from this research revealed a number of
significant relationships between symptoms and emotional
distress. For instance, both fatigue and somatic symptoms
were significantly correlated with anxiety while cognitive
difficulty was significantly related to depression. However,
the latter was found only for uncorrected scores when as-
sessed using Pearson's r (see Appendix II).
Since 75 96 of the CFS(ME) patients reported moderate or
severe levels of fatigue on the PFRS, this symptom was not
only the most common but also the most disabling complaint.
However, when it was entered in the multiple regression
analysis, it did not contribute significantly to the va-
riance in either anxiety or depression. Thus while it may
influence the emotional distress associated with CFS(ME) to
some degree, its role may be more limited than has been
suggested previously (Butler et al 1991).
Less common than fatigue were cognitive difficulties.
Nevertheless, over 6n of the CFS(ME) patients rated these
as moderate or severe on the PFRS. The raised scores may
have resulted from co-existing depression (e.g. Deale and
David 1994, Macdonald et al 1993b, Krupp et al 1994). How-
ever, studies on other samples have revealed notable dif-
ferences in the cognitive deficits associated with CFS and
affective disorders (Sandman et al 1993, Smith et al 1993).
While it was not possible to determine the direction of the
association between cognitive difficulties and depressive
mood in this study, the possibility that the former could
have contributed to the latter deserves further attention.
For example, problems with memory and concentration may
undermine the appraisal of stressors and the planning,
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selection and monitoring of appropriate responses (cf. Earll
1989, Nerenz and Leventhal 1983). Cognitive dysfunction
might also lead to misunderstandings in interpersonal
relationships, including those with medical professionals.
Thus by interfering with the patient's problem-solving
capacities, cognitive difficulties could increase emotional
distress and adversely affect adjustment (Davidoff et al
1992). The significant relationship between cognitive
difficulty and both anxiety and depression in the patients
with SCI is consistent with this view.
Other illness-related variables which were associated with
emotional distress were somatic symptoms which correlated
with anxiety in the CFS(ME) group, and fatigue, which
correlated with depression in the people with SCI. These
findings are in line with the research on other disorders
although in many studies, the reported relationship between
depression and disability is somewhat stronger (e.g. Bukberg
et al 1984, Carroll et al 1993, Craig et al 1994, Dabs et
al 1983, Fleminger et al 1991, Stewart et al 1965).
Functional impairment 
Illness and disability-related variables were also associ-
ated with the second adjustment measure: functional impair-
ment. Indeed, it was significantly related to physical
functioning in both groups. In the CFS(ME) group, it also
correlated with the number of years which a patient had been
diagnosed. Thus the longer this period, the more impaired
the patient was in terms of ability to work etc. Likewise,
in the SCI group, functional impairment was related to the
level of lesion and the severity of somatic symptoms.
The comparatively weak relationship between functional
impairment and fatigue in patients with CFS(ME) was un-
expected. It conflicts with the cognitive behavioural model
which posits that this symptom is strongly associated with
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ongoing disability and distress (Butler et al 1991). In-
terestingly, the correlation between fatigue and functional
impairment in the SCI group also failed to reach signifi-
cance.
In contrast, the finding that cognitive difficulty was
significantly correlated with functional impairment in the
CFS(ME) group supports the view that problems with concen-
tration and memory may have a marked impact on these
particular patients' lives.
Finally, the lack of association between the HAD subscales
and functional impairment in both groups underlines the
independence of these measures and provides some support for
the view expressed by Trieschmann (1988) that: "sadness,
anger, anxiety, and hopelessness may all be apparent in
varying degrees for varying periods of time but usually will
not interfere with daily function to a major degree".
Uncertainty and its relationship with adjustment 
So far, the role of uncertainty has not received a great
deal of attention in relation to CFS(ME). However, two
findings indicate that it may be a significant influence on
the level of emotional distress. Firstly, the mean scores
of the CFS(ME) group (66.3) exceeded those documented in
many other conditions. Thus it was not only higher than that
of people with spinal injuries (56.7), but it also exceeded
those of patients with myocardial infarction (mean . 49),
multiple sclerosis (mean . 63) and various cancers (mean .
41) (Mishel and Epstein 1990). Secondly, uncertainty was
significantly related to anxiety and depression, and was a
significant predictor of both when assessed using multiple
regression.
Given the lack of knowledge about the aetiology and prog-
nosis of CFS(ME), the apparent connection between uncer-
219
tainty and emotional distress is not surprising. However,
it was interesting to note that the degree of uncertainty
was not influenced by the duration of illness; patients who
had been unwell for less than three years had only slightly
higher uncertainty scores than those who had been ill for
more than 7 years (mean 64.9 versus 63.7). This contrasts
with the report by Moser et al (1993) which revealed signi-
ficantly higher uncertainty scores in newly diagnosed
patients with systemic lupus erythematosis (SLE).
Two other findings are of interest in relation to CFS(ME).
Firstly, uncertainty was not related to functional impair-
ment, so it did not affect the patients' ability to work or
engage in leisure pursuits. Secondly, unpredictability was
not linked with either anxiety or depression, suggesting
that the fluctuations in the condition did not contribute to
these patients' emotional distress.
Given that the majority of people with SCI had rated their
condition as stable, their uncertainty scores were expected
to be relatively low. However, while the mean was signi-
ficantly lower than that of the CFS(ME) group, it exceeded
those of a number of other disorders. The extent to which
uncertainty influenced adjustment in the people with SCI is
unclear. For instance, in contrast to the CFS(ME) group,
there was no significant relationship between uncertainty
and emotional distress.
According to Mishel's theory (1988), uncertainty may be due,
in part, to the presence of fatigue and cognitive dysfunc-
tion which weaken the accuracy of appraisals. If this was
the case, there should be a significant relationship between
these symptoms and the MUIS score. However, while fatigue
and uncertainty were related in the SCI group, the corre-
lation co-efficients in the patients with CFS(ME) were
comparatively weak. Thus the high levels of uncertainty
among the latter were probably not the result of their
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symptoms.
Mishel also argued that lack of familiarity with health-
related events, e.g. the novelty of investigations, treat-
ments etc may play an important role. However, since in-
vestigations of CFS(ME) patients tend to be restricted to
blood tests to exclude other disorders and the number of
treatments are limited, this factor is probably not the
reason for the high degree of uncertainty in this patient
group.
Finally, it has been suggested that uncertainty may be con-
nected with the inadequacy of structure providers e.g. a
lack of social support. The finding of a significant corre-
lation between uncertainty and both the loss of friends and
the lack of resources from relatives is consistent with this
view, although of course, the direction of the relationship
cannot be determined.
The complexity of the subject is further illustrated by the
finding among the SCI group that higher levels of uncertain-
ty were associated with increased support from relatives.
This may reflect the paradox of social support, namely, that
in some cases, help from others has negative effects. For
instance, as Buunk and Hoorens (1992) have noted, support
can sometimes undermine feelings of competence and control,
particularly where this conflicts with values of self-
reliance and independence. Alternatively, as Dakof and
Taylor (1990) found, relatives may be more of a hindrance
than a help if they express too much worry or pessimism.
Social support and its relationship with adjustment 
One of the most interesting findings in this study was that
the levels of support from partners, relatives and friends
in the CFS(ME) group were similar to those recorded by
people with SCI.
	 This contrasts with the research of
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Faucett and Levine (1990) which showed that patients whose
illness had an uncertain aetiology received less support
than those whose condition had a known organic cause. How-
ever, it may be that the severity of the illness in the
CFS(ME) group influenced the support providers to a greater
degree than the doubts about the origins of the disease
(Skelton 1991).
Comparison with the data for other disorders is difficult,
since the LISRES scale used in this study is relatively new
and published reports which have included this measure are
limited. Moreover, most of the studies to date have com-
bined the scores for several variables e.g. resources from
relatives have included data relating to the mother and
father. Only the scores for spouse/partner resources have
been reported separately and can therefore be compared to
the findings reported above.
With regard to the latter, the scores of the CFS(ME)
patients were found to be similar to those of community
controls and patients with arthritis, but higher than those
for alcoholics and psychiatric patients (Moos et al 1989).
The similarity between the scores from the arthritis and
CFS(ME) group is another indication that having a disorder
with an ambiguous aetiology does not necessarily lead to
reduced support.
On the other hand, it could be argued that the extra demands
on people with CFS(ME) results in a greater need for support
and that they did not receive the additional help they
desired. For instance, as the findings above have shown,
patients have to cope with severe problems related to
fatigue and concentration as well as the uncertainty about
the progress and outcome of their disease. Moreover, treat-
ment options are limited (see Chapter 1) and there are still
relatively few specialised clinics where patients can go for
help and advice. Unfortunately, since the LISRES scale does
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not assess the adequacy of support, it is not possible to
determine whether it actually matched these patients' needs.
In terms of the relationship between the levels of social
support and emotional distress, the results of the CFS(ME)
group were consistent with research on other disorders,
showing that greater support was associated with lower
depression scores and that a lack of support was related to
increased emotional distress (e.g. Littlefield et al 1990,
Ray 1992, Revenson et al 1991, Rohde et al 1990, Wineman
1990)
The role of social support as a predictor of emotional dis-
tress in patients with CFS(ME) was examined in the multiple
regression analysis, alongside uncertainty. It was found
that although lack of contact with friends contributed to
the variance in anxiety and depression over and above the
influence of fatigue, it was not a unique predictor of
either. Thus although having a number of close friends with
whom one has regular contact may have helped to reduce
emotional distress, its effect was limited. An alternative
explanation, that the presence of distress led patients to
avoid social contact also deserves consideration. However,
if this were the case, one might have expected a similar
relationship to exist in the SCI group, or between distress
and contact with relatives, and this was not observed.
In addition to the research relating to the quality of sup-
port, this study also assessed the different sources of
support. One finding was that the resources from spouses
and partners exceeded that from friends and relatives in
both groups. Since partners are often the primary providers
of social support, and the levels in this case were rela-
tively high, it was hypothesized that married patients with
CFS(ME) might be less distressed than single ones. However,
inspection of the data revealed that this was not the case.
The mean depression scores for married and single patients
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were 8.89 and 7.46 respectively. Similarly, the means for
anxiety were 10.22 and 8.96 respectively. Thus the single
patients reported slightly less distress than the married
ones.
Nevertheless, the source of support does appear to play a
role in terms of adjustment to CFS(ME). For example, contact
with friends was negatively and significantly correlated
with depression but contact with relatives was not. Indeed,
the strength of the correlation between contact with rela-
tives and emotional distress was extremely low.
A separate issue is whether the quality of support has a
stronger relationship with mood that the quantity of support
(Cohen and Wills 1985, Fitzpatrick et al 1991, Goodenow et
al 1990). Unfortunately, since this study only included
three measures assessing the 'quantity' of support, it is
difficult to draw firm conclusions. However, it is notice-
able that the correlation between the resources from rela-
tives and mood exceeded that between contact with relatives
and mood. The discrepancy was far less marked for these
variables where it concerned friends, showing once more that
the connections between social support and either depression
or anxiety depends in part on the source of the support and
that a simple comparison between structural and functional
measures could be misleading. The reason for the lack of
association between the various social support variables and
emotional adjustment in the SCI group is unknown.
Aside from its links with emotional distress, social support
was also associated with the second adjustment measure:
functional impairment. However, due to the design of the
study, it is not possible to determine whether the loss of
friends contributed to functional impairment or whether the
latter led to the loss of friends.
Finally, the loss of friends was related to certain illness
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and disability-related variables. In the patients with
CFS(ME), it was significantly correlated with the years
since diagnosis, while in the SCI group, loss of friends was
associated with the level of the lesion and degree of
physical functioning. Thus the more severe the disability,
the greater the loss of friends.
In summary, the findings suggest that variables such as
cognitive difficulties, uncertainty and lack of social
support may contribute to the emotional distress associated
with CFS(ME). Consequently, any analysis of the patients'
experience which does not take these possible influences
into account, may be incomplete.
Further research is required, not only to examine the
effects of variables such as uncertainty, support and
cognitive dysfunction in more detail, but also to assess the
value of counselling in which these problems are acknow-
ledged and addressed.
4.5.3 Methodological issues 
The results of this study should be interpreted with caution
for a number of reasons. First of all, the symptoms of
CFS(ME) tend to fluctuate markedly, from hour to hour and
from week to week (e.g. Gilliam 1938, Patarca et al 1993).
Thus a patient may feel reasonably well one day but severely
ill 24 hours later. In this sample, only 17% described their
condition as stable, compared with 14.4% of the patients
surveyed by Hinds and McCluskey (1993) and 25% of those
examined by Dowsett et al (1990). This contrasts with the
results from the people with SCI, of whom 64% rated their
condition as stable. Although the changeability of CFS(ME)
makes it difficult to obtain a truly representative assess-
ment of disability, it is noteworthy that the scores for all
the symptom subscales were similar to those of another group
with CFS, and that as expected, they exceeded those from a
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student comparison group (Ray et al 1992b).
A second point which should be taken into account when
evaluating the data is the limited number of variables
assessed. Since most people with CFS(ME) are very ill and
they find it difficult to concentrate for long periods of
time, it was decided to restrict the number of questions
asked. However, this meant that factors which may have been
a major influence on the mood and functioning of the pa-
tients could have been excluded. For instance, possible
mediators of emotional distress which were not assessed in
this study include coping strategies (e.g. Blakely et al
1991, Ehmann et al 1990, Lazarus 1991, Weisman and Worden
1976, Ray et al 1993), personality variables such as self-
efficacy (e.g. Terry 1992, Long et al 1989), satisfaction
with medical advice and care (Dakof and Taylor 1990, Stewart
and Sullivan 1982, Toombs 1992), and membership of a support
group (Dimond 1983, Robinson 1988). Any of these factors
could have influenced the severity of anxiety and depres-
sion, as well the experience of the illness as a whole, and
this deserves further research.
A third problem which should be considered when interpreting
the results is that some of the symptoms reported as
troublesome by the CFS(ME) patients were not included in the
PFRS. One of these was nausea which was a main symptom in
19% of the group. It is therefore possible that the lack of
association between somatic symptoms and functional im-
pairment could have been due, in part, to the fact that im-
portant complaints were not assessed. It would also have
been useful to obtain an outsider's rating for symptoms and
level of disability, but this would have put an extra burden
on the patients and was therefore not pursued.
Unfortunately, the size of the SCI group in the current
study limits the conclusions which can be drawn in relation
to spinal injuries. For instance, it was not always pos-
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sible to compare variables, since in some cases (e.g. gen-
der), there were too few people in one of the groups to make
such a comparison meaningful. However, it should be pointed
out that in terms of demographic and disability-related
characteristics, the sample was not atypical. For instance,
as in other studies, about a half the patients were injured
in road traffic accidents, men greatly outnumbered women and
most were not employed (cf. Grundy et al 1986, Oliver et al
1988, Trieschmann 1989). On the other hand, this was a
community sample and unlike many of the previous studies
assessing the emotional distress associated with SCI, the
patients were not in a hospital environment which might have
protected them from experiencing higher levels of uncertain-
ty and anxiety.
4.5.4 Questions arising from the research
Although uncertainty appears to be a significant problem in
CFS(ME), it is not clear whether it has a direct relation-
ship with anxiety and depression or whether it is mediated
through its effects on coping. For example, it has been
suggested that patients can deal with the lack of certainty
associated with disease by obtaining relevant information
and by finding medical help or advice. Although all the
patients in this study had access to a consultant and
information, there was no assessment of the amount of
contact with the practitioner, or their use of information.
A further source of knowledge, contact with others who have
faced the same problems, was not assessed either. Given the
lack of understanding among the general population (see
Study 1), and the inadequacies of the services provided by
the medical profession (Denz-Penhey and Murdoch 1993),
advice and support from patient groups may do much to reduce
the levels of uncertainty and emotional distress (Dimond
1983). Consequently, the role of patient groups deserves
further attention.
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Aside from the lack of advice and support, people with
CFS(ME) may also be disadvantaged by other problems. For
example, their attempts at coping could be undermined by
high levels of fatigue or cognitive dysfunction (Lazarus
1991). In this study, fatigue was common and often severe
but this symptom did not have as close a relationship with
functional impairment as cognitive difficulties did.
However, this does not rule out the possibility that this
symptom could interfere with coping and other aspects of
adjustment.
Also of interest in this respect are the high levels of
anxiety. Although the latter may be a result of the somatic
symptoms and the degree of uncertainty, it is also possible
that the reverse is true, i.e. that the symptoms and the
uncertainty are actually caused by the patients' anxiety. If
that is the case, it follows that emotional distress could
play a major role in perpetuating chronic fatigue syndrome
(Wessely et al 1991, Sharpe 1994).
Unfortunately, the cross-sectional design of this study
means that the direction of the relationship between vari-
ables can not be determined. However, since just over
thirty per cent of the patients did not have high anxiety
scores, and given that most studies have not reported si-
milar rates of anxiety disorder in patients with CFS, it is
more likely that the present sample was unusual, represen-
ting perhaps, individuals who had not yet received the help
they required, and were not able to manage their illness in
an effective way. It would be useful, therefore, to repeat
the study in a second sample of patients with CFS using a
longitudinal design to allow a more detailed evaluation of
the relationship between fatigue, cognitive dysfunction,
uncertainty and emotional distress.
A longitudinal design would also help to determine if and
how symptoms change as a result of regular contact with and
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support from a medical practitioner, and whether specific
coping strategies have a positive effect on emotional
distress and functional impairment.
A further question which should be addressed is the rela-
tionship between fatigue and depression. In this study, the
correlation between these variables was relatively low in
the CFS(ME) group but modest positive correlations between
fatigue and psychiatric symptoms have been found in other
groups of CFS patients (McDonald et al 1993, Ray et al
1992b), as well as people with Parkinson's disease (Friedman
and Friedman (1993) and systemic lupus erythematosus (Krupp
et al 1990). However, fatigue was not correlated with de-
pression in patients with multiple sclerosis (Krupp et al
1988, Moller et al 1994) or post-polio fatigue (Bruno et al
1994b), and did not contribute to the depression reported by
patients with rheumatoid arthritis (Belza et al 1993). Given
these contradictory findings, further studies are required
to clarify the situation.
4.6 Summary
In this study, patients with CFS(ME) reported more severe
fatigue and cognitive difficulty, and they were more im-
paired in terms of work and other activities than people
with spinal cord injuries. The CFS(ME) group also recorded
higher levels of depression, although when one fatigue-
related item was omitted, the difference between the groups
was no longer significant.
The results also suggest that uncertainty may play an impor-
tant role in both anxiety and depression, and this possi-
bility should be taken into account both in research and in
clinical practice.
In contrast, most of the social support measures showed only
a limited relationship with emotional distress. However,
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contact with friends was significantly associated with lower
anxiety and depression scores.
Overall, these findings indicate that factors such as the
severity of symptoms, uncertainty and the lack of support
may add to the patients' emotional distress and therefore
undermine both their adjustment and recovery.
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CHAPTER 5 
Learning to cope with post-infectious fatigue syndrome
A follow-up study
5.1 Introductioq
The previous studies have shown that many patients with CFS
are severely impaired and that many experience high levels
of emotional distress. However, while drugs can help to
alleviate specific symptoms such as depression and pain,
there is still no treatment which has led to consistent
improvements in the illness as a whole.
Given the limited value of prescribable drugs, some doctors
have begun to explore other ways of managing the disability
and distress associated with CFS. The approach which has
received most attention in this respect is cognitive-
behavioural therapy (CBT).
CBT is based on the assumption that a person's thoughts and
beliefs influence their behaviour as well as their emotional
and physiological state. Even in disorders with an under-
lying organic cause, the presence of faulty or irrational
thoughts may undermine effective coping, impede recovery and
significantly increase emotional distress. The main task in
CBT is therefore to identify and challenge maladaptive cog-
nitions such as distortions, overgeneralisations and all-or-
nothing thinking (Rimm and Masters 1979). Patients are also
encouraged to engage in adaptive tasks and activities which
were previously avoided.
In dealing with CFS, therapists try to challenge any dys-
functional attributions which may have led patients to avoid
exertion or to adopt other strategies which might have
perpetuated their distress (see Chapter 1). At the same
time, patients are instructed to gradually increase their
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activities and not to be afraid of the fatigue which may
ensue (Butler et al 1991, Sharpe 1993).
It is claimed that programmes featuring 'graded exercise'
improve the individual's physical fitness and accordingly,
their fatigue. Moreover, by engaging in planned
activities, it is hoped that patients will regain their
sense of mastery and thus overcome their feelings of
helplessness and hopelessness (Sharpe 1994).
There are currently five published accounts of studies which
have assessed the effectiveness of CET in CFS. Two were
uncontrolled trials (Butler et al 1991, Cox and Findley
1994) and three were controlled (Lloyd et al 1993, Friedberg
and Krupp 1994, Sharpe et al 1996).
As shown in Table 1, the results of the uncontrolled trials
were encouraging. However, the findings from the controlled
trial have been less consistent. For instance, one of the
controlled trials which combined CBT and planned, graded
exercise found that this combination was not superior to
clinic attendance or a placebo drug (Lloyd et al 1994). In
a second study, the treated patients showed significantly
greater improvements than the controls on the Karnof sky
scale but there were no significant differences between the
groups on the other measures (Sharpe et al 1996).
The third controlled trial differed from the two above in
that the programme involved a combination of CBT, group
therapy, relaxation training and "shared coping" (Friedberg
and Krupp 1994). Furthermore, the researchers advocated that
patients should stay within the limits imposed by the
illness rather than increase their activity according a
schedule. They rejected graduated increases in exercise
because they found no evidence of phobic avoidance among
their patients and many were thought to be performing near
or at their activity ceiling already. While the results
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revealed no significant differences between the treated
patients and controls, improvements were noted in the
subgroup with above average depression scores.
Table 1. Studies assessing psychological therapies for
CFS
Treatments
	 Criteria Results
(number of subjects)
Reference
1. Uncontrolled trials
CBT, graded exercise	 Own
plus anti-depressants
where appropriate
(N=50).
Butler et al 1991.
27 completed treatment.
Significant improvement
noted in fatigue, func-
tional impairment, dep-
ression, somatic symp -
toms. 70% of those with
some treatment felt
better or much better.
As above. Follow-up	 87% who completed treat
at four years (N=46).	 ment (total 23) had im-
Bonner et al 1994.	 proved. 13% of those
who did not complete
treatment also im-
proved.
CBT, graded exercise	 CDC
plus anti-depressants
(N=28).
Cox and Findley 1994.
57% had increased acti-
vity levels six months
after discharge. 14.3%
noted reduced symptoms,
35.7% were unchanged,
7% were worse.
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Table 1 cont. 
Treatments	 Criteria Results
(number of subjects).
Reference.
2. Controlled trials
CBT, graded exercise,
	 Aus*
immune therapy (IT)
(N.20) versus CET,
graded exercise, pla-
cebo (N=21), versus IT
clinic attendance (N.26)
versus placebo, clinic
attendance (N.23).
Lloyd et al 1993.
CET, graded exercise
	 Oxford
(N.30) versus diag-
nosis and advice to
increase activity
(N=30).
Sharpe et al 1996.
CBT, gentle exercise,	 CDC
relaxation and shared
coping. CFS (N.22)
versus untreated CFS
(N=22) versus depressed
group (N.20).
Friedberg and Krupp
1994.
No sign. difference be-
tween groups. Trend to-
wards greater improve-
ment in quality-of-life
scores among the CBT+IT
group but no improve-
ment in their POMS
or activity scores.
No significant diff-
erences between the
groups after completion
of trial but treated
patients showed greater
improvements (e.g. in
functioning) at follow-
Up.
No significant improve-
ment in CFS groups.
However, CFS patients
with higher depression
reported less fatigue,
stress and depression
after the trial.
* Aus Australian
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Since the number of studies evaluating CET is limited, it is
difficult to ascertain its effectiveness for CFS at the
present time. However, there is evidence that this treat-
ment may be beneficial for specific subgroups, for instance,
patients with concurrent clinical depression (Friedberg and
Krupp 1994, Butler et al 1991). Indeed, the fact that 20 of
the 32 CFS patients (63) tested by Butler et al were diag-
nosed with major depression may partly explain the discrep-
ancy between their results and some of the other trials.
Moreover, the finding that CBT appears to be more effective
in patients with co-existing depression is consistent with
the results from other medically-ill populations (e.g.
Larcombe and Wilson 1984).
CET and graded exercise may also be helpful in patients who
are overly anxious about activity and whose fatigue may be
attributed almost entirely to physical deconditioning,
demoralization and low mood (Butler et al 1991). However, it
is still unclear just how many patients with CFS actually
fit this stereotype. For instance, Faas (1992) has chal-
lenged the descriptions of people with CFS as fearful of
activity and passive. Like Friedberg and Krupp (1994), her
patients had a tendency to do too much rather than too
little. She also noted that those individuals who had been
diagnosed early and who had followed advice to rest had
generally improved quickly, and had been able to return to
something resembling their old levels of activity within a
relatively short period of time.
Given the equivocal results of the controlled trials, it
could be argued that the current emphasis on challenging
somatic attributions and reducing the levels of decondi-
tioning may not address all the sources of disability and
distress in this patient group. For example, the model
which most therapists use as a basis for CBT assumes that
there is no underlying disease process which can cause a
recrudescence or exacerbation of symptoms. Indeed, few
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accounts have considered the possibility that some com-
plaints may not be attributable to deconditioning and
depression, and that therefore the current advice to
increase activity irrespective of one's state of health may
not always be appropriate.
Another possible limitation of CBT is that the therapists'
views regarding the aetiology of the symptoms and the role
of psychiatric morbidity have tended to conflict with the
beliefs and experiences of many people with CFS. The lack of
agreement may undermine the patient-therapist relationship
and lead to high attrition rates (Hickie et al 1995b).
An alternative approach resembles the broad-based programmes
which have been devised for patients with medical conditions
such as cancer. These do not aim to treat the underlying
causes of the illness, but try to enhance the patients'
psychological well-being and reduce their disability.
Patients can be treated individually or in groups but all
the programmes tend to include the following components:
- education about the condition,
- stress management,
- enhancement of coping skills to deal with the disorder and
its effects,
- provision of emotional support.
For example, Fawzy et al (1990b) devised a 6-week, struc-
tured, group-based programme for postsurgical patients with
malignant melanoma. It contained a number of elements
including information (e.g. about cancer prevention);
psychological support; stress-management (e.g. relaxation
training) as well as a discussion of effective coping
strategies to deal with personal difficulties such as
isolation, fear, change of body image and general mood.
After 6-months, the treated patients recorded significantly
lower scores for depression, fatigue and total mood distur-
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bance than the no-treatment controls. The strategies which
were associated with successful outcome included talking to
others for information and support, and distraction (e.g.
going out, doing something for oneself). Coping modes which
correlated with increased psychological distress included
passive resignation, taking drugs or avoiding others.
Other broad-based programmes offering support and informa-
tion to patients with chronic disorders have also been found
to improve mood and quality-of-life (e.g. Cunningham et al
1993). Indeed, one increased the survival rate of patients
with cancer (Spiegel et al 1989).
5.1.1 ire broad-based programmes helpful for patients with
CFS? 
There is evidence that people with CFS would welcome pro-
grammes such as those described above. For instance, pa-
tients surveyed by Denz-Penhey and Murdoch (1993) identified
a number of areas which "needed to be worked on" e.g. rec-
ognition of factors which trigger relapses, problems with
managing stress, difficulties in relationships and the de-
velopment of communication skills. While one-to-one coun-
selling was rejected on the basis of cost and the perceived
judgmental attitudes of some counsellors, the patients indi-
cated that affordable, safe and effective counselling would
be very helpful.
Whether such an approach might be effective in terms of
reducing symptomatology is difficult to predict. However,
from a theoretical point of view, a broad-based management
programme could help to alleviate the psychological distress
and possibly limit the disability associated with CFS as
follows:
1. information about the nature of the illness should in-
crease the patient's understanding of their condition, en-
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abling them to interpret symptoms correctly and to identify
factors which trigger exacerbations. This in turn could help
to reduce the uncertainty and unpredictability associated
CFS. Since uncertainty has been linked to both anxiety and
depression in patients with CFS(ME) (see Chapter 4), this
approach might reduce the severity of psychological dis-
tress. Information may also counter the helplessness and
demoralization which undermine effective coping (Braden
1990) and predispose some patients to depression (Butler et
al 1991).
2. Knowledge about effective coping strategies and available
resources could help the individual to increase their sense
of mastery and personal control. Lack of control has been
linked with increased emotional distress in people with
multiple sclerosis and spinal cord injuries (Devins et al
1993c, Schulz and Decker 1985).
3. Physicians can provide much needed emotional support as
well as advice (Mishel 1988, Mishel and Braden 1988).
Indeed, help and guidance from physicians has been pre-
viously associated with reduced psychological distress
(Elliott et al 1992).
One of the few broad-based treatment programmes which is
available to CFS patients in the UK is that devised by Dr.
Ho-Yen (1990, 1993). His approach acknowledges the pos-
sibility of ongoing disease and the fluctuating nature of
the symptoms. It also recognises the importance of informa-
tion in order to gain control and the distress caused by
factors such as the lack of understanding.
His 5-step management programme includes:
1. Advice aimed at limiting and preventing psychological
problems. Antidepressants are used in low-doses where
appropriate.
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1. Information. Patients are encouraged to learn more about
their illness so that they can understand their disorder and
identify the triggers of relapses. To help them, he has
written a book about post-viral syndromes (Ho-Yen 1993).
Patients are also encouraged to learn about themselves e.g.
what might have predisposed them to become ill, and to exa-
mine their reactions to the illness e.g. to recognise and
confront fears etc.
3. Regular assessment of the illness and the patient's
feelings using a daily diary. This lists the hours of
relaxation and the patient's activities, quality of sleep,
problems and mood and is used by the patient and consultant
to identify variables associated with relapse and improve-
ment.
4. Advice about energy and exercise. For instance, using
the diary, patients can estimate how much activity can be
carried out without causing symptoms. This strategy of
identifying limits and adjusting activity according to
available energy levels is sometimes known as pacing. Dr.
Ho-Yen advocates gentle exercise (which does not result in
an exacerbation of symptoms), as opposed to graded exercise
(where activity is increased regardless of the consequen-
ces). Sleep is encouraged, as is relaxation, to increase
the patient's available energy reserves. Advice regarding
energy also includes a discussion of ways to deal with
mental exertion, stress and difficult relationships.
5. Advice regarding food and diet. This includes a discus-
sion of the Hay system, identification of allergies (which
he regards as very rare) and limiting alcohol intake. Spe-
cific advice about diet is usually not given until 6 months
after the first consultation.
Patients are seen every two months to discuss their progress
and any problems which arise.
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Given the emphasis on specific self-management practices
e.g. keeping a diary, pacing of activity, avoiding stressful
relationships etc, the effectiveness of the programme may be
influenced by the patient's perceived self-efficacy, i.e.
their belief that they can do the tasks recommended for
them. For example, in a trial of patients with arthritis,
increased levels of self-efficacy was associated with re-
duced pain and depression (Long et al 1989). However, there
has been little research into the self-efficacy of patients
with CFS and it has not been assessed in the trials of CBT.
It may also be of interest to compare the different ap-
proaches to exercise. Dr. Ho-Yen's advice to conserve
energy is consistent with the coping strategy referred to as
'accommodating to the illness' (Ray et al 1993). In a recent
study on patients with CFS, this strategy was associated
with lower scores for anxiety but with greater functional
impairment. In contrast, the strategy of 'maintaining
activity', which Dr. Ho-Yen's programme discourages, was
linked with increased anxiety but with less functional
impairment (Ray et al 1993). These findings suggest that
advice to keep within one's limits may be enhance emotional
well-being, while other approaches such as graded activity
may be more helpful to improve general functioning (cf.
Sharpe et al 1996).
Finally, it has been suggested that different strategies may
have different effects depending on the duration of illness.
For instance, Ray et al (1995) found that 'accommodating to
the illness' was related to increased fatigue in those who
had been ill longer but not in those who had been ill for a
shorter period. If this is correct, then Dr. Ho-Yen's pro-
gramme may be more helpful for those who have not been ill
for very long.
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5.2 Research aims 
1. The main aim of the study was to ascertain the effec-
tiveness of Dr. Ho-Yen's programme in the management of
patients with post-infectious CFS. Outcome measures were
the symptom scores, anxiety, depression and functional
impairment.
2. The data were also examined to assess the effect of the
programme on uncertainty, perceived self-efficacy and type
of coping strategies.
3. A further analysis was performed to establish whether the
programme had differential effects in particular subgroups,
for instance, patients with high scores for depression,
anxiety and fatigue, or people who had been ill for a
shorter period of time.
4. The baseline scores for all participants were examined
in order to assess whether the relationships between symp-
toms, uncertainty, emotional distress and functional impair-
ment, which were documented in patients with CFS(ME) in
Study 2, were replicated in this sample. An additional
variable, membership of a self-help group, was included to
ascertain its association with emotional distress, disabi-
lity and coping.
5.3 Method
5.3.1 Sample characteristics and procedure
The patients were recruited from the waiting list of Dr. Ho-
Yen, a consultant microbiologist at the Raigmore Hospital in
Inverness. They were contacted personally by Dr. Ho-Yen to
ask if they would participate in the research. Those who
were willing in principle were then sent a letter explaining
the trial and asking for their consent. Patients were subse-
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quently assigned to one of two groups depending on their po-
sition on the waiting list.
The treatment group comprised patients who had been on the
waiting list for one to six months. They were sent their
first set of questionnaires two weeks prior to their first
consultation and the second set between five and six months
later, prior to their fourth appointment.
The control group comprised patients who had been on the
waiting list for one month or less. They were sent the first
set of questionnaires immediately following receipt of the
consent form and they completed the second set just prior to
their first consultation, approximately six months later.
This design was chosen because at the time of the study, the
delay between acceptance on the waiting list and the first
consultation was about 7 months. This was sufficient to
carry out two assessments with a time interval equivalent to
that of the treatment group. Thus the waiting list controls
provided an estimate of the effect of time, while the as-
sessments of the treatment group allowed for a before/after
treatment comparison.
An alternative design using randomised groups was rejected
because this would have required half the patients to spend
a further 6 months without diagnosis and treatment, which
was considered inappropriate given the severity of the
symptoms.
At the first consultation, Dr. Ho-Yen checked the patient's
diagnosis and explained his programme (see description
above). This lasted about one hour. The patients returned
every two months for a further 5-10 minutes in which their
progress could be checked and specific problems discussed.
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Before	 Before
Waiting list	 Time 1	 Time 2
Months	 0	 6	 12
since join-
ing waiting
list
(approx.)
Group 1	 Ti	 T2
(treatment)
Group 2	 Ti	 T2
(waiting
list controls)
T1-2 Time 1 and 2 (assessments)
Figure 1. Summary of study design
Post-infectious fatigue syndrome (PIFS) was diagnosed using
the criteria formulated by Dr. Ho-Yen (1990, see Appendix
1). Most patients were thought to have a post-viral syn-
drome but a few patients whose fatigue followed bacterial
and parasitic infections e.g. Lyme disease, were also
included. Accordingly, the disorder will henceforth be
referred to as CFS(PIFS).
Twenty-five patients were initially entered into treatment
group and 27 became waiting list controls. In total, eight
patients were excluded from the analysis; three did not have
CFS(PIFS), two did not wish to continue treatment and the
questionnaire from one patient was lost in the post. Another
patient was excluded because she stopped taking oral contra-
ceptives which led to a marked improvement in all symptoms
while on the waiting list. This suggests that the severity
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of her complaints at baseline may have been influenced by
the use of this drug and that the change in scores at Time
2 cannot be interpreted as reflecting the natural course of
CFS(PIFS). Finally, one patient was followed-up after only
three months and this was not considered to be long enough
to evaluate the effect of the treatment satisfactorily. His
data were therefore also excluded from analysis. As a
result, there were 22 patients in each of the groups.
Only one person refused to participate in this study. More-
over, once the trial had begun, the drop-out rate was ex-
tremely low.
None of the participants had a concurrent condition which
could have had a significant influence on the assessment of
outcome. However, 8 (36.4%) patients in the treatment group
and 15 (68%) of the waiting list controls reported having an
additional illness. These included asthma, epilepsy, loca-
lised arthritis, ulcers, diverticulitis, hiatus hernia,
recurrent sinusitis and kidney infections. It was assumed
that the patients were taking the medications prescribed for
these conditions and that at the time of testing, their
presence was not considered a major influence on the
symptoms reported.
Between the first and second assessments, 15 (68%) of the
treatment group changed their diet or began new therapies
for their CFS-related symptoms and 14 considered these as
helpful. Two began taking antidepressants. Similarly, 12
(55%) of the controls changed their diet or began a new
treatment and 2 were prescribed antidepressants. The new
treatments were considered helpful by 7. The change towards
a healthier diet and use of anti-depressants for CFS etc is
consistent with Dr. Ho-Yen's programme, although in many
cases, the 'treatments' were prescribed by another advisor
(acupuncturist, GP). Since the number in each group who
were taking antidepressants at some stage during the trial
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was similar (9 of the treated patients versus 6 of the
controls), the treatment group's scores at Time 2 can still
be interpreted as reflecting the general recommendations
incorporated in the programme.
None of the patients were paid for their participation.
5.3.2 Details of the questionnaires 
First assessment 
Each set of questionnaires comprised the Profile of Fatigue-
Related Symptoms (Ray et al 1992a), the Functional
Impairment . Scale (Marks 1986), the Hospital Anxiety and
Depression Scale (Zigmond and Snaith 1983) and the 23-item
Mishel Uncertainty in Illness Scale-Community Form (Mishel
and Epstein 1990). Details relating to these can be found in
Chapter 4.
In addition, patients were asked to complete the following
questionnaires:
Background Information
This questionnaire asked for demographic information inclu-
ding gender, age, years of education beyond 16, occupation,
marital status and housing. It also included an item to
determine whether income consisted entirely of social se-
curity benefits ('Low Income').
General Information
This questionnaire asked patients about the main symptoms
experienced, the duration and onset of the illness (i.e.
acute/gradual), the use of drugs in the present and past,
membership of self-help groups and presence of other medical
conditions. A question was also included to assess whether
patients had already read Dr. Ho-Yen's book and followed his
advice, as this could affect baseline measures for both
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groups.
Two further items assessed the level of activity and fre-
quency of symptoms. These are described in more detail in
Chapter 4. However, in contrast to the previous study, the
scoring was reversed so that high scores now reflected less
favourable health status. A third question asked patients
about the course of their illness during the past 6 months.
The choice of answers ranged in order from 'worsened a lot'
(scored 1) to 'improved a lot' (scored 5).
The Illness Management Questionnaire (IMO) 
This questionnaire assessed problem-focused coping strate-
gies and was specifically designed for use by people with
CFS (Ray et al 1993). Patients were asked to describe their
approach to the illness in the last six months on a scale
from 1 ('never') to 6 ('always'). The scores reported
consist of the means for each subscale.
The scale comprises four factors which have been interpreted
as follows:
1. Maintaining activity: attempting to ignore symptoms;
carrying on even though
adverse effects of activi
2. Accommodating to the
one's life in order to
unwell and disregarding possible
ty.
illness: organizing and planning
avoid over-exertion and control
stress. Accepting limitations.
3. Focusing on symptoms: a preoccupation with symptoms,
linked with an appraisal of helplessness and of one's life
as dominated by the illness.
4. Information-seeking: seeking relevant information and a
readiness to try remedies.
Ray et al (1993) reported that alpha reliabilities for these
scales were high, ranging from .85 to .93.
Self-efficacy Scale 
This measure comprised a modified version of the Self-
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Efficacy Other Symptoms subscale (Long et al 1989). Pa-
tients were asked to rate their confidence regarding their
ability to control their illness on a scale ranging from 10
('very uncertain') to 100 ('very certain'). The questions
included: 'How certain are you that you can control your
fatigue' and 'How certain are you that you can deal with the
frustration of your illness'. The score was the mean for all
six items.
Since this measure was originally devised for patients with
arthritis, references to 'arthritis' were changed to 'fa-
tigue', 'illness' or 'PVFS', depending on the context. (PVFS
is the name used by Dr. Ho-Yen in his clinical practice.)
Furthermore, in one question, a reference to 'feeling blue'
was changed to 'feeling down'.
The alpha co-efficient for internal reliability in the
original study was found to be .87 and the test-retest
reliability was satisfactory (Long et al 1989).
Patients were informed by letter that their answers would be
confidential. Indeed, the questionnaires were coded by
number and access to the data was limited to the researcher
and consultant.
Second assessment 
At the second assessment, patients were again asked to fill
in the PFRS, IMQ, Self-Efficacy Other Symptoms subscale,
HAD, Functional Impairment Scale and MUIS-Form C. In
addition, there were questions to determine if the patients
had begun any new treatments since the last assessment, and
if there had been any change in their state of health.
Answers to the latter ranged from 'much better' (scored 1)
to 'much worse than before' (scored 5).
Further items assessed the level of activity and frequency
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of symptoms. There was also an open-ended question asking
patients who had improved to identify the reasons for this.
A final question asked participants to rate the medical care
and support which they had received for this illness from
doctors other than Dr. Ho-Yen. Scores ranged from 1 ('very
poor') to 5 ('very good').
Copies of all the questionnaires can be found in Appendix I.
5.4 Results 
The results will be presented in two parts. The first sec-
tion focuses on the differences between the groups and the
changes associated with the treatment in relation to the
outcome variables, plus uncertainty and self-efficacy. This
will be followed in part 2 by an analysis of the relation-
ships between these variables using the Time 1 scores from
both groups.
Due to the overlap between the PFRS subscale for emotional
distress and the two HAD subscales, only the latter was
included in the analyses.
5.4.1 Statistical analysis 
Analysis of the MUIS Scale revealed that many patients had
found it difficult to complete all the items. Since low
scores in these cases might be wrongly interpreted as
indicating low levels of uncertainty, questionnaires with
more than four missing items were discarded. As a result,
Time 1 data was available for only 13 patients in the
treatment group and 16 controls.
Categorical data from the two groups were compared using the
Chi-square test with Yates correction for two-by-two compa-
risons (Siegel 1956). Data on an ordinal scale, and inter-
val data whose scores deviated from the normal distribution,
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were analysed using the Mann-Whitney U test (Cramer 1994).
Other group comparisons were evaluated using a T-test for
independent samples.
The effect of the treatment on the outcome variables was
assessed using analysis of covariance (ANCOVA). This was
considered more appropriate than a test of change scores
(Time 1 minus Time 2) or MANOVA with repeated measures
because the participants were not randomly selected and it
was therefore not possible to control for potential bias in
the composition of these groups such as differences in
baseline scores. The results were checked to insure that
they satisfied the conditions necessary for use of ANCOVAs.
Initial analysis of the data from the treatment group re-
vealed the presence of outliers among the Time 2 scores for
anxiety, depression, self-efficacy and uncertainty. Since
these may lead to errors when calculating ANCOVAs, it was
decided to reduce their effect by giving them a value one
unit larger than the next most extreme score as recommended
by Tabachnick and Fidell (1983). This strategy preserves the
deviancy of a case but reduces the chance of misleading
results. The transformation made little change to the re-
sults relating to self-efficacy so the original data were
retained.
Where the group differences using transformed data reached
significance, the analysis was repeated but omitting the
outlier altogether. Details of these calculations can be
found in Table 3, Appendix III.
Failure of linearity in the fatigue scores led to a square
root transformation of the values. However, given the
similarity of the results (see Table 3, Appendix III), the
original data were retained.
All equations were computed using the ANOVA command in
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SPSS.PC. The MANOVA command was used to obtain F values and
to check for homogeneity of variance and regression. The
alpha level was set at 0.05 and all tests were two-tailed.
The internal consistency of the measures which had not been
used in earlier studies was assessed using Cronbach's alpha.
The results, shown below, indicate that the self-efficacy
scale and all four IMQ subscales had an acceptable level of
internal reliability.
Table 1. Summary of Alpha coefficients for reliability
Variable	 Treatment group 	 Control group
IMQ
Maintaining activity .92 .92
Accommodating to the
illness .90 .89
Focusing on symptoms .79 .90
Seeking information .83 .84
Self-efficacy
Six items .83 .86
5.4.2 Demographic information
The mean age of the treatment group was 39.6 years (SD
13.40), the youngest participant being 15. Seventy-three
per cent of the patients were female, 59% were married and
50% had completed secondary school. At entry to the study,
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9% were still studying, 27% were on sick leave, 5% had re-
tired and 36% were doing either part-time or full-time work.
Eighty-six per cent of those who responded to the question
reported that they had changed their job or reduced their
hours because of their illness. Only 14% were totally
dependent on social security benefits. For more detailed
information, see Appendix III.
The mean age of the waiting list controls was 37.7 years,
the youngest being 14. In this group, 59% were female and
50% were married. At the time of the study, 59% had com-
pleted secondary school, 14% were still studying, 41% were
on sick leave, 9% had retired and just 18% were in part-time
or full-time work.
There were no major differences between the groups in terms
of age, marital status, years spent in education after the
age of 16, house ownership and dependence on benefits. Fur-
thermore, the proportion of patients classified as profes-
sional or semiprofessional (e.g. teachers, nurses) were
exactly the same. However, the control group contained more
people in unskilled manual jobs (p>.05). It also included a
slightly greater number of men and more patients who were on
sick leave.
To determine the possible effects of the difference in
gender, the scores for the key variables at Time 1 were
compared using the Mann-Whitney U Test. This showed that men
were significantly more depressed than women (p<.05).
5.4.3 Information about the illness variables 
The findings relating to the illness variables are sum-
marised below. None of the differences between the groups
reached significance.
The median duration of illness among the treatment group was
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5 years (SD 3.69) with a range from 6 months to 14 years.
The controls had generally been ill for a shorter time
(median 2.1 years, SD 3.34, range 8 months to 15 years,
p..06).
In 40% of the patients from treatment group, the symptoms
had begun suddenly following an infectious illness such as
glandular fever or influenza. During the six months prior to
the study, 36% had been getting worse, 23% were stable and
41% had been improving. Among the controls, 63% reported a
sudden onset and in 74% of the cases, the trigger was an
infectious condition. Fifty per cent had been getting worse
in the 6 months prior to the study, 18% felt the same and
32% noted some improvement.
Both groups were severely impaired. In terms of activities,
just 4.5% of the treatment group and none of the controls
were able to do more than a half of what they could do prior
to their illness. Indeed, 86% of the former and 95.5% of the
controls experienced symptoms most or all of the time.
Ten (45.5%) patients in the treatment group and 12 (54.5%)
of the controls were taking drugs at entry to the study. In
some cases, these formed part of the management for other
disorders. However, up to a third were using drugs often
prescribed for CFS.
The majority of the patients in both groups had not joined
any patient group. However, 41% of the treatment group and
50% of the controls had read Dr. Ho-Yen's book on PVFS.
Moreover, 55% of the former and 36% of the latter were
following his advice most or all of the time. This dif-
ference was not statistically significant. For further
details relating to the illness, see Appendix III.
Finally, patients were asked what they thought of the medi-
cal care and support from doctors other than Dr. Ho-Yen.
252
Twenty-seven per cent of the treatment group rated it as
poor or very poor, 23% felt that it was adequate but 50%
classed it as good or very good. Among the controls, 1896
felt that the treatment to date had been poor, 27% viewed it
as adequate but 55 rated it as good or very good.
Results for the key variables at Time 1 
The baseline scores for the somatic symptoms, anxiety,
impairment, self-efficacy, uncertainty and coping revealed
no significant differences between the groups (see Tables 2,
3 and 4). However, the controls reported slightly more
severe fatigue, cognitive difficulty and depression at Time
1 than the treatment group.
5.4.4 Changes associated with treatment 
Asked about the changes in their condition during the six
months between Time 1 and Time 2, 82% of the treatment group
rated themselves as better or much better, 9 96 regarded
themselves as unchanged and 9 felt worse. There were also
increases in the level of activity, with 55% able to do half
or more compared with the past. At Time 2, five patients
(23) had improved to such an extent that further treatment
was thought unnecessary.
In contrast, 50% of the controls felt better overall, 32%
perceived no change and 18% were worse or much worse than
before. However, 41% could do half or more compared to what
they used to be able to do. Although the improvements were
greater in the treatment group, analysis using the Mann-
Whitney test showed that their ratings of change were not
significantly greater than those reported by the controls.
Illness-related variables 
The differences associated with treatment relating to the
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three symptom subscales is shown in Table 2. Analysis of
covariance, controlling for baseline scores, revealed that
there were no major group differences in the scores for cog-
nitive difficulties at Time 2. However, there was a signi-
ficant difference for both fatigue, F (1,40) 	 5.13, p..03
and somatic symptoms, F (1,40) 	 4.66, p..04.
Table 2. Means (and SD) of illness-related
measures
Treatment group Control group
Time 1 Time 2 Time 1 Time 2 F
Symptom subtcales
Fatigue
Mean 3.50 2.68 4.20 3.84 5.13*
SD 1.61 1.41 1.14 1.40
Cognitive difficulty
Mean 2.53 2.28 3.06 2.96
SD 1.33 1.42 1.44 1.51 1.17
Somatic symptoms
Mean 1.94 1.54 2.29 2.26 4.66*
SD 1.34 1.15 1.04 1.06
* p < .05.
Uncertainty self-efficacy and coping
Inspection of the data for uncertainty suggested marked re-
ductions in the scores for both groups (see Table 3). Unfor-
tunately, a lack of homogeneity of variance and the dif-
ferences in the size of the groups reduced the robustness of
ANCOVA, so the effect of the treatment was assessed using a
T-test on the change in scores. This indicated no signi-
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ficant difference between the groups.
Table 3. Means (and SD) for uncertainty, self-efficacy and
the IMQ subscales
Treatment group Control group
Time 1 Time 2 Time 1 Time 2 F
Uncertainty
Mean 64.77 54.30 70.19 62.71 na
SD 7.88 12.14 15.87 14.05
Self-efficacy
Mean 47.05 62.14 47.22 50.20 6.79**
SD 17.97 14.55 16.20 17.87
Coping subscales
Maintaining activity
Mean 3.22 2.59 3.42 3.13 na
SD .85 .79 .83 .87
Accommodating to
the illness
Mean 4.00 4.45 4.17 4.34 1.57
SD .88 .86 .83 .91
Focusing on symptoms
Mean 3.60 3.46 3.67 3.59 .20
SD .83 1.05 1.08 1.03
Seeking information
Mean 3.21 3.46 3.29 3.22 na
SD .91 .86 1.11 1.21
* p..01
na Ancova not computed.
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The scores for self-efficacy increased during the six months
of the study, with the more marked changes in the treatment
group. Analysis of covariance revealed that the difference
between the groups was significant, F (1,38) 	 6.79, p..013.
The effects of the treatment on coping strategies were
assessed using ANCOVAs for the scores for accommodating to
the illness and focusing on symptoms. Failure to meet the
requirements for ANCOVA meant that the data for the two
remaining strategies were analysed using a two way ANOVA for
the change in scores with the two factors being the baseline
score (high/low) and group. There was no main effect for
group for either maintaining activity or seeking infor-
mation. However, there was a significant interaction between
group and maintaining activity (F.4.4 [1,40], p..042).
When asked whether they had been able to put Dr. Ho-Yen's
advice into practice, some patients admitted that they had
not. Reasons included feeling depressed and isolated as a
result of the reduction in activity, and financial con-
straints.
Adjustment variables 
In this study, adjustment was assessed using the scores on
the HAD and the Functional Impairment Scale (see Table 4).
Due to missing data, the number of cases varied per sub-
scale.
Analysis of covariance on the original data revealed no
significant differences between the groups, although there
was a trend towards significance for anxiety (F 3.77,
p..059). However, since one case had unusually high scores
on the HAD, the values were transformed as described above
and the analysis was repeated. This revealed significant
group differences for both depression, F (1,41) 4.52,
p..04 and anxiety, F (1,41) .4.62, p..04.
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There were no differences in the Time 2 scores for func-
tional impairment, F (1,39) = 1.03, p=.32, or for the
corrected depression scores, F (1,41) = 2.80, p=.10.
Table 4. Means (and SD) for anxiety, depression and
functional impairment scores
Treatment group Control group .
Time 1 Time 2 Time 1 Time 2 F
Anxiety
Mean 8.77 7.14 8.81 8.73 4.62*a
SD 4.90 3.86 4.00 3.93
Depression
Mean 7.95 6.59 9.59 9.05 4.52*a
SD 3.84 4.12 4.04 3.62
Depression corrected
Mean 5.82 4.91 6.86 6.59 2.80a
SD 3.26 3.58 3.89 3.43
Functional Impairment
Mean 22.81 20.86 22.91 22.73 1.03
SD 4.74 6.24 4.73 5.71
* p<.05
a variable where outlier was transformed.
The prevalence rates for possible and probable cases of cli-
nical anxiety and depression are shown in Table 5. The es-
timates for possible anxiety and depression at Time 1 were
similar in both groups. Indeed, about 50 of the subjects
had scores suggestive of clinical disorder, with rates of
depression being the highest among the waiting list con-
trols. However, the difference did not reach significance.
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Table 5. Prevalence of possible and probable
cases of anxiety and depression
Treatment group	 Control group
Time 1	 Time 2 Time 1 Time 2
Anxiety
> 8 No.	 12/22	 9/22	 12/21	 11/22
%	 55	 41	 57	 50
> 11 No.	 8/22	 3/22	 7/21	 9/22
Ps	 36	 14	 33	 41
Depression
> 8	 No. 13/22 11/22 14/22 14/22
% 59 50 64 64
> 11 No. 5/22 3/22 11/21 11/22
% 23 14 50 50
Depression corrected
> 8	 No. 8/22 4/22 11/22 11/22
% 36 18 50 50
> 11 No. 1/22 1/22 4/22 2/22
-1k 4.5 4.5 18 9
After 6 months, there was a slight reduction in the number
of cases of possible clinical disorders among the treatment
group but not among the controls. In contrast, there was a
much more marked fall in the number of probable disorders
among the treated patients, and for depression, the dif-
ference between the groups reached significance (x2 = 5.1,
p=.02).
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Omitting the item 'I feel as if I am slowed down' from the
calculation for depression reduced the estimates for both
groups. For example, the Time 1 rate for probable clinical
depression fell from 23% to 4.5% among the treatment group
and from 50% to 18% among the controls. This particular item
therefore had a marked influence on the estimates of cases.
However, since there is no generally agreed position on cut-
off points for corrected scores, further analysis relating
to this variable was not considered meaningful.
5.4.4.1. The influence of self-efficacy on outcome
To determine if self-efficacy had influenced the success of
the programme, the analysis was repeated with the scores for
self-efficacy at Time 2 as an additional covariate.
The results showed that after adjusting for self-efficacy at
Time 2, there were no significant differences between the
groups on any of the measures. Thus the patients' self-
efficacy had mediated the outcomes noted at Time 2.
5.4.4.2
	 The role of duration. fatigue. functional 
impairment and emotional distress on outcome 
To ascertain if the programme benefited a specific subset,
the Time 1 scores from the treated patients were split at
the median, producing two samples defined in terms of high
or low scores on specific variables. The latter comprised:
duration, fatigue, functional impairment, anxiety and de-
pression. Since the data did not satisfy the requirements
for ANCOVA, the comparison of the newly created groups
focused on the change in their scores for the outcome
measures using T-tests for independent samples or where
inappropriate, the Mann-Whitney test. Alpha was set at .05.
The results indicated that people who had been ill for a
shorter period of time did not show greater changes in
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scores compared to patients who had been ill longer. There
were also no differences in outcome when patients were de-
fined according to the degree of functional impairment and
emotional distress.
Fatigue had no effect on the change in outcome, except in
terms of perceived self-efficacy. In this case, those who
reported more initial fatigue showed greater changes in
self-efficacy scores (t=2.34, df 10.55, p..04).
5.4.4.3
	 of improvement
When asked to what they attributed their improvement during
the previous 6 months, both treated patients and controls
mentioned increased rest and relaxation. A few also noted
the value of supplements and alternative therapies such as
acupuncture and homoeopathy.
5.4.5 The relationships between variables 
The relationships between variables were examined to deter-
mine if the correlations found in Study 2 were replicated in
the patients studied here. Pearson's product-moment corre-
lation coefficients were calculated using the pooled scores
for Time 1. Where the data were not distributed normally,
i.e. education, duration of illness and years diagnosed,
Spearman's rank correlation coefficient was used instead.
The key variables in this part of the analysis were fatigue,
anxiety, depression, functional impairment and uncertainty.
The relationship between membership of a self-help group and
these variables was assessed using the Mann-Whitney test for
independent samples and for categorical data, with the x2
test.
Given the number of comparisons, the alpha level was set at
0.01 to reduce the risk of Type 1 errors.
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Relationships between demographic data and key variables 
There were no significant correlations between the demo-
graphic data and any of the key variables. The exception was
the years of education after the age of 16 which was sig-
nificantly related to functional impairment (r. .56,
P<.001).
The relationships between illness and key variables 
The analysis of the symptom scores showed that fatigue,
cognitive difficulty and somatic symptoms were all
significantly related to anxiety and depression (see Table
6). Furthermore, fatigue and cognitive difficulty both
correlated with functional impairment.
Table 6. Relationships between illness and key variables
at Time 1
Anxiety Depression Depression
corrected
Functional
impairment
Fatigue .50** .58** •53** .42*
Cognitive
difficulty .43* •47* .46* .51**
Somatic
symptoms •59** .39* .42* .22
Functional
Impairment .32 .53** .53** 1.00**
* p  .01	 * p <.001
The relationship between uncertainty. self-efficacy. coping
strategies and key variables 
It should be noted that many of the patients had not been
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formally diagnosed at Time 1, and some therefore found it
difficult to complete the uncertainty questionnaire, with
its questions about diagnosis, advice and treatment. This
reduced the sample size to 29.
The results indicated modest correlations between uncer-
tainty and the key variables. However, as shown in Table 7,
the relationships with depression and with the corrected
depression score reached significance. Furthermore, the
correlation between uncertainty and anxiety showed a trend
towards significance (r..36, p..05).
Self-efficacy was negatively related with fatigue (r -.46,
p<.01) and with both measures of depression (see Table 7).
In contrast, there was only one significant correlation
Table 7. Relationships between uncertainty, self-efficacy,
coping and key variables at Time 1
Anxiety Depression Depression
corrected
Functional
impairment
Uncertainty .36 •57* •59** .26
Self-efficacy -.36 -.46* -.45* -.06
Coping:
Maintaining
activity .31 .21 .18 -.17
Accommodating
to illness -.13 -.05 -.12 .28
Focusing on
symptoms .18 .22 .23 •39*
Seeking
information -.07 -.21 -.18 .12
* p 5_.01
	 * p
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between coping and the key variables. This was the rela-
tionship between focusing on symptoms and functional
impairment (see below).
Membership of a patient group and support from doctors 
Patients who were members of the local or the national self-
help group did not report more fatigue or higher levels of
emotional distress compared to people who had not joined
such a group. Nor was membership related to amount of
activity, frequency of symptoms or whether patients had
taken sick leave. However, members did report greater
functional impairment than non-members (z.-2.8, p..006).
More detailed analysis revealed that this relationship was
limited to activities connected with work (z.-2.7, p..007)
and that there were no group differences for household
duties and leisure pursuits.
There was also a link between membership of a patient
association and two coping strategies. More specifically,
people who had joined a self-help group were more likely to
focus on symptoms than the others, and less likely to
maintain activities. However, the differences between the
two groups just failed to reach significance (z.-2.27 and
z.-2.36, p..02 respectively).
The patient's opinion of the support given by their doctors
was not associated with any key variable.
5.5 Discussion
5.5.1 The effects of the treatment 
The main aim of this study was to evaluate the effectiveness
of a broad-based treatment programme for CFS. After six
months, the results revealed significant differences between
the treated patients and the waiting list controls on a
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number of variables, including fatigue, somatic symptoms,
self-efficacy and anxiety. There were also significant
differences in the number of patients who scored above the
cut-off point for probable clinical depression. However, no
group differences were found for the number of cases of
clinical anxiety, the severity of cognitive symptoms, the
degree of uncertainty and the level of functional impair-
ment. Moreover, although patients changed their coping
strategies in the expected direction, the differences
between the groups failed to reach significance.
The programme provides an alternative approach to most of
the other treatments currently available for CFS. For
instance, in contrast to CET, it does not attempt to treat
the causes of the illness, nor does it assume that external
attributions will adversely affect coping and outcome (cf.
Ray et al 1995). Indeed, Dr Ho-Yen's own views regarding
the aetiology of CFS generally match those held by patients
(cf. Sharpe 1994). This may have prevented the type of con-
flicts which have been documented in relation to CBT (cf.
Hickie et al 1995) and limited the attrition rate.
However, the main difference between this management pro-
gramme and CET is the former's emphasis on rest. Thus
patients are given advice about ways to conserve energy, for
instance by giving up sport, getting sufficient sleep, and
by increasing relaxation (Ho-Yen 1993). In contrast to CBT,
they do not have to engage in certain activities when they
were tired, nor do they have to meet targets set by the
therapist. Indeed, this may have been one reason why there
was only a limited reduction in functional impairment
scores.
A more detailed comparison with other controlled trials is
difficult given the differences in samples, design and
assessment of outcome. However, it is noteworthy that the
patients on Dr. Ho-Yen's programme were seen less often and
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for a shorter period of time than the participants in the
other trials. Consequently, some may not have received the
additional counselling and emotional support which they
required to deal with their individual problems and this may
be why their anxiety and depression scores remained compa-
ratively high.
Despite the variable results, 82% of the treated patients
rated themselves as better or much better at Time 2.
Moreover, five (23%) recovered to such an extent that
further treatment was deemed unnecessary. However, the
reasons for the improvement noted here, and in relation to
the key measures, are unclear. For example, the significant
differences, between the groups at Time 2 were all mediated
by increases in perceived self-efficacy. Thus the programme
boosted the patients' confidence about being able to cope,
and this in turn, influenced outcome (Holman and Long
1992).
At the same time, there was only a limited shift in the
actual strategies used. For example, given the programme's
emphasis on the need to balance rest and energy, one might
have predicted a significant increase in the strategy of
accommodating to the illness. Yet, while there was a change
in the expected direction, the results suggest that patients
may have found it difficult to pace their activities and
avoid overexertion. Indeed, some patients admitted not
being able to follow the advice to rest. Moreover, one or
two reported that if they spent more time resting, they felt
isolated and became depressed. Others mentioned difficul-
ties with finances as a result of which they could not take
further time off work. Unfortunately, since none of the
questionnaires included an item focusing specifically on
rest, it was not possible assess how many patients had actu-
ally reduced their activities and whether this particular
strategy was related to outcome or not.
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It is also possible that the remaining symptoms undermined
the modification of the patient's behaviour. According to
the self-help model proposed by Braden (1990), severe
illness is positively associated with disruptive factors,
and these can interfere with the patients' ability to engage
in self-help. One of the problems in this respect may have
been the continuing difficulties with concentration and
memory. These may have undermined both the appraisal of
stressors and the selection of appropriate responses (Earll
1989, Nerenz and Leventhal 1983).
Adherence to the programme did result in lower scores for
maintaining activity. However, a similar, albeit smaller
change was , also found among the controls. The latter is
consistent with anecdotal evidence that most patients cut
down on activity through trial and error, or as a result of
experience (English 1991, Fleming 1991 and see Study 1).
Another variable which was expected to show marked changes
was the degree of uncertainty. The results at Time 1 had
revealed very high scores in both groups. Indeed, the mean
for the controls exceeded that for most other patient groups
tested to date (Mishel and Epstein 1990). However, while the
scores of the treated patients fell during the trial, the
change was not significantly different from that recorded by
the controls.
To obtain a more complete picture of the variables associ-
ated with successful outcome, patients were asked to what
they personally attributed the improvements in their health.
Most of those who answered this question valued the advice
to increase rest. However, a few also listed other treat-
ments such as vitamin injections, acupuncture and supple-
ments. Only one person attributed the improvement in symp-
toms to antidepressants.
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The value of the programme for specific subgroups
One of the additional aims of the study was to ascertain
whether the more severely affected patients had a different
outcome from those who were less severely ill. The results
showed, however, that treated patients who were initially
more anxious or depressed could not be distinguished from
those with lower scores. This contrasts with the findings of
Friedberg and Krupp (1994) who reported that patients with
high scores for depression benefited more from their treat-
ment than those who were less depressed.
The data were also analysed to determine the value of the
programme for the more chronically-ill. This followed a
suggestion by Ray et al (1995) that the advice to rest and
pace activities might be helpful only for those who have
been unwell for a relatively short period of time. The
treated patients were therefore subdivided into two groups
according to the duration of their symptoms, but no dif-
ferences were found in relation to outcome. Coversely,
there was a link between fatigue and self-efficacy. Thus
patients with more severe fatigue at Time 1 showed signi-
ficantly greater changes in self-efficacy than people with
less severe fatigue. This finding may indicate the former's
motivation to follow Dr. Ho-Yen's advice.
In summary, the results suggest that a broad-based programme
providing information, support and specific advice on coping
may help to alleviate some of the symptoms and the distress
associated with CFS. However, there was only a limited im-
provement in terms of cognitive difficulties and functional
impairment, and the levels of anxiety and depression re-
mained comparatively high. Thus it is possible that some
individuals might have benefited from more extensive
counselling and advice.
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Improvements in the controls 
It is noteworthy that 5CA of the controls felt better when
reassessed after six months. Indeed, only 18 96 felt worse
than before. Part of the improvements may have been due to
a change in therapy prescribed by their doctor or alter-
native practitioner. However, only 7 of the 12 patients who
began new treatments found them helpful. When patients were
asked to what they attributed their improvement during the
previous 6 months, some mentioned rest and relaxation,
others referred to changes in diet or taking supplements.
Interestingly, no-one listed the use of drugs.
5.5.2 The possible variables underlying emotional distress 
and functional impairment 
To assess which factors were associated with emotional
distress and functional impairment, the relationships
between the key variables were analysed using pooled scores
from Time 1. This part of the study also allowed a com-
parison to be made between the patients with CFS(PIFS) and
the people with CFS(ME) investigated previously (see Chapter
4) .
The findings from this study revealed that there was a sig-
nificant relationship between the severity of symptoms and
emotional distress. For instance, as in the case of patients
with CFS(ME), somatic symptoms correlated with anxiety and
cognitive difficulty correlated with depression. However, in
contrast to the previous study, there was a much stronger
and significant correlation between fatigue and depression.
The apparent link between symptoms and emotional distress
found above is consistent with research on other patient
groups (e.g. Friedman and Friedman 1993, Krupp et al 1990,
see also Chapter 3).
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Another finding which was replicated was the association
between cognitive difficulty and functional impairment. As
was argued in relation to CFS(ME), this variable has often
been overlooked as a potential source of disability and
distress.
A further relationship which could be compared was that
between uncertainty and emotional distress. It was found
that uncertainty significantly correlated with depression,
replicating the finding documented in patients with CFS(ME).
However, in contrast to the earlier study, the correlation
between uncertainty and anxiety was more modest and just
failed to reach significance.
The link between uncertainty and depression, which has also
been reported in other patient groups (Christman et al 1988,
Mishel and Braden 1987, Wineman 1990), supports the view
that the former may undermine the psychological well-being
of patients with chronic fatigue, and that it should be
taken into account when considering the origins and tteat-
ment of co-existing psychiatric morbidity. However, further
studies using larger samples are required to clarify the
relationship between uncertainty and the severity of symp-
toms and to ascertain its specific role in the aetiology of
clinical depression and anxiety.
A variable which had not been assessed before was self-
efficacy. The results of the scores obtained prior to the
programme revealed a significant correlation between self-
efficacy and depression. This is consistent with other
research (e.g. Long et al 1989, Terry 1992) and indicates
that lack of self-efficacy is an additional variable which
should be taken into account when considering the psycholo-
gical status of the chronically-ill.
In terms of the relationship between coping and adjustment,
the only strategy which was significantly associated with a
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key variable was focusing on symptoms. The correlation
between this strategy and functional impairment has also
been documented by Ray et al (1993).
It is possible that focusing on symptoms may have encouraged
patients to become more vigilant and introspective, thus
increasing their awareness of the illness's impact on their
lives (Mechanic 1993, Pavlou and Stefoski 1983). Indeed,
this could have exacerbated perceived disability and it may
have led to greater emotional distress (Hansell and Mechanic
1986, Ray et al 1993).
The lack of a relationship between either maintaining acti-
vity or accommodating to the illness and the HAD scores was
also reported by Ray et al (1995). Thus whether patients
ignore symptoms and keep going or plan their activities and
pace themselves does not appear to have major consequences
as far as anxiety or depression are concerned. On the other
hand, Ray et al (1993) found a significant correlation be-
tween accommodating to the illness and functional impair-
ment, suggesting that for some patients at least, pacing may
reduce what patients are able, or feel able to do.
In general, however, it is not possible to draw firm
conclusions about the role of specific strategies in the
adjustment to CFS. More research is required to examine the
relationship between coping and outcome in larger samples,
and to determine the influence of rest and emotion-focused
strategies which were not assessed here.
Two other issues which were addressed in this study related
to the influence from doctors and self-help groups. Using
scores from Time 1, it was found that support from doctors
did not play a significant role in terms of adjustment.
Neither did membership of a patient support group, except
for the relationship with impairment at work. However, there
was no evidence that members of a patient group were more
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likely to give up work and take sick leave. Indeed, the
converse may be true, i.e. that problems relating to
employment may have led the patients to join a support
group.
5.5.3 Methodological issues 
At the time of testing, the length of the waiting list was
approximately seven months. Given the severity of the ill-
ness and the fact that randomization would have increased
the waiting time for many of the patients, it was decided to
opt for the quasi-experimental design described above. This
avoided additional delays, but may have created artifactual
differences between the groups.
In order to reduce the influence of selection bias and non-
random errors, the response to treatment was assessed after
adjusting for baseline rates. Nevertheless, there were a
number of differences between the groups which may have
affected the results. For example, in the months prior to
the study, 41% of the treatment group had already begun to
improve, compared with 32% of the controls. While the
greater tendency towards improvement among the treated
patients may have had a positive effect on outcome, it
should be noted that at Time 1, there were no significant
differences between the groups on any of the key variables.
The groups also differed in terms of the length of illness;
the treated patients having been ill longer than the con-
trols. However, analysis at Time 1 and Time 2 revealed that
there was no relationship between duration and outcome.
Another difference between the groups concerned the propor-
tion of patients taking antidepressants. Indeed, 7 of the
patients in the treatment group were taking such drugs at
the start of the trial, compared to 4 of the controls. If
their use had a positive influence on the course of the
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illness, it would have affected the treatment group more
than the controls. Indeed, it could be one reason why the
treatment group had slightly lower baseline scores for
fatigue, cognitive difficulty, and depression than the
patients on the waiting list. However, only one or two
people attributed their improvement during the programme to
the drugs.
An additional factor which should be considered when
interpreting the data is the small sample size. This
precluded a more comprehensive analysis of the results, for
instance, the use of multiple regression to identify
predictors of outcome.
It should also be noted that the management programme was
conducted by a single consultant with limited resources. In
his view, short, bimonthly appointments seemed to be satis-
factory for most of the patients. However, the limited time
available was probably not sufficient to deal with all the
problems experienced and this may be one reason for the
continuing anxiety and cognitive difficulties reported by
some of the patients in the trial.
Caution is also required in the interpretation of the fin-
dings relating to fatigue, anxiety and depression. With
regard to the fatigue, transformation of the scores had only
a limited effect. Other procedures were also attempted but
these were considered unsatisfactory as they may have in-
creased the risk of a Type II error. Since the lack of
linearity for fatigue affected only one group and following
expert advice, the data was assessed using analysis of co-
variance. Nevertheless, given the difficulties relating to
the data, it is possible that the group differences for this
variable may be more modest than the results suggest.
This is also the case for the data relating to anxiety and
depression. The problem here was an outlier which had a
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marked effect on the results. Since the values concerned
came from the same source and conflicted with the indi-
vidual's reports of improvement, and because inclusion may
have increased the risk of a Type 1 error, it was decided to
transform that person's scores. The analysis was also
repeated without the outlier, but as the results were
similar to those using the transformed score, the latter
were retained.
Finally, there were specific problems associated with two of
the measures. Firstly, the IMQ did not include specific
questions addressing the amount of rest. Since anecdotal
reports identified increased rest as the most important
reason for , improvement, further research to assess this
strategy in a more formal way may be useful.
Secondly, the MUIS Community Form which was used to assess
uncertainty assumes that patients have been diagnosed and
are being treated. This means that patients who were still
waiting for a diagnosis found it difficult to complete the
whole questionnaire. Because low scores might have been
wrongly interpreted as reflecting lack of uncertainty rather
than lack of diagnosis, all questionnaires with more than 4
missing items were discarded. This not only led to a
significant loss of information, particularly among the
controls, but also made it difficult to interpret the data
on uncertainty at Time 1.
While the results suggest that uncertainty should be inclu-
ded in future studies into the psychological well-being of
patients with CFS, amendments to the MUIS are required to
increase its reliability and accuracy.
5.6 Summary
The results of this study showed that a programme focusing
on increased rest and relaxation led to marked improvements
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in fatigue, somatic symptoms and perceived self-efficacy.
Indeed, at six months, the differences between the treated
patients and waiting list control on these measures reached
significance. There were also differences between the groups
for anxiety and depression, although the scores for some of
the patients remained high. Moreover, there were limited
changes in the severity of cognitive difficulties and the
degree of functional impairment. Thus while the treatment
programme helped many people, a significant number might
have benefited from more extensive counselling, advice and
support.
When asked for the reasons for improvement, most patients
mentioned increased rest. This, however, was not directly
reflected in the measures used to assess coping.
Finally, the analysis of the relationships between variables
at Time 1 suggested that the severity of the illness played
an important role both in terms of emotional distress and
functional impairment. Moreover, uncertainty was signifi-
cantly related to depression as was a lack of self-efficacy.
Some of these findings replicated the results documented in
Study 2.
Overall, the results suggest that this type of programme may
provide a useful basis for the clinical management of
patients with post infectious chronic fatigue syndrome.
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CHAPTER 6 
Summary. conclusions and recommendations for future
research 
The studies described in this thesis examined the psycho-
logical effects of CFS and the patients' response to their
illness. Information was also obtained about the nature,
extent and possible origins of the psychological problems
experienced by people with CFS. Finally, a 5-step treatment
programme was evaluated to ascertain if information, support
and practical advice could improve symptoms and alleviate
distress.
Previous studies on CFS had tended to focus on the preva-
lence of psychiatric morbidity and the association between
certain beliefs and ongoing fatigue (David 1991, Sharpe
1994). Their findings formed the basis both of the
cognitive-behavioural model and the cognitive-behavioural
rehabilitation programmes (Butler et al 1991, Sharpe et al
1996). However, given the relative paucity of information
about the illness and its impact on the patients' lives, the
thesis here is that some sources of emotional distress may
not have been recognised.
The results of the first two studies showed that CFS is far
more complex, both in terms of the type of symptoms and its
effects than the cognitive-behavioural model suggests. The
third study supported some of these findings and also re-
vealed that patients on a broad-based programme had less
fatigue, fewer somatic symptoms and less emotional distress
than the waiting list controls. The following sections will
review the main results in more detail.
6.1 CFS and its effects: the patients' perspective 
The first study assessed a number of different aspects of
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the illness. Information was collected from 53 members of
the ME Association and 17 patients who were recruited from
local general practices. However, since this part of the
research was conducted before the introduction of the UK
criteria for CFS (Sharpe et al 1992), all the patients had
been diagnosed as having either ME or PVFS.
Fatigue was the most frequently reported symptom but many
patients also described symptoms such as muscle pain,
difficulties with memory and concentration, weakness and
malaise. Other prominent complaints included visual dis-
turbances, nausea and sensitivity to temperature changes,
all of which are often overlooked (e.g. Lapp and Cheney
1995, Thomas 1993, Sharpe 1993).
A question which asked the patients' views on the aetiology
of CFS revealed that many attributed their illness to
infection. However, this was rarely regarded as the sole
cause, and many implicated a busy and stressful life as a
contributory factor. The latter conflicts with suggestions
that most patients adhere exclusively to external attribu-
tions and that they refuse to consider psychological ones
(Lawrie and Pelosi 1994, Surawy et al 1995, Woods and
Goldberg 1991). Nevertheless, when asked about unlikely
causes, a number mentioned factors such as lack of activity
and clinical depression. This indicates that many patients
rejected the main psychiatric explanations for CFS.
A question about their perception of the future revealed
that the majority of the patients were generally optimistic,
predicting a slow recovery and gaining more control. This is
inconsistent with the suggestions in the literature that CFS
is frequently associated with helplessness, hopelessness and
demoralization (Butler et al 1991, Sharpe 1994).
Another finding was that the illness had a profound effect
on almost every aspect of the sufferers' lives. Aside from
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the practical problems related to the symptoms e.g. mobili-
ty, self-care and household management, many patients faced
occupational difficulties and a loss of income (cf Locker
1983).
The illness also led to a perceived loss of control and a
restricted life. For instance, limited energy levels meant
that patients often had to reorganise their priorities, and
drop or reduce the time spent on previously valued leisure
pursuits. Others were so disabled that they described their
lives as an "existence". On a personal level, it often
changed many people's personalities, reducing their self-
confidence, and in some cases, their self-esteem. The con-
dition also led to strained relationships with family and
friends, to a loss of contact with significant others and
hence to social isolation and loneliness.
Further indications of the disabling nature of the illness
were obtained from comments on the meaning of CFS. Some
people listed emotions such as anger, frustration, sadness
and despair. Others noted that the condition had led to a
complete change in their lives, to "devastation", "trauma"
and a "hell on earth". Likewise, a number described their
illness in terms of a constant "fight", "battle" and
"struggle".
These answers underline the severity of the illness as well
as the many challenges which patients faced. However, it may
be argued that neither have been fully recognised in the
cognitive-behavioural model, with its emphasis on physical
and mental fatigue. The results also suggest that the
nature of the symptoms and the effects of the disability may
have contributed, at least in part, to the emotional dis-
tress which many experienced.
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6.2 The emotional distress associated with CFS 
Study 2 assessed the levels of emotional distress in a more
structured way and tried to clarify the influence of speci-
fic variables such as the severity of symptoms and the qua-
lity and quantity of social support. The sample comprised 58
patients with CFS(ME) recruited from a hospital clinic in
Essex and the results were compared with those 25 people
with spinal injuries (SCI).
The findings showed that the level of anxiety among patients
with CFS(ME) was not significantly different from that re-
corded by the comparison group. However, there were many
CFS(ME) patients whose scores suggested the presence of a
clinical disorder. In fact, the percentage of patients with
severe anxiety was higher than expected and contrasted with
estimates reported in the literature (Buchwald et al 1994,
Hickie et al 1990, Katon et al 1991, Pepper et al 1993).
This indicates that the presence of anxiety may be an ad-
ditional source of suffering in many patients with CFS and
that it deserves more attention, both in the research on
psychopathology and in clinical practice (Butler et al 1991,
Lynch et al 1992, Sharpe 1994, Wessely and Powell 1989).
The other measure of emotional distress assessed depression.
It was found that the level of depressive symptoms was mar-
kedly higher than that of the comparison group. However,
when one fatigue-related item was omitted, the difference
between the groups was no longer significant. This is im-
portant because the inclusion of that item could have given
a misleading view of the prevalence of depressive mood in
CFS. For example, the number of cases of possible clinical
depression among people with CFS(ME) was estimated to be
55%, but removing this item reduced this figure to just 28%.
As far as the estimate of probable clinical depression is
concerned, the rate of 22$ is lower than most of the figures
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reported to date (e.g. Lane et al 1991, Wessely and Powell
1989, Yeomans and Conway 1991). The discrepancy between the
various estimates could be interpreted in a number of ways.
First and foremost, it may be the result of the type of
measure used. The HAD, used in studies 2 and 3, is a
screening tool rather than a means of making accurate diag-
noses (Rodin et al 1991). Even so, the estimate above was
also lower than that found in another study which used the
HAD (Yeomans and Conway 1991).
Secondly, the higher rates of psychiatric illnesses reported
by other researchers could reflect sample differences (David
1991, Katon et al 1991, Wessely and Powell 1989, Lane et al
1991). For instance, the use of different diagnostic cri-
teria may have led some to include patients with other fa-
tigue syndromes such as fibromyalgia. There may also have
been inter-group variations in the severity of illness and
level of physical and functional impairment.
Study 3, which assessed 44 patients with CFS(PIFS) on two
occasions, provided further evidence that the condition is
associated with significant emotional distress. Indeed, more
than a half of those tested at Time 1 had scores suggesting
the possible presence of clinical disorders.
6.3 The relationship between illness and adjustment 
The results of Study 2 revealed that emotional distress was
not correlated with physical functioning as measured by MOS
Short Form. This was true for both the CFS(ME) group and the
people with SCI, indicating that the difficulties with wal-
king and other physical functions did not contribute sig-
nificantly to depressed mood. Conversely, there was a sig-
nificant relationship between the severity of symptoms and
psychological distress, and many of the findings reported
below were replicated in Study 3.
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For instance, fatigue correlated with anxiety in both
studies, which supports the suggestion by Lazarus (1991)
that "when we are fatigued, demands that might have been
challenging and exhilarating are now too much to handle,
leading to a sense of threat and anxiety feelings". On the
other hand, the possibility that anxiety may have perpetu-
ated ongoing fatigue can not be ruled out and this should be
taken into account, not only when interpreting the research
but also when determining appropriate treatments.
Study 2 also examined the relationship between cognitive
difficulty and emotional distress. It was found that the
former correlated with depression and this was again rep-
licated in Study 3. Cognitive difficulty also correlated
with anxiety, but only in Study 3.
While it is possible that the documented problems with
memory and concentration were the result of concomitant
affective disorders, research reported elsewhere suggests
that the performance on certain psychoneurological tests is
not affected by mood (DeLuca et al 1995, DeLuca et al 1993,
Smith et al 1993). Moreover, studies have found significant
differences in terms of the degree of cognitive impairment
recorded by patients with CFS and depression (e.g. Sandman
et al 1993). Thus mood disorders probably do not account for
all the cognitive deficits associated with CFS.
Further studies are needed not only to investigate the
relationship between cognitive functioning and emotional
distress in more detail, but also to consider its role in
adjustment to CFS. For instance, cognitive difficulties
could interfere with the appraisal of stressors and the
selection and evaluation of appropriate coping strategies
(Earll 1989). In the case of patients with CFS, problems in
information processing may be especially maladaptive because
of the uncertainty which surrounds this disorder. Indeed,
failure to comprehend information about the illness may
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increase anxiety and fear and reduce the perception of
control (Dimond 1983). Lastly, problems with memory and
concentration should be recognised and treated because they
may lead patients to misinterpret medical advice and mis-
understand the views of significant others.
The findings relating to the number and severity of somatic
symptoms are less easy to interpret. The symptom scores were
significantly related to anxiety in both studies 2 and 3,
and with depression in Study 3. Again, it is difficult to
establish whether the symptoms contributed to the patient's
distress or whether the reverse is true.
Aside from.their links with emotional distress, the symptoms
of CFS were also associated with functional impairment.
Although the strongest predictor of this adjustment measure
was found to be physical functioning, cognitive difficulty
made a significant contribution to the variance in func-
tional impairment scores in Study 2 and correlated sig-
nificantly with the latter in Study 3. Fatigue was also
associated with functional impairment, but only in Study 3.
Thus while fatigue may have had a disruptive effect in the
lives of some patients with CFS (Fisk et al 1994, Monks
1989), problems with concentration and memory appeared to
have a greater influence with regard to their ability to
work and pursue leisure activities.
Interestingly, there was no association between somatic
symptoms and functional impairment. Thus complaints such as
dizziness, sore throats, pain or digestive disorders did not
influence the patients' ability to work or vice versa. How-
ever, one potentially important symptom, nausea, was not
assessed and therefore the findings relating to somatic
symptoms and impairment may not be reliable.
The lack of information in the medical press concerning the
severity and possible influence of symptoms other than
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fatigue might help to explain the apparent discrepancy
between the patients and doctors' conceptualization of CFS
(eg Toombs 1992). It may also have added to the latter's
'abnormal illness perception' as described by Denz-Penhey
and Murdoch (1993). There is therefore a need to increase
awareness of these symptoms, not only to further the clini-
cians' understanding of the illness-experience but also help
them assess the requirements for vocational rehabilitation,
and to develop more effective treatments.
6.4. The role of uncertainty
The findings from both studies 2 and 3 suggest that emo-
tional distress was related, at least in part, to the
uncertainty of the illness. However, the association with
anxiety was stronger in Study 2 than amongst the patients
from Study 3. The inconsistencies between samples may re-
flect differences in the way in which patients appraise
their illness (Mishel et al 1991). For instance, many of the
patients in Study 3 were tested before they had received a
diagnosis. However, because they knew this problem would
soon be resolved, they might have been less anxious than the
CFS(ME) group who had already been diagnosed and who may
have been troubled by more challenging questions, e.g. the
reasons for the fluctuations or their failure to improve.
It is also possible that the weaker links between uncer-
tainty and anxiety in Study 3 may have been influenced by
the slightly lower symptom scores. In fact, the findings
support the view that variables such as uncertainty might
have a greater effect on emotional well-being in those who
are more severely ill. This could also explain why uncer-
tainty was more closely linked to psychological distress in
the patients with CFS(ME) than in the people with spinal
injuries.
Although the results are consistent with Mishel's uncer-
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tainty in illness theory (Mishel 1988, 1990) and the re-
search on other patient groups (Mishel et al 1991, Wineman
1990), it is possible that the high uncertainty scores among
the CFS patients were the result of emotional disturbances,
rather than a cause. Indeed, there may be a vicious circle,
whereby uncertainties about the illness exacerbate the
patients' fears and anxieties, which in turn increase
perceived uncertainty and so on.
Further longitudinal research is required to clarify the
influence of perceived uncertainty on the psychological
well-being of people with CFS. In the meantime, this
variable should not be overlooked when considering the
possible determinants of emotional distress and the more
severe clinical disorders in this patient group.
6.5 The role of social support 
Following the reports of patients in Study 1, the role of
social support was examined in more detail in Study 2. It
was found that stressful relationships with partners were
significantly related to increased depression while re-
sources from friends were associated with lower depression
(corrected score). The findings also showed that the
relationship between social support and emotional distress
varied according to the source of the former. For instance,
although contact with friends was significantly related to
lower depression scores, this was not the case for contact
with relatives.
It is of course possible that the presence of depression led
to a reduction in contact with friends and an increase in
stressful relationship with partners (Billings et al 1983,
Fitzpatrick et al 1991). However, if mood disorder was the
primary reason for the reduced social support, one might
have expected similar correlations for contact with re-
latives. Moreover, information obtained from the inter-
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views in Study 1 suggests that the uncertainty about the
aetiology of the illness was a major source of conflict and
distress.
As Donoghue and Siegel (1992, p42) noted "fatigue without an
evident cause makes us suspicious; we treat the person with
'unsubstantiated fatigue' with distrust". In their view,
illnesses with a degree of social unacceptability, including
CFS, can have "an extraordinary impact on the psychological
well-being of a person... If a disease is deemed unaccep-
table, overtly or covertly, by society, its victims suffer
the added burden of isolation and shame".
Similar experiences have also been reported in relation to
other conditions which have no clearly identifiable organic
cause (Faucett and Levine 1990). In contrast, the uncontro-
versial diagnosis and social acceptability of spinal inju-
ries may have prevented the type of disputes reported by
patients with CFS, as a result of which there was no clear
association between lack of social support and emotional
distress among the people with SCI.
Unfortunately, the importance of social support for people
with CFS has received comparatively little attention so far.
Yet, as research on other chronic conditions has shown, it
may help patients and care-givers to understand the problems
they face, it may reduce uncertainty and ambiguity and also
enable them to find and use effective coping strategies
(Mishel and Braden 1987). It may also increase their moti-
vation to take certain actions and accordingly reduce
emotional distress (Revenson 1993). Aside from its links
with adjustment (Brown 1988, Radley 1988), lack of support
might also have a direct effect on the disease process. For
instance, research has found that loneliness and isolation
can undermine immune function, thus increasing the risk of
further ill-health (Laudenslager 1987, Levy 1990).
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Since problematic relationships can cause considerable suf-
fering, they need to be taken into account both when con-
sidering the origins of psychological distress and in terms
of patient care. The partners may also benefit from sup-
port, particularly in the early stages when they may not yet
have learnt how to deal with the sudden relapses and the
limited availability of medical advice. Later on as the
patient's needs change, care-givers may value additional
information and in some cases, more tangible forms of
assistance at home.
6.6 Coping with CFS 
The types of strategies used to cope with CFS were investi-
gated in studies 1 and 3. The results from Study 1 showed
that patients did not respond to their illness primarily by
resting and 'waiting for a cure' (cf. Wessely et al 1991).
Indeed, a variety of strategies were reported, including
emotion-focused ones like positive thinking and diversion,
as well as problem-focused strategies such as pacing of
activities, seeking information and support, a change in
diet, and the use of complementary therapies. Some patients
also mentioned relaxation and counselling and a significant
number took or had taken psychotropic drugs. These findings
conflict with suggestions that patients with CFS adopt a
relatively passive approach to their condition, and they
indicate that the descriptions of CFS which focus primarily
on avoidance behaviours may be incomplete (cf. Surawy et al
1995, Wessely et al 1991).
Study 3 investigated coping further by assessing four dif-
ferent type of strategies. The results showed that neither
accommodating to the illness nor maintaining activity was
significantly related to emotional adjustment. Indeed, the
only strategy to be linked with outcome was focusing on
symptoms. This suggests that any treatment requiring pa-
tients to pay close attention to how they are feeling may
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encourage introspectiveness and lead to greater perceived
disability (Mechanic 1993). Alternatively, the relationship
between functional impairment and focusing on symptoms might
be mediated by fatigue (cf. Ray et al 1995).
The value of pacing as a specific strategy remains unclear.
It was used by some patients assessed in Study 1 and it has
been reported as helpful by other patient groups (e.g.
Wiener 1984, Monks 1983). However, the lack of an asso-
ciation between accommodating to the illness, which covers
this strategy, and the various outcome measures suggests
that any benefits are probably limited. It is also possible
that this strategy may only be of value in specific sub-
groups (Ray et al 1995, see also section 6.7).
When asked for their personal opinion, patients in Study 3
considered that resting was the most helpful of all strate-
gies. This finding is consistent with the experience of CFS
specialists (e.g. Macintyre 1992, Shepherd 1992), with the
literature (e.g. Dawes 1991, Denz-Penhey and Murdoch 1993,
Fleming 1994) and with the views of patients from Study 1.
Unfortunately, the measures used in Study 3 did not assess
rest on its own and it was therefore not possible to clarify
the relationship between rest and outcome in a more formal
way.
Further studies using larger samples are required to eva-
luate the effectiveness not only of rest but also of stra-
tegies such as pacing and relaxation. These should be as-
sessed at different stages of the illness, to ascertain if
they are helpful (or unhelpful) throughout or only during a
certain phase (Ray et al 1995). Moreover, it may be useful
to study different degrees of rest to determine if there is
an optimum level which promotes recovery.
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6.7 The effects of treatment 
The management programme which was examined in Study 3 fo-
cused on the importance of rest and relaxation and thus
constitutes an alternative to CBT, with its emphasis on
increasing activity (Butler et al 1991). The results showed
that after adjusting for the baseline scores, there were
significant differences between the treated group and
controls for fatigue, somatic symptoms, anxiety, depression
and self-efficacy. Further analysis revealed that the
benefits were not restricted to a particular subset of
patients, e.g. those with high levels of depression (cf.
Friedberg and Krupp 1994). Although the sample was small and
the results for fatigue and depression should be interpreted
with caution, the findings above suggest that the programme
may be a useful, basic approach towards the management of
CFS (cf. Friedberg and Krupp 1994, Lloyd et al 1993).
It should be noted, however, that the rates of emotional
distress after 6 months of treatment remained comparatively
high. This indicates that for some patients, the programme
did not meet all their needs. The results also underline
the importance of further research into the determinants of
anxiety and depression, and the value of fostering skills
which will enable patients to cope with their emotions more
effectively. The latter could involve giving additional in-
formation about the illness, increasing the time spent on
identifying triggers of relapses and teaching patients spe-
cific relaxation techniques.
Further consideration should also be given to the treatment
of cognitive difficulties, the scores for which showed
little change at Time 2. In contrast, there was a marked
increase in the patients' self-confidence about being able
to control the illness. This proved to be an important
variable since self-efficacy mediated the outcomes described
above. The results also revealed an inverse relationship
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between self-efficacy and depression at Time 1, showing that
confidence about controlling the illness may help to reduce
emotional distress. It is also consistent with research on
other disorders (e.g. Holman and Long 1992, Terry 1992) and
suggests that self-efficacy should be included not only in
assessment of psychological morbidity but also in the
evaluation of all psychological interventions for CFS.
Lastly, although the programme did not include ongoing
counselling for carers, there is evidence from the lite-
rature on other chronic conditions that this could improve
interpersonal relationships. For example, health care
professionals could teach patients and their carers how to
develop and maintain family ties. In addition, they could
show partners how to assess the patient's support needs and
inform them how to recognize and accept help and emotional
encouragement provided by others (Revenson 1993).
To summarise, the programme appeared to be a promising form
of treatment for many patients with CFS(PIFS), although
there is evidence that some individuals might have benefited
from additional counselling and advice. Whether the pro-
gramme is as effective for other fatigue syndromes e.g.
fibromyalgia, has yet to be established.
6.8 The role of the health-care profession
Although about a half of the patients in Study 3 were happy
with the medical advice and support they had received from
doctors other than Dr. Ho-Yen, a significant number were
not. Together with the anecdotal reports from patients in
Study 1, this provides some evidence that a sizeable propor-
tion of health care professionals remain unsympathetic to-
wards people with CFS (cf. Dalrymple 1992, English 1991,
Hartnell 1987).
Although unsatisfactory medical support was not related to
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outcome in Study 3, there have been suggestions that a lack
of diagnosis and conflicts with health care professionals
may affect the course of the illness' as well as the pa-
tients' emotional state. For example, without a diagnosis
which fits their experience, patients may find it hard to
interpret their symptoms and to determine effective coping
responses (Mishel 1988, Nerenz and Leventhal 1983, Stewart
and Sullivan 1982). Furthermore, failure to legitimize the
person's ill-health could encourage the person to 'carry on'
as normal beyond the time when they are capable, thus pla-
cing unnecessary demands upon their adaptive capacities
(Rippere 1992b).
The lack of a diagnosis might also damage the patient in
other ways. For instance, a survey of 50 people with CFS
revealed that the absence of an acceptable diagnosis led to
fear, anxiety, confusion self-doubt and bitterness. Some
patients also lost their sense of identity and purpose
(Woodward et al 1995). Indeed, Woodward et al (1995) found
that receiving a diagnosis gave meaning to the patients'
suffering and allowed them to create a linguistic distinc-
tion between themselves and their illness. They could begin
to say "I am not crazy; it's this illness that is crazy". It
also eased their distress and instead of contributing to
chronicity as doctors feared, early diagnosis avoided some
of the harmful social and psychological consequences
associated with uncertainty. Thus patients tended to see
their illness as less traumatic, and they felt less despair
and helplessness.
Adverse reactions have also been noted in relation to
inaccurate diagnoses. For example, Rippere (1991, 1992b) has
described how receipt of an inappropriate psychological
diagnosis can undermine feelings of self-efficacy and self-
confidence, leading in some cases to an emotional state
resembling post-traumatic stress syndrome.
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At the same time, doubts about the origins of the illness
may initiate negative reactions from family and friends.
This is particularly likely if others adhere to the view
that psychological disorders are 'all in the mind' and that
the person could sort themselves out 'if only they wanted
to'. According to Denz-Penhey and Murdoch (1993), this can
lead to "a fault, guilt, blame, shame game" which is ex-
tremely unhelpful for those who are ill.
The support and guidance from health care professionals is
also important following diagnosis, especially for those
conditions where the treatment options are limited (Elliott
et al 1992). Aside from symptomatic treatment, they can
help patients adjust to disorders like CFS by giving them
information and teaching them skills so they can:
1. interpret and manage new or changing symptoms; minimize
physical disability (e.g. by avoiding deconditioning or
nutritional deficiencies),
2. establish realistic expectations and emotional responses
to the vicissitudes of the illness,
3. become adept at ways to solve problems as they arise and
4. use the available resources in the community to advantage
(Holman and Long 1992).
Above all, doctors should try to offer patients support,
reassurance and hope (cf. Woodward et al 1995). Moreover,
given the nature of the illness, a multi-disciplinary
approach involving physicians, counsellors and nutritionists
may be more appropriate than the traditional biomedical or
psychiatric management of patients.
6.10 Methodological issues 
There were certain limitations in methodology and design
which should be taken into account when evaluating the
results. Some of these have already been discussed in
relation to the individual studies. Others will be briefly
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described below.
For example, because there is no diagnostic test for CFS, it
is possible that some of the participants may have suffered
from another, unrecognised condition. In fact, Australian
researchers found that even the use of strict criteria did
not prevent 20t of their patients being wrongly classified
(Wilson et al 1994b). Given that the diagnosis of CFS
remains a clinical one, it was hoped that the consultants'
extensive experience would reduce the error rate in studies
2 and 3 to an absolute minimum.
There are also other reasons why the symptoms scores must be
interpreted, with care. For example, the fluctuating nature
of CFS means that the scores collected at one particular
time may not accurately reflect the severity of the illness
in general. While the reliability of the data could have
been improved by asking the patients to complete question-
naires once a week for a month or two, this would have
placed too great a burden on the participants so this was
not pursued. The results of both studies therefore repre-
sent just one estimation of the severity of the symptoms
experienced during the previous week.
A further problem which has to be considered is that the
responses regarding symptoms could have been influenced by
'disease prototypes'. According to Bishop (1991), people
have schemata of diseases and when they experience symptoms,
they try to match them with the available prototypes in
their memory. When reporting symptoms, they are more likely
to recall complaints which fit in with a certain prototype
and to ignore or downplay symptoms which don't. In other
words, the way in which information about symptoms are rep-
resented in one's memory can produce a bias when recalling,
interpreting and describing those symptoms. Since the media
has focused on the problem of fatigue, recall bias may have
influenced the patients' reports related to this symptom.
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However, most lay articles on CFS have not discussed cog-
nitive impairment in any detail, so these symptoms probably
do not figure very strongly in most patients' prototype of
CFS. Consequently, the recall bias for cognitive problems
was probably limited.
Another factor which may have influenced the symptom repor-
ting is what Watson and Pennebaker (1992) refer to as nega-
tive affectivity (NA). This is described as a pervasive
personality trait which is more or less synonymous with
several other dispositional constructs, including neuroti-
cism, trait anxiety, pessimism and general maladjustment.
Negative affectivity is therefore a dimension which reflects
negative mood and self-concept.
Watson and Pennebaker have suggested that high-NA subjects
are more likely to complain about their internal physical
sensations and to exaggerate or magnify their actual health
problems. Thus one might expect high-NA patients to over-
report the symptoms associated with CFS. As these studies
did not include any personality measures, it is not pos-
sible to evaluate the possible role that negative affec-
tivity may have played. However, it is interesting to note
that the patients did not rate all the symptoms equally
highly. Indeed, it was not uncommon to find patients with
high levels on some subscales and very low scores on others.
This is not consistent with a general tendency to over-
report all health complaints.
Finally, it should be noted that some patients may have been
influenced by the stigma associated with mental illness. As
a result, they might have suppressed feelings of sadness and
despair, either consciously or unconsciously, and focused on
physical symptoms such as headaches, myalgia and pain in-
stead. This could have affected the scores for anxiety and
depression, and might lead to the misdiagnosis of psychi-
atric disorders in clinical practice (Komaroff 1994, Lane et
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al 1991).
6.10 An alternative model of CFS 
On the basis of the research presented above, it may be ar-
gued that the cognitive-behavioural model of CFS does not
acknowledge the complexity of CFS. More specifically, the
findings suggest that it underestimates the disabling ef-
fects of symptoms other than fatigue. Moreover, its ana-
lysis of the emotional distress associated with CFS does not
appear to consider the influence of non-medical variables
such as uncertainty and social support and most of all, it
does not recognise the consequences of disbelief and
controversy.
The model may also have oversimplified the patients' res-
ponse to their illness. For example, it seems to suggest
that most patients react in a similar way, i.e. by blaming
external causes, by avoiding activity and by rejecting psy-
chological treatments which might help them to cope (Butler
et al 1991, Sharpe 1993, Surawy et al 1995, Wessely et al
1991, Wessely 1993). This conflicts with the results from
Study 1 which revealed that most patients used a variety of
strategies and that many accepted that psychological factors
may have played a contributory role in the onset of their
disease. Moreover, the fact that about a third of the
patients with CFS were taking antidepressants is incon-
sistent with the view that these individuals refuse all
psychiatric help (Wessely 1993). Likewise, the interest in
self-help and the largely optimistic views about the future
are difficult to reconcile with the model which predicts
that most patients will inevitably become helpless and
demoralized (Butler et al 1991).
The model below acknowledges that many different factors may
increase emotional distress and undermine adjustment to CFS.
They include the type, severity and impact of the symptoms;
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ONGOING ILL -HEALTH (
	
+ nature and severity of
symptoms	 ----4
+ disruption to life
+ uncertainty
+ lack of support 	 ----4
+ lack of appropriate medi-
cal intervention	 ----4
+ low self-efficacy	 ----4
+ maladaptive behaviour -----)
+ stigmatisation?	 -----)
w
EMOTIONAL DISTRESS
PREDISPOSING FACTORS
e.g.
history of chronic stress,
psychiatric disorders,
failure to get adequate
rest
INFECTION
+ stress and pressure ----4
+ failure to rest ----4
+ additional infections ----4
+ emotional distress ----4
+ other factors undermining -->
host resistance	 ----4
Figure 1. Model showing the main variables associated with
emotional distress in CFS
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the uncertainty which surrounds CFS, the unsatisfactory so-
cial support as well as the lack of medical help and advice.
It is proposed that the failure to acknowledge such vari-
ables will reduce our understanding of the 'dis-ease' and
consequently undermine both treatment and recovery.
It should be noted, however, that neither the attributions
about aetiology nor the avoidance of activity are regarded
as a major sources of ongoing disability and distress. Ad-
mittedly, these factors may be relevant in specific indi-
viduals, where certain beliefs may lead them adopt maladap-
tive behaviours, such as total bedrest, withdrawal from
significant others, continued overexertion and the refusal
of appropriate help (cf. Antoni et al 1994). In such cases,
CBT must continue to be the treatment of choice (Goldenberg
et al 1994, Larcombe and Wilson 1984).
Further research is required to assess the validity of the
model, not just for patients with CFS but also for syndromes
associated with the exposure to toxins and adverse reactions
to vaccinations. However, it is important that studies
should continue to separate the various subgroups. Without
the careful delineation of samples, it will not be possible
to identify any differences in aetiology or response to
treatment.
6.11 The stigmatisation of CFS 
One problem associated with CFS which was not formally stu-
died here but which may affect the welfare of patients and
which therefore deserves more attention is the stigmatisa-
tion of the illness.
For instance, patients have been consistently stereotyped in
a negative way, those who support and represent them have
been discredited and the illness itself has been trivialised
as comprising little more than tiredness and malaise. More
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specifically, patients have been portrayed as poor problem
solvers who refuse to consider and deal with their emotional
conflicts in order to avoid the stigma of mental illness.
For example, Cluff (1991) wrote that:
"When we say 'chronic fatigue syndrome' (CFS), we
are describing an experience of people who have
symptoms that ... all of us experience many times
during our lives - lassitude, fatiguability and
tiredness. Generally, as I have gotten older, I
do not enjoy getting up early in the morning as
much as I did when I was younger. We could assume
I am acquiring CFS as a result of advancing age".
In addition, Silver (1994) claimed that:
"The extreme reluctance of ME sufferers to admit
that their condition is of psychological origin
demonstrates that the much-vaunted acceptance by
our society of psychiatric conditions is bogus.
If the condition is viral in origin, it is "real"
and therefore beyond the individual's control; but
if on the other hand it has a psychological cause
... it is only an elaborate form of malingering,
more a character defect than a bone fide illness."
These comments are not just implying that patients are exag-
gerating their distress but also that they do not require
some of the resources available to the physically ill
(wheelchairs, home help etc). Moreover, the portraits are
composites of misguided individuals. In the first quote, the
suggestion is that patients have comparatively trivial symp-
toms which everyone else can cope with (i.e. tiredness). In
the second, the insinuation is that CFS is a psychological
disorder but that (all) patients have a prejudiced view of
psychiatry and refuse to acknowledge the real source of
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their distress.
Other commentators have gone further by claiming that
sufferers themselves are largely responsible for their
ongoing ill-health with the implication that if they would
accept the real origins of their fatigue (i.e. psychological
problems), they would get well (Lawrie and Pelosi 1994).
In line with the depictions of other stigmatized groups,
there are no positive attributes associated with either the
patients or their illness. Moreover, highly selective repor-
ting has reinforced the negative stereotype (e.g. Read
1993), supporting the inferior identity of the CFS patient
and in some cases, portraying them as a threat. For exam-
ple, Silver (1994) claimed that any doctor or researcher who
suggests that ME has a psychological component can expect
intimidation and persecution. He added:
"Medical journalists of my acquaintance will not touch
the subject because they fear the response... One
television producer was so intimidated by the response
to a programme he made about ME that he vowed never to
return to the subject. He had his family to consider
and was not prepared to risk their well-being over
something which is, after all, only of marginal
importance to most people".
In short, the current image of the ME patient is of people
who are simply tired but don't want to face up to their psy-
chiatric problems, and who don't tolerate any other opin-
ions. It is the image of an inferior, deviant person who is
a threat to others. Clearly, this portrayal makes it dif-
ficult for those affected to maintain a positive view of
themselves. The negative stereotype may also shape public
attitudes and undermine social support (Schur 1980). In-
deed, the general social disvaluation could encourage the
avoidance of social contact and lower the patient's self-
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esteem.
Some of the participants in Study 1 referred to the lack of
understanding among significant others and the problems of
not being believed. However, whether it also contributed to
their self-concept and emotional distress as has been noted
in patients with rectal cancer (Macdonald 1988), remains a
matter for debate.
The stigmatisation of CFS may certainly help to explain the
hostility shown by organisations and institutions involved
in the financial support for the chronically-ill. For in-
stance, Lloyd and Pender (1994) reported that:
"The label of CFS stimulates widely varied
responses from both public and private sector
agencies. These responses range from overt
persecution of the patient (presumably with the
aim of having a claim withdrawn) to aggressive
antagonism of the validity of the label via
medicolegal avenues. Rarely, support and
acceptance of the disorder and its associated
disability is provided".
The views cited above support the argument that the exis-
tence of stigma should be considered alongside the occu-
pational, educational, environmental, psychological and
medical constraints associated with illness and disability.
6.12 Final remarks 
The results of the studies above, plus the literature on CFS
have shown that a narrow, medicalized view of suffering is
clearly inadequate (Charmaz 1983). In order to obtain a
more complete and accurate picture of the condition, re-
searchers should take a greater account of subjective
information relating to CFS (cf. Toombs 1992). Such a shift-
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in-focus is essential, not only to obtain a fuller under-
standing of the illness-as-lived but also to improve patient
care.
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APPENDICES
APPENDIX I 
Definition of ME(CFS) and ME(PIFS)
Summary of revised CDC criteria (1994)
Letters and questionnaires for Study 1, 2 and 3
I-1
Definition of chronic
	
syndrome
encephalomyelitis) used in Study 2 
Source: Dowsett et al (1990) and Ramsay (1992).
A syndrome commonly initiated by respiratory infection
and/or gastro-intestinal infection but a gradual or more
dramatic onset following neurological, cardiac or endocrine
disability is recognized.
The cardinal features are:
a complaint of general or local muscular fatigue following
minimal exertion with prolonged recovery time; neurological
disturbance, especially of cognitive, autonomic and sensory
functions; variable involvement of cardiac and other
systems; a prolonged relapsing course. There is also a
marked variability of symptoms both within and between
episodes.
Definition of post-viral/infectious fatigue syndrome used
in Study 3 
Source: Ho-Yen (1990).
The patient with post-viral fatigue syndrome:
1. Has had generalized, relapsing fatigue exacerbated by
minor exercise causing disruption of usual daily activities
for at least three months.
2. Complaints of prominent disturbance of concentration
and/or short term memory impairment.
3. Has no other obvious, organic causes for a similar
syndrome.
Supportive evidence (at least four items from section A, B
and C)
A. History
Patient well before illness
1-2
An initiating viral* illness (clinical
description/viral serology)
Myalgia
Gastrointestinal disturbance
Headaches
Depression
Tinnitus
Paraesthesiae
Sleep disturbance
Cardiovascular complaints
Adverse effect of alcohol
Adverse effect of heat
B. Clinical
Lymphadenopathy
Localized muscle tenderness
Pharyngitis
C. Laboratory
Evidence of viral* infection
Abnormalities in immune function
* Patients with evidence of bacterial or parasitic
infections would be diagnosed as having post-infectious
fatigue syndrome.
Revised CDC Criteria
Source Fukuda et al 1994. 
The revised CDC criteria for CFS require the presence of
self-reported persistent or relapsing fatigue lasting 6 or
more consecutive months, plus 4 or more of the following
symptoms occurring at the same time and post-dating the
onset of fatigue:
1. selfreported impairment in short-term memory or
concentration severe enough to cause substantial reduction
1-3
in previous levels of occupational, educational, social or
personal activities
2. sore throat
3. tender cervical or axillary lymph nodes
4. muscle pain
4. multijoint pain without joint swelling or redness
6. headaches of a new type, pattern or severity
7. unrefreshing sleep
8. post-exertional malaise lasting more than 24 hours.
1-4
STUDY 1
Letter asking for volunteers.
Letter sent with questionnaires
Copy of questionnaire
1-5
Department of Human Sciences
Head of Department:
John T E Richardson DPhil CPsychol FBPsS
Uxbridge, Middlesex UB8 3PH
United Kingdom
Telephone Uxbridge (0895) 56461
Telex 261173 G Fag (0895) 32806
Brunel
THE UNIVERSITY OF WEST LONDON
20th November 1989
Dear Sir/Madam
I am a postgraduate student at Brunel University interested in the
different ways people with Myalgic Encephalomyelitis cope with the
effects of this illness.
To this end, I am hoping to talk to eighty sufferers about their
experience of this most debilitating condition. If you agree to
participate, I would arrange to meet you at a place and time that
suits you. The first interview will take about an hour and, to
supplement the information you give me, I may ask you to fill in a
number of short questionnaires. Then after six months or so, I
will meet you again, to see if your condition and views have changed.
If you would like to help this research, please contact me, either by
telephoning 01-977-2386 or by returning the slip attached to this letter.
The interviews will be taped so I have a detailed record of what you tell
me. However for reasons of confidentiality, I will at no time divulge
your identity to anyone else.
Thanking you in anticipation
Yours faithfully
Ellen M. Goudsmit
Chartered Psychologist
Name
Address
Tel. No
I would like to help with this research on coping with Myalgic
Encephalomyelitis.
Please return to E. Goudsmit, 23 Melbourne Rd, Teddington, Middx TW11 9QX
I - 6
Brunel
THE UNIVERSITY OF WEST LONDON
Department of Human Sciences	 Uxbridge, Middlesex UB8 3PH
Head of Department: 	 United Kingdom
John T E Richardson DPhil CPsychol FBPsS
	
Telephone Uxbridge (0895) 56461
Telex 261173 G Fax: (0895)32806
M.E. QUESTIONNAIRE
Dear
Thank you for volunteering to help me with this research. The
enclosed questionnaire may look long and complicated, but please
don't be disheartened.	 It begins by asking for background
information about you and your illness. This is followed by
some questions asking you to describe, in your own words, your
views on its causes and effects. That is what this study is
about: M.E. as seen from the sufferers' point of view.
Being a sufferer myself, I know that you may find it difficult to
concentrate for long periods of time. I therefore suggest that
you do not try to complete the questionnaire in one go but that
you complete one or two sections, read the next section, then
take a break.	 If you still have the energy, fill in another
section, otherwise leave it for a day or so. As far as the
study is concerned, the more you can tell me, the better, so take
as much time as you feel you need.
When you've gone through the whole questionnaire, you might like
to keep it for a few days before returning it to me. That will
give you the chance to reconsider some of the responses or to add
to them. As I said before, I am only interested in your views
and opinions and, as such, there are no right or wrong answers.
All your ideas are relevant. Needless to say, if I quote you in
my final report, I will not divulge your identity to anyone.
If you have any queries, please do not hesitate to contact me.
If you wish to phone, I am usually around from 2.00 to 8.00pm.
I look forward to hearing from you,
Yours sincerely
ELLEN GOUDSMIT
PLEASE RETURN THE COMPLETED QUESTIONNAIRES TO E. GOUDSMIT,
23 MELBOURNE RD., TEDDINGTON, MIDDX., TW11 9QX IN THE ENCLOSED
PREPAID ENVELOPE.
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BACKGROUND QUESTIONNAIRE
To help me with my research, I would be grateful if you could answer
the following questions.
Name 
Address 
Phone No
Age 
Sex	
K2tIS
Please tick which best describes the work that you do:
Student	 Employed part-time
Housewife	 Employed full-time
Unemployed	 Retired
If you have a job, what is it 	
If you are a woman and you are not employed, what is your husband
or partner's job 	
Have you changed your job, or given up your job, as a result of the
illness? Please describe 	
Education
Did you complete (please tick)
Secondary education?
College/university?
Other professional training?
Age when you left?
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Marital status (Please tick where appropriate)
Single
Married
Living with a partner
Separated
Divorced
Widowed
If your marital status has changed since becoming ill, please
describe 	
Children (please state number, sex and age) 
	
lousing Are you: (Please tick appropriate answer)
Owner occupier?
Private tenant?
Council tenant?
Do you live alone?
Income
What is your weekly disposable income? Please tick the appropriate
answer.
Less than £70
Between £70 and £200
More than £200
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GENERAL INFORMATION
1. How long have you had M E  7 
2. Was the onset sudden or gradual? 	
3. If acute, did it start as a specific infection such as glan-
dular fever, hepatitis, flu? 	
4. When were you diagnosed? Month 	 Year 	
5. Who diagnosed you? 	
6. Which tests were used to diagnose you? (Please tick where appro-
priate)
Elisa IgM Coxsackie
VP1 (Prof. Mowbray's test)
Other blood test (please specify)
Muscle biopsy
Brain scan (if yes, please state which scanner was used)
7. If no laboratory tests were used, how were you diagnosed? (e.g.
clinical history, VEGA test etc.)
8. Has the illness (please tick your answer)
Stayed the same since the beginning?
Fluctuated, with relapses followed by remissions?
Generally/steadily deteriorated?
Improved?
9. What are your main symptoms? 	
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M.E. OUESTIONNAIRE PART 2 
To help me with my research, I would be grateful if you could answer
the following questions as fully as you can. (If you need more
space, please use the back of the sheet).
A. CAUSES 
1. At the moment, no one knows what causes M.E. In your opinion,
which factors played a part in making you ill? Please list as
many as you can in the space below.
2. Taking everything you have read and heard about M.E. into
account, which factors do you think are likely causes?
3. Taking everything you have read and heard about M.E. into
account, which factors do you think are unlikely causes?
B THE EFFECT OF THE ILLNESS 
Illness affects people's lives in many ways. I would like to know
to what extent and in which ways M.E. has affected those who suffer
from it.
1. What can you not do now that you used to be able to do? 	 In
this section, I'm particularly interested in the ways M.E. has
affected your work and daily life, (e.g. shopping, hobbies).
1-12
2. How has the illness affected other people in your life and your
relationships with others?
3. How has it affected you as a person, your feelings and attitudes
in general; your feelings about yourself?
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C. COPING
1. What things have you done, or do you do, to get better and to
deal with day-to-day symptoms?
2. What things have helped you deal with the illness in general,
so it does not overwhelm you?
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D. Can you sum up what having M.E. has meant to you? Please write
down the first things that come to mind.
E. How do you see your future?
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F. Finally, what advice would you give to a newly diagnosed
sufferer?
Thank you very much for your time and energy.
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STUDY 2 
Letter sent with questionnaires - CFS(ME) group.
Letter asking for volunteers - SCI group.
Letter sent with questionnaires.
Part I.	 Background questionnaire - CFS(ME) group.
General questionnaire - CFS(ME) group.
Background questionnaire - SCI group.
General questionnaire - SCI group.
Profile of Fatigue-Related Symptoms (PFRS).
Part II. Functional Impairment Scale.
Physical Functioning Scale (from MOS Short-Form).
Question assessing need for help with activities.
Part III. Questionnaire assessing interpersonal resources
and stressors (from LISRES).
Part IV. Hospital Anxiety and Depression Scale (HAD).
Mishel Uncertainty in Illness Scale-Form C (MUIS-
C) plus additional items assessing unpredicta-
bility.
1-17
CFS(ME) Group	 23 Melbourne Road
TEDDINGTON
Middx.
TW11 9QX
081-977-2386
November 1992
REF: EMG/M.E.
Dear Sir/Madam,
Thank you for volunteering to help me with my research. I know
the enclosed package of questionnaires looks daunting but most
of the items are short and require little more than a tick. If
you can spare some time, I would be most grateful.
The first section begins by asking for background information
about you and your illness. This is followed by some questions
about the effects which M.E. has had on your social and personal
life.
Being a sufferer myself, I know that you may find it difficult
to concentrate for long periods of time. I therefore suggest
that you do not try and complete all the questionnaires in one
go but that you complete one or two, then take a break. If you
still have energy left, fill in another one, otherwise leave it
for a day or two. Needless to say, all your answers will be
strictly confidential.
I hope to obtain data on several illnesses and disabilities
because different problems will affect people in different ways.
If you have any queries, please do not hesitate to contact me.
If you wish to phone, I'm usually around from 2.00 to 8.00 pm.
Thank you for your time. I look forward to hearing from you,
Yours faithfully,
Ellen M. Goudsmit
Encs. Questionnaires and SAE.
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SCI Group 23 Melbourne Road
TEDDINGTON
Middx.
TW11 9QX
October 1992
Dear Sir\Madam,
I am a postgraduate student at Brunel University, researching the
effects of having a chronic illness or disability.
Having had to cope with disability myself, I would like to docu-
ment how different conditions affect people's lives in Britain
today. If you would like to help me, I will send you a set of
questionnaires which will ask about your disability, daily life,
relationships and how you feel about yourself. Most of the
questionnaires are quite short and shouldn't take too long to
fill in.
I hope to obtain data on several illnesses and disabilities, so
that I can compare and contrast the experiences of different
groups.
Needless to say, all your answers will be strictly confidential.
If you have any questions, please do not hesitate to call me.
I'm usually at home between 2 and 8 pm (081-977-2386).
Thank you for your time. I hope that you can help me and look
forward to hearing from you.
Yours faithfully,
Ellen M. Goudsmit
If you are willing to help with my research, please complete this
Slip and send it to me at the address above, or give me a call.
Name
Address
Phone number 
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23 Melbourne Road
TEDDINGTON
Middx.
TW11 9QX
081-977-2386
February 1993
REF: EMG/SCI
Dear
Thank you for volunteering to help me with my research. I know
the enclosed package of questionnaires looks daunting but most
of the items are short and require little more than a tick. If
you can spare some time, I would be most grateful.
The first section begins by asking for background information
about you and your disability. This is followed by questions
which enquire about the effects of your injury on your social and
personal life.
If you find it difficult to concentrate for long periods of time,
please don't try and complete all the questionnaires in one go.
One of the reasons why I've used differently coloured paper for
the sections is that I thought it may help you, should you decide
to divide the work over several days. Needless to say, all your
answers will be strictly confidential.
I hope to obtain data on several illnesses and disabilities
because different problems will affect people in different ways.
If you have any queries, please do not hesitate to contact me.
If you wish to phone, I'm usually around from 2.00 to 8.00 pm.
Thank you for your time. I look forward to hearing from you,
Yours sincerely
Ellen M. Goudsmit
Enos. Questionnaires and SAE.
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PART I 
BACKGROUND OUESTIONNAIRE (M.E.) 
SOME OUESTIONS ABOUT YOU AND YOUR ILLNESS 
To help me with my research, I would be grateful if you could
answer the following questions.
Name 
Piddress 
Phone no.
Aga
Sax
Hark: Please tick which of the following best describes the work
you do:
Student '	Employed part-time
Housewife	 Employed full-time
Unemployed	 Retired
Unemployed - on sick leave
If you have a job, what is it? 	
If you are not currently employed, what, if any, was your
previous job?
Have you changed your job, or have you had to retire because of
your illness?
Education:
Did you complete (please tick)
Secondary education?
College/university?
Other professional training?
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How many years did you spend studying or training after the age
of 16? (Please circle your answer).
Years	 0	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12
Marital status (Please tick)
Single
Married
Living with a partner
Separated
Divorced
Widowed
If your marital status has changed since becoming ill, please
describe
Children (please state number, age and sex) 
	
Housing Are you: (Please tick)
Owner occupier?
Private tenant?
Council/housing association tenant?
Do you live alone? 	
Income
Does your entire income consist of social security benefits?
(Please tick)
Yes
No
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GENERAL INFORMATION
1. How long have you had M E  7 
2. Was the onset sudden or gradual, 	
3. If acute, did it start as a specific infection such as
glandular fever, hepatitis, flu? 	
4. When were you diagnosed? 	 19 ..
5. Who diagnosed you?
6. Which tests, if any, were used to diagnose you? (Please
tick)
Elisa 1gM Coxsackie
VP1 (Prof. Mowbray's test)
Muscle biopsy
Brain scan (if yes, please state which scanner was used)
Other laboratory tests (please specify) 	
7. If no laboratory tests were used, how were you diagnosed?
(e.g. clinical history, VEGA test etc.)
8. What are your main symptoms?
9. In the past 6 months, has the illness (please tick the most
appropriate answer)
Stayed the same?
Fluctuated, with relapses followed by remissions?
Generally/steadily deteriorated?
Improved?
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yes/no	 months ago
yes/no	 months ago
yes*/no	 months ago
10. Are you having any treatment/taking any drugs at present,
either for M.E. or for another condition?
Yes/No
If yes, please give details
11. Which, if any, treatments have you had for M.E. in the past? 
Please also indicate how many months ago any treatment ended.
Antibiotics
Antiviral drugs (eg acyclovir)
Antifungal drugs (eg nystatin)
Antidepressants
Sleeping pills/tranquillisers
Homeopathy
Acupuncture
Allergy treatment
Magnesium injections
Vitamin/mineral supplements
Psychotherapy/counselling
Dietary changes
Graded exercise/cognitive
therapy
Inpatient rehabilitation
programme (eg Findley, Weir)
Any other?
*If yes, please give details
	
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
yes/no	 	  months ago
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12. How much does your illness now affect your everyday life?
(please tick)
I can do hardly anything compared with before
I can do about a quarter of what I could do before
I can do about half of what I could do before
I can do about three-quarters of what I could do before
I can do most of what I could do before
13. Do you now have symptoms
all the time?
most of the time?
some of the time?
rarely?
14. Have you been told that your condition will improve?
Yes/No
15. Do you have any other medical problems, aside from M.E.?
If yes, please describe.
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SCI Group	 Questionnaire no.
PART I 
SOME QUESTIONS ABOUT YOU AND YOUR DISABILITY
To help me with my research, I would be grateful if you could
answer the following questions.
Aaa
Sex
Work: Which of the following best describes the work you do
\§1.ease
Student	 Employed part-time
Housewife
	
Employed full-time
Unemployed
	
Retired
Unemployed - on sick leave
If you have a job, what is it?
If you are not currently employed, what, if any, was your
previous job?
Have you changed your job, or have you had to retire because of
your disability?
Did you complete (please tick)
Secondary education?
College/university?
Other professional training?
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How many years did you spend studying or training after the age
of 16? (Please circle your answer).
Years	 0	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12
Marital status (Please tick)
Single
Married
Living with a partner
Separated
Divorced
Widowed
If your marital status has changed since you were injured, please
describe
Children (please state number, age and sex) 	
Housing Are you: (Please tick)
Owner occupier?
Private tenant?
Council/housing association tenant?
Do you live alone? 	
Income
Does your entire income consist of social security benefits?
(Please tick)
Yes
No
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GENERAL INFORMATION
1. How long have you been injured? 	
2. What caused the SCI7 	
3. Where exactly is the injury? 	
4. Is your lesion (please tick)
complete?
incomplete?
5. Do you mostly use (please tick)
a wheelchair?
crutches or other aids?
both?
6. Do you have injury-related symptoms such as pain, muscle
spasms, numbness, regular infections etc? If yes, please list
the main ones.
7. Do you have any other medical problems, not due to your
injury? If yes, please describe.
8. In the past 6 months, has your condition (please tick the
most appropriate answer)
Stayed the same?
Fluctuated?
Generally/steadily deteriorated?
Improved?
9. How much does your disability now affect your everyday life?
(please tick)
I can do hardly anything compared with before
I can do about a quarter of what I could do before
I can do about half of what I could do before
I can do about three-quarters of what I could do before
I can do most of what I could do before
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10. Apart from problems with mobility and movement, do you
experience symptoms (please tick)
all the time?
most of the time?
some of the time?
rarely?
11. Do you take any drugs to manage symptoms like pain, spasms
etc? (For instance Baclofen).
Yes
No
If yes, please give details 	
12. Have you been told that your condition could improve?
(Please tick)
Yes
No
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YOUR SYMPTOMS IN THE PAST WEEK
Below is a list of problems which may or may not apply to you. For
each problem, please say to what extent you have experienced this
during the PAST WEEK (including today). Do not think for too long
before answering but give your immediate reaction. Please be careful
not to miss out any of the items. Remember, we are talking about the
past week and not your condition in general. Give your answer by
circling any number from 0 to 6, to the right of the item, where
Feeling physically tired even when
taking things easy
Your limbs feeling heavy
Getting easily upset by things
Difficulty concentrating
Stomach pain
Not having the physical energy
to do anything
Difficulty standing for long
Losing your temper easily
Difficulty remembering things
Muscles feeling weak even after
resting
Feeling depressed
Muscles tender to the touch
Slowness of thought
Tremor or twitching
The slightest exercise making you
physically tired
Being irritable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0 = not at all
3 = moderately
6 = extremely
1
1
2	 3
1	 2	 3
1	 2	 3
1	 2	 3
1
1	 2	 3
1	 2	 3
1
1	 2
1	 2	 3
1	 2	 3
1	 2	 3	 4 5 6
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0 = not at all
3 = moderately
6 = extremely
Difficulty reasoning things out 0 1 2 3 4 5 6
Burning, tingling or crawling
sensations
0 1 2 3 4 5 6
Numbness in some part of your body 0 1 2 3 4 5 6
Back pain 0 1 2 3 4 5 6
Feeling anxious 0 1 2 3 4 5 6
A feeling of confusion ("mental fog") 0 1 2 3 4 5 6
Bouts of sweating (day or night) 0 1 2 3 4 5 6
Feeling physically drained 0 1 2 3 4 5 6
Dizziness or giddiness 0 1 2 3 4 5 6
Absent-mindedness 0 1 2 3 4 5 6
Worrying about things that do
not matter
0 1 2 3 4 5 6
Feeling physically tired even after
a good night's sleep
0 1 2 3 4 5 6
Difficulty understanding e.g. what
someone was saying to you
0 1 2 3 4 5 6
Feeling pessimistic about the future 0 1 2 3 4 5 6
Cold hands or feet 0 1 2 3 4 5 6
Having to stop doing something, that was
easy in itself, because it made you tired
0 1 2 3 4 5 6
Muscles feeling weak after slight
exercise
0 1 2 3 4 5 6
Difficulty following things e.g. a
simple plot on TV
0 1 2 3 4 5 6
Hot or cold spells 0 1 2 3 4 5 6
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0 = not at all
3 = moderately
6 = extremely
Feeling tense 0 1	 2	 3	 4 5 6
Feeling faint 0 1	 2	 3	 4 5 6
Difficulty finding the right word 0 1	 2	 3	 4 5 6
Feeling chilled or shivery 0 1	 2	 3	 4 5 6
Tearfulness 0 1	 2	 3	 4 5 6
Irregular or rapid heart beats 0 1	 2	 3	 4 5 6
Feeling worthless 0 1	 2	 3	 4 5 6
Forgetting what you were trying
to say
0 1	 2	 3	 4 5 6
Being easily angered when things
went wrong
0 1	 2	 3	 4 5 6
Feeling mentally tired even after a
good night's sleep
0 1	 2	 3	 4 5 6
Diarrhoea or constipation 0 1	 2	 3	 4 5 6
Feeling nervous 0 1	 2	 3	 4 5 6
Feeling sad 0 1	 2	 3	 4 5 6
The slightest effort making you
mentally tired
0 1	 2	 3	 4 5 6
Feeling like you had a temperature 0 1	 2	 3	 4 5 6
Other people annoying you 0 1	 2	 3	 4 5 6
A sore throat 0 1	 2	 3	 4 5 6
Feelings of resentment 0 1	 2	 3	 4 5 6
Being slow to react 0 1	 2	 3	 4 5 6
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0 	 1	 2 	 3 	 4 	 5 	
not at	 slightly	 definitely
all
7	 8
very severely
I cannot
do it
6	
markedly
PART II 
THE EFFECTS OF YOUR ILLNESS/DISABILITY
A.	 GENERAL FUNCTIONING
Please circle a number for the items on this page to indicate how
your illness/disability has affected different areas of your life.
1. WORK
Because of my illness/disability, my ability to work/go to school
is impaired:
	
0 	 1 	 2 	 3 	 4	 5 	 6 	 7 	 8
not at	 slightly	 definitely	 markedly very severely
	
all
	
I cannot work
2. HOME MANAGEMENT
(cleaning, tidying, shopping, cooking, looking after home or
children, paying bills)
Because of my illness/disability,
is impaired:
my ability to look after my home
3. SOCIAL LEISURE ACTIVITIES
(with other people, e.g. going to parties, pubs, clubs, outings,
visits, dating, home entertainments)
Because of my illness/disability, my social life is
0	 1	 2 	 3 	 4 	 5	 6 	
not at	 slightly	 definitely	 markedly
all
impaired:
7	 8
very severely
I never do
these
4. PRIVATE LEISURE ACTIVITIES
(done alone, e.g. reading, gardening, collecting, sewing)
Because of my illness/disability, my private leisure activities
have been affected:
	
0 	 1 	 2 	 3 	 4 	 5 	 6 	 7 	 8
not at
	
slightly	 definitely	 markedly very severely
	
all
	 I never do
these
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B.	 SPECIFIC PHYSICAL ACTIVITIES 
How, if at all, has your condition limited you in each of the
following activities?
(Please tick one box on each line)
Severely	 Somewhat	 Not
limited	 limited	 limited
at all
1. The kinds or amounts
of vigorous activities
you can do, like lifting
heavy objects, running
or participating in
strenuous sports 	 	 0	 0	 0
2. The kinds or amounts of
moderate activities you
can-do, like moving a
table, carrying groceries
or bowling 	 	 0	 0	 0
3. Walking uphill or climbing
a few flights of stairs. 0 0 0
4. Bending, lifting or
stooping 	 0 0 0
5. Walking to the end of the
street (without aids) .... 	 0	 0	 0
6. Eating, dressing, bathing,
or using the toilet 	 	 0	 0	 0
C.	 FELP WITH ACTIVITIES 
Which of the following activities are so difficult for you that in
most instances, you either enlist help from another person or you
use a specialised piece of equipment/aid to assist you? (please
tick).
Getting in/out of bed	 Cooking
Eating	 Getting dressed
Toileting	 Driving
Writing	 Working
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PART III 
THE PEOPLE IN YOUR LIFE
FRIENDS 
Here are some questions about your friends. (Please do not include
your relatives, or spouse/partner as friends when answering these
questions.)
1. How many close friends do you have, people you feel at ease
with and can talk to about personal matters?
Four or
[]None
	
[]One	 []Two	 []Three	 []more
2. How often are you in touch with the friend or friends to whom
you feel closest?
Less than	 Once or	 Several
once a	 twice a	 Once a	 times a
[]Never	 []month	 []month	 []week	 (]week
3. Did you lose friends as a result of your illness/disability?
[]None	 [] Some	 []Most
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4. Here are some more questions about your friends. Please indicate
how often these things happen with your friends.
	
Some-	 Fairly
Tow often:	 Never Seldom times	 Often	 Often
Can you count on
your friends to help
you when you need it? 	 H	 H	 H	 H	 H
Do your friends cheer
you up when you are sad
or worried?	 H	 H	 H	 H	 H
Do you confide in
any of your friends?
Do you share mutual
interests or activities
with your friends? 	 H	 H	 H	 H	 H
Do any of your friends
disagree with you about
important things?	 H	 H	 H	 H	 H
Are any of your
friends critical or
disapproving of you?	 H	 H	 H	 H	 H
Do your friends
really understand how
you feel about things? 	 []	 H	 H	 H	 H
Do any of your friends
get on your nerves?	 []	 [1	 H	 H	 H
Do any of your friends
get angry or lose their
temper with you?	 []	 []	 H	 H	 H
Do your friends
respect your opinion?	 H	 H	 H	 H	 H
Do any of your
friends expect too
much of you?	 [1
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Does he or she
get on your nerves?
Does he or she
get angry or lose their
temper with you?
[ ]	
El	 El	 [ 1	 [1
El
[]	 []	 [1	 []
[1	 []	 []	 []
[l	 [l	 1]	 [l
Does he or she
respect your opinion?
Does he or she
expect too much of you?
BPOUSE/PARTNER
5. The following questions concern your current relationship with
your spouse/partner. For each question, please indicate how often
these things happen with your spouse/partner.
If you do not have a spouse or partner, please move on to the next
section and mark this page with the letters NA.
	
Some-
	
Fairly
ROW often: 
	
Never Seldom times	 Often	 Often
Can you count on
him Of her to help
you when you need it?
	 H	 H	 M	 H
Does he or she cheer
you up when you are sad
or worried?
Do you confide in
him or her?
Do you share mutual
interests or activities
with him or her?
Does he or she
disagree with you about
important things?
[l	 []	 []	 []	 []
[ l 	 []	 E l	 I]	 E l
[ 1	 []	 El	 []	 El
1]
	
[l	 []	 [1	 [l
Is he or she critical
or disapproving of you? 	 t]	 []	 El	 []	 []
Does he or she
really understand how
you feel about things?	
t]	 [ l	 [1	 []	 []
- 3 7
RELATIVES 
Here are some questions about your close relatives, other than your
spouse/partner.
6. During the last month, how often did you get together with one
or more of your relatives (those that do not live with you)?
	
Less
	 Several
Not at	 than	 Once or	 Once a	 times a
[]all	 Honce	 []twice	 (]week	 (]week
7. How many relatives do you feel close to - that is, relatives
you feel at ease with and can talk to about personal matters?
Four or
[]None
	
[]One	 []Two	 []Three	 []more
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gow often: 
Can you count on any
of your relatives to help
you when you need it?
Do any of your relatives
cheer you up when you
are sad or worried?
Do you confide in
any of your relatives?
Do you share mutual
interests or activities
with any of your relatives?
Do any of your relatives
disagree with you about
important things?
Are any of your rela-
tives critical or
disapproving of you?
Do any of your relatives
really understand how
you feel about things?
Do any of your relatives
get on your nerves?
Do any of your relatives
get angry or lose their
temper with you?
Do any of your relatives
respect your opinion?
8. When you spend time with your relatives, including those living
with you, how often do these things happen?
	
Some-	 Fairly
	
Never Seldom times	 Often	 Often
H H M H H
H H H H
M [3 [l [3 [I
[] H [I [I H
[3 Cl Cl
f] I] (1 CI Cl
[1 [] [] [1 []
[] H M [I
[] [] [] [] []
[] [] [] [] []
Do any of your relatives
expect too much of you? 	 H	 H	 H	 H
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PART IV
YOUR MOODS
The following questions will give me an indication of how you have been
feeling recently. Please read each item and put a tick beside the
response which comes closest to how you have felt in the last few days.
Don't take too long over your replies; your immediate reaction will
probably be more accurate than a long thought out response.
I feel tense or 'wound up'
Most of the time
A lot of the time
From time to time, occasionally
-Not at all
I still enjoy the things I used to enjoy
Definitely as much
Not quite so much
Only a little
Hardly at all
I get a sort of frightened feeling as if
something awful is about to happen
Very definitely and quite badly
Yes, but not too badly
A little, but it doesn't worry me
Not at all
I can laugh and see the funny side of things
As much as I always could
Not quite so much now
Definitely not so much now
Not at all
Worrying thoughts go through my mind
A great deal of the time
A lot of the time
From time to time but not too often
Only occasionally
I feel cheerful
Not at all
Not often
Sometimes
Most of the time
I can sit at ease and feel relaxed
Definitely
Usually
Not often
Not at all
I feel as if I am slowed down
Nearly all the time
Very often
Sometimes
Not at all
I get a sort of frightened feeling like
'butterflies' in the stomach
Not at all
Occasionally
Quite often
Very often
I have lost interest in my appearance
Definitely
I don't take so much care as I should
I may not take quite as much care
[take just as much care as ever
I feel restless as if I have to be on the move
Very much indeed
Quite a lot
Not very much
Not at all
I look forward with enjoyment to things
As much as ever I did
Rather less than I used to
Definitely less than I used to
Hardly at all
I get sudden feelings of panic
Very often indeed
Quite often
Not very often
Not at all
I can enjoy a good book or radio or TV
programme
Often
Sometimes
Not often
Very seldom
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THE UNCERTAINTY ASSOCIATED WITH ILLNESS AND DISABILITY
Instructions: Please read each statement, taking your time. Then place
a tick under the description that most closely matches how
you are feeling TODAY. For instance, if you agree with
the statement, tick under "Strongly agree" or "Agree". If
you disagree with a statement, then tick under either
"Strongly disagree" or "Disagree". If you are undecided
about how you feel, then tick under "Undecided".
This questionnaire was devised to cover a range of condi-
tions. Please respond to every statement, relating it as
best you can to your own condition.
Where a question refers to treatment or medical advice and
you are no longer being treated for your condition, please
take your last consultations as an example. If you cannot
recall these, just mark that statement with the letters
NA (not applicable).
1. I don't know what's wrong with me.
Strongly agree Agree Undecided Disagree Strongly Disagree
2. I have a lot of questions without answers.
Strongly agree Agree Undecided Disagree Strongly Disagree
3. I am unsure if my condition is getting better or worse.
Strongly agree Agree Undecided Disagree Strongly Disagree
4. It is unclear how bad my main symptoms might be.
Strongly agree Agree Undecided Disagree Strongly Disagree
5. The explanations they give about my condition seem hazy to me.
Strongly agree Agree Undecided Disagree Strongly Disagree
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6. The purpose of each treatment/piece of advice is clear to me.
Strongly agree Agree Undecided Disagree Strongly Disagree
7. My symptoms continue to change unpredictably.
Strongly agree Agree Undecided Disagree Strongly Disagree
8. I understand everything explained to me.
Strongly agree Agree Undecided Disagree Strongly Disagree
9. The doctors say things to me that could have many meanings.
Strongly agree Agree Undecided Disagree Strongly Disagree
10. My treatment/the advice I'm given is too complex to figure out.
Strongly agree Agree Undecided Disagree Strongly Disagree
11.It is difficult to know if the treatment/advice I am getting is
helping.
Strongly agree Agree Undecided Disagree Strongly Disagree
12.Because of the unpredictability of my condition, I cannot plan for
the future.
Strongly agree Agree Undecided Disagree Strongly Disagree
13. My symptoms keep changing. I have good and bad days.
Strongly agree Agree Undecided Disagree Strongly Disagree
14.I have been given many different opinions about what is wrong with
me.
Strongly agree Agree Undecided Disagree Strongly Disagree
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15. It is not clear what is going to happen to me.
Strongly agree Agree Undecided Disagree Strongly Disagree
16. The results of my tests are inconsistent.
Strongly agree Agree Undecided Disagree Strongly Disagree
17. The effectiveness of the treatment/advice is undetermined.
Strongly agree Agree Undecided Disagree Strongly Disagree
18. Because of the treatment/advice, what I can do and cannot do keeps
changing.
Strongly agree Agree Undecided Disagree Strongly Disagree
19. I'm certain they will not find anything else wrong with me.
Strongly agree Agree Undecided Disagree Strongly Disagree
20. The treatment/advice I am receiving has a known probability of
success.
Strongly agree Agree Undecided Disagree Strongly Disagree
21. They have not given me a specific diagnosis.
Strongly agree Agree Undecided Disagree Strongly Disagree
22. The seriousness of my condition has been determined.
Strongly agree Agree Undecided Disagree Strongly Disagree
23. The doctors and nurses use everyday language so I can understand
what they are saying.
Strongly agree Agree Undecided Disagree Strongly Disagree
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24.I can predict how long my condition will last.
Strongly agree Agree Undecided Disagree Strongly Disagree
25.I usually know if I am going to have a good or bad day.
Strongly agree Agree Undecided Disagree Strongly Disagree
26.I can generally predict the course of my condition.
Strongly agree Agree Undecided Disagree Strongly Disagree
27.My physical distress is predictable; I know when it is going to
get better or worse.
Strongly agree Agree Undecided Disagree Strongly Disagree
Many thanks for your time and energy.
Most of these questions have asked about problems which might have
arisen as a result of your condition. If there are any difficulties
that you have experienced but which have not been mentioned, you might
like to indicate these briefly in the space below. I would also be
interested to learn of any positive aspects of your illness or disabi-
lity.
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STUDY 3 
Letter asking for volunteers (Patient Information Sheet).
Consent Form.
Time 1 
Letter sent with questionnaires.
Part I.	 Background questionnaire (sent with PFRS).
Part II. General assessment (course of illness, level of
activity, frequency of symptoms).
Also sent: Functional Iwpairment Scale.
Part III. Illness Management Questionnaire (IMQ).
Self-Efficacy Scale.
Part IV. Mishel Uncertainty in Illness Scale Form C (MUIS-
C). Also sent: HAD.
Time 2 
Letter sent with questionnaires (wording for treatment group
was similar except when referring to date of next consul-
tation).
Follow-up questionnaire (new treatments, level of activity,
frequency of symptoms, reasons for improvement and support
from medical profession). Also sent: PFRS, Functional Im-
pairment Scale, IMQ, Self-Efficacy Scale, HAD, MUIS-C.
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Tel: 0463 704000 Fax: 0463 711322
Raigmore Hospital NHS Trust
Perth Road
Inverness IV2 3UJ aigmore
ospital
NHS TRUST
Microbiology Department ext 4206/7
Patient Information Sheet
Dear
You have been referred by your doctor to the Post Viral Fatigue
Syndrome clinic in the Microbiology Department at Raigmore
Hospital. As you may know, Dr Ho-Yen is involved in several
aspects of research into Post Viral Fatigue Syndrome, mainly in
the management and the laboratory investigations that may be
useful in diagnosing such patients. At the moment, he is
involved in a study with Ms Ellen Goudsmit, a postgraduate
student at Brunel University into how patients cope with their
illness.
Dr Ho-Yen and Ms Goudsmit would be very grateful for your help
in this study. The study is composed of several questionnaires
for you to answer at various times. Please find enclosed the
questionnaires. We recognise that this will take some time and
we are very grateful for your cooperation. You may find it
easier not to attempt to do all of the questionnaires at the same
time. However, we would be very grateful if you would make the
effort to complete the questionnaires over the next week. Please
return the questionnaire in the enclosed envelope. Over the next
year, you will be given a further two sets of questionnaires so
that we can establish the progress that you have made.
You are under no obligation to take part in this study, and you
are completely free to withdraw at any time you wish and this
will not affect your continuing medical management in any way.
Needless to say, all you answers will be strictly confidential.
Dr Ho-Yen will telephone you over the next few days so the he can
answer any questions that you may have.
Your cooperation is greatly valued.
With best wishes,
Yours sincerely,
ELLEN GOUDSMIT	 DR DARREL HO-YEN
"Partnership in Care"
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CONSENT FORM
CONSENT BY PATIENT/VOLUNTEER TO PARTICIPATE IN 
	
Name of Patient/Volunteer : 	
Name of Study : 	
Principal Investigator . 	
I have read the patient/volunteer information sheet on the above
study and have had the opportunity to discuss the details with
	
 and ask questions.	 The doctor has
explained to me the nature and purpose of the tests to be
undertaken. I understand to my satisfaction what is proposed to
be done and that I am Under no obligation to take part in this
study.
I have agreed to take part in the study as it has been outlined
to me, but I understand that I am completely free to withdraw
from the study at any time I wish and that this will not affect
my continuing medical treatment in any way.
I understand that these trials are part of a research project
designed to promote medical knowledge, which has been approved
by the Ethics Committee, and may be of no benefit to me
personally.
I also understand that where appropriate my General Practitioner
will be informed that I have taken part in this study.
I readily and freely consent to participate in the study which
has been satisfactorily explained to me.
Signature of Patient/Volunteer • 	
Date •
I confirm that I have explained to the patient/volunteer named
above, the nature and purpose of the tests to be undertaken.
Signature of Investigator : 	
Date .
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23 Melbourne Road
TEDDINGTON
Middx.
TW11 9QX
081-977-2386
February 1994
REF: EMG/HY.
Dear Sir/Madam,
Thank you for volunteering to help Dr. Ho-Yen and myself with our
research. I know the enclosed package of questionnaires looks
daunting but most of the items are short and require little more
than a tick. If you can spare some time and complete these
questionnaires within the next week or so, we would be most
grateful_
The first section begins by asking for background information
about you and your illness. This is followed by some questions
about the ways your condition has affected your daily life and
the extent to which you can control your symptoms. Finally,
there are some questions which will tell us how you have tried
to cope with your illness so far, if the advice and explanations
you have been given are clear, and whether the symptoms are
predictable or not.
We know that you may find it difficult to concentrate for long
periods of time. We therefore suggest that you do not try and
complete all the questionnaires in one go but that you complete
one or two, then take a break. If you still have energy left,
fill in another one, otherwise leave it for a day or two. After
you've finished, please check that you've filled in every page.
All your answers will be strictly confidential.
We are aware that some of the questions appear similar to others.
However, please bear with us! It's important that you respond
to every item on each of the questionnaires; otherwise we will
not be able to analyse the results.
If you have any queries, please do not hesitate to contact me.
If you wish to phone, I'm usually around from 2.00 to 8.00 pm.
Thank you for your time. I look forward to hearing from you,
Yours faithfully,
Eden M. Goudsmit
Encs. Questionnaires and SAE.
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Questionnaire No.
PART I 
BACKGROUND OUESTIONNAIRE
SOME QUESTIONS ABOUT YOU AND YOUR ILLNESS
A..a.e
aeic
Work: Please tick which of the following best describes the work
you do:
Student	 Employed part-time
Housewife	 Employed full-time
Unemployed	 Retired
Unemployed - on sick leave
If you have a job, what is it?
If you are not currently employed, what, if any, was your
previous job?
Have you changed your job, reduced your hours or have you had to
retire because of your illness? (Please tick)
Yes
No
Education:
Did you complete (please tick)
Secondary education? 	 yes	 no
College/university?	 yes	 no
	
Other professional training? yes
	 no
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How many years,
the age of 16?
if any, did you spend studying or training from
(Please circle your answer)
Years	 0	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12
Marital status (please tick)
Single
Married
Living with a partner
Separated or divorced
Widowed
Has your marital status changed as a result of your illness?
(Please tick)
Yes
No
Children (please state number and age)
Rousing Are you: (please tick)
Owner occupier?
Private tenant?
Council/housing association tenant?
Do you live alone? 	
Income
Does your entire income consist of social security benefits?
(Please tick)
Yes
No
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GENERAL INFORMATION
1. How long have you been ill?
2. Was the onset sudden or gradual? 	
3. If sudden, did it follow a specific infection such as
glandular fever, hepatitis, flu? 	
4. What are your main symptoms?
5. Have you already been given a diagnosis? (Please tick)
Yes
No
6. If yes, what is the diagnosis? 	
7. When were you diagnosed? 	 month ....	 year ....
If you have not yet received a diagnosis, please tick ...
8. Who made the diagnosis? 	
If not applicable, please tick ...
9. Have any laboratory tests been used to diagnose your illness?
Yes
No
10. Have you read Dr. Ho-Yen's book 'Better Recovery from Viral
Illness'?
Yes
No
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11. If yes, have you been following his advice concerning rest,
exercise, and avoiding stress etc? (Please tick the most
appropriate answer)
Not yet
Sometimes
Most of the time
All the time
12. Are you a member of a self-help/support group for people
with PVFS/M.E.?
Yes
No
13. Are you having any treatment/taking any drugs at present?
Yes
No
If yes, please give details 
	
14. Which, if any, treatments have you had for your illness in
the past? Please also indicate how many months ago any treatment
ended.
Antibiotics
	 yes/no	 	
 months ago
	
Antiviral drugs (eg acyclovir) yes/no
	
	
 months ago
	
Antifungal drugs (eg nystatin) yes/no
	 	
 months ago
Antidepressants
	 yes/no	
	  months ago
	
Sleeping pills/tranquillisers yes/no
	
	  months ago
Homeopathy	 yes/no	
	  months ago
Allergy treatment
	 yes/no	
	
 months ago
Vitamin/mineral supplements
	 yes/no	
	
 months ago
Dietary changes
	 yes/no	
	
 months ago
Psychotherapy/counselling 	 yes/no	
	  months ago
Graded exercise/cognitive
therapy
	 yes/no	
	
 months ago
Any other?
	 yes*/no
	
	  months ago
*If yes, please give details
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15. Have you been told that your present condition will improve?
(Please tick)
Yes
No
16. Do you have any other medical problems, aside from your
present illness?
Yes
No
If yes, please describe.
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TART II 
GENERAL ASSESSMENT
1. In the past 6 months, has the illness (please tick the most
appropriate answer)
improved a lot?
improved a little?
stayed the same?
worsened a little?
worsened a lot?
2. Do you now have symptoms
rarely?
some of the time?
most of the time?
all the time?
3. How much does your illness now affect your everyday life?
I can do most of what I could do before
I can do about three-quarters of what I could do before
I can do about half of what I could do before
I can do about a quarter of what I could do before
I can do hardly anything compared with before
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4 = quite often1 = never
2 = almost never
 5 = very often
3 = sometimes	 6 = always
I make myself carry on, despite
how I feel
I try to do the things I did
before my illness
I avoid emotionally stressful
situations
I plan my activities carefully, to
take account of my limitations
I deliberately break "the rules"
to give my spirits a lift
I tell myself I can overcome
the fatigue
I tell myself I don't feel too bad
You have to realise you are helpless
in the face of this illness
I organise my life to avoid
overdoing things
I push myself to stay active.
I tell myself I can't let my symptoms
stand in the way of what I want to do
PART III
DEALING WITH YOUR ILLNESS
Listed below are a number of ways in which people may deal with
their illness. These include things that they feel and tell
themselves, and things that they do or avoid doing. Think of your
own experience of being ill, and say to what extent you respond to
your illness in the way described by each of the statements below.
There are no right or wrong answers: say what is TRUE FOR YOU. Your
feelings and the things you do may vary from time to time. In your
answers, describe your overall response to your illness DURING THE
PAST MONTH.
For each statement, circle a number where
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2
3 4 5 6
1 2 3 4 5 6
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I try not to think about my illness
I think a great deal about my symptoms
I try to strike a balance between
resting and being active
You have to realise that your life
is ruled by the illness
I try not to pay attention to
my symptoms
I find out as much as I can
about this illness
From my own
I know 'what
You have to
normal life
My symptoms
of my mind
experience, I feel
is best for me to do
give up trying to lead a
are always at the back
I manage my time so that I don't
have to do too much in one day
I do something regardless of how
it affects my symptoms
I look for new information about
this illness
I try to pretend my symptoms aren't
there
I try to make my life stress-free
I push myself until I can do no more.
I plan my day so that there are times
when I am active and times when I can
rest
I control my negative feelings
1 = never 4 = quite often
2 = almost never 5 = very often
3 = sometimes 6 = always
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
/ 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
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1 = never	 4
2 = almost never	 5
3 = sometimes	 6
I look up medical information
Even if I feel ill, I just keep going
I try to ignore my symptoms
My illness is the most significant
thing in my life
I am constantly aware of how I
am feeling
Even though unwell, I just go on
as if I was feeling OK
I do something I want to do, even
though I know I will feel worse
after
I make sure that I don't overdo things
I follow the advice of others
I select an approach to my illness
and persevere with that
I pay close attention to how well
or badly I am feeling
I read books and articles about
my illness
I spend a lot of time thinking
about my illness
I try to control how much stress
there is in my life
I try to keep some energy
"in reserve" in case I need it
I take a chance and do something,
even though I may feel worse later
I try anything I hear of that might
help me to get better
!
= quite often
= very often
= always
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
1 2 3 4 5 6
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very
uncertain
moderately
uncertain
very
certain
very
uncertain
moderately
uncertain
very
certain
very
uncertain
moderately
uncertain
very
certain
CONTROLLING THE ILLNESS 
In the following questions, we'd like to know how you feel about your
ability to control your illness. For each of the following
questions, please circle the number which corresponds to the
certainty that you can now manage your symptoms and perform the
following activities or tasks.
1. How certain are you that you can control your fatigue?
10	 20	 30	 40	 50	 60	 70	 80	 90	 100
very	 moderately	 very
uncertain	 uncertain	 certain
2. How certain are you that you can regulate your activity, so as
to be active without aggravating your symptoms?
10	 20	 30	 40	 50	 60	 70	 80	 90	 100
3. How certain are you that you can do something to help yourself
feel better if you are feeling down?
10	 20	 30	 40	 50	 60	 70	 80	 90	 100
very	 moderately	 very
uncertain	 uncertain	 certain
4. As compared with other people with PVFS, how certain are you that
you can manage the fatigue during your daily activities?
10	 20	 30	 40	 50	 60	 70	 80	 90	 100
5. How certain are you that you can manage all your main symptoms
so that you can do the things you enjoy doing?
10	 20	 30	 40	 50	 60	 70	 80	 90	 100
6. How certain are you that you can deal with the frustration of
your illness?
10	 20	 30	 40	 50	 60	 70	 80	 90	 100
very	 moderately	 very
uncertain	 uncertain	 certain
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PART IV
THE UNCERTAINTY ASSOCIATED WITH ILLNESS AND DISABILITY
Instructions: Please read each statement, taking your time. Then place
a tick under the description that most closely matches how
you are feeling TODAY. For instance, if you agree with
the statement, tick under "Strongly agree" or "Agree". If
you disagree with a statement, then tick under either
"Strongly disagree" or "Disagree". If you are undecided
about how you feel, then tick under "Undecided".
This questionnaire was devised to cover a range of condi-
tions. Please respond to every statement, relating it as
best you can to your own illness.
If you have not yet received any treatment or medical
advice for your illness, just mark statements relating to
treatment with the letters NA (not applicable).
1. I don't know what is wrong with me.
Strongly agree Agree Undecided Disagree Strongly Disagree
2. I have a lot of questions without answers.
Strongly agree Agree Undecided Disagree Strongly Disagree
3. I am unsure if my illness is getting better or worse.
Strongly agree Agree Undecided Disagree Strongly Disagree
4. It is unclear how bad my main symptoms will be.
Strongly agree Agree Undecided Disagree Strongly Disagree
5. The explanations they give about my condition seem hazy to me.
Strongly agree Agree Undecided Disagree Strongly Disagree
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6. The purpose of each treatment/piece of advice is clear to me.
Strongly agree Agree Undecided Disagree Strongly Disagree
7. My symptoms continue to change unpredictably.
Strongly agree Agree Undecided Disagree Strongly Disagree
8. I understand everything explained to me.
Strongly agree Agree Undecided Disagree Strongly Disagree
9. The doctors say things to me that could have many meanings.
Strongly agree Agree Undecided Disagree Strongly Disagree
10.My treatment/the advice I'm given is too complex to figure out.
Strongly agree Agree Undecided Disagree Strongly Disagree
11.It is difficult to know if the treatment/advice I am getting is
helping.
Strongly agree Agree Undecided Disagree Strongly Disagree
12.Because of the unpredictability of my illness, I cannot plan for
the future.
Strongly agree Agree Undecided Disagree Strongly Disagree
13.The course of my illness keeps changing. I have good and bad days.
Strongly agree Agree Undecided Disagree Strongly Disagree
14.I have been given many different opinions about what is wrong with
me.
Strongly agree Agree Undecided Disagree Strongly Disagree
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15. It is not clear what is going to happen to me.
Strongly agree Agree Undecided Disagree Strongly Disagree
16.The results of my tests are inconsistent.
Strongly agree Agree Undecided Disagree Strongly Disagree
17.The effectiveness of the treatment/advice is undetermined.
Strongly agree Agree Undecided Disagree Strongly Disagree
18.Because of the treatment/advice, what I can do and cannot do keeps
changing.
. Strongly agree Agree Undecided Disagree Strongly Disagree
19. I'm certain they will not find anything else wrong with me.
Strongly agree Agree Undecided Disagree Strongly Disagree
20.The treatment/advice I am receiving has a known probability of
success.
Strongly agree Agree Undecided Disagree Strongly Disagree
21.They have not given me a specific diagnosis.
Strongly agree Agree Undecided Disagree Strongly Disagree
22.The seriousness of my illness has been determined.
Strongly agree Agree Undecided Disagree Strongly Disagree
23.The doctors and nurses use everyday language so I can understand
what they are saying.
Strongly agree Agree Undecided Disagree Strongly Disagree
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Many thanks for your time and energy.
If you have any comments to make on any of the questionnaires, or if you
would like to add information which you think might be relevant, please
do so here.
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Raigmore Hospital NHS Trust
Perth Road
Inverness 1V2 3UJ
Tel: 01463 704000 Fax: 01463 711322
Ay. .al:more
ospital
NHS TRUST
Microbiology Department ext 4206/7
DHY\LW\Q2
Dear
You agreed to take part in the research project on how patients
cope with their illness. It is hoped that the results of this
study will enable us to determine how to best manage patients.
You were sent a questionnaire when you joined the waiting list.
You are about to have your first appointment and it is very
helpful for us to look at how you have progressed over the
period.
Please find enclosed a second questionnaire which we would like
you to fill up. Please send the questionnaire back to Dr Ho-Yen,
Microbiology Department, Raigmore Hospital. If there are any
problems, please do not hesitate to contact me.
Yours sincerely,
LORNA WYCHERLEY
Secretary to Dr Ho-Yen
"Partnership in Care"
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No:
FOLLOW-UP OUESTIONNAIRE
PART I 
In the last five to six months, have you felt (please tick the most
appropriate answer)
much better?
better?
the same?
worse than before?
much worse than before?
In the last 5 or 6 months, have you begun any of the following
treatments or remedies? (Please tick appropriate answer)
Yes	 No
supplements
anti-candida or allergy diet
reflexology
acupuncture
homeopathy
antidepressants (please name)
sleeping pills (please name)
tranquillisers (please name)
antifungal medication
antibiotics
other (please describe)
If you have tried any of the above, please indicate if you found it
(them) helpful.
Treatment	 helpful	 not helpful
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1. Do you now have symptoms
rarely?
some of the time?
most of the time?
all the time?
2. How much does your illness now affect your everyday life?
I can do most of what I could do before
I can do about three-quarters of what I could do before
I can do about half of what I could do before
I can do about a quarter of what I could do before
I can do hardly anything compared with before
3. If you have improved in the last five or six months, what do you
feel are the most important reasons for this?
4. Excluding Dr. Ho-Yen, how would you rate the medical care and
support you received for this illness from your doctor(s)? (Please
circle the number which most closely corresponds with your assessment).
1 	
	
2 	 3 	 4 	 5
Very poor	 Poor	 Adequate	 Good	 Very good
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APPENDIX II 
Results from Study 2 
Results from the 'CFS-plus' group
Demographic information and details of illness-related
variables
CFS(ME) group
SCI group
Relationships between variables
CFS(ME) group
SCI group
Results of the 'CFS-plus' group 
These CFS patients were generally similar to the main group
in terms of age, gender, education and other demographic
variables. However, as far as their illness was concerned,
there were a number of differences. For instance, all
except one of the patients in this group reported having a
gradual onset and a greater proportion felt that their
condition was deteriorating. They were also more severely
impaired in terms of physical functioning and they had very
high scores for fatigue and cognitive difficulty.
Meanwhile, the findings of the social support measures
revealed that they had less contact and received fewer
'resources from relatives than the main group. They also
reported a greater number of interpersonal stressors both
from friends and relatives. However, they had similar scores
for contact with and support from friends.
The 'CFS-plus' group had very high anxiety and depression
scores. Indeed, all the patients scored above the cut-off
point suggesting possible clinical anxiety or depression,
and all but one scored above the cut-off point for probable
clinical anxiety or depression.
At the time of the assessment, three of the 'CFS-plus' group
were on anti-depressants, and one had been prescribed tran-
quillisers.
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Table 1. Demographic information for the I CFS-plus' group
Variable
Age
Median (SD)
Range
Gender
35	 (10.3)
19-50
No. t
Men 1 14
Women 6 86
Marital status No. t
Single 5 71
Married 2 29
Marital status changed
during illness 2 Zg
Education completed No. t
Secondary school 4 57
College/University 1 14
Professional training 1 14
Did not complete 1 14
Mean years (SD) spent in edu-
cation from the age of 16 2.1 (2.2)
Range 0-5
Employment status No.
Housewife 1 14
Unemployed 1 14
On sick leave 4 57
Parttime work 0
Fulltime work 0
Retired 1 14
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Table 1 cont.
No. t
Classification of work
Professional 1 14
Managerial 1 14
Manual skilled 2 29
Manual unskilled 2 29
Have never worked 1 14
Changed job or reduced hours
due to disability 6 86
Housing
Owner-occupier 1 14
Council tenant/housing
Association 6 86
Living alone 4 57
Income
Dependent on
social security benefits 3 43
11-4
\
No.Variable
Table 2. Details of illness-related variables for 'CFS-
plus' group
Onset
Sudden 1 14
Gradual 6 86
Known infectious trigger
Yes 3 43
No 4 57
Tests used in diagnosis of illness
IgM Coxsackie 0
VP1 1 14
Muscle biopsy 0
Brain scan 1 14
Other laboratory tests 2 29
More than two of the above 2 29
Clinical history only 1 14
Course of condition
Fluctuating 1 14
Deteriorating 5 71
Improving 0
Unknown 1 14
Current use of drugs
Yes 6 86
No 1 14
Presence of other medical
conditions
Yes 7 100
No 0
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Table 3. Means (SD) relating to independent variables
for the 'CFS-plus' group
Variable	 Mean	 SD
Symptoms
Fatigue	 5.10	 1.21	 7
Emotional distress	 3.93	 1.91	 7
Cognitive difficulty 	 4.91	 .95	 7
Somatic symptoms	 3.39	 1.45	 7
Interpersonal resources and stressors
Friends resources	 13.43	 5.16	 7
Spouse resources	 15.67	 7.37	 3
Relatives resources	 9.33	 4.27	 6
Friends stressors	 10.14	 4.98	 7
Spouse stressors	 9.33	 3.06	 3
Relatives stressors	 13.50	 3.67	 6
Friends contact	 7.14	 1.68	 7
Relatives contact	 4.00	 1.53	 7
Friends loss	 2.00	 .58	 7
MVIS scores
Uncertainty	 78.86	 11.89	 7
Unpredictability	 18.57	 3.69	 7
Illness-related variables
Duration	 14.00	 11.14	 6
Years diagnosed	 4.00	 2.38	 7
Number of symptoms 	 5.14	 1.35	 7
MOS Physical functioning	 8.50	 2.07	 6
Help required	 2.14	 2.73	 7
RAD
Anxiety
	
14.57	 4.65	 7
Depression	 13.43	 3.51	 7
Depression corrected	 10.71	 3.64	 7
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Table 3 cont. 
Variable	 Mean	 SD	 N
Functional impairment
Total	 29.29
	 2.36	 7
11-7
O.
I
tal
0
0
P
tn
Ow,
V
V)
..-- H CO N
,
cn
0
N
i
ow
•
N N 01.0
rx4 ll) V) 0 n13 N 0
U Cv.) H Z H di Z
03
i
H
H
40.,
rn
N	 00	 0 03 di CO	 N
••n••	 OW CO N	 010 di II
	H0
1.r)
i	 .
4I) tO	 0 0 LI)	 0 0 N H N
	 rf)
M N	 Z N	 Z 1-I H
1-1 W in r---	 cv
`cli	 •;11
11 N in II 	H
N N
0
44
0
-I-I
C.)
TS
a)
o
9-1 $4
.0
fai
ni)4
0
-14
rt)
tn Aen--...
0 Cl) 0) 0	 iC)
E
a) 4.) rC) 4-) 	4)
A 0 RS a) 0)-r1	 03
(W 0 4.) H -ri
w
H
.2
-ri
-r4
rd
a)
Z
t n
0
fel
1:4 $4
q)
10
a)
0 5(1)0
Z 3
ta
I'l
RS
44
•1
tn
0
9-I
co
$4
S-1
a)
Z
.2 	
P
al
.0	 C4
0 W
ti	 co
P q) 0 $4
0 b) q) ,....q)
Kg 0 e4
fai
0
N
.
er)
0 N VI N c0 ......• •41 N N W ,41 V
I-I
tr)
olP M N ri
CO M
do r-(	 r-1 T-I N
W H
H •	 I
C) 0 re) W m 01 No 0 H M	 rf) di H W
C/2 Z Csi Z
00$.4
Cr)
rn
C') H rn ce) ...... vio N1' al 0 W
IT)
X
op ci) m m
u) N Go H H
H H H
O HCl) • •	 1 •
rxi 0 v CO 01 H M 0 0 03 0 Tr ,-I kr) alC.) Z Ln H 1-1 Z H v-1
>4
r-I	 •1-1
ow
Ol
0
-1-1
0
(j	 a)
-4 4)
0
9-1
4-1
0
W
Pi
CO
1-1
4-I
0
a)
b)
it
TS c) i-I 4..) a) i--) .0
a) .0 a) H u) 4.) .54w4•4
4-30.1 c)al >-.A H alrd	 5 5
to
z
>	 /4	 1-4
as	 0	 0
r-1 0 0 0 CO 0 •L.) 10	 W	 3	 3
c14 ___0 0 c.) $4 P RI WW	 .-1
0 as a)
-H
ul .1-1
rti
a)
44 4.)
0)
4-1	 >4	 W	 W
J.)	 9-1	 0	 ..	 5	 5
() ili
0
0")
W
CO
W
0
0
>4 0
OW 4-1
0	 3	 1-1	 0	 -H	 -r1
a)	 a)	 c).,	 -.-1	 .i.)	 4..)
0
0
0
C.) 1-1.-I 4-10 rd 0RI " IA	 0)1.)	 0 (1.9
13	 ow	(19	 u2	 4..)	 r-I
P H
" , 1 (1) 0 S-1 -H W(
	
ni p 4.)	 0	 0	 0	 rd	 0
4-1
ra
ci) C.) tai A X	 c)	 1:4 P..,0 u)	 M	 0	 o	 fai	 rii
O 1-4
z 001:1
NI 6115
0
t-I
CO	 l.0 CO l.0	 0 N V	 co11 
OP	 N	 H	 H	 N M	 l33
0	 N	 vil N N11 0 Lil CO r-1 0 r4	 C`•
Z	 H
C*••
	M	 Cs•	 LI 	 N
t-I	 N N
•
0	 a	 CONLDVN
v-I	 .44
rc;	 rn
a)	 P
ri	 0
ri	 0
-14	
.0
e—I .S4	 a)
..	 (a	 Ca	 0	 rii	 rt:i	 >-,
$4	 u	 r0 "H	 a)	 a) 1-)
o	 -1-1	 .	 a) 8-1	 .S4	 0 -1-1A 0 '0 ..-1 0
0 CD r-I 04
	
$.4
	
0	 0 r44:i -r4Cl)
	 44 ri
	 C.) -ri r-I -r-I "••n 	 a) .0
0 0c
	 ri) 4-) ,-1 ,s4 u)
	
P fa4.3	 0 1-1 4.3 (11 9-1 CO 0	 S4	 CO
CIS	 0 0 rd --.. 1-1 M 0 0 .0 cl)	 P -,-3
4..)	 0 -r-I -14 S4 4.) Ca 0 S-I 0 >
	
0 rO
ta 4:,	 9-3 Ea 14 w Ca	 0 -r-1 a)
W	 .1.3 CO W 13 -I-I H r-I 44	 0	 .0 044	 n:S (1) t7) 0 0 (ES rt3
	 P	 0 4.)
P -ri	 C.) 44 It CLI 9-I 0 0
	 • (1) (1)	 -rn
(1.) 4.)	
-1-1005500X.0>
	
a/
gi 1:411)	
1‘.1	 l-1 rd 0 rcl ni RS .__: u rd
94 Cli ZUK4EZMOM	 rO 0(1) 'I0
rn	 tr)
r-i	 ot)	 0
RI	 rtS	 ni
al	 ri0	 40
10	 N	 CO	 Tr	 N
do 	CO	 H	 N	 L11
0	 0	 cf)	 NO	 W	 rn
Z N	 H
04
0
0
$4
01
— 01 al a) H rn 0 01
H
H
i
H
H
ril de L11 N H N
X
U)
Cr4 0 Izte Lil cr) NN W N
0 Z 01 H H
CO
li
C.71 -1-1
0 4-1
• -1 W
CO CO 0
0 4-) W
0 0 A
•0
..,
W$.4 >1
$4 4-) 4-) (1.3 4..)
W
-1-1
0
ni
0(zi Cli a) •-10	 $4
04 0 0 0 .0 0 0 00 W(1) 0 4.) 0 0
0
C.)
4..) 4.) 9-1
.0
-1-1 H
al
4-)	 Q)
0	 co
0 al H ni a)
I 4_) 9-1 9-1 tn E b1 'CI	 H
I-1 cd 00 0 0 0	 ca
a)
a)	 > 0
0
0
ul >
9-1
>
W	 -r-I
fai	 C.)
H (71
g	 faiPri
o Ea 9-I -IA 0)0
jg
-ri
$.4
0
•ri
taZ
C.) f:4 1-1 0 CD
0
t)
(21	 ca
(II .0
e.
0H
Table 2. Details about the illness of the CFS(ME) group
Variable	 No. %
Tests used to diagnose illness
IgM Coxsackie 0
VP1 2 3
Muscle biopsy 0
Brain scan 2 3
Other laboratory tests 12 21
More than two of the above 12 21
None/unknown 3 5
Clinical history only 27 47
Current use of drugs
Yes 38 66
No 20 34
Level of activity
compared with pest (n.57)
Can do little 10 18
Can do a quarter 24 41
Can do a half 13 23
Can do three-quarters 9 16
Can do most 1 2
Frequency of symptoms (n.57)
All the time 21 37
Most of the time 31 54
Some of the time 5 9
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Table 2b. Details about the disability of the SCI group
No.
Lesion (n=21)
Complete 13 61.9%
Incomplete 8 38.1%
Cause
Road traffic accident 12 52%
Other accident 8 35%
Illness 3 13%
Use of mobility aids
Wheelchair 18 72%
Crutches 3 12%
Both 3 12%
None 1 4%
Current use of drugs
Yes 15 60%
No 10 40%
Level of activity compared with pest
Can do little 8 32
Can do a quarter 4 16
Can do a half 3 12
Can do three-quarters 5 20
Can do most 1 4
Can not assess 1 4
Frequency of symptoms (n=24)
All the time 1 4
Most of the time 6 25
Some of the time 9 38
Rarely 7 29
Never 5 4
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Relationships between varialQ1e2
CFS(ME) group
The relationships between the four PFRS subscales were
assessed using Pearson's r. As shown in Table 3, all the
correlation co-efficients were significant, the strongest
relationship being between fatigue and cognitive diffi-
culty. Given the strong relationship and the theoretical
overlap between the emotional distress subscale and the HAD,
it was decided not to include the former in the main
analysis.
Table 3. Intercorrelations (Pearson's r) among PFRS
subscales for the CFS(ME) group
Fatigue Emotional
distress
Cognitive
difficulty
Somatic
symptoms
Fatigue
Emotional
distress
Cognitive
difficulty
Somatic
symptoms
1.00** •43**
1.00**
.74**
.46**
1.00**
.60**
.55**
.49**
1.00**
** 1)5..001
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Table 4. Correlations (Pearson's r) between main vari-
ables and HAD subscales for the CFS(ME) group
Anxiety	 Depression Depression
corrected
Age -.23 .11 .11
Education -.05 -.14 -.13
Physical functioning .12 -.01 .03
Help required -.09 .05 .03
Functional impairment -.10 .26 .20
Duration -.10 .11 .08
Years diagnosed -.02 .02 .04
No. of Symptoms .15 .09 .10
Level of activity .09 -.15 -.11
Frequency of symptoms .08 .04 .06
Uncertainty .54** .35* .41*
Unpredictability .15 .19 .22
Friends resources -.18 -.27 -.33
Spouse resources -.11 -.14 -,16
Relatives resources -.12 -.29 -.31
Friends stress .15 .19 .19
Spouse stress .37 .36 .42*
Relatives stress .33 .29 .28
Contact with friends -.33 -.34* -.37*
Contact with relatives .02 .02 .04
Loss of friends .22 .24 .25
Anxiety 1.00** .40* .46**
Depression .40* 1.00** .98**
Depression corrected .46** .98** 1.00**
* p<.ol ** p..001
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Table 5. Correlations (Spearman's Rho) between main vari-
ables and PFRS subscales for the CFS(ME) group
Fatigue Cognitive
difficulty
Somatic
symptoms
Age -.02 .04 -.00
Education -.16 -.05 -.14
Physical
functioning -.44** -.22 -.24
Help required .02 .14 .12
Duration .29 .28 .21
Years diagnosed .17 .13 .09
Number of
symptoms .19 .27 .07
Level of
activity -.44** -.35* -.13
Frequency
of symptoms -.36* -.26 -.19
* p<.01	 ** p<.001
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Table 7. Correlations (Spearman's Rho) between main vari-
ables and interpersonal stressors for the CFS(ME) group
Friends
stress
Relative
stress
Spouse
stress
Loss of
friends
Age -.08 -.37* .16 -.27
Education .12 .09 .03 .20
Help required .14 -.03 .07 .14
No. symptoms .03 -.09 -.23 .13
Level of.
activity .02 -.01 .18 -.38*
Frequency of
symptoms -.03 -.19 .24 -.27
Fatigue -.12 .04 -.18 .17
Cognitive
difficulty .10 .06 -.19 .15
Somatic
symptoms .07 .09 .13 .05
Friends resources -.26 -.08 -.32 -.19
Spouse resources -.12 -.25 -.44* -.04
Relatives resources -.33 -.36* -.14 -.16
Friends stress 1.00* .48** .43* .36*
Spouse stress .44* .34 1.00** .09
Relatives stress •47* 1.00** .34 .37*
Contact friends -.12 -.10 -.14 -.37*
Contact relatives -.10 -.02 .17 -.13
Loss of friends .36* .37* .09 1.00**
* p .01 ** p.001
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Appendix IIB
Relationships between variables: SCI group
Table 3b. Intercorrelations (Pearson's r) among PFRS
subscales for SCI group
Fatigue Emotional
distress
Cognitive
difficulties
Somatic
symptoms
Fatigue
Emotional
distress
Cognitive
difficulty
Somatic
symptoms
1.00** .66**
1.00**
.60*
.71**
1.00**
.62**
.46
.45
1.00**
** p<.001
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Table 4b. Correlations (Pearson's r) between the main
variables, HAD subscales and functional impair-
ment for the SCI group
Anxiety
	 Depression Depression Functional
corrected	 impairment
Age -.11 -.10 -.14 .03
Education -.44 -.33 -.33 -.28
Physical functioning .04 -.25 -.17 -.77**
Help	 required .00 .24 .19 .64**
Functional impairment .30 .49 .43 1.00**
Duration -.04 -.39 -.46 .15
Lesion .09 -.11 -.09 -.58*
Number of symptoms .16 .31 .25 .50
Level of activity -.01 -.62* -.48 -.70**
Frequency of symptoms -.07 -.29 -.22 -.67**
Fatigue .36 .58* .43 .43
Cognitive difficulty •55* .51* •53* .35
Somatic symptoms .40 .31 .20 .61*
Uncertainty .17 .25 .29 .22
Unpredictability .09 .13 .14 .06
Friends resources -.31 -.35 -.42 -.29
Spouse resources -.62 -.25 -.27 -.08
Relatives resources -.25 -.15 -.14 -.02
Friends stress -.12 -.40 -.36 -.32
Spouse stress .24 .01 -.07 -.18
Relatives stress -.05 -.42 -.40 -.19
Contact with friends -.34 -.28 -.22 -.18
Contact relatives -.17 .06 -.10 -.01
Loss of friends -.03 -.22 -.17 .52*
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Table 4b cont. 
Anxiety Depression Depression Functional
corrected impairment
Anxiety	 1.00**	 .46	 .43	 .30
Depression	 .46	 1.00**	 .96**	 •49
Depression corrected	 .43	 .96** 1.00**	 •43
* p.01 ** p.001
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Table 5b. Correlations (Spearman's Rho) between demo-
graphics, disease-related variables, uncertainty
and PFRS subscales for the SCI group
Fatigue Cognitive
difficulty
Somatic
symptoms
Age -.01 -.17 .29
Education -.03 -.43 -.15
Physical functioning .34 -.31 -.58*
Help required .20 .41 •53*
Duration .09 -.16 .45
Lesion -.29 -.24 -.26
No. symptoms .62** .41 .74**
Level of activity -.22 -.18 -.47
Frequency of
symptoms -.40 -.11 -.65**
Uncertainty .75** .51 .64*
Unpredictability .14 .04 .04
* p .01. ** p.5..001
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Table 6b. Correlations (Spearman's Rho) between main
variables and interpersonal resources for the SCI
group
Friends	 Relatives	 Spouse
resources	 resources resources
Contact	 Contact
with	 with
friends relatives
Age -.07 -.14 -.25 .17 -.40
Education .24 .04 -.18 .05 .05
Help required .14 .32 .19 .10 .33
No. of symptoms .24 .37 .17 .29 .17
Level of
activity .06 -.11 -.23 .13 -.28
Frequency of
symptoms .16 -.11 -.31 .27 .04
Friends resources 1.00** .67** .34 .42 .56*
Spouse resources .34 .59 1.00** .15 .34
Relatives res. .67** 1.00** .59 .44 .55*
Relatives stress .26 .01 -.15 .29 -.22
Friends stress -.02 -.05 -.14 .19 -.05
Spouse stress -.07 -.15 -.42 .01 -.19
Contact friends .42 .44 .15 1.00** .22
Contact relatives .56* .55* .34 .22 1.00**
Loss of friends -.25 .04 .32 -.16 .02
* p..01 ** p .001
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Table 7b. Correlations (Spearman's Rho) between main
variables and interpersonal stressors for the
SCI group
Friends
stress
Relatives
stress
Spouse
stress
Loss of
friends
Age .32 .20 .65* -.01
Education .32 .26 .42 -.24
Help required -.27 -.19 -.26 .48
No. of symptoms .06 .09 -.19 .12
Level of activity .37 .38 .31 -.27
Frequency of
symptoms .09 -.09 .23 -.38
Uncertainty .21 .22 -.18 .02
Unpredictability -.07 .14 .10 .06
Friends resources -.02 .31 -.20 -.28
Spouse resources -.14 -.10 -.56 .32
Relatives resources -.05 .02 -.22 .04
Relatives stress .27 1.00** -.04 .11
Friends stress 1.00** .28 .02 .02
Spouse stress .03 -.04 1.00** -.33
Contact friends .19 .29 .01 -.16
Contact relatives -.05 -.22 -.19 .02
Loss of friends .03 .11 -.33 1.00**
p .01. ** p .001
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